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More people are living with, through and beyond cancer which makes cancer survivorship 
an increasingly important area of public health focus. Cancer survivors manage cancer and 
treatment-related health impacts and life complexity during and post-treatment. These 
cancer-related impacts, whether visible or invisible, can cause intermittent yet considerable 
problems. Cancer survivorship research explores ways to improve care and management 
for people living with, through or beyond cancer.  
Evidence-based intervention is a fruitful area for cancer survivorship research. Intervention 
can inform survivorship care pathways. Chronic care approaches have not been adequately 
explored as a basis for survivorship intervention. Using Te Whare Tapa Wha and Wagner’s 
Chronic Care Model as theoretical frameworks, the application of supported self-
management programs in cancer care is explored herein. This thesis reports on survivorship 
experiences and a pilot study of a supported self-management intervention program for 
cancer survivors in New Zealand (NZ). 
Background: The objectives of this thesis are to report on NZ cancer survivors’ experiences 
and explore the acceptability, feasibility and pilot delivery of a supported self-management 
program. Supported self-management intervention programs aim to empower and support 
people living with chronic conditions to navigate social, physical, emotional and spiritual 
impacts associated with chronic disease management. The supported self-management 
intervention program chosen for trial, The Flinders Program, is tailored based on self-
assessment surveys and guided interviews/sessions. It results in development of a care plan 
and, ideally, improved wellbeing. To date, supported self-management programs have not 
been trialled in NZ as a component of cancer care survivorship pathways that emphasise 
wellbeing. 
Methods: The purpose of this study was to explore NZ survivors, as well as health and 
supportive care workers’, experiences of cancer treatment impacts and care gaps. A 
supported self-management intervention program was delivered in a NZ hospital setting to 
see if it could acceptably and feasibly address cancer survivor impacts and unmet needs. A 
Medical Research Council (UK) framework guided the two-phase study design. The pilot 
was limited to patients diagnosed with colorectal cancer because these cancers are 
common in NZ and intervention with colorectal cancer survivors is comparatively under-
researched. The first phase of the study qualitatively explored the lived experiences of 
survivors and the views on survivorship held by a selection of health and supportive care 
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workers. The data showed unmet survivor needs, existing self-management strategies 
employed, and possible acceptability of The Flinders Program. The second phase of the 
study piloted The Flinders Program with cancer patients over three sessions coinciding with 
standard appointments during treatment. Phase two aimed to test the feasibility of 
procedures for recruitment, randomisation, intervention delivery and outcome evaluation in 
outpatient cancer clinics. The intervention was delivered using a two-arm pre- post-
assessment design to inform intervention acceptability and feasibility. Process evaluation 
explored enablers/ barriers of intervention delivery while distress, resilience, self-efficacy 
and quality of life patient-reported outcomes were assessed. 
Results: The MRC Framework on complex interventions provided a strong structure for 
conducting planned and stepped intervention research. The phase one qualitative study 
findings were that both Māori and non-Māori cancer survivors experienced social, physical, 
emotional and spiritual impacts through cancer treatment that affected their ability to self-
manage effectively during active treatment and in the post-cancer treatment transition and 
extended survival period. Survivor impacts were managed through survivorship work. Phase 
one data indicated cautious acceptability of The Flinders Program. Phase two data showed 
that the supported self-management intervention program is questionably feasible, but had 
the potential to contribute to improved self-management competence if issues related to 
enablers and barriers at the individual (i.e. self-management readiness) and environmental 
levels (i.e. staff resourcing) could be addressed.  
Discussion: A Chronic Care Model-based supported self-management intervention, The 
Flinders Program, can be delivered in cancer care settings to address survivorship impacts. 
However, there are important differences between the setting of chronic conditions and the 
cancer clinical setting as identified by survivors’ shared experiences. The Flinders Program 
was deemed acceptable to both Māori and non-Māori survivors as well as health and 
supportive care workers participating in the pilot study but there were feasibility challenges 
associated with delivering the program in hospital-based cancer treatment settings. The 
Flinders Program did impact on patient-reported outcome measures but in no clear 
significant pattern or consistent manner. Further intervention research into supported self-
management programs or other types of survivorship care is needed to progress 
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The following Māori terms are used in this thesis. The English definitions are sourced from 
Moorfield's (2005) online Te Aka Māori-English, English-Māori Dictionary. 
Aotearoa North Island - now used as the Māori name for New 
Zealand 
Aroha affection, sympathy, charity, compassion, love, empathy 
Hauora be fit, well, healthy, vigorous, in good spirits 
Hinengaro mind, thought, intellect, consciousness, awareness 
Iwi extended kinship group, tribe, nation, people, nationality, 
race - often refers to a large group of people descended 
from a common ancestor and associated with a territory 
Kaupapa topic, policy, matter for discussion, plan, purpose, 
scheme, proposal, agenda, subject, programme, theme, 
issue, initiative 
Kaupapa Māori Māori approach, Māori topic, Māori customary practice, 
Māori institution, Māori agenda, Māori principles, Māori 
ideology - a philosophical doctrine, incorporating the 
knowledge, skills, attitudes and values of Māori society 
Koha gift, present, offering, donation, contribution 
Mana prestige, authority, control, power, influence, status, 
spiritual power, charisma - mana is a supernatural force 
in a person, place or object. Mana goes hand in hand 
with tapu, one affecting the other. The more prestigious 
the event, person or object, the more it is surrounded 
by tapu and mana.  
Manaaki show respect 
Māori Māori, indigenous New Zealander, indigenous person of 
Aotearoa/New Zealand  
Pākehā English, foreign, European, exotic - introduced from or 
originating in a foreign country 
Pono truth, non-fiction, validity 
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Tangata whenua local people, hosts, indigenous people - people born of 
the whenua, i.e. of the placenta and of the land where 
the people's ancestors have lived 
Tangata tiriti The people of the Treaty of Waitangi, non-indigenous 
New Zealanders 
Tinana body, trunk (of a tree), the main part of anything. 
Tapa to call, name, recite 
Tapu be sacred, prohibited, restricted, set apart, forbidden, 
under atua protection  
Tautoko support 
Tika truth, correctness, directness, justice, fairness, 
righteousness, right 
Tikanga correct procedure, custom, habit, lore, method, manner, 
rule, way, code, meaning, plan, practice, convention, 
protocol - the customary system of values and practices  
Waiora health, soundness 
Wairua spirit, soul 
Whā be four, 4 
Whakama to lose mana, to be ashamed, shy, bashful, embarrassed 
Whakamana to give authority to, give effect to, give prestige to, 
confirm, enable, authorise, legitimise, empower, validate 
Whakawhānaungatanga process of establishing relationships, relating well to 
others 
Whakapapa genealogy, genealogical table, lineage, descent 
Whānau extended family, family group, a familiar term of address 
to a number of people. In the modern context the term is 
sometimes used to include friends who may not have 
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Whare house, building, residence, dwelling, shed, hut, 
habitation, suit 
Wheke octopus, squid - a general term, particularly for 
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Glossary of terms 
The following terms are used to identify categories of people described in this thesis.  
Cancer survivor Someone living with, through or beyond cancer. 
The definition of the following terms comes from the He Anga Whakaahuru: Supportive 
Care Framework (Central Cancer Network 2016) document. 
Health and supportive care workers Term used to apply to anyone working the health 
system and non-government organisations 
(NGOs) as well as those working in social care 
agencies who may have contact with a person 
who is affected by cancer. 
Person affected by cancer Term used to refer to both the person with cancer 
and those for whom the cancer has an impact. 
Whānau Māori term used to refer to both descent-based 
whānau and whānau who come together for a 
common purpose. Metge (1995) defines the two 
kinds of whānau as whakapapa-based whānau 
and kaupapa-based whānau. This acknowledges 
that for people, their whānau can be both their 
family of descent as well as those people they 
define as important who make up their support 
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CHAPTER 1: Introduction 
 
Cancer survivors share the unlucky experience of being diagnosed with cancer. Cancer 
incidence is rising due to an ageing population; however, so is survival. Attributed most 
commonly to earlier detection and better treatment options, cancer no longer tops the list 
of acute self-limiting diseases. Overall, the numbers of people living with, through or 
beyond cancer are increasing. Hence, there are increasing numbers of cancer survivors in 
the general population. 
Cancer survival comes at a cost. Cancer survivors report intermittent, yet often lingering, 
impacts related to the cancer itself and various treatments. These ongoing problems can 
affect wellbeing. These problems, as reported by cancer survivors, include fatigue, sleep 
difficulty, fear of recurrence, anxiety, depression, negative body image, sensory 
neuropathy, gastrointestinal problems, urinary incontinence, and sexual dysfunction 
(Denlinger and Barsevick 2009). Care pathways that deliver evidence-based intervention 
for cancer survivors can promote wellbeing and help support survivors to address the 
problems they experience living with, through and beyond cancer. 
There is a huge diversity and complexity in survivors’ experiences and care needs 
globally. My interest in this topic was triggered by the results which emerged from the 2009 
NZ national cancer patient experience survey (O’Brien et al. 2010). Unmet survivorship 
needs were identified; particularly apparent were the ongoing everyday life impacts 
described in response to the two open-ended questions on respondent experiences. Three 
reports (Cancer Control Council of New Zealand 2009; Cancer Control New Zealand 2010; 
Cancer Control Council of New Zealand 2010) and two journal articles (O’Brien et al. 2010; 
Britton et al. 2010) were written from the data. 
The unmet needs and perceived gaps in cancer care reported in the NZ literature indicate 
the need for further research to address survivorship care (Cormack et al. 2005; Dew, 
Signal et al. 2015; Egan et al. 2014; Doherty 2006; Ministry of Health and University of 
Otago 2010; Sarfati, Koczwara, and Jackson 2016; Walker et al. 2008). In the early stages 
of this research, my aim was to raise awareness of the experiences of survivorship as well 
as contribute to quality improvement in NZ cancer care delivery.  
As my research planning progressed, I gained more clarity on the role of cancer 
survivorship and the need for further research to address care pathways that lie within and 
beyond the acute stage of diagnosis and treatment. Overseas research affirms that 
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survivors can face life-long health risks and challenges as a result of their cancer and its 
treatments (Oeffinger et al. 2014; Hewitt, Greenfield, and Stoval 2006; National Institute for 
Clinical Excellence 2004). These include physical and psychological functioning limitations 
that affect everyday life and feelings of wellbeing. The USA, UK, Canada and Australia 
have undertaken demonstration projects to inform care pathway redesign to address 
health risks and challenges faced by survivors (Halpern et al. 2014; Jefford et al. 2013; 
Jefford et al. 2015; National Cancer Survivorship Initiative 2010). A clearer study direction 
for me, based in the survivorship space, emerged out of my review of the literature. The 
literature review identified a gap in NZ-based survivorship demonstration projects. Further, 
no international survivorship demonstration projects have yet been seamlessly integrated 
into redesigned care pathways overseas. Therefore, this project can add to the rapidly 
evolving practice and knowledge base for improved survivorship care.  
I am a non-NZ born, non-indigenous researcher who has adopted NZ for my family’s 
home. This study applied my leanings toward self-determination based on my upbringing 
as an adoptee in an immigrant family living in the USA. My brother had special needs and 
my main caregiver managed severe allergies. We spent a lot of time in medical clinics. 
This experience impressed upon me the need for support that integrated people’s social 
reality with clinical advice and care delivery. 
I hope to contribute to practical research that could benefit New Zealanders. In NZ, 
colorectal cancer is one of the most prevalent cancers. However, colorectal cancer 
survivor cohorts are under-represented in NZ research. More research is needed to 
identify and evaluate interventions that can assist individuals and whānau living with, 
through and beyond colorectal cancer in NZ to collaboratively manage treatment and 
ongoing survivorship needs.  
An important point that needed consideration was my ability to conduct robust research as 
an ‘insider’ in cancer care. I have worked in cancer clinics and as a senior analyst for 
Cancer Control NZ. I currently manage supportive care services at the Cancer Society of 
NZ. Therefore, I am not a detached and neutral objective outsider in this field. This poses 
risks to research validity and can introduce bias (Crotty 1998). On the other hand, an 
insider brings advantages to research in that networks are established, terminology and 
technical understanding already has a base, and rapport based on familiarity with some 
shared experiences can be more readily achieved (Rooney 2005).  
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Considering my insider status and non-resident status, it was important that I practice 
reflexivity to conduct this research with critical awareness of the filters, shaped by my own 
experiences, culture and history, through which I made sense of the collected data. 
Reflexivity can help mitigate potential bias or threats to validity (Brannick and Coghlan 
2007). A colleague recommended a checklist as a basis for reflexive practice which 
included paying attention to personal motivations, choices about participants, emotional 
status, surprising findings, presenting findings neutrally and exploring why emphasis was 
being placed in some areas if there were signs of bias (Robson 2002; Robson 2011).  
I attempted to practice in a neutral and culturally safe manner to minimise any real or 
perceived power imbalances between researcher and research participants in this study. 
The research process was designed to be empowering and incorporate principles of 
indigenous research practice including prioritisation of Māori and commitment to 
transformative practices that can address inequities (Health Research Council of New 
Zealand 2010; National Ethics Advisory Committee 2012). To achieve this, I received 
invaluable advice from Māori study advisors. 
There is not likely to be a ‘one-size fits all’ survivorship care pathway waiting to be 
discovered, considering the diversity of people in NZ. This pilot study explored one 
interventional approach that integrated consideration of environmental factors and drivers. 
Previous studies have shown that single, short-term, supportive care or survivorship 
interventions are typically unable to sustain long-term improvements in clinical or patient-
reported outcomes for survivors. Over the last few years I have sought a simple answer: 
the single, predefined intervention that can work. My critique of the literature highlighted 
that prescribed, decontextualized, one-off interventions do not seem to align with human 
behaviour and often fail. Multi-faceted interventions that allow tailored approaches based 
on assessment of person-led priorities and recognition of complexity are gaining 
acceptance across public health interest areas. Tailored interventions seem to be one way 
to avoid oversimplification and associated intervention failure. 
Supported self-management intervention can be delivered as a tailored program1, using a 
combination of strategies and tools. Research into this interventional approach can add to 
the knowledge and practice base for delivery of person-centred, integrated and 
                                               
1The spelling of the word programmes is often shown as ‘programs’ throughout this thesis because the 
trademarked intervention delivered, The Flinders Program, uses that spelling and the use of a consistent 
spelling of that word throughout the thesis aims to reduce complexity and avoid confusion for the reader. 
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collaborative survivorship care. The supported self-management intervention program 
piloted and described in this thesis incorporates various other interventions, tools and 
strategies tailored to survivors’ and families’ complexities and identified values, priorities 
and goals. The umbrella term ‘supported self-management program’ is most commonly 
associated with tailored approaches that integrate various tools and techniques. This 
thesis describes development of evidence for an outpatient clinic-based supported self-
management intervention program with, and for, Māori and non-Māori people affected by 
colorectal cancer in NZ. It explores the acceptability, feasibility, utility, and appropriate 




The research questions guide the research which explores NZ survivors’ cancer 
experiences and delivery of a supported self-management intervention program in 
hospital-based cancer clinic settings. 
1. What are cancer impacts and how are they experienced by survivors in NZ? 
2. What other factors contributed to life and health complexity, and coping for NZ 
cancer survivors? 
3. Can a supported self-management intervention help address cancer and complexity 
impacts for survivors? 
4. Is a supported self-management program acceptable in outpatient cancer care 
settings? 
5. Can a supported self-management intervention program be feasibly integrated into 




Two studies were conducted to address the research questions. The aim of the phase one 
study was to qualitatively explore survivors’ and clinicians’ experiences and views. The 
aim of the second study was to pilot the acceptability and feasibility of a supported self-




The specific phase one objectives were to: 
• Qualitatively explore, with survivors and health professionals, cancer treatment 
impacts, life and health complexity, as well as management strategies utilised by 
NZ cancer survivors during and post-treatment; and, 
• Use an intervention vignette to gauge the perceived acceptability of The Flinders 
Program, a supported self-management program, in the NZ hospital-based cancer 
clinical setting. 
The specific phase two objectives were to: 
• Test study design aspects of recruitment, randomisation, intervention delivery and 
assessment by linking in with clinical flow in cancer care clinics; 
• Provide insights into supported self-management program content as well as 
enablers and barriers to intervention delivery in the context of cancer survivorship; 
• Explore and compare outcome measures of self-efficacy; and, measures of global 




Methodology and theoretical orientation, which flow from philosophy, have led to the 
choice of specific research methods to address the objectives of this research. Aspects of 
philosophy explored included epistemology or the nature of knowledge, ontology or the 
nature of being, and axiology or the assignation of value. In consideration of my views on 
what is knowledge, what is reality and what is of value, my chosen approach was 
pragmatic. 
Pragmatism is identified with research into ‘what works, under what circumstances’ 
(Mertens et al. 2010) and explores practical consequences (Creswell and Plano Clark 
2010). It is practical and fits with a critical realist worldview that considers an objective 
‘truth’ or reality but recognises that there are different perspectives on truth and that 
experienced ‘reality’ is a type of subjective truth (Mertens et al. 2010). Pragmatism bridges 
the duality between objective and subjective realities.   
Mixed methods is a data collection technique that complements pragmatism. It combines 
quantitative and qualitative methods. Just as designing a research study is both art and 
 
 6 
science, the lines between methods of inquiry are not always mutually exclusive (Patton, 
2002,12).  In this study, both qualitative and quantitative methods were applied and the 




This introductory chapter provides a brief context for this thesis.  
Chapter 2: Background is a foundational chapter presented in three parts. In part one, 
the NZ experience of cancer and the various stages and challenges associated with 
cancer treatment are described, with emphasis on colorectal cancer. Part two explores 
cancer impacts and the experience of cancer as a chronic condition. An overview of The 
Chronic Care Model (Wagner et al. 1996) is provided as the framework to guide the choice 
of intervention. Part three provides an overview of healthcare intervention, and introduces 
a guiding intervention framework (Medical Research Council 2009), and specific 
considerations indicated for intervention delivery in NZ. 
Chapter 3: Literature Review explores the evidence-base for supported self-
management. It presents information on the historical delivery of supported self-
management programs. A synthesis of the international evidence for this interventional 
approach in cancer care is then provided. A critical appraisal of NZ and overseas evidence 
on supported self-management is presented. The Flinders Program was chosen as the 
supported self-management intervention to be studied based on the evidence.  
Chapter 4: Phase one presents the rationale, methods, results and discussion of the 
qualitative modelling phase of the study framework. Focus groups were held with 
survivors. Key informant interviews were conducted with a selection of health and 
supportive care workers. Data from focus groups and interviews are synthesised and 
presented. The discussion section reviews considerations for progression to phase two of 
the study framework.  
Chapter 5: Phase two presents the rationale, methods and results of the quantitative 
exploratory pilot study. The Flinders Program was administered to people completing 
active treatment for colorectal cancer in the hospital-based cancer treatment setting in NZ. 
Recruitment, data collection and intervention delivery processes are reviewed in this 
chapter. The results and analyses are described. 
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Chapter 6: Discussion summarises the research and integrates the findings to address 
the five research questions.  Enablers and barriers to the intervention are discussed. 
Strengths and limitations of the framework are presented. Clinical and research 
implications for survivorship care and The Flinders Program intervention are identified. 
Recommendations to progress survivorship research are made. 
 
Consultation and approvals 
 
Both phases of the research studies were submitted concurrently for approval to specific 
advisory groups and ethics committees. In 2012, formal Māori consultation took place with 
Ngai Tahu and the Capital & Coast Research Advisory Group – Māori. Study approval was 
granted. In addition, the studies received approval from the Central Health & Disability 
Ethics Committee that same year (12/CEN/12).  Locality assessment and approvals were 
also provided by Capital & Coast District Health Board. Approval was also obtained from 
the developers of The Flinders Program who are based at Flinders University in Adelaide, 
Australia. 
A list of presentations delivered at international conferences based on the research 
described in this thesis can be found in the final appendix (Appendix 0). Also included is a 
reprint of an April 2016 survivorship overview article published in CanNet, a journal of the 
NZ Nurses Organisation. That article initiated discussions that has led to a national 
survivorship framework project currently underway in NZ. It is a joint project between the 
Cancer Society, the regional cancer networks and the Cancer Nurses College. The 
inaugural workshop was held on 2 November 2016. The information presented in this 
thesis is proving invaluable to progressing that project.   
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CHAPTER 2: Background 
 
Cancer impacts on one in three New Zealanders (Ministry of Health 2016; Cancer Society 
of New Zealand 2016). It is the leading cause of morbidity and mortality in NZ (Ministry of 
Health 2015a; Tobias and Turley 2012). Interventions to address the life and health 
impacts of cancer on patients and survivors is the context for this thesis. This chapter 
presents background information on contemporary cancer care, cancer impacts and 
delivery of interventions.   
Research into the high burden of cancer in NZ and the associated ethnic inequity have 
signalled the need for ongoing research and quality improvement in cancer care delivery 
(Ministry of Health and University of Otago 2010; Robson et al. 2005; Robson et al. 2010). 
The steadily increasing numbers of NZ cancer survivors (Soeberg et al. 2012) points to the 
need for more NZ-based research to address inequities and support survivors with 
managing the intermittent, yet often lingering, impacts of cancer.2 
This background chapter is in three parts. Part one provides an overview of cancer in NZ 
with a focus on colorectal cancer. Part two explores survivors experiences and impacts of 
cancer as well as the role of The Chronic Care Model (Wagner et al. 1996). An overview of 
interventions is presented in part three with specific considerations identified for cancer 
survivorship. These three parts establish the foundation for this thesis on NZ cancer 
survivor experiences and the acceptability, feasibility and pilot delivery of a supported self-
management intervention program as a component of survivorship care pathways. Overall, 
the key message of this chapter is that awareness of the ‘work’ of cancer survivorship and 
delivery of effective interventions as part of redesigned care pathways is multifaceted. 
Research into interventions cognisant of individual and environmental factors is needed. 
 
  
                                               
2 The studies described in this thesis focus on interventions for survivors of adult-onset cancers while 
recognising that childhood cancer survivors are also an important part of the cancer survivor community. 
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Part one: Cancer survival and cancer care trends 
 
Cancer is a leading cause of sickness and death nationally in NZ (Ministry of Health 
2015a). There were 21,050 cases of new cancers reported to the NZ Cancer Registry in 
2011 (Ministry of Health 2015a). The most prevalent registered cancers in that year were 
breast, prostate and colorectal cancers (Ministry of Health 2015a). Attributed to an ageing 
population and increasing population, numbers of cancer diagnoses are on the rise in NZ, 
particularly among those 65 years of age and older (Tobias and Turley 2012; Ferlay et al. 
2015). The ongoing impacts and burden of cancer on health and wellbeing are substantial 
for cancer survivors (Parkin et al. 2001; Ministry of Health and University of Otago 2010).  
Colorectal cancers comprise the disease reference context for this work because these 
cancers are common in NZ (Ministry of Health 2015a; World Health Organization 2008) 
and there is an unequal burden on mortality by ethnicity (Robson et al. 2010). Further, 
research with colorectal cancer cohorts is underfunded considering relative disease 
burden (Carter and Nguyen 2012) and more research is needed to support cancer 
survivorship. Therefore, the focus for these studies is on addressing common impacts and 
complexities associated with colorectal cancer as well as intervention to help address 
these problems. 
 




Cancer survival is increasing in many Westernised countries due to earlier detection and 
more effective treatment options. Prior to the 1980’s, the cancer trajectory was mostly 
linear and finite extending from symptoms, diagnosis, treatment, limited remission, 
recurrence and death (Aziz 2007). Research progress over the last half century has 
contributed to improvements that include earlier diagnoses and better treatment options 
(Levit et al. 2013). These improvements have resulted in long-term remission or cure for 
many of those diagnosed with cancer (Hewitt, Greenfield, and Stoval 2006). Data available 
from cancer management registries illustrate this trend. Figure 1 shows cancer survival 
trends in the USA (National Cancer Institute 2016) and Figure 2 shows these trends for the 




Figure 1: USA cancer survivor numbers and projections 1973 – 2024 
Source: De Moor et al. 2013, 563 
 
Figure 2: All cancers age-standardised one-year net survival, England and Wales, 1971-2011  
Source: Cancer Research UK 2014, http://www.cancerresearchuk.org/ 
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Rising numbers of cancer survivors in NZ are reflective of similar epidemiologic cancer 
trends as highlighted for the USA and the UK. Cancer Research UK states cancer survival 
has doubled in the last 40 years and that 50% of people diagnosed with cancer will now 
live, on average, ten or more years (Cancer Research UK 2014). In NZ, the 2012 Cancer 
Trends report was based on data from linked census and cancer data sets analysed for 
the years 1991 through 2004. Although survival rates were noted to vary by cancer site, 
ethnicity and socioeconomic group, the report documented an overall increased survival 
from cancer and a 3% annual improvement in cancer survival across 21 different cancers 
(Soeberg et al. 2012). Data showed that the overall cancer death rate in NZ fell by 32 
percent (Soeberg et al. 2012). This declining cancer death rate is shown in Figure 3 which 
illustrates numbers of attributable cancer deaths for the years 2002 to 2012 (Ministry of 
Health 2015a). Figure 3 shows the number of deaths from cancer increasing during the 
decade, related to a growing population and an ageing demographic, but an overall 
decline in the cancer death rate (Ministry of Health 2015a). The correlate of a declining 
death rate is rising cancer survival.  
 
Figure 3: Number of deaths and corresponding cancer survival rate over a 10-year time 




More recent NZ Ministry of Health data points out a rise in numbers of cancer survivors 
(Ministry of Health 2015b). Data from a 2015 report showed five-year cumulative relative 
survival increased from 0.58 to 0.62 between 1998 and 2007. Data also showed 78% of 
New Zealanders diagnosed with cancer in 2010-11 survived over one-year relative to 
background mortality (Ministry of Health 2015b). 
Cancer survivors are currently estimated to represent 32.5 million people globally 
(Koczwara 2015) and between three and four percent of the populations of the UK, 
Australia, NZ and the USA (Aye, Elwood, and Stevanovic 2014; Ministry of Health 2015b; 
Soeberg et al. 2012; Australian Institute of Health and Welfare 2012; Macmillan Cancer 
Support 2011; American Cancer Society 2015). The one-year, five-year and 10-year 
cancer survival rates in each of these countries has been projected to continue to rise over 
the coming years (Cancer Research UK 2014; National Cancer Institute 2016; Ministry of 
Health 2010a). 
 
Inequities in cancer care and outcomes 
 
A second global epidemiologic trend of importance is the persistence of disparities by age, 
income, ethnicity, geography and cancer site (Aziz 2007). It is clear that cancer is 
inequitably distributed between socioeconomic groups, ethnic groups, males and females 
and people living in different geographical areas of NZ (Minister of Health 2003b). 
Reducing inequities is a key principle that has consistently been noted in NZ government 
health strategies since 2000 (Minister of Health 2016a; Minister of Health 2003b; Dyson 
2002; Ministry of Health 2002; King 2001).  
Disparities have been documented in stage at diagnosis (Blakely et al. 2012; Byers et al. 
2008; Priest et al. 2010), access to cancer treatment and psychosocial services (Alter 
2009; Sarfati et al. 2009; Hill et al. 2010) and mortality (Byers et al. 2008; Cunningham et 
al. 2014; Hill et al. 2010; Shaw et al. 2006; Soeberg et al. 2012).  The combined and 
concerted efforts of many overseas and NZ researchers have highlighted significant 
disparities in cancer incidence, mortality and care over the decades (Blakely et al. 2004; 
Cormack et al. 2005; Hill et al. 2013; Robson et al. 2005; Soeberg et al. 2012; Walker et 
al. 2008).  
The reasons for disparities in health and inequitable access to care are complex. 
Disparities have been shown to be strongly associated with unequal distribution of the 
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determinants of health (Blas and Kurup 2010; Tobias and Turley 2012). Individual factors, 
such as lifestyle behaviours, also play a role (Minister of Health 2003b). The leading 
advisory body in the USA, the Institute of Medicine (IOM), recommends that interventions 
are developed and tested in specific populations that experience disparities (Adler and 
Page 2008; Alter 2009). 
Māori are the indigenous people of NZ. They are inequitably impacted by cancer. 
Reducing inequities for Māori is a Treaty of Waitangi obligation addressed by numerous 
policy documents including the current NZ Health Strategy (Minister of Health 2016a) and 
Māori Health Strategy (Ministry of Health 2002). Addressing inequities is woven through 
NZ cancer-specific health strategies and action plans (Minister of Health 2003b; Cancer 
Control Taskforce 2005). Nevertheless, studies show continued disparities. One-year 
cancer survival for non-Māori remains approximately 10% higher than for Māori with a 
trend of steady increases across both groups (Ministry of Health 2015b). The Cancer 
Trends study utilised relative survival rates to quantify survival estimates and 
demonstrated persistent survival inequity affecting Māori and those from lower 
socioeconomic groups (Soeberg et al. 2012). Concerns have been highlighted in several 
studies that cancer care pathways in NZ contribute to inequitable access to care (Doolan-
Noble et al. 2006; Doherty 2006; Waitemata DHB 2006; Hill et al. 2010). Equity is an 
important consideration for survivorship research. 
The argument proposed in this thesis is that NZ cancer care pathways need to evolve to 
address epidemiologic trends such as those described in relation to survival and inequity. 
Early evolutionary changes are apparent with work progressing on comorbidities and 
cancer (Sarfati, Koczwara, and Jackson 2016; Stairmand et al. 2015), documenting 
discrepancies in decision-making in cancer care (Dew et al. 2015; Stairmand et al. 2015) 
and highlighting cancer patient experience (Dew et al. 2015; Egan et al. 2014; O’Brien et 
al. 2010; Slater et al. 2013; Walker et al. 2008). However, a gap in survivorship care 
persists and intervention research is needed to progress evidence-based survivorship 





Cancer care in NZ: The cancer control continuum 
 
Cancer survival is a measure of the effectiveness of cancer control measures (Ministry of 
Health 2015b). The NZ Cancer Control Strategy aims to impact on cancer control by 
outlining systematic and planned approaches that reduce the impact of cancer and reduce 
inequities across the cancer control continuum (Minister of Health 2003b). The cancer 
control continuum extends from prevention through diagnosis, treatment, rehabilitation and 
palliative care (Minister of Health 2003b).  
The 2003 Cancer Control Strategy and 2005-2010 Action Plan did not include a 
survivorship component (Minister of Health 2003b; Cancer Control Taskforce 2005). 
Nowadays, survivorship is the contemporary term used when describing life and cancer 
care during and post-treatment (Hewitt, Greenfield, and Stoval 2006). It does not replace 
rehabilitation, but is an additional and integral part of the continuum. Because survivorship, 
is not included in the 2003 NZ Cancer Control Strategy, survivorship interventions may not 
be prioritised (Cancer Control Taskforce 2005). Therefore, consideration of redesigned 
care pathways that aim to “improve[e] the quality of care provided to cancer survivors 
[through delivery of] comprehensive, coordinated and tailored care” (Halpern et al. 2014, 
e19) may not be as well supported by existing NZ policy documents as warranted by the 
survivorship statistics.  
 
Cancer care pathways: Survivorship shift and colorectal cancer  
 
In this section, cancer care pathways from the point of diagnosis through survivorship are 
summarily described. The inclusion of a survivorship lens supports exploration of specific 
considerations not always associated with these stages. Examples of the expanded scope 




A definitive diagnosis of cancer often happens after a period of time that includes 
identification of signs and symptoms, assessment, tests, and confirmation (or elimination) 
of a cancer diagnosis (Minister of Health 2003b). Once a cancer diagnosis is confirmed, 
treating clinicians formulate treatment options. In NZ, these options are often discussed at 
multidisciplinary team meetings (Dew et al. 2015; Stairmand et al. 2015). Clinicians may 
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discuss options with patients leading up to decisions on a treatment plan (National Bowel 
Cancer Tumour Standards Working Group 2013).  
A cancer diagnosis has been shown to be a common source of fear, anxiety and stress for 
the newly designated patient and their whānau (Adler and Page 2008). Cancer-related fear 
and anxiety are commonly experienced at the time of diagnosis (Little et al. 1998; Zabora 
et al. 2001; Naus, Price, and Peter 2005; O’Brien et al. 2010). These stressful feelings 
impact on individual decision-making ability (Dy and Purnell 2012; Stiggelbout et al. 2012). 
Those affected by cancer must decide who to tell and how to manage day-to-day amidst 
disruptions to usual routines (Levit et al. 2013). Research shows that the impact of a 
cancer diagnosis and treatment on the whānau is often as significant as that experienced 
by the individual survivor (Fitch, Bunston, and Elliot 1999; Giovannetti et al. 2012; Slater et 
al. 2013). 
A cancer diagnosis contributes to life and health complexity for many people. Health 
complexity can be triggered or exacerbated by cancer (Schaink et al. 2012; Sarfati, 
Koczwara, and Jackson 2016). Health complexity models have been developed that 
incorporate socioeconomic, cultural, structural and other environmental factors that can 
affect care and outcomes (Safford, Kiefe, and Allison 2008; Schaink et al. 2012). People 
diagnosed with cancer report experiencing a flow on effect leading to marital, family, social 
and vocational role challenges (Levit et al. 2013; Hewitt, Greenfield, and Stoval 2006). The 
2008 IOM report entitled Cancer Care for the Whole Patient: Meeting Psychological Needs 
recommends greater integration of psychosocial support services to address cancer-
related complexity and impacts (Adler and Page 2008). 
Colorectal cancers are the context used to illustrate diagnosis pathways in this thesis. 
People may be diagnosed with colorectal cancers through routine screening, symptomatic 
presentation to a primary care practice or emergency department, or via asymptomatic 
incidental detection (National Bowel Cancer Tumour Standards Working Group 2013).  
Incidence and prevalence data on colorectal cancers are relevant in this context. 
Colorectal cancers affect people of all ages, genders and ethnicities in NZ (Ministry of 
Health 2015a). Colorectal cancer includes cancers of the large bowel, rectosigmoid 
junction and rectum (Ministry of Health 2015a). These cancers are the in the top three of 
most common cancer diagnoses in NZ (Ministry of Health 2015a) and internationally 
(IARC 2012; World Health Organization 2014). People who reside in NZ have among the 
highest incidence and mortality rates for colorectal cancer internationally (IARC 2012). 
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Colorectal cancer incidence rates are higher for men with greater prevalence amongst 
older age groups (Cunningham et al. 2009; Ministry of Health 2015a). Colorectal cancer 
incidence rates are up to twice as high for European/Other groupings than for Māori, 
Pacific and Asian peoples (Soeberg et al. 2012).  
There are documented inequities in colorectal cancer incidence and mortality, as well as 
care, in NZ. For example, age standardised colorectal cancer incidence rates are lower for 
Māori compared to non-Māori, but mortality rates are similar (Ministry of Health 2015a). In 
other words, Māori are more likely to die once diagnosed. NZ data has shown that Māori 
are likely to have more advanced disease at the time of diagnosis and lower rates of 
access to health services (Cormack et al. 2005; Robson, Purdie, and Cormack 2010). 
These are just some of the differential trends and inequities in colorectal cancer incidence, 
mortality and care by ethnicity identified in the literature (Shaw et al. 2006). 
One contributor to complexity that is common in colorectal cancer survivors is comorbidity 
(Sarfati et al. 2013). Comorbidity is defined as the presence of concurrent long-term health 
conditions and it is associated with poorer cancer survival and health outcomes (Sarfati, 
Koczwara, and Jackson 2016). Comorbidities can pre-exist a cancer diagnosis or develop 
during or post-treatment.3 A 2004 study conducted in the USA showed that cancer 
survivors often do not receive recommended care for concurrent health conditions with 
detrimental effect (Earle and Neville 2004). The study reported that “comorbid conditions 
are the major threat to life for many cancer survivors” (Earle and Neville 2004,1712) due to 
the potential to neglect care for other serious illnesses. Presence of comorbidity or other 
health complexity may impact on diagnosis and delivery, or uptake, of best-practice 
healthcare (Sarfati, Koczwara, and Jackson 2016; Schaink et al. 2012). The lifeworlds of 
cancer survivors are often characterised by comorbidity as well as socioeconomic, cultural 
and other life complexities that can impact on diagnosis and treatment decision making 
(Galvin and Todres 2013; Dew, Stubbe et al. 2015; Stairmand et al. 2015).  
Comorbidity is common in NZ with chronic cardiovascular illness, metabolic illness or 
diabetes coexistent in a third to half of all adults diagnosed with cancer (Sarfati, Koczwara, 
and Jackson 2016). Specific to colorectal cancer, a 2009 independent audit of clinical 
notes in NZ found that two-thirds of colorectal cancer survivors were diagnosed with 
                                               
3 Cancer-related conditions that develop and persist related to the cancer itself or during active treatment are 
called long-term effects while conditions that develop post-treatment as outgrowths from the effects of 
treatments on an organ system or psychological process are called late effects (Aziz 2007). 
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comorbidities including hypertension (35%), ischaemic heart disease (17%), and 
respiratory disease (16%) (Cunningham et al. 2009). Comorbidity has been found to 
impact on diagnosis and treatment in NZ (Stairmand et al. 2015; Sarfati et al. 2009). In 
Sarfati et al’s 2016 overview of the impact of comorbidity on cancer and its treatments, the 
authors identified a gap in application of chronic care models to cancer survivor care and 
management. They recommend that “we need to move beyond the present single-disease 
model of studying cancer and embrace the complexities of studying and managing people 
with complex medical conditions” (Sarfati et al. 2016, 8). This translates to ensuring 
interventions aiming to improve survivorship care and outcomes consider health 




In NZ, colorectal cancer treatment guidelines provide best-practice advice on treatment 
options. Recommended options usually involve combinations of surgery, cytotoxic agents 
or chemotherapy, biologically targeted agents or immunotherapy, and radiation therapy 
(New Zealand Guidelines Group 2011). The multidisciplinary team approach is a common 
feature of colorectal cancer treatment planning in NZ with discussions about individual 
patient management occurring between surgeons, medical and radiation oncologists, 
pathologists, radiologists, and clinical nurse specialists as members of a clinical team 
(Stairmand et al. 2015; Dew, Stubbe et al. 2015; National Bowel Cancer Tumour 
Standards Working Group 2013; New Zealand Guidelines Group 2011).  
Clinical colorectal cancer management is supported by the Standards of Service Provision 
for Bowel Cancer Patients in New Zealand - Provisional (2013), previously published 
guidelines (NZ Guidelines Group, 2011) and guidance (Ministry of Health 2010b). These 
policies and standards for care “allow clinical regimens to be administered to best 
advantage” (Herrstedt and Walsh 2011, 335) increasing the possibility of achieving best-
case treatment outcomes in terms of response rates and survival. Individuals and whānau 
seeking colorectal cancer treatment from a NZ healthcare facility are routinely managed 
through acute, disease-specific care pathways delivered by regional cancer treatment 
centres (Cancer Control New Zealand 2010). The focus of treatment is control of disease 
with the goal most commonly being ‘cure’. The cancer treatment phase of the cancer care 
trajectory lasts anywhere from a few days, for surgical removal of a tumour, to many years 
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with phases referred to as neoadjuvant or adjuvant first-line, second-line and subsequent 
modalities (National Bowel Cancer Tumour Standards Working Group 2013). 
Surgical resection of the bowel is the most common treatment modality for people 
diagnosed with colorectal cancer in NZ (Cunningham et al. 2009; New Zealand Guidelines 
Group 2011). A section of bowel that contains the tumour is cut out along with margins of 
healthy bowel. The resulting bowel segments may be either re-connected or a stoma 
formed from attaching the proximal end of the bowel to the surface of the abdomen. 
Individuals with some forms of colorectal tumours (i.e. rectal cancers) and for cases 
presenting with metastatic disease, surgery may be preceded by neoadjuvant radiotherapy 
and chemotherapy to shrink the size of the tumour and enable secondary review of 
surgical treatment options. 
Colorectal cancers are staged, according to tumour aggressiveness and spread, at the 
time of surgical removal of the tumour (National Bowel Cancer Tumour Standards Working 
Group 2013). The TNM disease staging system, as maintained by the American Joint 
Committee on Cancer and the International Union for Cancer Control, is considered the 
strongest predictor of survival (International Union for Cancer Control 2007). Prognosis is 
usually good for treated local (stage I) and regional (stage II) colorectal cancers. Further 
treatment, with adjuvant chemotherapy, is thought to reduce the likelihood of recurrence 
for cancers that have spread or metastasised to regional lymph nodes (stage III) or distant 
lymph nodes (stage IV). Adjuvant chemotherapy is likely to be recommended if 
pathological evidence obtained at surgery indicates that the cancer may have spread to 
regional lymph nodes. Post-surgical adjuvant chemotherapy for stage III and IV tumours 
often begins within eight weeks post-surgery. Stage IV describes a tumour that has spread 
to sites distal to the bowel or rectum as identified by abdominal ultrasound, computerised 
tomography or magnetic resonance imaging Treating clinicians may use targeted 
therapies but this stage designation carries with it a poor prognosis. The liver and lungs 
are the most frequent sites for distant metastases or recurrent disease. Relative survival 
rates differ by stage at diagnosis with better colorectal cancer survival rates associated 
with stage I and II cancers. In NZ, approximately 60% of cancer survivors reach the five 
year survival milestone (Aye, Elwood, and Stevanovic 2014).   
Best-practice guidelines refer to delivery of evidence-based clinical and supportive care 
services for cancer patients (Ministry of Health 2010b; National Bowel Cancer Tumour 
Standards Working Group 2013). Supportive care is an approach to address the holistic 
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aspects of cancer care (Ministry of Health 2010b). It includes “essential services required 
to meet a person’s physical, social, cultural, emotional, nutritional, information, spiritual 
and practical needs through their experience with cancer” (Ministry of Health, 2010, p. 3). 
These services aim to improve the quality of life for those with cancer and whānau during 
diagnosis and treatment. The NZ Cancer Control Strategy (Minister of Health 2003b) 
states that provision of supportive care is a key component of high-quality cancer 
treatment. In 2010, the NZ Ministry of Health published supportive care guidance for health 
and supportive care workers (Ministry of Health 2010b). An implementation plan for the NZ 
Supportive Care Guidance identified three priority areas of focus for supportive care 
delivery: care coordination, psychosocial support and information support (Health 
Outcomes International 2011). As a result, NZ cancer services provided by district health 
boards (DHBs) routinely include care coordination. Cancer care coordinators and key 
support workers aim to integrate supportive care into the care continuum (Li et al. 2013; 
Collinson et al. 2013). Additional psychosocial and information support, for example 
counselling and support groups, are routinely available from community providers (Cancer 
Society of NZ, 2016). However, in reality, supportive care assessment is not routinely 
provided and access to supportive care is variable, services are inconsistently provided 
and programs rarely evaluated (Cancer Society of New Zealand and NZ Guidelines Group, 
2006). There is a lack of evidence for cancer-specific supportive care service provision 
(Standard 14 of the Standards of Service Provision for Bowel Cancer Patients in New 
Zealand - Provisional (2013), which is likely to hinder delivery of these aspects of cancer 
care (National Bowel Cancer Tumour Standards Working Group 2013). In summary, the 
situation in NZ reflects that portrayed in the IOM report Cancer Care for the Whole Patient: 
Meeting Psychological Needs, which states “the remarkable advances in biomedical care 
for cancer have not been matched by achievements in providing high-quality care for the 




The most internationally accepted definition of cancer survivorship is the one proposed by 
the National Coalition for Cancer Survivorship which reads “the experience of living with, 
through and beyond a diagnosis of cancer” (Hewitt, Greenfield, and Stoval 2006). This 




An individual is considered a cancer survivor from the time of diagnosis, through the 
balance of his or her life. Family members, friends and caregivers are also impacted by 
the survivorship experience and are therefore included in this definition (National 
Cancer Institute 2015, 1). 
The definition of cancer survivorship is not universally accepted in NZ. Many health 
practitioners and publications use this terminology to refer to the time after completion of 
active treatment due to clinical vagaries and prevailing paradigms (Hewitt, Greenfield, and 
Stoval 2006; Halpern et al. 2014). The American Society for Clinical Oncology (ASCO) 
rises above the terminology debate by acknowledging the term survivorship “means 
different things to different people but it refers to the process of living with, through or 
beyond cancer” (ASCO 2014, 4). 
There are well-documented issues with survivorship terminology referred to in the 
literature (American Society for Clinical Oncology, 2014; de Silva and Health Foundation 
2011; Hewitt , Greenfield, and Stoval 2006; Jefford et al. 2015). The term ‘survivor’ relates 
to being a victim for some (Hewitt, Greenfield, and Stoval 2006). Alternative terms for 
survivor suggested or in use include ‘people living with or beyond a history of cancer’, 
‘people affected by cancer’, ‘consumers’ or ‘thrivers’ (Hewitt, Greenfield, and Stoval 2006; 
Macmillan Cancer Support 2011).The debate over terminology presents a barrier to 
progressing research in this area. The thesis acknowledges this debate and the difficulties 
it presents in achieving clarity, but rises above it by identifying the definition adopted in this 
thesis and progressing survivorship research despite it. 
Prior to the 1980’s, a cancer diagnosis was likely to result in aggressive treatment, with 
little recognition of side effects that impacted on quality of life, followed by palliative 
treatment and untimely death (Miller, Merry, and Miller 2008; Ganz, Casillas, and Hahn 
2008). Dr Fitzhugh Mullan was one of the first of a new breed of long-term cancer 
survivors. He coined the term ‘cancer survivor’ in his ground-breaking 1985 New England 
Journal of Medicine article, entitled ‘The Seasons of Survival’ (Mullan 1985). He pointed 
out the need for advocacy for those living with and beyond cancer to address unmet needs 
over three time periods which he coined as seasons. He called these seasons of survival: 
acute survivorship, extended survivorship and permanent survivorship (Mullan 1985). He 
described the category of acute survival as beginning at diagnosis and extending through 
primary treatment when fear and anxiety were constant and heightened. Extended survival 
began at the end of primary treatment when fear of recurrence and recovery from 
treatment-related physical limitations took place amidst periodic follow-up appointments. 
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Mullan’s permanent survival season encompassed the five-year survival mark indicating 
“cure” but often with ever-present secondary impacts on mental and physical health. 
Since Mullan’s 1985 article, cancer has become increasingly survivable. This has heralded 
a new paradigm in cancer care based on consideration of cancer as a treatable chronic 
disease represented by an extended cancer trajectory. The National Cancer Survivorship 
Initiative from the UK outlined this pathway as seen in Figure 4. 
 
Figure 4: National Cancer Survivorship Initiative Vision, UK 2010 
 
In 2007, Aziz published a review of the state of knowledge from cancer survivorship 
research studies (Aziz 2007). Cancer survivorship, as a discipline, was described as 
focusing on identifying and meeting the needs of people affected by cancer and its 
treatments (Halpern et al. 2014). Aziz’s article highlighted the advances in cancer 
survivorship research from 1985. It documented that long-term impacts were previously 
considered less important than successful treatment outcomes (Aziz 2007). Aziz’s article 
also outlined contemporary challenges and opportunities. The overview outlined the need 
for interdisciplinary approaches that: 
1. Seek to identify, examine, prevent and control adverse sequelae of cancer and its 
treatments, such as fatigue and sexual dysfunction; 
2. Manage, treat and prevent comorbidities; 




4. Pay special attention to disparities in survivorship outcomes by age, income, 
ethnicity, geography or cancer site; and, 
5. Explore the impact of the survivorship experience on the family and vice versa 
(Aziz 2007, 419). 
Cancer survivorship is contemporarily characterised by a wide array of cancer-related 
impacts reported by cancer survivors. Research shows that survivors experience and 
manage ongoing life and health complexity during and post-treatment (Sarfati et al. 2009; 
Hewitt, Greenfield, and Stoval 2006; Aziz 2007; Eakin, Youlden, and Baade 2007; Ministry 
of Health 2015b; Koczwara 2015). As survivor advocacy and survivorship research 
progresses, so does the understanding of survivor seasons. Accordingly, Mullan’s (1985) 
original stages of survivorship have been variously re-framed due to recognised variation 
in cancer-related impacts, survival rates and unmet needs for different cancers and 
population groups. Miller et al. (2008) revisited the seasons and expanded them to nine 
categories called: acute survivorship, transitional survivorship, three categories of 
extended survivorship and four categories of permanent survivorship.  
Transitional survivorship, when treatment finishes and post-treatment survivorship work 
begins, is now recognised as a particularly vulnerable time of change for survivors (Miller, 
Merry, and Miller 2008). Transition is a particularly difficult period of the cancer trajectory 
for survivors to manage because confidence in health and life management has been 
knocked and needs to be rebuilt (Hewitt, Greenfield, and Stoval 2006; Zapka et al. 2012; 
Mannix-McNamara 2012; Foster and Fenlon 2011). The individual cancer experience, 
more often than not, includes transitional and extended survivorship phases, however, this 
cancer trajectory change has not been well documented in NZ. Further, care pathways 
have not evolved accordingly. 
Rehabilitation is sometimes seen as synonymous with survivorship. Rehabilitation is 
defined as services to achieve optimal functioning across the domains of impairment, 
activity and participation (WHO 2001). As is the case for supportive care, there is variable 
access to rehabilitation services in NZ (Minister of Health 2003b). For example, 
rehabilitation may be provided post-surgery, while a patient is recovering as an inpatient, 
but not offered for physical impairment related to outpatient chemotherapy or radiation 
treatment. Rehabilitation is considered a component of cancer support in published NZ 
reports (Cancer Society of NZ and NZ Guidelines Group 2006; Ministry of Health 2003a) 
but there is a paucity of research that has addressed cancer rehabilitation in NZ 
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specifically (Cancer Society of NZ and NZ Guidelines Group 2006; Ministry of Health 
2003b).  
There is evidence from chronic care and long term condition research that support can 
help people improve their quality of life and feel empowered to better manage their own 
health (Foster and Fenlon 2011; Bodenheimer, McGregor and Sharifi 2005). 
Recommendations from international survivorship studies have indicated the need for 
more research. It is clear that the healthcare delivery system and settings influence the 
capabilities and opportunities for survivorship models and care provision. More 
survivorship research is needed incorporating structural approaches in parallel with 
developments for intervention in other disease settings (Parkhurst 2013). 
Survivorship research aims to find ways to address multi-faceted life and health 
complexities faced by survivors. A 2011 UK scoping review on the priorities for 
survivorship research concluded that research was needed in non-breast cancer survivor 
cohorts, on later phases of survivorship, and in rehabilitation and self-management 
approaches (Richardson et al. 2011).  
Demonstration projects and survivorship interventions have taken place in many overseas 
cancer centres of excellence, community settings, and within the UK and Australia’s 
national health systems (Oeffinger et al. 2014). Key agencies involved in survivorship 
research and advocacy are the National Coalition for Cancer Survivorship (USA), the 
LIVESTRONG Foundation (USA), MacMillan Cancer Support (UK) and The Australian 
Cancer Survivorship Centre at the Peter MacCallum Cancer Centre, in Melbourne, 
Australia. Koczwara specifically identified differing challenges and tensions in Australia 
associated with managing cancer survivorship in oncology versus the primary care 
environment (Koczwara 2015). Survivorship intervention settings have varied with no one 
setting identified as ideal. 
Survivorship research studies have been carried out with cancer site-specific and 
survivorship-stage specific populations. Projects have been described as physician-led, 
nurse-led, and community-led (Dy and Purnell 2012; Halpern et al. 2014; Jefford et al. 
2015). These projects have included numerous components. Two of the most common 
components were the survivorship care plan (Grunfeld et al. 2011; Klemanski, Browning, 
and Kue 2016) and shared care approach (Aziz 2007; Jefford et al. 2015; Landon, 
Grumbach, and Wallace 2012; Oeffinger et al. 2014).  
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Survivorship studies have utilised alternate approaches, such as counselling (Halpern et 
al. 2014) and risk stratification of survivors based on complexity and likelihood of late 
effects (Aziz 2007). Survivorship research to date has shown promise for redesigned care 
pathways incorporating these approaches or other tailored interventions to help survivors 
better manage challenges to their physical health, finances, relationships, emotions, 
identity and future prospects (Jefford et al. 2008; Kelly and Millward, 2004; Little et al. 
1998; McCaughan et al. 2011; Walton et al. 2009; Watson, Mooney, and Peterson 2009). 
Survivorship demonstration projects, meta-analyses and systematic reviews have not 
provided conclusive evidence regarding how best to meet the needs of survivors or deliver 
best-practice survivorship care (Halpern et al. 2014; Viswanathan et al. 2014; Koczwara 
2015). The 2014 Agency for Health Care Quality and Research technical brief on existing 
models of survivorship care concluded:  
The optimal nature, timing, intensity, format, and outcome of survivorship care models 
continue to be uncertain. The paucity of evidence limits our ability to make conclusions 
about the effectiveness of survivorship care models. Further research regarding 
survivorship care models, focusing on issues including settings, processes and 
continuity of care, payments, types of health care providers involved, collaborations 
and communications, outcomes and differences associated with cancer type or patient 
sociodemographic characteristics is needed before recommendations and conclusions 
regarding model development, implementation and evaluation can be made 
(Viswanathan et al. 2014, viii). 
Four specific survivorship initiatives from NZ were identified in the grey literature: 
Consumer advocacy, the Bridge to Health program (Cancer Society Otago/Southland 
Division 2015), as well as the Living Well  and Kia Ora - E te iwi programs (Doherty and 
Borrell 2013). One additional on-line resource was identified.  
NZ cancer survivors have played a role in increasing the awareness of cancer survivorship 
challenges and encouraging redesign of care pathways to reflect the contemporary cancer 
trajectory. The cancer survivors group, Cancer Voices NZ, was established in 2004 
(Cancer Voices NZ Charitable Trust, 2016). Cancer Voices NZ aimed to address the first 
recommendation of the seminal cancer survivorship book From Cancer Patient to Cancer 
Survivor: Lost in Transition which is to “raise awareness of the needs of cancer survivors, 
and establish cancer survivorship as a unique phase of cancer care” (Hewitt, Greenfield, 
and Stoval 2006, 2). Although the group is no longer active, previous members of Cancer 
Voices NZ have been trained as patient advocates (Cancer Voices NZ Charitable Trust 
2016). These survivor advocates continue to represent the consumer voice on regional 
and national advisory groups (Health Quality and Safety Commission 2015). Input from the 
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growing numbers of survivor patient advocates and consumer groups, on health policies 
and programs, has contributed to a growing awareness of the need for a dedicated 
survivorship focus in healthcare, research and policy arenas (Koczwara 2015). NZ cancer 
survivors now live for many years with impacts that range from physical to psychosocial, 
they are a growing advocacy voice, and their numbers are predicted to rise substantially in 
future decades (Ministry of Health 2015a; Soeberg et al. 2012). 
Bridge to Health is a cancer survivorship program that was developed in Dunedin by Dr 
Sue Walthert of Otago University. Dr Walthert, a breast cancer survivor and GP, created 
the program to address the reported gap in community-based cancer survivorship support. 
The Otago/Southland Division of the Cancer Society delivers the Bridge to Health program 
for those who opt-in to join. The program aims to provide survivorship support and 
encourage the primary care provider-patient relationship (Cancer Society Otago/Southland 
Division 2015). It involves an initial two-hour education seminar followed by four 
workshops. The workshop topics address physical activity and personal fitness, nutrition, 
relationships and sexuality, and emotional wellbeing. Three vouchers for free GP visits are 
provided to participants at the completion of the program to encourage follow-up care. A 
2012 evaluation report was referenced on the website but was not available for perusal. 
The report was described as documenting development, implementation and audit of the 
program. It indicated that the program met participants’ needs and was useful (Cancer 
Society Otago/Southland Division 2015). 
The Living Well and Kia Ora E Te Iwi cancer support programs are also group-based 
educational support programs. The Living Well Program was originally developed in the 
1980’s by the Cancer Council Victoria, Australia and later purchased by the Cancer 
Society of NZ. These programs were intended to be delivered as ‘once a week for six 
weeks sessions facilitated by trained staff and guided structurally and educationally by 
delivery manuals. Program delivery models have been adapted. No review report of Living 
Well was available in the public domain. Kia Ora E Te Iwi is a kaupapa Māori adaptation 
the Living Well Program. The original and adapted programs have been administered over 
the years using alternative delivery models such as weekend courses, monthly meetings 
or a winter lecture series. The aims of these programs are to help people with cancer and 
their caregivers or whānau increase knowledge, confidence and coping skills (Doherty and 
Borrell 2013). The 2013 Kia Ora E Te Iwi review report described program implementation 
and views of key stakeholders (Doherty and Borrell 2013). The review did not aim to 
evaluate the effectiveness of programs, but recommended next steps on the basis of key 
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informant interviews. Key informants reported delivery to be challenging but identified Kia 
Ora E Te Iwi program development as an example of successful Kaupapa Māori 
intervention that has been delivered under the philosophy of Whānau Ora. 
Recommendations for the future included identifying sustainable funding for programs, 
development of an ongoing reporting and monitoring system, and more training support for 
facilitators (Doherty and Borrell 2013). 
The Nelson Regional Breast & Gynaecological Trust offer a link to a Survivorship Passport 
written by local cancer survivor activist, Andrea Fairbain. This 31-page resource contains 
practical tips that women and their supporters can ‘pick ‘n mix’ to a) manage health and 
recovery, and b) celebrate life (Fairbairn 2011). There was no evaluation report identified 
for this resource. 
With regard to colorectal cancer survivor care pathways, there were no specific resources 
identified. Colorectal cancer survivors experience mid- and long-term consequences from 
the disease and its treatment (Hewitt, Greenfield, and Stoval 2006). Hewitt et al. (2006) 
described the late effects associated with colorectal cancer and its treatments as: 1) 40% 
risk of cancer recurrence; 2) increased risk of a secondary primary cancer; 3) higher rates 
of psychosocial distress; 4) bowel dysfunction; 5) colostomy; 6) sexual dysfunction; and, 7) 
peripheral neuropathy. Life for colorectal cancer survivors is often characterised by 
lingering impacts on wellbeing and health (Ohlsson-Nevo et al. 2012; Baravelli et al. 2009; 
Jones et al. 2016). 
Sarfati et al. (2009) and Hill et al. (2010) identified the significant impact of comorbidities 
on colorectal cancer management and survival in NZ. As discussed earlier, they reported 
that the majority of people diagnosed with colorectal cancer are older and that they tend to 
have competing chronic diseases to manage, such as hypertension, diabetes, obesity, 
asthma, and/or frailty (Sarfati et al. 2009). Comorbidities have been found to alter 
treatment options offered to those affected (Sarfati et al. 2009; Hill et al. 2010). The 
physical and psychosocial post-treatment impacts associated with cancer can become, in 
themselves, comorbidities as these impact on health and wellbeing long-past the end of 
treatment. 
In summary, people affected by colorectal cancer have their cancer treatment managed 
mainly within the hospital system but their additional health and life challenges may not be 
well supported. On completion of colorectal cancer treatment and rehabilitation, NZ 
patients often receive a discharge letter, a copy which is also sent to their primary care 
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provider and any other referring doctor. Further follow up occurs at intervals determined by 
the different treatment modalities involved in the care continuum. However, much of post-
treatment care for treatment side-effects is provided by the care pathway readily available 
to survivors; namely, primary care providers. A wide variety of alternative survivorship care 
pathways have been studied overseas, but gold standard survivorship care remains 
elusive. Survivorship research and support can be initiated early in survivorship (i.e. during 
active treatment) or at transition from treatment or post-treatment. 
 
Part one summary 
 
The research presented in part one of this background chapter has provided a brief 
overview of the cancer trajectory from diagnosis through treatment whilst incorporating the 
concepts of survivorship. The standard NZ cancer journey is described as consisting of 
overlapping stages: diagnosis, treatment and survivorship. Each stage was described in 
relation to colorectal cancer as the context of interest.  
Research shows that there are increasing numbers of cancer survivors and survivorship 
research is needed. This part one background chapter summarised cancer care pathways; 
from diagnosis through post-treatment. Key foundational researchers in the context of 
interest were identified to be NZ-based Professor Diana Sarfati (Sarfati et al. 2009; Shaw 
et al. 2006; Hill et al. 2010) and Australia-based Associate Professor Michael Jefford 
(Jefford et al. 2008, 2011, 2013, 2015). This background section provided background 
data and insights on cancer survival and cancer trends that emphasised the NZ 
perspective and colorectal cancer context.   
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Part two: Survivorship impacts and models of care 
 
In this second part of the chapter, an overview of cancer impacts experienced by 
survivors, a framework of cancer survivorship work, and two applicable models of care are 
presented. Models of care shape services. They can guide how interventions can be 
effectively incorporated into service delivery. Cancer survivorship impacts are categorised 
as social, physical, emotional and spiritual which align with the Te Whare Tapa Whā model 
(Durie 1994). The work of cancer survivorship in managing these impacts is described 
using the Adapted Illness Trajectory Framework (Klimmek and Wenzel 2012) which is 




Research shows that survivors navigate a range of impacts and transition points (Hubbard, 
Kidd, and Kearney 2010). It is recognised that there are substantial differences in 
survivorship impact due to differing cancer types, treatments, perceptions and experiences 
(Soeberg et al. 2012). Navigation of these cancer-related impacts often continues long-
past the end of treatment with lingering effects. The Te Whare Tapa Whā model (Durie 
1994) can be used to categorise causes and impacts of cancer across four areas: social, 
physical, emotional and spiritual. Survivors in NZ report coming to terms with their cancer 
experiences in various ways that alter their identity, life story and life-worlds (Egan et al. 
2014).  
Colorectal cancer survivor specific studies have been conducted overseas. In Australia, a 
2008 report identified that dealing with fatigue, treatment transition, fear of recurrence, and 
unrealistic personal expectations were the most problematic challenges for colorectal 
cancer survivors in one Australian study (Jefford et al. 2008). Other challenges reported 
were managing ongoing post-treatment pain and gastrointestinal impacts as well as trying 
to carry out clinical advice on diet and physical activity (Jefford et al. 2008). In NZ, cancer 
survivor experience studies have been conducted including colorectal cancer survivors 
(Egan et al. 2014) but there have been no studies specifically focused on intervention for 
this group of survivors. This represents a gap that can be addressed through further NZ-





Cancer impacts on survivors’ sense of normality, sense of identity and self-confidence 
(Charmaz 2002; Hubbard et al. 2010). Social impacts of diagnosis and treatment have 
been reported in the literature (Dowswell et al. 2011; Pan et al. 2011; Ohlsson-Nevo et al. 
2012; Anderson, Steele, and Coyle 2013; Dunn et al. 2013; Denlinger and Barsevick 
2009). Social isolation is cited as a common occurrence noted to occur in survivors 
(Charmaz 2002) with intermittent disruptions to communication and relationships reported 
(Zhang and Siminoff 2003). 
Cancer as a chronic illness is characterised by biographical disruption (Bury 1982). Cancer 
has been described as disruptive to both daily life and a planned future (Hubbard, Kidd, 
and Kearney 2010). Disrupted daily life and future plans leave survivors feeling frightened 
and anxious; aware that they are not living up to societal norms, and with a fragile and 
constantly altering sense of self and identity (Naus et al. 2009; Hubbard, Kidd, and 
Kearney 2010). New meanings were needed to guide survivors’ future goals and decision-
making (Cardoza 2016; Kantor 2016). 
Unresolved social impacts were reported to be exacerbated by practical difficulties with 
work and travel (Mehnert 2011; Lobb et al. 2009). Both men and women reported changes 
in employment during cancer treatment (Mehnert 2011; Lobb et al. 2009; Richardson et al. 
2011). For those unable or unwilling to return to work, social isolation was exacerbated by 
financial stress (Mehnert 2011). One research study from Holland found that 62% of 
working age survivors returned to work following cancer treatment (Spelten, Sprangers, 
and Verbeek 2002). However, the cancer experience affected their perception of work. 
Cancer-related identity changes were associated changed attitudes toward work (Kennedy 
et al. 2007). One study described the difficulties experienced by male survivors who 
reported a burdensome shift in identity from hard-worker and authoritative father to 
perceived weak man (Elmberger, Bolund, and Lützén 2002). In another study, female 
survivors reported anxiety and internal struggles associated with not being able to meet 
family needs (Fitch, Bunston, and Elliot 1999). Seemingly, people do not want illness 
dominating their lives and they seek a sense of past normality. However, work and home 
roles are often affected by a cancer diagnosis and this results in impacts on self-esteem, 
identity and priorities (Galvin and Todres 2013; Hubbard, Kidd, and Kearney 2010; Fitch, 





The most common physical impacts associated with cancer treatments in the literature 
were fatigue, pain and gastrointestinal symptoms. Definitions for these symptoms were 
sourced from the National Comprehensive Cancer Network (NCCN) guidelines. The 
NCCN guidelines provide clinicians with strategies for management of cancer-related 
symptoms including recommendations for ongoing assessment, education, pharmacologic 
treatments, physical activity, and counselling and other psychosocial interventions. 
The NCCN defines cancer-related fatigue as a “persistent, subjective sense of tiredness 
related to cancer and cancer treatment that interferes with usual functioning” (National 
Comprehensive Cancer Network 2014b). In one cross-sectional national survey of 
American cancer survivors, cancer-related fatigue rates were reported to be high with 80% 
of people receiving chemotherapy and 90% of people receiving radiotherapy reporting this 
symptom at intervals during treatment (Henry et al. 2008; Hofman et al. 2007). Overall, 
cancer-related fatigue impacted on between 50-90% of people living with, through and 
beyond cancer with this symptom known to be both a cancer indicator and a side-effect of 
treatment that can persist long beyond treatment for many survivors (Hofman et al. 2007; 
Campos et al. 2011; National Comprehensive Cancer Network 2014b; Jones et al. 2016). 
The NCCN defines cancer pain as “an unpleasant, multidimensional, sensory, and 
emotional experience associated with actual or potential tissue damage, or described in 
relation to such damage” (National Comprehensive Cancer Network 2014a). Cancer pain 
can result from tumour pressure on tissues, nerves and bone or disruption in organ 
function (Cardoza 2016). It also can be associated with treatment and associated 
procedures, particularly those that require the use of needles. Pain is known to be a 
common yet variable physical impact that can evolve into a chronic pain syndrome for 
survivors (Cardoza 2016). 
Gastrointestinal symptoms impacting across all cancers include changes in taste, nausea, 
vomiting, constipation or diarrhoea (Cardoza 2016). Many treatments impact on the cells 
of taste buds and those that line the gastrointestinal tract which triggers these symptoms. 
The NCCN has antiemesis guidelines that assist clinicians with strategies for 
pharmacologic and non-pharmacologic management of gastrointestinal conditions 
(National Comprehensive Cancer Network 2012). Specifically referring to colorectal cancer 
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survivors, research has identified post-operative stoma and ostomy device management 
as an ongoing challenge (Pan and Tsai 2012; Kidd et al. 2008; Baravelli et al. 2009). 
Additional side-effects known to impede recovery of increased functional ability include 
lymphatic system disruption resulting in painful swelling called lymphoedema (Hewitt, 
Greenfield, and Stoval 2006), cognitive impairment (Levit et al. 2013), sexual dysfunction 




Emotional health can be affected throughout the cancer trajectory. Common psychological 
impacts identified from the literature include distress, depression and  anxiety (Mulrooney, 
Neglia, and Hudson 2008). The emotional impact most often described in conjunction with 
cancer treatment is ‘distress’ (Hewitt, Greenfield, and Stoval 2006; Kantor 2016). Distress 
is described as a negative emotional reaction to uncertainty and fear about outcomes or 
death (Zabora et al. 2001). Other common emotional impacts associated with cancer are 
the more specific diagnoses of depression and anxiety. 
The NCCN defines distress as a “multifactorial unpleasant emotional experience of a 
psychological (cognitive, behavioural, emotional), social, and/or spiritual nature that may 
interfere with the ability to cope effectively with cancer, its physical symptoms, and its 
treatment” (National Comprehensive Cancer Network, Holland, and Bultz 2007). Distress 
experiences range from feelings of sadness and vulnerability to depression, anxiety and 
panic (National Comprehensive Cancer Network 2013). Psychological distress levels 
fluctuate but it has been reported to be experienced by 35% or more of people undergoing 
cancer treatment (Zabora et al. 2001). A large scale prospective study of colorectal cancer 
survivors found that “a substantial proportion of participants reported high levels of 
distress, with one-third still distressed five years post-diagnosis” (Dunn et al. 2013, 1763). 
Specific disorders such as depression and anxiety are identified in survivors. Depression, 
defined as persistent low mood, has been identified in 16% of cancer patients (Osborn, 
Demoncada, and Feuerstein 2006). Research suggests anxiety is a more prevalent 
problem during survivorship (Kantor 2016). Fear of recurrence is one common and 
recurrent form of illness-related anxiety in survivors that can manifest as hypochondria or 
avoidance behaviours (Lobb et al. 2009; Denlinger and Barsevick 2009). Prescriptions for 
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psychotropic drugs used to treat depression and anxiety are more commonly written for 
survivors compared to the general public (Ng et al. 2013). 
Some researchers have proposed that illness-related anxiety can have positive outcomes. 
Tedeschi and Calhoun introduced the concept of post-traumatic growth in 2004 (Tedeschi 
and Calhoun 2004). This concept describes a process of positive change after a life-
altering event that can result in “an increased appreciation for life in general, more 
meaningful interpersonal relationships, an increased sense of personal strength, changed 




Spirituality has several working definitions. It is defined in both purely religious terms and 
in broader terms relating to meaning, purpose and values in life (Egan 2009). This thesis 
adopts Puchalski’s definition which states that spirituality is “the way people find meaning 
and purpose, and how they experience their connectedness to self, others, the significant, 
or sacred” (Puchalski 2012, iii49). 
Spiritual impacts were comprehensively described in Egan’s 2009 national study of 
spirituality toward the end of life (Egan 2009). Egan highlighted the significant differences 
in definition, perceptions and experiences of spirituality held by NZ peoples. For Māori, 
spirituality was described as an integral part of cultural identity and wairua (Egan 2009). 
Wairua is one of the four cornerstones of Durie’s Te Whare Tapa Whā Māori health 
philosophy (Durie 1994). A quote from a different study illustrates the importance of 
spirituality for one Māori female.  
Spiritual is Māori. Māori as a culture are a spiritual people …that does not mean that 
we are god fearing people, I am a spiritual person not a church person (Whitehead 
2010). 
Spiritual impacts identified in the cancer-specific literature include existential concerns, 
such as lack of meaning in life or worries about the afterlife, feelings of grief and loss, guilt 
and shame, or concerns about reconciliation with the past (Puchalski 2012). A sense of 
spiritual abandonment, sometimes indicated by a person describing perceived lack of love 
in their life or anger at God, has been described as a factor contributing to spiritual distress 
(Puchalski 2012).  
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Spiritual distress can be assessed and addressed in many ways, not solely through 
delivery of spiritual care. Spiritual care has been found to improve survivors’ quality of life 
and satisfaction with care (Puchalski 2012). The UK National Institute for Clinical 
Excellence guidance for supportive and palliative care recommends that spiritual care 
include “informal sharing of ideas about the ultimate purpose of existence” (National 
Institute for Clinical Excellence 2004, 96). Spirituality is a pathway for survivors to reframe 
their identity in the context of cancer, find greater meaning in life, and recognise what is 
ultimately of importance and value to them (Egan 2009).  
 
Addressing cancer impacts as chronic 
 
Cancer is defined as a chronic condition by the World Health Organization (World Health 
Organization 2008) and the IOM (Hewitt, Greenfield, and Stoval 2006). In NZ, chronic care 
and long-term condition terminology are used interchangeably. A long-term condition 
refers to “any ongoing of recurring health issue that has a significant impact on the lives of 
a person and/or their family, whānau or other carers for six months or more” (Bycroft and 
Boyd 2011, 11).  
A parallel can be drawn between the illness experiences of people living with chronic 
conditions such as asthma, diabetes and arthritis, and cancer survivors (Lancet 2012; 
National Health Committee 2007b; Schoen et al. 2009; Michie, Miles, and Weinman 2003). 
A diagnosis of cancer or other chronic condition impacts on physical and psychosocial 
health (Tritter and Calnan 2002; Hubbard, Kidd, and Kearney 2010; Lancet 2012). These 
illness experiences can be disabling, painful, embarrassing and stigmatizing (Tritter and 
Calnan 2002).  There is an impact on perceptions of identity or how people feel about 
themselves (Hubbard, Kidd, and Kearney 2010; Blaxter 2004; Kelly and Millward 2004). 
Illness experiences reflect health loss and experience data show that survivors feel others 
perceive them differently after diagnosis (Kelly and Millward 2004; Foster and Fenlon 
2011).  
There is some debate about whether cancer really is like other chronic conditions (Tritter 
and Calnan 2002). Cancer is described as differing in three key ways. The first is that it is 
mainly treated in the secondary care setting of the hospital compared to most other 
chronic conditions which are treated in primary care. The treatment environment impacts 
on the experience of care. Chronic condition treatment in primary care is often planned 
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and proactive while the secondary care treatment of cancer is more often reactive with 
referral back to primary care at treatment completion (Kadu and Stolee 2015; Mays 2013). 
Second, the impacts of cancer and cancer treatment are often substantially greater and 
life-threatening. Tritter & Calnan (2002) argue that classifying cancer as a chronic 
condition minimises these toxic and substantial impacts and does a disservice to survivors. 
Third, different cancers and cancer treatments are associated with different side-effects 
and risks of late-effects. The impacts on individuals can differ greatly based on cancer type 
and treatment type. This variability and unpredictability in impacts prompted these authors 
to question whether engagement in self-management is realistic for survivors. This 
question remains unanswered but there is an extensive literature on the potential benefits 
for survivors presented in Chapter three. 
The common intermittent yet lingering impacts of cancer on physical and psychosocial 
health indicate that cancer may fit classification as a chronic condition (National Health 
Committee 2007a). Cancer is currently treated as an acute condition within NZ health 
services but it is increasingly conceptualised as a chronic condition in global health policy 
(World Health Organization 2014). This conceptual shift is likely to have implications for 
care delivery. A paradigm shift from cancer being treated as an acute and self-limiting 
condition to one that is long-term and chronic, requires redesigned care pathways 
addressing survivorship care (Lee et al. 2012). Therefore, care pathway redesign in light of 
chronic care approaches is indicated for further research. 
 
Chronic illness-based approaches in cancer survivorship 
 
Chronic illness-based approaches in cancer survivorship focus on increasing wellbeing 
through preventing reoccurrence of acute symptoms and minimising adverse 
consequences (Hewitt, Greenfield, and Stoval 2006). According to the literature, there are 
three key problem areas for people managing chronic conditions. These are: 1) medical 
management including taking medications and changing diet, 2) creating and maintaining 
new and meaningful life roles regarding jobs, family and friends; and, 3) coping with the 
anger, fear, frustration and sadness of having a chronic condition (Corbin and Strauss 
1988).  
There are established chronic condition self-management programs delivered 
internationally that address these key problem areas (Bodenheimer et al. 2002; Lorig et al. 
2001; Lawn et al. 2015; Australian Capital Territory Department of Health 2013; Johnston 
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et al. 2012). Chronic condition self-management has various definitions.  The nationally 
agreed definition in Australia states that chronic condition self-management is “a 
process…directed toward managing the impact of the disease or condition on all aspects 
of living by the patient with a chronic condition. It includes, but is not limited to, self-care 
and it may also encompass prevention” (NHPAC 2006). The following principles are 
believed to contribute to this process:  
• Having knowledge of the condition and/or its management 
• Adopting a self-management care plan agreed and negotiated in partnership with 
health professionals, significant others and/or carers and other supporters 
• Actively sharing in decision-making with health professionals, significant others and/ 
or carers and other supporters 
• Monitoring and managing signs and symptoms of the condition  
• Managing the impact of the condition on physical, emotional, occupational and 
social functioning 
• Adopting lifestyles that address risk factors and promote health by focusing on 
prevention and early intervention 
• Having access to, and confidence in the ability to use support services (National 
Health Priority Action Council 2006; Australian Capital Territory Department of 
Health 2008; Australian Capital Territory Department of Health 2013). 
Chronic condition self-management has not been extensively explored in the setting of 
cancer survivorship. Part of the reason for this evidence gap relates to ongoing debate on 
whether cancer legitimately classifies as a chronic condition (Tritter and Calnan 2002).  
In 2009, Naus et al. published a cancer survivorship care model based on the 
conceptualisation of cancer as a chronic illness. The Cancer Survivor Adaptation Model 
was comprised of three components: personal context, adaptation process, and quality of 
life outcomes (Naus et al. 2009). Personal context referred to a persons’ beliefs and 
lifeworld in which the cancer was experienced. Adaptation process was identified as an 
ongoing and dynamic goal appraisal process. Quality of life outcomes were identified as 
the main outcomes impacted in both positive and negative ways. The Cancer Survivor 
Adaptation Model highlighted the importance of evolving survivor goals, non-static 
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adaptation processes and domain-specific quality of life measures including distress, goal 
satisfaction and perceptions of control. The model indicated a place for long-duration 
interventions to support survivors with goal adaptation and identity change. The Cancer 
Survivor Adaptation Model proposed that survivorship interventions needed to provide 
long-term support for survivors’ evolving priorities and goals in order to increase 
perceptions of control and quality of life (Naus et al. 2009). 
Building on Naus’ (2009) work, two Johns Hopkins University nurse scholars applied 
Corbin & Strauss’ 1985 Illness Trajectory Framework to cancer survivorship (Klimmek and 
Wenzel, 2012). The original Corbin & Strauss Illness Trajectory Framework was developed 
from in-depth interview data with 60 couples managing chronic diseases (Corbin and 
Strauss 1985; Corbin and Strauss 1988; Klimmek and Wenzel 2012). The researchers 
relied on grounded theory to more generally raise awareness of the invisible work 
associated with chronic illness management at home. The Adapted Illness Trajectory 
Framework identified the ways in which illness-related work, biographical work, and 
everyday life work interact for survivors. Klimmek and Wenzel provided examples of tasks 





Table 1: Domains and tasks of illness-related work 
Illness-related work domain 
(examples) 
Tasks and examples 
Regimen work Adhering to prescribed therapies and recommendations  
• Obtaining necessary medications and supplies  
• Learning the medication regimen and exercises  
• Reconstructive surgery  
• Lifestyle modifications  
• Scheduling and coordinating treatment visits  
Symptom management Managing symptoms or late effects  
• Monitoring and reporting symptoms to health and 
supportive care workers  
• Managing ongoing symptoms  
• Preventing or managing late effects of cancer treatment  
• Managing psychological sequelae (e.g., delayed distress, 
post-traumatic stress disorder) 
Care planning and maintaining 
continuum of care 
Maintaining the continuum of cancer care  
• Transitioning back to community and primary care  
• Communicating needs, treatment, and survivorship care 
plan to all health and supportive care workers 
 
Source:  Klimmek and Wenzel 2012, E502 
Table 2: Domains and tasks of biographical work 
Biographical work domain 
(examples) 
Tasks and examples 
Contextualising Putting the cancer experience into context, including  
• Seeing cancer and its consequences as part of everyday 
life  
• Integrating survivorship care and follow-up into daily life 
Coming to terms Coming to accept the implications of cancer and cancer 
survivorship by  
• Experiencing limitations or changes  
• Reviewing implications of these changes  
• Searching for meaning and reconciling  
• Relinquishing one’s former expectations and grieving 
losses  
• Restructuring perspective  
• Looking toward the future 
Reconstituting identity Adjusting to changes in one’s identity, including:  
• Physical • Sexual • Social • Spiritual • Psychological 
Integrating one’s identity into a new conceptualization of 
wholeness around limitations or consequences of cancer 
Recasting biography Giving new direction to one’s life plans, including  
• Managing uncertainty and growing as a survivor 
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Table 3: Domains and tasks of everyday life work 
Everyday life work domain 
(examples) 
Tasks and examples 
Relationship work Maintaining, renewing, or resolving social relationships, 
including 
• Negotiating intimacy and sexual relationships  
• Managing others’ unhelpful attitudes and expectations 
• Educating friends, family, and colleagues 
• Protecting loved ones from impacts of cancer 
Occupational work Performance of paid or unpaid formal work duties, including 
• Adjusting job duties as a result of limitations or symptoms 
• Negotiating return to work, employment transitions, or job 
loss 
• Dealing with issues of workplace discrimination 
Emotional and psychological 
work 
Managing variable emotions in response to feeling rules, 
including 
• Putting on a “game face” or brave front 
• Coping 
Maintaining or improving one’s psychological wellbeing, 
including 
• Managing daily and long-term stress 
• Managing prior mental health issues such as depression 
Health maintenance • Management of prior health issues or chronic conditions 
Housekeeping Maintaining the household, including 
• Modifying home environment to accommodate any loss of 
function 
• Housekeeping, shopping, cooking, yard work, and home 
maintenance 
 
Source: Klimmek and Wenzel 2012, e505 
The Adapted Illness Trajectory Framework provides a useful foundation to describe the 
work of cancer survivorship (Klimmek and Wenzel 2012). It succinctly highlights the 
diversity of issues faced by survivors and potential strategies that could be addressed by 
tailored intervention. The framework also supports survivorship intervention initiating 
during treatment to support illness-related work. The Adapted Illness Trajectory 
Framework informed the qualitative phase one study discussion guide and the delivery of 





Māori whānau-centred care 
 
Māori are tangata whenua, the indigenous people of NZ. The life-worlds of the groups 
referred to as tangata whenua and tangata tiriti (i.e. non-Māori New Zealanders) differ with 
respect to history, culture and social influences (Metge 1995). Perspectives on health and 
wellbeing differ between the two groups (Jansen, Bacal, and Crengle 2008; Walker et al. 
2008).  
The published models of Māori health integrate key elements that reflect priority values for 
many Māori. Mason Durie’s foundational Te Whare Tapa Whā model integrates four key 
elements as cornerstones of the whare or house that reflect Māori views on health and 
wellbeing (Durie 1994). The cornerstones represent the physical, the psychological, the 
family and the spirit which are held in balance when a person is experiencing wellbeing. 
Tinana represents the physical element. Hinengaro refers to the mental state. Wairua 
refers to the spirit. Whānau encompasses the immediate and wider family (Durie 1994). 
Later models contextualised these same four elements within a wider array of influencing 
environmental elements including te whenua or the land, and te reo the language (Ministry 
of Health 2015; Pere 2005a; Pere 2005b). Durie’s model was adopted in this study 
because it is a concise foundational model and it is widely used in the health sector 
(Doherty and Borrell 2013; Central Cancer Network 2016). 
Studies of Māori-specific experiences of healthcare have highlighted the application of 
Māori values and philosophies of health. Reports of Māori-specific experiences of health 
frequently mention whānau and increasing access to culturally appropriate carers (Cram, 
Smith, and Johnstone 2003; Kidd et al. 2013). These key considerations have been 
applied in delivery of programs under the  Whānau Ora initiative (Ministry of Health 2008) 
and in mental health services under the Meihana model (Pitama, Robertson, and Cram 
2007). Therefore, these approaches are referred to in this thesis as Maori whānau-centred 
care. 
Cram et al. (2003) published a qualitative Kaupapa Māori study of Māori health 
experiences and health practices. The authors conducted a content analysis on the 
transcript data from 28 semi-structured interviews with Māori living in Auckland, NZ. Key 
themes were identified around holistic health and the important influence of personal, 
whānau, and societal influences on health and wellbeing. The findings emphasised the 
importance attributed to wairua (spirituality) and how it contributes to rationalising the 
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causes of ill health. Other key influences included whānau involvement, 
whakawhānaungatanga (establishing relationships) with health and supportive care 
workers, and use of traditional ways (Cram, Smith, and Johnstone 2003). This study 
contributed evidence on how to deliver respectful and collaborative healthcare that can 
have a positive impact on the health of Māori individuals, their whānau, hapu and iwi. 
Cultural safety is an important aspect of Māori whānau-centred care (Harding 2013; Wepa 
2004). Cultural safety is a term developed by nursing educators which emphasised 
consideration of the impact of one’s own culture on practice (Wepa 2004). A recent 
Kaupapa Māori study by Kidd et al. (2013) explored the views of Māori men with regard to 
cultural safety in relation to their chronic illness experiences. The authors point to the need 
for  “health services to value the importance of being Māori, and to respond to issues 
relating to whakamā such as dignity, shyness, and not wanting to draw attention to 
oneself” (Kidd et al. 2013, 138). Relationship building and respectful engagement have 
been identified as important themes for the delivery of culturally safe and effective 
healthcare (Harding, 2013; Kidd et al. 2013; Slater et al. 2013; Wepa 2004).  
The Health Equity Assessment Tool (HEAT) was developed to aid intervention 
assessment and delivery in light of equity considerations (Signal et al. 2007). The HEAT 
user’s guide identified that interventions may be targeted to different levels (i.e. structural, 
intermediary pathways, health and disability services, and impact) and each requires 
unique considerations for equity. Published interventional approaches aiming to deliver 
Māori whānau-centred care emphasised people being treated as resourceful, skilful and 
strategic problem solvers (Kidd et al. 2013; Maoriora ki te Ao 2010; Padesky and Mooney 
2012; Te Puna whanau ora network alliance 2012).  
Strengths-based interventions in support of Māori health and wellbeing relate to tino 
rangatiritanga (Sanders and Munford 2010; Turia 2011; Cram, Smith, and Johnstone 
2003). Tino rangatiritanga is often translated to mean self-determination (Moorfield 2005). 
Self-determination in healthcare requires an approach that supports development of 
competence, autonomy and relatedness within an individual’s physical, emotional, social 
and cultural environment.  
The individual, whānau, and community are holistically and inextricably intertwined in 
Māori whānau-centred care models. However, these elements are also linked with health 
determinants in the literature (Slater et al., 2013; Tobias & Turley, 2012). Health 
determinants refer to the personal, social, economic, cultural and environmental factors 
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and drivers that influence health status (Blas and Kurup 2010). Within the healthcare 
environment, care delivery and clinical factors and drivers can be described at different 
levels of influence on the individual, whānau, and community (i.e. intrapersonal, 
interpersonal, institution or organisation, community and system levels) (Zapka et al. 2012; 
Golden and Earp 2012; Lang and Rayner 2012). Interventions are impacted by health 
determinants related to environmental factors and drivers. Environmental context is an 
important consideration in health intervention development and delivery that addresses 
inequity.  
Māori whanau-centred care aims to recognise and deliver care that values and addresses 
the complex and dynamic interactions of person, culture, environment and spirit (Turia 
2011). Māori whanau-centred care, based in Māori health philosophies, is a model of care 
that has been operationalised through Whānau Ora initiatives (Maoriora ki te Ao 2010). In 
these approaches, holistic consideration is given to the cause and treatment that best 
marries symptom contexts with a combination of physical, environmental, spiritual and 
social solutions (Kidd et al. 2013; Slater et al. 2013; Turia 2011). Māori whanau-centred 
approaches to healthcare integrate collaborative and empowering healthcare to support 
overall wellbeing delivered using principles of cultural safety. These are also important 
considerations for intervention research that can address inequities and deliver care that is 
acceptable for Māori. 
 
Māori health and cancer experiences  
 
The literature points to inequity in cancer care and outcomes for NZ Māori (Hill et al. 2010; 
Ministry of Health 2015a; Robson et al. 2005; Robson et al. 2010; Shaw et al. 2006). 
Several studies attribute the inequity associated with cancer care and outcomes to a 
combination of factors (Hill et al. 2010; Robson et al. 2005; Robson et al. 2010). Proposed 
factors contributing to inequity include NZ’s monocultural-based health system (Dew, 
Signal et al. 2015; Walker et al. 2008; Hill et al. 2010), lack of recognised cultural 
competence among health and supportive care workers delivering cancer care (Dew, 
Signal et al. 2015), and discrimination due to racism (Walker et al. 2008). Each of these 
factors lead to differential care for Māori cancer patients (Hill et al. 2010). 
Cancer diagnosis and treatment pathways in NZ have been identified as challenging for 
Māori (Cormack et al. 2005; Dew, Signal et al. 2015; Walker et al. 2008). The literature on 
Māori-specific cancer experiences has established that cancer care delivery fails to meet 
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Māori needs and expectations (Cormack et al. 2005; Doolan-Noble et al. 2006; Hutt Valley 
DHB et al. 2006; Slater et al. 2013; Walker et al. 2008). Several studies have shown 
differences between how the cancer journey is perceived by Māori compared to non-Māori 
(Dew, Signal et al. 2015; Slater et al. 2013; Walker et al. 2008).  
Dew, Signal et al. (2015) conducted a qualitative study in which 34 respondents were 
interviewed about their access to and experiences of cancer care. The 19 Māori and 15 
non-Māori participants were asked to describe their experiences of cancer care. The 
qualitative interview data were analysed and differences in categorisations and descriptors 
used were found.  Four key areas differentiated between how Māori and non-Māori 
described their experiences of cancer care. These areas were described as: 1) use of 
alternative therapies, 2) the bearing of whānau, 3) discrimination, and 4) respect, 
embarrassment and care. These areas were identified as key contributors to cultural 
dissonance that impacted on the experience of cancer care for Māori in the NZ health 
system (Dew, Signal et al. 2015). 
Slater et al. (2013) based their study on interviews with 12 Māori cancer patients. The data 
gathered from these experience accounts highlights the importance of whānaungatanga 
(relationships). The authors interpret this data to illustrate the importance of building 
effective established relationships with primary healthcare practitioners as well as Māori 
health and supportive care workers. These relationships are described as critical 
foundations for positive experiences and support for patients and whānau affected by 
cancer (Slater et al. 2013). 
A 2008 qualitative study by Walker et al. reported on Māori experiences of cancer and 
ways to address perceived gaps in care. Results were reported in relation to 
environmental context incorporating health system, healthcare process and patient-level 
factors. Key issues of importance for Māori were identified as whānau involvement in the 
cancer journey, holistic approaches, and recognition of the cultural context as it relates to 
emotional and spiritual support. The authors identified components of cultural context 
included recognition of wairua (spirituality), importance of whakawhānaungatanga 
(relationships), and the role of whakapapa (genealogy). Participant suggestions for 
improvements to cancer services included better resourcing of Māori providers, cultural 
competence training for all health and supportive care workers, the use of systems 




These three studies conclude that cultural factors and expectations influence healthcare 
experiences generally, and cancer care specifically. The studies share similarities in 
findings. For example, each study emphasises the importance of whānau and 
whānaungatanga for Māori. Although the studies have small sample sizes and the findings 
are not generalizable to the target population studied, the results show more similarities 
than differences. Taken together, these results suggest that care delivery expectations are 
influenced by cultural context. Further, improvements to care delivery for Māori can be 
informed by consideration of cultural elements with resulting emphasis on relationships, 
whānau and cultural safety. 
 
The Chronic Care Model 
 
A basic tenet of this thesis is that The Chronic Care Model can inform redesigned 
survivorship care pathways. A cancer survivorship lens expands the scope of cancer care 
and “challenges old paradigms that oncology’s work is done after treatment” (McCorkle et 
al. 2011, 50). If cancer is conceptualised as a chronic condition, then evidence and models 
relating to optimal care of chronic conditions are relevant. Redesigned care pathways that 
integrate relevant chronic condition-based approaches in cancer care may be a way 
forward that is acceptable and equitable. 
The Chronic Care Model is described as a framework that identifies principles to support 
best-practice person-centred chronic illness care in light of structural drivers and 
organisational configurations (Wagner 1998; Wagner et al. 1996). The Chronic Care Model 
was developed after a review and categorisation of intervention research for various 
chronically ill populations (Wagner et al. 1996). Intervention research literature indicates 
the importance of six elements (Bodenheimer, Wagner, and Grumbach 2002). The key 
integrating concept for The Chronic Care Model is that successful approaches to chronic 
care must integrate each of the intervention elements to yield improved outcomes.  
The Chronic Care Model demonstrates how productive interactions between an informed 
activated patient and a prepared proactive practice team are supported by six key 
elements. The six elements must work in tandem. The Model aims to improve integration 
and delivery of care for people affected by chronic conditions (Wagner et al. 1996). The 




Figure 5: Wagner’s (1996) Chronic Care Model  
Source: MacColl Institute, 2016 
Wagner’s model sets out components of best-practice delivery and delivery settings to 
reach improved health outcomes for people with chronic conditions (Wagner et al. 1996). 
The Chronic Care Model is based on the concept that productive and planned interactions 
between health practitioners and patients, fostered by the community and health system, 
are the basis for improved outcomes. Each of the six elements are derived from a 
considerable literature base (Bodenheimer, Wagner, and Grumbach 2002; Coleman et al. 
2009; Wagner 1998). These elements will each be described in turn.  
The first element of the Chronic Care Model is community. This element consists of 
community programs, local agencies, schools, faith organisations, businesses and clubs 
that provide support, resources and policies toward improved health.  
The overarching health system element is comprised of four sub-elements: self-
management support, delivery system design, decision support and clinical information 
systems. These health care organisation delivered elements aim to support productive 
interactions and improved outcomes for patients (Coleman et al. 2009). These elements 
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are equally important and must be considered together. For example, clinical information 
systems and decision support tools inform options that are accessed by patients through 
accessible delivery system design. Supported self-management is important to establish a 
collaborative partnership between healthcare practitioners and people affected by illness 
to support decision-making on options.  
Self-management support as a key element of The Chronic Care Model is described first 
given that it is the topic of this thesis. “Chronic condition self-management is a process 
that includes a broad set of attitudes, behaviours and skills” (NHPAC 2006). A 
comprehensive definition was provided earlier in the chapter on page 36. This process is 
included as a key element of The Chronic Care Model because the approach has an 
extensive evidence based (Glasgow et al. 2002; Wagner 1998; Wagner et al. 1996). Since 
first publication of The Chronic Care Model, self-management support has received 
growing attention as a way of empowering patients to be partners in the effective 
management of their health (Bodenheimer et al. 2002; Boger et al. 2015; Chodosh and 
Morton, 2005; Newbould, Taylor, and Bury 2006; Sarfati et al. 2016). Self-management 
support has traditionally been delivered via information, online programs, workshops and 
intervention programs (Foster and Fenlon 2011). A supported self-management program 
helps people to identify their needs and priorities, in collaboration with health and 
supportive care workers, resulting in enabling and empowering solutions-based 
interactions (de Silva and Health Foundation 2011). Established, well-known, evidence-
based self-management programs have originated in the USA, UK and Australia 
(FHBHRU 2005; Lorig et al. 2001; Newbould et al. 2006). The literature review in the next 
chapter explores self-management and supported self-management programs in more 
depth. 
A second key element of The Chronic Care Model is delivery system design. This element 
relates to how care is delivered. Evidence shows that care providers that are encouraged 
to deliver quality care, supported by professional development and clinical leadership, 
leads to improved patient outcomes (Wagner et al. 1996). The delivery system design 
element is shown to be best supported by care pathways and evidence-based clinical 
practice guidelines (Wagner et al. 1996; Wagner 1998).  
Decision support is a third key element of The Chronic Care Model. Tools embedded 
within clinical information systems can inform best-practice treatment options derived from 
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clinical variables. The element of decision support is about encouraging availability of 
information tools for delivery of best-practice care by health and supportive care workers. 
Clinical Information systems, a fourth key element, incorporates clinical notes as well as 
results and reminder systems in electronic health records. Registries, to catalogue disease 
incidence, mortality and, at times, care management are included under this element. 
For people affected by chronic conditions, an active role in care management has been 
identified as an important aspect of productive interactions and improved outcomes within 
The Chronic Care Model (Coleman et al. 2009; Bodenheimer, Wagner, and Grumbach 
2002). There is growing emphasis globally being placed on encouraging active and expert 
patients that want to collaborate in their healthcare and wellbeing (Wilson 2008). In NZ, 
person-centred care based in collaboration is indicated by key NZ policy documents. Two 
of the guiding principles of the NZ Cancer Control Strategy are that activities should 
“reflect a person-centred approach” and “actively involve consumers and communities” 
(Minister of Health 2003b). However, research does indicate that not all people want the 
same type of participation in person-centred care. Individual characteristics that have been 
found to present a barrier to person-centred care have included 1) unwillingness to appear 
ignorant; 2) uneasiness in communicating within a perceived power imbalance i.e. with a 
member of a higher social class; 3) provider reluctance to share control of the interaction, 
and/or; 4) patient concession to expert authority (Roter 1977). By applying chronic care 
approaches that are proactive, planned and population-based, work towards achieving 
personalised person-centred cancer care in NZ may become less aspirational and more 
operational. 
The Chronic Care Model has been applied and reviewed in numerous studies aiming to 
improve chronic illness management in various health care settings (Barr et al. 2003; 
Battersby et al. 2010; Coleman et al. 2009; Kadu and Stolee 2015; Pearson et al. 2005). 
The 2008 ABCC study aimed to provide standardised guidance to improve NZ DHB 
effectiveness and efficiency of health service delivery using The Chronic Care Model as a 
foundation (Connolly 2011). The ABCC study followed-on from the 2007 National Health 
Committee recommendation that DHBs set disease-management programs within the  
Chronic Care Model in order to ensure effectiveness, and that generic disease-
management programs be developed in preference to single disease-management 
programs (Connolly 2011; National Health Committee 2007a). Some DHBs were found to 
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be effectively delivering healthcare within The Chronic Care Model, but standardised 
implementation was needed and further evidence-based research was recommended. 
 
Part two summary 
 
The literature shows that cancer impacts on life and challenges self-management. Cancer 
survivors report visible and invisible impacts related to living with, through and beyond 
cancer. These impacts create vulnerabilities that are experienced and described 
differentially across individuals and groups. Cancer-related impacts are common, 
personal, variable across time and wide-ranging. 
Models of care provide useful guides to deliver intervention that may address survivorship 
impacts. Various models can be used to guide intervention research. The foundational 
Māori health model, Te Whare Tapa Wha, fits the holistic nature of cancer survivorship 
impact described in the literature and is well-regarded in the NZ health context (Durie 
1994).  
A key consideration for survivorship intervention in NZ is equity and acceptability for Māori. 
Delivery of intervention that is acceptable for Māori, can be informed by Māori whānau-
centred care approaches. These aim to prioritise establishing relationships and inclusion of 
whānau, alongside using cultural safety and strengths-based approaches, in supportive 
environmental contexts. 
The diversity of work of cancer survivorship has been described using the Adapted Illness 
Trajectory Framework (Klimmek and Wenzel 2012). Cancer survivors manage variable 
and intermittent holistic impacts both during and post-treatment. Therefore, intervention at 
the front-end of the cancer trajectory is considered to have potential utility to support 
survivorship work during and post-treatment. 
The Chronic Care Model integrates various elements relevant for any healthcare 
intervention (Wagner et al. 1996). It is a well-regarded and evidence-based model of care 
that can inform intervention relevant to the NZ survivorship context. The impacts of cancer 
are often chronic but there is debate as to whether classifying cancer as a chronic 
condition is useful. The cancer trajectory is different from other chronic conditions 
pathways so it is unclear if chronic care interventions can be transplanted to support 
cancer survivorship. However, chronic conditions research has a long history and provides 
a strong foundation for exploring cancer survivorship approaches. Further, The Chronic 
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Care Model is not prescriptive and can include priorities derived from Māori whānau-
centred care approaches. 
In summary, this part two section of the background chapter highlights survivorship 
impacts and models of care. Based on the evidence, three models were presented and 
described as relevant to address the research questions: Te Whare Tapa Wha (Durie 
1994), the Adapted Illness Trajectory Framework (Klimmek and Wenzel 2012), and The 
Chronic Care Model (Wagner et al. 1996). The Te Whare Tapa Wha model illustrates the 
wide-ranging impacts that characterise Māori health philosophies and perspectives (Durie 
1994). The Adapted Illness Trajectory Framework describes the work of cancer 
survivorship (Klimmek and Wenzel 2012). The Chronic Care Model shows six key 
principles that work in tandem to deliver best-practice chronic conditions care (Wagner et 
al. 1996). These three models were drawn upon to guide the two-phased intervention 
program research presented in this thesis.  
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Part three: Intervention 
 
Quality improvement is a primary aim of the NZ health system (Minister of Health 2003a; 
Minister of Health 2016a). Research into health interventions can provide evidence for 
approaches that progress quality health delivery toward better care, efficiencies and 
service improvement (The Health Foundation 2013). Health interventions were defined in a 
2000 UK National Institute for Clinical Excellence report as “drugs, devices, procedures 
and the organisational and support systems within which healthcare is delivered” (National 
Health Committee 2005).  
Healthcare interventions include roles, policies or programs put in place as “a set of 
actions with a coherent objective to bring about change or produce identifiable outcomes” 
(Rychetnik et al. 2002). Interventions can target improvements in patient-reported 
outcomes, clinical care outcomes, or organisational and system outcomes (The Health 
Foundation 2013; World Health Organization 2006).  
Service delivery interventions are of a wide variety and can be categorised in many ways. 
For example, one way to categorise a service delivery intervention is to identify the level 
on which the intervention is targeted. Effective interventions are influenced by, and may 
impact on, outcomes at the individual or intrapersonal level, interpersonal or family and 
care team level, institutional or organisational level, and systems levels (Golden and Earp 
2012). These levels provide a means to categorise interventions as well as to identify 
enablers and barriers to intervention delivery. Examples of interventions aimed at the 
structural level are national or organisational policies. Institutional level interventions target 
improvements in resources or policy at the organizational level. Interpersonal-level 
interventions aim to create change in social relationships between members of a family or 
with a care team. Intrapersonal level interventions target change in the knowledge, belief 
or skills of individuals. Ideally interventions target more than one level, but interventions 
targeting more than one level have been identified as difficult to administer due to 
structural barriers such as limited resources (Golden and Earp 2012). 
Multiple factors and drivers impact on intervention acceptability, feasibility and 
effectiveness. Examples of factors or drivers that impact on interventions are change 
champions and resource availability (The Health Foundation 2014). The level of impact of 
any intervention is affected by personal and environmental factors. Important 
considerations for monitoring intervention acceptability, feasibility and effectiveness are 
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fidelity and scaling. An intervention study with high levels of fidelity is reproducible (Carroll 
et al. 2007; Horner, Rew, and Torres 2006). Scaling a study involves a series of processes 
to introduce interventions, within an existing context, through a program delivery structure 
that accounts for enablers and barriers, with the aim of improving coverage and equitable 
access to the intervention (Mangham and Hanson 2010).  
Analytical frameworks, such as RE-AIM, have been developed to guide intervention 
implementation and evaluation within the environmental context (Glasgow et al. 2001; 
Glasgow 2002; Glasgow et al. 2006; National Cancer Institute Cancer Control Science 
Implementation Team 2012). RE-AIM is a well-known and widely utilised scientific 
framework and checklist for assessing the strengths and weaknesses of interventions in 
real-world settings, with emphasis on implementation fidelity (Glasgow et al. 2001; 
National Cancer Institute Cancer Control Science Implementation Team 2012). RE-AIM 
stands for reach, effectiveness, adoption, implementation and maintenance (Glasgow 
2002). This analytical framework supports evaluation of complex health service 
interventions across relevant domains to inform intervention adaptations required in 
feasibility studies that lead to improved randomised or multi-site trials. 
Evaluation theory postulates that interventions themselves do not result in improved 
outcomes (Astbury and Leeuw 2010). They, instead, generate mechanisms that may 
impact on behaviours of individuals and organisations that can affect outcomes (Keating 
2014; Astbury and Leeuw 2010). Identifying causal mechanisms that deal with complex 
systems and service users can be difficult. Although proving causality and effectiveness in 
intervention studies is fraught and difficult, “identifying mechanisms that link cause and 
effect relations is crucial for the development of deeper and more fine-grained 
explanations of social phenomena” (Astbury and Leeuw 2010, 363). In the context of this 
thesis, it is unlikely that the complexity of survivorship can be addressed by a single 
intervention. However, it is hoped that insights can be developed incrementally over 
multiple studies generating increasing evidence. 
 
Complex intervention framework 
 
Humans and the systems they create are complex systems because different individuals 
and organisations can act independently and unpredictably. Therefore, in accordance with 
Complexity Theory, outcomes from interventions can be surprising and chaotic (Thompson 
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et al. 2016). An intervention framework assists with outlining an approach that generates 
multiple types of evidence to evaluate intervention context and possible mechanisms to 
help generate useful outcomes and insights into causality. 
The UK’s Medical Research Council (MRC) has published guidance on complex 
interventions (MRC 2009) in an attempt to develop a standardised approach that 
recognises that interacting intervention components may result in variability of outcomes. 
The MRC document A Framework for the Development and Evaluation of Randomised 
Controlled Trials for Complex Interventions states that "the greater the difficulty in defining 
precisely what exactly are the `active ingredients' of an intervention and how they relate to 
each other, the greater the likelihood that you are dealing with a complex intervention" 
(MRC 2000, 1). 
The framework document published by the MRC in 2000 outlined a linear phased 
approach to randomised controlled trial (RCT) design (MRC 2000). The sequential 
framework consists of five steps. The ‘pre-clinical’ or theoretical phase is step one 
whereby interventions and their proposed mechanisms of action are identified from the 
literature. Identified confounders and strategic design issues associated with interventions 
are also reviewed in this first step. Step two is referred to as the modelling phase. It 
involves developing a deeper understanding of intervention components and how they 
may inter-relate through computer simulations or qualitative testing. Step three is the 
exploratory trial phase whereby a protocol is tested out in a real world setting. Step four 
is the definitive RCT phase using a tested protocol that is defensible, reproducible and 
adequately controlled. Step five is the long-term implementation phase which entails a 
separate study to establish the real-life effectiveness of the intervention over time. The 
framework emphasises good practice methodology for informing development of RCTs 
outlining a focus on identification of the mechanisms or key ingredients of a complex 
intervention that produce effects or outcomes (MRC 2000).  
In 2008, the MRC published updated guidance that evolved their vision from a linear 
approach to one that enabled increased flexibility and allowed for refinement across and 
between phases (Craig et al. 2008). In hindsight, the MRC noted that health interventions 
require coordinated efforts at multiple points which was not reflected by the original 
approach (Sahasranaman 2011). The key difference between the updated model and the 
original one is the iterative and flexible approach as well as a recognition that multiple 
approaches to multi-site study-designs beyond the RCT were valid and useful. The 
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updated, iterative framework, shown in Figure 6, informed the methods for the studies 
reported on in this thesis (MRC 2009). 
 
Figure 6: 2009 MRC framework for developing and evaluating complex interventions 
 
The use of the MRC Guidance enables iterations of development and feasibility testing to 
generate evidence for intervention. The MRC framework was utilised to guide the research 
presented in this thesis. A phase one qualitative study was devised to ‘model’ the 
intervention. A phase two randomised single-site exploratory pilot study was envisioned. 
Ultimately, the goal was delivery of an effective intervention which could be scaled up as 
one of several standardised cancer survivorship pathways. 
 
Intervention and survivorship 
 
NZ’s cancer care pathways are designed to deliver individual outcomes and to meet 
system priorities such as addressing disparities, decreasing waiting times, improving 
access, and sustaining services within a climate of constrained resources (Mays 2013). 
One recent survivorship intervention delivered in NZ involved introduction of cancer care 
coordinator roles into hospital-based cancer care settings (Cancer Institute NSW 2011; 
Collinson et al. 2013). Cancer care coordinators in NZ are generally hospital-based clinical 
nurse specialists that work with people affected by cancer to help them connect with 
essential health services and reduce delays in treatment (Collinson et al. 2013). Care 
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coordination roles enable delivery of support by multiple tools and strategies based on 
patients expressed needs and priorities. Cancer care coordinators were identified as a 
cost-effective person-centred intervention in cancer care (Blakely, 2013; Blakely et al., 
2015).  
In the UK, the National Cancer Survivorship Initiative has provided the overarching 
structure for delivery of survivorship interventions (National Cancer Survivorship Initiative 
2010). Self-management support was included in the ‘recovery package’ (National Cancer 
Suvivorship Initiative 2013). Redesigned care pathways were tested. Survivors of breast, 
prostate, colorectal and lung cancers undertook goal assessment and risk stratification to 
inform novel ways to deliver survivorship care (Oeffinger et al. 2014). An evidence-based 
report was produced as a basis to guide delivery of interventions aiming to improve 
survivorship outcomes (National Cancer Suvivorship Initiative 2013). 
In Australia, a series of demonstration projects have taken place. In 2011, the Victorian 
state government in Australia funded six two-year cancer survivorship demonstration 
projects targeting post-treatment transition (Jefford et al. 2015). The projects included 
shared care and nurse-led delivery models and supported self-management/wellness 
interventions. The projects’ process and project-specific outcomes were compared and 
reviewed. The enablers and challenges/barriers for the projects were presented in a tiered 
ecological categorisation at the individual, organisation and system levels. Individual 
enablers included patient readiness to engage in survivorship tasks while the barriers for 
health practitioners were identified around terminology and lack of flexibility in project 
delivery. Organisational enablers included clinical champions and staff recognition of 
survivorship issues while the barriers were cited as organisational processes that could not 
readily identify transitioning survivors, lack of individual readiness for change, time-
consuming interventions constrained by appointment time expectations, and difficulty 
measuring cost and outcomes. The need for risk-stratified pathways and development of 
survivorship priority and unmet needs assessment were emphasised. System enablers 
included workforce education and training, existing relationships with primary care, and 
partnerships with community providers. The system barriers included lack of tools and 
ways to implement needs assessment and risk stratification. The overall conclusion was 
that early preparation of patients for survivorship with tailored interventions was useful, but 




Summary of background chapter 
 
Cancer survivors represent a growing segment of the population. Increases in cancer 
survival are an epidemiological trend that has informed research directions in the discipline 
of public health. The impacts of cancer cut cross social, physical, emotional and spiritual 
domains. These impacts sometimes have a significant lingering effect on the wellbeing of 
individuals and whānau affected by cancer. Interventions may be useful to address these 
impacts and improve care delivery. 
Models of care inform intervention delivery. Durie’s 1994 Te Whare Tapa Wha model 
provides a framework to view health and wellbeing from a Māori perspective. It is used to 
guide understanding and delivery of culturally safe interventions that aim to reduce 
inequities. Cancer is increasingly classified as a chronic condition. Wagner’s 1996 Chronic 
Care Model provides a framework that fits with cancer survivorship. Supported self-
management is an integral element of this model. 
The MRC guidance on complex interventions provides an established framework for 
development and monitoring of intervention delivery. The broad aim of this research is to 
deliver an intervention that can trigger improvement in the care and outcomes for cancer 
survivors. This research is needed because improvements in cancer survival have not 
been paralleled by development of care pathways that adequately address the ongoing 
needs of survivors. This research is based on use of an intervention framework, guided by 
models of care, to support intervention delivery.
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CHAPTER 3: Supported self-management and cancer 
survivorship 
 
This chapter presents the evidence and rationale for implementing and evaluating 
supported self-management as a potential intervention to support cancer survivors. The 
background information provided in Chapter two described increasing numbers of cancer 
survivors as well as persistent inequities in cancer care and outcomes. The issue being 
addressed in this thesis is that cancer survivorship is associated with long-term, often 
chronic, impacts and ongoing problems. These impacts span across the Te Whare Tapa 
Wha four cornerstones of health and wellbeing: physical, emotional, spiritual and social 
(Durie 1994). The Chronic Care Model was chosen as a guiding framework for intervention 
identification aimed at exploring this gap in survivorship care (Wagner et al. 1996). 
Interventions and a guiding intervention delivery framework, The MRC Guidance on 
Complex Interventions, was then described to inform the methodology to proceed (MRC 
2009). 
Supported self-management intervention programs are person-centred approaches with 
potential applicability in NZ cancer care pathways. First, working definitions of self-
management and supported self-management are presented in this chapter. A brief history 
of the development of supported self-management, its theoretical foundations, and three 
structured programs are then outlined. The enablers and barriers of supported self-
management interventions are summarised in order to establish the context for choosing 
one of the three structured programs for implementation in the NZ cancer care context. 
The final sections summarise the findings from the large and rapidly expanding body of 
supported self-management literature to outline gaps warranting further investigation. 
 
Self-management and supported self-management 
 
Health self-management occurs when individuals seeking healthcare take one or more 
actions to manage and monitor their own health and wellbeing. Actions that indicate self-
management of health include “eating well, exercising, taking medicines as prescribed, 
keeping in good mental health, watching for changes, coping if symptoms worsen and 
knowing when to seek professional help” (de Silva 2011, vii).  
Self-management has an extensive literature base. It is variously described as a 
philosophy (Flinders Health Behaviour & Health Research Unit 2011), a model of care 
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(Lee et al. 2012) and an intervention outcome (Fowles et al. 2009). In these various 
manifestations, self-management is always associated with chronic or long-term 
conditions. Seven principles commonly associated with chronic condition self-management  
are shown in Figure 7 (FHBHRU 2005; Lawn and Battersby 2009). 
 
Figure 7: Seven principles of chronic condition self-management 
 
Early proponents of self-management proposed that effective self-management was 
indicated by: 1) collaboration with health and supportive care workers; 2) a documented, 
systematic approach including routine assessment of both parties’ priorities and goals; 3) 
action planning and goal setting that is regularly monitored for effectiveness; and, 4) 
effective use of resources to support health (Wagner 1998; Clark et al. 1991; Lorig et al. 
2001; Bodenheimer et al. 2002). Dr Kate Lorig, an expert in this field and developer of The 
Stanford Program, one of the first supported self-management programs, defines self-
management support programs as follows: 
Self-management programs aim to help patients with medical management, 
maintaining life roles, and managing negative emotions, such as fear and depression. 
In addition, programs provide patients with the necessary knowledge, skills, and 
confidence (self-efficacy) to deal with disease-related problems. Finally, self-
management prepares patients to collaborate with their health care professionals and 
the health care system (Lorig et al. 2001, 257). 
Self-management is a term associated with various meanings and widely applied. It has 
been used to describe information delivery, online programs, workshops and programs 
and many other techniques and tools (NHPAC 2006). 
The terms self-management and self-care are often used interchangeably adding to 
terminology confusion. In the wider context of self-care, self-management can be 
Seven principles of chronic condition self-management 
Individuals with chronic conditions: 
1. Have knowledge of their condition 
2. Follow a treatment plan (care plan) agreed with the health professionals 
3. Actively share in decision making with health professionals 
4. Monitor and manage signs and symptoms of their condition 
5. Manage the impact of conditions on the physical, emotional and social life 
6. Adopt lifestyles that promote health  




considered a way to achieve self-care (Omisakin and Ncama 2011) or as a stand-alone 
endeavour. Self-care is defined herein as actions taken on one’s own. Self-care may 
include actions taken to reduce the risk of disease (Clark et al. 1991; Omisakin and Ncama 
2011) or to preserve identity, function and normality (Kidd et al. 2008; Pan et al. 2011). In 
NZ, indigenous Māori self-care may include traditional practices, called rongoa, that 
supports wellbeing via plant-based medicines and massage (Dew et al. 2015). More 
broadly, self-care differs from supported self-management because self-care practices and 
applications may occur away from the purview of health and supportive care workers. 
Supported self-management involves “engaging in activities that protect and promote 
health, monitoring and managing the symptoms and signs of illness, managing the impact 
of illness on functioning, emotions and interpersonal relationships, and adhering to 
treatment regimes in partnership with health professionals and community resources” 
(Center for the Advancement of Health and Center for Health Studies of the Group Health 
Cooperative of Puget Sound 1996, 1). Supported self-management is one of the six key 
elements of The Chronic Care Model (Glasgow, Orleans, and Wagner 2001). The 
overarching aims of supported self-management interventions are to inspire and foster use 
of skills and strategies by the person accessing healthcare for collaborative problem-
solving, health monitoring and decision-making enabled and empowered by a partnership 
with health and supportive care workers (Chodosh and Morton 2005).  
Information on supported self-management was sourced from the English language 
literature captured in two major databases, Medline and Google Scholar, as well as from 
the grey literature identified in NZ and Australia. The terms ‘self-management’ and ‘self-
care’ alongside ‘cancer’, ‘neoplasm’ and ‘oncology’ were entered as search terms with 
results limited to between 1996 and 2015. Studies were restricted to English language 
reports with the target population being adults. The term ‘intervention’ was later added in 
to narrow down the results. An abstract review on just over 20,000 abstracts was 
conducted on the Medline results to help with narrowing the scope of the results of interest 
from the Google Scholar search field. Due to the size and range of the literature, this 
literature is presented as a narrative review rather than a formal systematic review. 
Further, this literature review summarizes meta-analyses prior to highlighting and critiquing 
individual self-management studies. 
This thesis focuses on delivery of a supported self-management program for people living 
with, through and beyond cancer. Within that context, self-management is noted to occur 
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when individuals take responsibility and actions to manage and monitor their physical, 
psychological, social and spiritual wellbeing while living with, through and beyond cancer. 
 
Foundations of supported self-management programs 
 
Supported self-management programs can be delivered as complex interventions that aim 
to systematically improve the way individuals self-manage chronic conditions and achieve 
a sense of wellbeing (Mills et al. 2014). These programs are complex interventions 
because they consist of multiple active ingredients that cover multiple topics delivered with 
various formats and strategies (Mills et al. 2014; MRC 2000). Supported self-management 
programs differ from other complex interventions targeting wellbeing because this 
approach is specifically structured around systematically fostering a partnership with 
health and supportive care workers (de Silva and Health Foundation 2011). Substantial 
evidence has been generated over the last 35 years to support improved health outcomes 
resulting from partnerships enabled and inspired by supported self-management 
approaches or programs. The historical foundations for this approach are critically 
reviewed in this section. 
In 2016, there is still no gold standard definition for self-management support. This thesis 
adopts the IOM definition of supported self-management: 
the systematic provision of education and supportive interventions by health care staff 
to increase patients’ skills and confidence in managing their health problems, including 
regular assessment of progress and problems, goal setting, and problem-solving 
support (Institute of Medicine 2003, 52). 
Over the years, the term self-management has been widely used as an intervention 
descriptor. This has led to discourse differences and contributed to wide variation in the 
way the term ‘supported self-management’ has been applied in the literature. The authors 
of supported self-management meta-analyses reviewed in this section describe wide 
variation in interventions delivered under this classification which contributes to 
methodological confusion. This state-of-affairs appears to limit the understanding of self-
management terminology and practice. It also contributes to a lack of comparability 
between various self-management programs. In order to categorise the numerous 
supported self-management programs reported in the literature, these programs have 
been differentiated from self-management promotion and education programs (Gao and 
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Yuan 2011). Table 4 identifies key variables that differentiate between these two types of 
self-management programs as described in the literature.  





promotion and education 
programs 
Program focus Partnership 
Collaborative problem-solving 
Patient education and 
disease-specific information 
delivery 
Offerings Problem identification, decision-
support,  collaborative identification 
of actions and alternative options, 
care planning 
Information, discussion 
points and technical skill 
practice 
Issues defined by Person receiving healthcare and 
healthcare practitioner 
Health and supportive care 
workers 
Outcome indicators Self-efficacy, QOL Knowledge measures and 
clinical indicators 
Disease orientation Can address comorbidity and 
complexity 
Disease-specific 
Key factors Health provider competencies 
delivered by way of skills and 
strategies to support individual and 
whānau motivation and self-
efficacy 
Health seekers with low 
health literacy or health 
confidence are optimal target 
group 
Examples The Flinders ProgramTM  
The Stanford Program 
The Expert Patients Program 
Living with Cancer Education 
Program 
Kia ora – E te iwi 
 
Supported self-management intervention programs differ from self-management promotion 
programs in program focus, tools, who defines problems, preferred outcome indicators, 
disease orientation and key contributing factors. There is no specific and accepted global 
definition of supported self-management and few core program components agreed as 
critical for successful program delivery (Warsi et al. 2012). In this thesis, attention to 
partnership and collaborative processes, fostered between a person seeking care, and 
health and supportive care workers, are regarded as key indicators of a supported self-
management intervention program. 
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In summary, supported self-management intervention programs are a subset of self-
management approaches. They are classified as complex interventions and include 
collaboration as a key component.  
 
Supported self-management programs 
 
Supported self-management programs, delivered by health and supportive care workers, 
aim to enable, inspire, empower and up-skill individuals affected by chronic health 
conditions, to take action in home and community settings to manage their physical, 
psychological, social and spiritual wellbeing (Bycroft and Boyd 2011). Supported self-
management programs prioritise collaboration as the basis for encouraging development 
of tailored strategies to support problem-solving and decision-making (Bodenheimer, 
McGregor, and Sharifi 2005). 
Research and development into supported self-management programs began in the 
1970’s. Early programs were disease-specific. Diseases for which supported self-
management programs were developed included asthma (Beasley, Cushley, and Holgate 
1989; D’Souza et al. 1994), diabetes (Counties Manukau DHB 2016; Fisher et al. 2005; 
Williams et al. 2005), arthritis (Lorig et al. 2001), and heart disease (Clark et al. 1991). 
Published NZ literature from the 1990’s described effectiveness of supported self-
management programs for New Zealanders diagnosed with asthma and diabetes 
(D’Souza et al. 1994; Counties Manukau DHB 2016). Overseas evaluation studies of 
disease-specific programs identified improvements in various clinical and functional health 
outcomes but results were found to be inconsistent, especially in studies working with 
older adult cohorts (Chodosh and Morton 2005). 
Clark et al. (1991) published one of the earliest reviews of supported self-management. 
The authors summarised available literature across five chronic conditions to ascertain if 
there was any consensus on self-management tasks supported. They identified four sets 
of self-management tasks that could empower people to reach optimal outcomes in 
chronic condition management. The first set of tasks involved promotion of motivation to 
develop and use strategies for wellbeing. The second set of tasks involved collaborative 
monitoring and management of the condition through partnership between individuals 
seeking care, and health and supportive care workers. The third set of tasks involved 
introduction and use of tools to build self-efficacy. The fourth set of tasks aimed to 
empower individuals to maintain life roles which was deemed important for self-esteem 
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and relations with others. The study concluded that the key tasks of supported self-
management fell into two distinct categories: at-home management and psychosocial 
coping (Clark et al. 1991).  
Contemporary generic supported self-management programs incorporate findings from 
earlier disease-specific programs. Standardised programs aim to link approaches that can 
address both the at-home and psychosocial tasks identified by Clark et al. (1991). In the 
late 1990’s, non-disease specific supported self-management programs began to emerge. 
These generic programs integrated collaborative problem-solving, goal-setting, skills for 
drawing on community resources, and motivational strategies to support, enable and 
inspire individual and family collaboration and decision-making with health and supportive 
care workers. 
In 2002, Barlow et al. systematically reviewed the growing international literature on 
generic, cross-condition supported self-management intervention. The review aimed to 
assess approaches to self-management and their effectiveness. The largest numbers of 
studies reviewed were from the USA and most programs described were aimed at people 
with asthma, diabetes or arthritis. Approaches included group-based, individual or a 
combination of both. About half of the studies published were shown to be underpowered 
RCTs with short follow-up timeframes. The authors found that supported self-management 
interventions showed wide variation in practice and that this variability impacted on the 
ability to assess and compare outcomes. The authors concluded that self-management 
programs can provide benefits for participants, particularly in the short-term for self-
efficacy. They recommended that future studies incorporate longer term follow-up with 
more disease-related and psychosocial outcome measures (Barlow et al. 2002). 
Two years later, Warsi and colleagues’ (2004) published another systematic review of 
supported self-management studies across multiple chronic conditions (Warsi et al. 2012). 
They limited their review to chronic disease self-management intervention studies that 
assessed clinical outcomes and used control groups. They concurred with Barlow et al. 
(2002) regarding the variability in methodology and reporting associated with supported 
self-management programs. They concluded that supported self-management programs 
did improve some clinical outcomes for select chronic diseases. Face-to-face delivery of 
support was the most important variable associated with improved outcome. The authors 
noted the need for tailoring interventions due to various strategies and tools being required 
by different individuals for different conditions at different times (Warsi et al. 2012).  
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Chodosh et al. (2005) conducted a meta-analysis of self-management for older adults 
diagnosed with three specific chronic conditions: osteoarthritis, hypertension and diabetes 
mellitus. They identified clinically and statistically significant improvements in some clinical 
outcomes for diabetes and hypertension. However, they concluded that there was a lack of 
agreement on self-management program definition and no mechanisms of action identified 
which seemed to impact on program uptake (Chodosh and Morton 2005). 
Across these three self-management meta-analyses, the evidence suggests that self-
management approaches can be effective in helping individuals improve self-efficacy and 
make improvements in various health-related outcomes (Warsi et al. 2012; Chodosh and 
Morton 2005; Barlow et al. 2002). Reviewed studies have shown that supported self-
management programs have been associated with improvement in quality of life and 
clinical outcomes. It has been suggested that these interventions also reduce healthcare 
resource utilisation use but the data on this outcome is equivocal (Health Foundation 
2011, 17). These meta-analyses identify general methodological limitations in supported 
self-management intervention studies related to small sample sizes, no clear identification 




The mechanisms of action involved in generating the impacts of supported self-
management programs on outcomes remain unclear (Chodosh and Morton 2005). The 
theories associated with successful self-management are predominantly psychological 
theories of individual behaviour. These include self-efficacy theory (Bandura 1982; Lev 
1997; Bandura 1977), social cognitive theory (Bandura 1986), goal-setting theory (Locke 
and Latham 2013) and coping theory (Folkman and Lazarus 1982). 
Self-efficacy is the most common outcome targeted by supported self-management 
approaches (Battersby, Lawn, & Pols 2010; Bodenheimer, Lorig, et al. 2002; Gallagher et 
al. 2008; National Institute for Health and Clinical Excellence 2007; Schrank et al. 2012; 
Wilson 2008). Self-efficacy relates to an individual’s perception of skills and abilities to act 
effectively and competently to achieve tasks in a given situation (Bandura 1977, 472). 
Bandura proposed that individuals can increase their self-efficacy and perception of their 
self-competence through increased awareness and practice (Bandura 1977). Increased 
self-efficacy for health management has been associated with decreases in negative 
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psychological states and greater motivation to set realistic health goals and attain them 
(Lev 1997).  
Cognitive behavioural strategies, including problem solving, goal setting and action 
planning, have been shown to increase self-efficacy (Kahl, Winter, and Schweiger 2012; 
Padesky and Mooney 2012). A 2006 meta-analysis, comparing cognitive behavioural 
strategies versus patient education alone, suggest cognitive behavioural strategies were 
more effective in helping cancer survivors to cope with short-term management of 
depression and anxiety and achieve long-term improvement in QOL (Osborn, Demoncada, 
and Feuerstein 2006). Supported self-management interventions often utilise cognitive 
behavioural approaches in efforts to increase an individual’s self-efficacy for living with and 
beyond cancer (Graves 2003).  
Bandura expanded self-efficacy research into social cognitive theory, which focused on 
individuals capacity to consciously change or take action within particular environmental 
contexts (Bandura 1986). Social cognitive theory is based on the premise that human 
functioning and regulation is influenced by both personal and environmental factors. 
People are portrayed as proactive and self-regulating. Therefore, they have the capability 
to consciously change and take action to develop new or improved coping skills (Bandura 
1986). A 2003 meta-analysis of 38 psychosocial intervention RCTs for cancer patients, 
incorporating QOL as an outcome measures, found that those based in social cognitive 
theory approaches were associated with improved QOL and psychosocial outcomes 
(Graves 2003). Graves (2003) concluded “that using social cognitive theory-based 
interventions maximizes improvement in overall QOL outcomes for adult cancer patients” 
(210). These findings suggest that supported self-management interventions with social 
cognitive theory-based elements can generate positive effects on QOL for cancer 
survivors, but may not result in changes to functional or clinical outcomes. 
Goal setting theory describes how the goal setting process can influence individual 
behaviour (Locke and Latham 2013; Locke and Latham 2006; Locke and Latham 1990). 
Locke & Latham’s theory suggests that self-identified or collaboratively developed goals 
contribute to goal commitment. The development of Specific, Measurable, 
Attainable/agreed, Relevant/realistic, and Time-bound (SMART) goals have been 
suggested as an extension of goal setting theory (Doran 1981). Attaining goals, particularly 
difficult goals, is suggested to produce a sense of competence and success (Locke and 
Latham 1990; Locke and Latham 2006; Locke and Latham 2013). Within supported self-
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management interventions, goal-setting is incorporated as a way of helping survivors 
develop strategies and build self-efficacy. 
Coping theory describes how emotion and cognitive appraisal processes are used to 
minimise or deal with stressors (Folkman and Lazarus 1982). There are numerous coping 
strategies identified in the literature, and relatively few theories of coping. Lazarus and 
Folkman (1984) categorised coping strategies into two groups: emotion-focused coping 
and problem-focused coping. Emotion focused coping strategies included distancing, 
escape-avoidance, accepting responsibility or blame, exercising self-control, and positive 
reappraisal. Problem-focused coping included self-controlling, information seeking, and 
evaluating pros and cons  (Lazarus and Folkman 1984). Supported self-management 
interventions often address coping strategy use in order to assist people with shifts from 
use of less-effective coping strategies to the use of more constructive or effective coping 
strategies (Corbin and Strauss 1988; Bodenheimer and Wagner 2002; Battersby et al. 
2010). 
The broad theoretical foundations described in this sub-section pose a barrier to 
conducting research into supported self-management interventions. The lack of a clear, 
theoretical framework for the origins and mediators of self-management make 
comparisons across studies and choice of outcome measures that reflect change in 
individual self-management competence problematic. Numerous measures have been 
proposed over the years as pertinent to self-efficacy, self-regulation and goal achievement 
(Boger, Demain, and Latter 2013). There is currently no consensus on which measures 




Supported self-management programs have been proposed to build resilience of people 
affected by long-term health conditions. The key components of supported self-
management programs are therapeutic alliance, partnership or collaboration, therapeutic 
techniques and goal setting (Battersby et al. 2010). Each of these will be described in turn. 
Therapeutic alliance is the first key element required in supported self-management 
intervention programs. A therapeutic relationship can be established between a healthcare 
practitioner and individuals or whānau (Kazdin 2007). A positive and successful 
therapeutic relationship ensures that two or more people can work together toward 
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improving health and wellbeing. It impacts on how well intervention techniques can be 
delivered (Kazdin 2007). A positive relationship often requires warmth, empathy, caring, 
genuine regard and competence shown by all participating parties (Beck 2011). A level of 
trust and willingness to work together indicates a positive working relationship (Kazdin 
2007). An effective therapeutic relationship has been found to have positive impacts on 
health (Schnur and Montgomery 2010). In an Australian qualitative study with cancer 
survivors, the importance of relationships enabling the survivor to give voice to their 
experience and be heard by professionals “who took the time to listen and try to 
understand” was found to be more important than the use of a specific therapeutic 
technique (MacCormack et al. 2001). Building a therapeutic relationship takes time and 
attention to relational processes, specifically whakawhānaungatanga in the NZ context. 
Collaboration is a second key element in supported self-management programs. It is 
sometimes referred to as goal consensus (Schnur and Montgomery 2010). A meta-
analysis of studies exploring the impact of collaboration on psychotherapy outcomes found 
better outcomes were associated with cooperative relationships and agreement on 
therapeutic goals (Tryon and Winograd 2011). Collaboration is the basis for person-
centred or client-centred interactions using strengths-based approaches (Padesky and 
Mooney 2012; Sanders and Munford 2010) or motivational interviewing (Miller and Rollnick 
2002; Britt et al. 2014; Rollnick, Miller, and Butler 2008). Collaboration is identified as 
important for cancer survivors because of the need to manage side-effects, comorbidities, 
and follow-up requiring combinations of medical and self-management (Hack et al. 2005) 
Therapeutic techniques, such as cognitive behaviour training or therapy (CBT), are a 
third key element. These involve use of approaches, such as collaborative problem 
solving, cognitive restructuring, stress management and guided imagery, to help people 
evaluate and adapt the way they think about a situation or issue (Beck 2011). These 
techniques can be delivered by trained counsellors, psychologists, psychotherapists and 
interventionists in individual or group formats (Padesky and Mooney 2012; Kahl, Winter, 
and Schweiger 2012; Beck 2011). Several meta-analyses have documented the 
effectiveness of CBT for people with various medical and psychological conditions (Butler 
et al. 2006; Hofmann et al. 2012). Studies of CBT with cancer patients have shown benefit 
for reducing distress and pain (Tatrow and Montgomery 2006; Osborn, Demoncada, and 
Feuerstein 2006; Hart et al. 2012; Beatty and Koczwara 2010) and addressing fatigue 
(Quesnel et al. 2003; Campos et al. 2011). In one meta-analysis reviewing studies that 
utilised CBT techniques with cancer survivors, individual approaches were shown to be 
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more effective in reducing emotional distress and improving quality of life than group 
approaches (Osborn, Demoncada, and Feuerstein 2006). 
Goal setting is the fourth integral component of supported self-management programs. It 
is considered vital to enhancing self-efficacy (Locke and Latham 2013; Locke and Latham 
2006). The founders of goal-setting theory purport that goals direct attention and effort 
toward positive action (Locke and Latham 2006). Goal-setting in supported self-
management programs are described as person-focused yet developed in a directed 
fashion in collaboration with the interventionist to address wellbeing. Interventionists foster 
awareness that goals must reflect lifeworld reality and not be based in judgments on how 
people should live their lives (Flinders Health Behaviour and Health Research Unit 2012). 
Supported self-management programs are complex interventions because they: 1) weave 
together a tailored set of strategies, 2) are grounded in therapeutic alliance and 
collaborative problem-solving, 3) incorporate goal-setting, regular monitoring of progress 
and problems, action planning, and shared decision-making, and 4) promote access to 
and use of community resources, health system navigation, and effective communication 
with health professionals. Strategies may be reflected in a tailored care plan (Flinders 
Health Behaviour and Health Research Unit 2011). Two publications, the 2011 Health 
Foundation’s supported self-management rapid review and the 2010 evidence-based 
review by Battersby et al., outline key components and principles of these approaches 
(Battersby et al. 2010; de Silva & Health Foundation 2011).  The key components of 




Figure 8: Supported self-management program components identified as useful 
Source: Health Foundation 2011, 17 
The 12 supported self-management program implementation principles are shown in 
Figure 9 (Battersby et al. 2010). 
 
Figure 9: Supported self-management program implementation principles 
Source: Battersby et al. 2010, 567 
In summary, evidence-based supported self-management programs are characterised by 
four key components: therapeutic alliance, collaboration, therapeutic techniques, and goal 
Supported self-management program components found to be useful through rapid 
review: 
• Involving people in decision making 
• Emphasising problem solving 
• Developing care plans as a partnership between service users and 
professionals 
• Setting goals and following up on the extent to which these are achieved 
over time 
• Promoting healthy lifestyles and educating people about their conditions and 
how to self-manage 
• Motivating people to self-manage using targeted approaches and structured 
information and support 
• Helping people to monitor their symptoms and know when to take 
appropriate action 
• Helping people to manage the social, emotional and physical impacts of their 
conditions 
• Proactive follow-up, and 
• Providing opportunities to share and learn from other service users. 
Supported self-management evidence-based implementation principles: 
Multifaceted interventions   Support by diverse providers  
Brief targeted assessment   Use of a non-judgmental approach 
Collaborative priority and goal setting Collaborative problem solving 
Patient self-efficacy    Active follow-up 
Evidence-based information to guide shared decision-making 
Self-management interventions delivered by diverse formats 
Guideline-based case management for selected patients 
Linkages to evidence-based community programs 
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setting. They are complex interventions that utilise assessment processes and can have 




Supported self-management intervention studies have utilised a wide range of outcome 
indicators. A 2013 systematic review on outcomes of chronic disease self-management 
interventions identified over 70 different types of outcomes assessed in a subset of 18 
studies (Nolte and Osborne 2013). The authors concluded “as evaluations heavily rely on 
patient self-report, current approaches to program evaluation may not be sufficient to 
assess the intended impact of self-management” (1805). Accordingly, the overall evidence 
for the effectiveness of supported self-management intervention programs is described as 
mixed.  
The evidence for effectiveness of self-management intervention for specific conditions, 
such as asthma (Coster and Norman 2009; Warsi et al. 2012), is more promising 
compared to evidence generated by reviews of generic self-management programs 
(Coster and Norman 2009). Most meta-analyses report some positive outcomes of generic 
self-management support programs, showing small to moderate effect sizes, but with 
inconsistencies as ell (Barlow et al. 2002; Ratima 2009; Chodosh and Morton 2005; Warsi 
et al. 2012). There have been multiple Cochrane reviews conducted which aim to show 
effectiveness of supported self-management intervention programs but the results have 
been inconclusive (Coster and Norman 2009; The Cochrane Collaboration 2008).  
It must be mentioned that supported self-management interventions have also been 
associated with unintended consequences and negative outcomes. One of the earliest 
published supported self-management studies evaluated an intervention to improve patient 
question asking during a medical visit. Negative outcomes identified were increased 
patient anxiety and reduced satisfaction with care (Roter 1977). More recent studies of 
supported self-management programs suggest that programs may increase inequities 
(Greenhalgh et al. 2011) and shift the focus from structural drivers and barriers to quality 
care resulting in further victim blaming (Parkhurst 2013). It is important to consider 
environmental context and equity at the forefront of intervention protocol development. 
Although delivery of low-intensity intervention, such as an opt-in supported self-
management workshop, may be more straightforward to design and evaluate, this 
approach may cause unintended consequences by widening the inequity gap between 
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active information seekers and those that avoid seeking help (Keating 2014). These 
potential negative outcomes must be considered, assessed, and measured, if possible.  
Clinical outcomes are often proposed as intervention effectiveness indicators. In various 
meta-analyses of the self-management literature, clinical variables measured did not yield 
consistent positive results across studies (Warsi et al. 2012; Chodosh and Morton 2005; 
Barlow et al. 2002). Supported self-management programs have been shown to influence 
some clinical indicators for specific diseases (e.g. asthma, diabetes, chronic obstructive 
pulmonary disease); however, there has been no clinical evidence of impact for other 
diseases (e.g. osteoarthritis) (Chodosh and Morton 2005; Warsi et al. 2012; Watson et al. 
1997). The evidence for psychosocial and quality of life outcomes was more consistently 
positive. 
A narrative review by renowned self-management researchers Holman and Lorig (2004) 
identified positive self-perception and improved coping self-efficacy as important outcomes 
for health. Psychosocial outcomes, such as self-efficacy and resilience, are outcomes that 
have been commonly measured in association with supported self-management 
interventions. Individuals affected by chronic disease report being distressed by not coping 
well with emotional reactions based in anger, fear, frustration and depression (Lorig et al. 
2001). Supported self-management has been shown to help people cope with distress by 
building self-efficacy for coping and developing resilience (de Silva and Health Foundation 
2011; Lorig et al. 2001). 
QOL is another outcome measure used commonly in supported self-management 
intervention research. The key meta-analysis that considered QOL outcomes, and not just 
clinical measures, identified small effect sizes and variable impact on this measure (Barlow 
et al. 2002). Individual studies of supported self-management intervention tend to show 
small to medium effects on this measure (Bodenheimer et al. 2002; Howell et al. 2012; van 
Weert et al. 2008; Watson et al. 1997). However, some studies point out that the 
underlying constructs measured by QOL instruments might be problematic with decreased 
sensitivity for measuring how supported self-management impacts on QOL as opposed to 
the intervention not impacting on QOL (Barlow et al. 2002; Battersby et al. 2010). 
Cost-effectiveness indicators have been assessed in supported self-management 
intervention studies. One common cost-effectiveness outcome measure utilised is 
reduction in healthcare utilisation (Chodosh and Morton 2005). This outcome measure has 
been shown to be inconsistently impacted across studies with some studies showing 
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reductions (Lorig et al. 2001; Wilson 2008) and others finding no change (National Primary 
Care Research and Development Centre 2007). 
Although there is an extensive literature in this area, the choice of outcome measures for 
supported self-management programs is inconsistent. Evidential reviews have shown that 
supported self-management intervention can improve key health outcomes for some 
patients (Warsi et al. 2012; Barlow et al. 2002; Chodosh and Morton 2005; Mccorkle et al. 
2011). The literature supports the utility of the approach for delivering modest 
improvements in health outcomes across conditions but more evidence is needed on key 
components, applicability of supported self-management interventions for specific 




Supported self-management programs have been delivered over the years by health and 
supportive care workers, and lay facilitators such as expert patients. They promote the 
development and renewal of skills and strategies for self-management.  
The foundation for these programs is in establishing therapeutic alliance and partnership 
with the working relationship guided by collaborative priorities for improving health and 
wellbeing. Cognitive behaviour therapy techniques are commonly associated with 
supported self-management programs (Richardson et al. 2011). These are often described 
in association with goal setting (Fisher et al. 2005; Battersby et al. 2010). In most cases, 
care plans and action plans are an integral part of supported self-management program 
intervention and these are intended to be routinely monitored and followed up. Most 
programs aimed to develop a collaborative plan which is intended to be followed up 
intermittently with health and supportive care workers. A key outcome of interest across 
programs is identified as self-reported change in perceived self-management competence. 
Figure 10 presents a schematic representation of key supported self-management 
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Figure 10: Self-management intervention diagram 
 
There are many supported self-management interventions and programs reported in the 
literature but most are not well validated and only in use for specific diseases or in specific 
areas. Therefore, specific programs mentioned in the literature are not all able to be 
named, described and critiqued in detail in this thesis.  
An overview of a selection of the largest established and evaluated programs is shown in 
Table 5. These programs are classified by mode of intervention delivery, timing, strategies 
utilised and required facilitator qualifications. The modes of intervention delivery include 
face-to-face group or individual sessions. Timing is flexible for face-to-face programs but 
less so for protocol-guided group formats delivered over six or more sessions. Therapeutic 
techniques range widely. Facilitator qualifications all include training but the facilitator may 
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From this point forward, this section narrows in focus to the three supported self-
management programs shown in Table 5. Because there is such wide variation in delivery, 
timing and approach within supported self-management programs, only these three 
generic, well-known, validated and robustly evaluated programs will be described in further 
detail. These programs are guided by program manuals and all require structured 
assessments with participants. However, they differ regarding delivery mode, timing, 
therapeutic techniques used, and facilitator qualifications required. The choice of program 
for this study was based on a comparison of the differing components of these three 





The Stanford Program 
 
Kate Lorig and colleagues at Stanford University in the USA developed a program that 
centred on empowering people to partner with health professionals to improve health 
outcomes. The seven-week Chronic Disease Self-Management Program (CDSMP) 
evolved from the Arthritis Self-Management Program. The program, which subsequently 
became known as the Stanford Program, focused on developing effective healthcare 
partnerships to support enhanced self-efficacy for people living with chronic conditions. 
Key components included patient skill-development for problem-solving, and decision-
making to include being better able to deal with consequences of chronic diseases within 
the social environment (Lorig et al. 2001). 
The Stanford Program is aimed at enabling, inspiring, and empowering people with chronic 
conditions to make informed choices and develop strategies to manage their condition. It is 
facilitated by either two trained health and supportive care workers or by one of these and 
a person living with chronic conditions themselves. The program is delivered as ‘generic’, 
meaning it is open to anyone with one or more self-defined long-term conditions. It is 
delivered once a week over six weeks in two-and-a-half-hour group sessions. Groups 
comprise 8-20 participants who range from those recently diagnosed to those managing 
conditions over the long-term. 
The strategies and skills delivered relate to ways people can effectively address common 
self-management problems and disease-related tasks to manage well day-to-day with the 
goal being improved health status and lower utilisation of healthcare (Lorig et al. 2001). 
For example, four ingredients of self-efficacy addressed by the program are task 
performance mastery, modelling, interpretation of symptoms and social persuasion 
(Bandura 1977; Holman and Lorig 2004). Based on the principles underlying the program, 
the course promotes the development of confident and knowledgeable patients who use 
strategies to manage their conditions effectively. 
The first RCT of the program involved over 1,000 people with diagnosed heart disease, 
lung disease, stroke or arthritis who were followed up for three years (Lorig et al. 1996). 
The variables evaluated in the trial were health status, healthcare utilisation, self-efficacy 
and self-management behaviours. Assessments in relation to health status included 
disability, social/role limitations, pain and physical discomfort, energy/fatigue, shortness of 
breath, psychological wellbeing/distress, depression, health distress, and self-rated 
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general health. Healthcare utilisation was measured by recording visits to physicians, visits 
to the emergency department, hospital stays, and nights in hospital. Patient-reported 
confidence in behaviours and management were assessed using a self-efficacy measure. 
Self-management behaviours measured were exercise, cognitive symptom management, 
mental stress management/relaxation, use of community resources, and communication 
with physician (Lorig et al. 1996). Program participants, compared to the control group, 
reported personal health outcome benefits and lower healthcare utilisation rates which 
persisted for up to three years. There were no differences noted in measures of 
psychological wellbeing, pain or discomfort (Lorig et al. 2001). An extensive review of the 
evidence on the Stanford Program, from many studies since that first RCT, was brought 
together in a meta-analysis focused on supported self-management and its potential for 
implementation with cancer populations (McCorkle et al. 2011). A more detailed overview 
of this cancer-specific meta-analysis is presented in the section on supported self-
management and cancer survivorship on p. 87. In brief, McCorkle et al.’s 2011 meta-
analysis reported that The Stanford Program delivered clinically-significant and improved 
patient-reported outcomes, in areas such as symptom management and communication. 
The Program was recommended as a useful way to influence and improve self-
management across conditions (McCorkle et al. 2011). 
 
The UK Expert Patients Programme 
 
The Expert Patients Programme was developed in the United Kingdom and is derived from 
The Stanford Program (Department of Health 2001). The Expert Patients Programme 
provides support and seeks to foster participants’ self-confidence to manage their chronic 
conditions. Weekly goal setting and action planning are key components of the 
programme.  
The program was established as a lay-led supported self-management program that was 
intended to inspire and empower people to improve their self-management of chronic 
disease in partnership with care provided by the National Health Service (Department of 
Health 2001). The Expert Patients Programme lay-led supported self-management 
program aimed to inspire the use of strategies and skills to increase agency and 
confidence related to, what is sometimes termed, the ‘expert patient’ role (Gao and Yuan 
2011; Wilson 2008). 
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The structure and delivery of the group program is by sessions. It is intended to be 
delivered once a week over six weeks in two and a half hour group sessions. The course 
addresses: 1) dealing with pain and tiredness, 2) coping with feelings, 3) relaxation 
techniques and exercise, 4) healthy eating, 5) communicating with family, friends and 
health and supportive care workers, and 6) planning for the future (Wilson 2008). It is most 
often facilitated by a healthcare practitioner and person living with chronic conditions 
themselves, trained as an expert patient facilitator (Rogers 2001). The program is 
delivered as ‘generic’, meaning it is open to anyone with one or more self-defined long-
term conditions. Groups comprise 8-20 participants which range from those recently 
diagnosed to those managing conditions over the long-term. The key difference between 
the Expert Patients Programme and The Stanford Program is that the former is meant to 
be led by a trained lay-person living with a chronic condition while the Stanford Program 
was designed to be led by health and supportive care workers. 
The 2001 Expert Patients Programme pilot study trained interested expert patients, 
defined as people living with a chronic condition, as lay trainers or volunteer tutors (Rogers 
2001). The pilot phase enrolled 629 participants who were randomized to an Expert 
Patients Programme course intervention or control group (National Primary Care Research 
and Development Centre 2007). The intervention group reported increases in self-efficacy, 
energy levels and psychological wellbeing; however, no comparative significant 
improvements were noted for exercise levels or reduction in healthcare utilisation (National 
Primary Care Research and Development Centre 2007). Although results from the Expert 
Patients Programme pilot study indicated some small positive effects overall, concerns 
were raised over its ‘fit’ with people from vulnerable populations (Rogers 2001). Difficulties 
with engaging people from ethnic minority groups and areas of high deprivation were 
noted in the pilot study and were reported to have been subsequently identified in later 
supported self-management research studies (Rogers 2001; National Primary Care 
Research and Development Centre 2007). There were no published evaluation reports 





The Flinders Program 
 
The Flinders ProgramTM is an evidence-based supported self-management intervention 
developed in Adelaide, Australia at Flinders University. It is structured around a set of tools 
for patient-centred assessment, planning and motivational processes (Battersby et al. 
2010). It differs from the other two supported self-management programs reviewed here 
because it is designed to be delivered face-to-face to one individual, but it is flexible 
enough to incorporate supporters and whānau. 
The Flinders Program is designed to be accessed by referral from a healthcare practitioner 
and can be introduced to anyone with one or more long-term conditions. The program 
incorporates the Flinders Program standardised tools, namely, the Partners in Health 
scale, the Cue and Response interview, and the Care Plan. It allows for multiple sessions 
delivered by a trained healthcare practitioner in one-to-one sessions at clinics, community 
centres or homes. There is no set time frame outlined for number of sessions or durations 
of sessions. Although standardised like the Stanford Program, the Flinders Program aims 
to support patients in a tailored approach that develops confidence so they can manage 
their conditions effectively. 
The Flinders Program originated around the same time as the Stanford Program.  It 
developed as a consequence of the 1997 SA HealthPlus Trial which sought to test 
whether coordinated care could improve health outcomes (Battersby, 2005). The study 
found that elements of self-management support were provided based on service 
coordinator perception of self-management competence rather than on any standardised 
assessment combined with risk assessment of illness severity or complexity (Battersby 
2005; Petkov et al. 2010). The 11-item Partners in Health scale, a standardised 
assessment tool reflecting self-management competence, was delivered and validated 
during the SA HealthPlus trial to address this state of affairs (Battersby, Harvey, and Mills 
2007; Battersby et al. 2003; Petkov et al. 2010). Evidence from this early intervention 
study indicated a role for the one-on-one approach to address patient self-management of 
chronic medical and mental health conditions (FHBHRU 2011). The Flinders Program filled 
a gap providing a standardised yet tailored approach that was delivered one-to-one and 
incorporated assessment tools and strategies for self-management skill development. 
After further monitoring and development of The Flinders Program, Battersby et al. 
published an article identifying 12 evidence-based supported self-management 
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implementation principles (outlined on pg. 69) that were integral to the program (Battersby 
et al. 2010). A Flinders Program intervention study rationale and functional design was 
published in 2011 to guide intervention research carried out with the program (Battersby et 
al. 2010).  
The Flinders Program has been widely delivered in Australia. A pre-post study with 176 
people managing a variety of chronic conditions found clinically-significant increases in 
patient-reported self-efficacy as well as decreases in patient-reported pain, fatigue and 
service usage (Harvey et al. 2008). The Flinders Closing the Gap Program was launched 
in 2012. It was targeted for Aboriginal and Torres Strait Islander populations and aimed to 
reduce ethnic disparities in chronic disease care (FHBHRU 2012). In this program, trained 
community workers acted as facilitators and health navigators (FHBHRU 2012). The 
Flinders Program strategies and skills helped people with chronic conditions acquire 
information and practice skills to carry out different medical regimens and lifestyle changes 
as well as support physical and psychosocial transitions (FHBHRU 2011). 
While the Flinders program has not been delivered, or piloted, in the secondary-care 
setting or hospital-based clinic context, several features of the program’s design suggest it 
may be most appropriate for delivery of acceptable and equitable self-management 
support in hospital-based cancer clinic settings. The Flinders program is structured to be 
delivered face-to-face and research indicates this delivery mode achieves better outcomes 
(Warsi et al. 2012). The individualised delivery mode, rather than group delivery mode, is 
considered more equitable for delivery in cancer clinical settings because it is less reliant 
on opt-in. It is also identified to be the preferred mode of intervention delivery for 
establishing strong relationships, a key priority for Māori whānau-centred cancer care 
(Slater et al. 2013). Individualised delivery is considered to provide better opportunities for 
therapeutic alliance and collaboration. The techniques of person-centred goal-setting, 
action planning and care planning are seen as most appropriate to be delivered face-to-





Program enablers and barriers 
 
Supported self-management program uptake is dependent on many factors at the 
individual and environmental levels (Bycroft and Tracey 2006). The studies reported on in 
this thesis aimed to explore the fit of a supported self-management program in the 
hospital-based cancer setting. Therefore, a review and critique of factors that may act as 
facilitators or barriers is considered an important addition to the literature review. The 
individual, interpersonal and environmental factors that may impact on this type of 




There is little consistency noted across studies on specific outcomes impacted by 
supported self-management programs but reviews agree that self-management programs 
can be beneficial for the individual affected by chronic conditions (Barlow et al. 2002; 
Chodosh and Morton 2005; Warsi et al. 2012; de Silva and The Health Foundation 2011).  
Individual factors that impact on, and also result from, self-management intervention 
include ability, confidence, motivation and activation of individuals to self-manage (Dixon, 
Hibbard, and Tusler 2009). In other words, an individual’s innate capacity to self-manage 
impacts on the extent to which self-management programs can be effective (Battersby, 
2005; (Dixon, Hibbard, and Tusler 2009). Personal barriers to self-management include 
low health literacy, lack of motivation, life or health complexity, and lack of capacity to 
engage with self-management (FHBHRU 2012). Enablers of self-management 
competence include coping ability and motivation. Coping self-efficacy has been shown to 
predict more ability to adapt to changing circumstances and uncertainty overall (Bandura 
1977).  
At the individual level, there is not always a linear progression toward increased self-
management competence identified as an intervention outcome (Dixon, Hibbard, and 
Tusler 2009). A 2009 self-management study found that activation and motivation may be 
developmental and variable for individual patients (Dixon, Hibbard, and Tusler 2009). In 
other words, individuals can go through phases on their way to becoming competent and 
effective self-managers. Further, individuals to whom treatments, medication and advice 
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are provided within a clinical setting manage in different ways indicating that tailored 
support fits best with this diversity in management styles (FHBHRU 2011). 
It is important to consider unintended consequences.  Self-management competence often 
requires behaviour change which can be a lengthy and challenging process (Mayor 2006). 
Potential unintended consequences, such as intermittent increases in anxiety, must be 





Interpersonal enablers include health practitioner motivation, delivery style and 
competency. Health practitioner interest and skill level vary in relation to these 
competencies. Hibbard et al. (2004) identified that facilitator confidence played a key role 
in outcomes. There is a clinician toolkit that lists important self-management program 
facilitator competencies as shown in Figure 11 (Schaefer et al. 2009).  
Self-management support strategies described as useful for delivery of these 
competencies include establishing the person’s agenda, active listening, person-centred 
communication techniques such as motivational interviewing (Britt et al. 2014; Rollnick, 
Miller, and Butler 2008) and goal setting. The recommendation to clarify facilitator 
competency to deliver these strategies was emphasised in several self-management 
program reviews (Ratima 2009; Schaefer et al. 2009). Health and supportive care workers 
require an interest and willingness to work collaboratively with patients as well as specific 
skills training to effectively deliver supported self-management programs. Some programs 




Figure 11: Supported self-management program competencies for facilitators 
Source: Partnering in self-management support: A toolkit for clinicians by The Institute for 




Environmental factors, such as organisational policies and delivery standards, can be 
considered enablers or barriers. Health policies increasingly promote person-centred care 
which is loosely associated with self-management (Ahmad et al. 2014; The Health 
Foundation 2014). Care coordination is a type of person-centred support in place in NZ to 
assist patients to navigate the complex system and various support organisations 
effectively (Blakely 2013; Blakely et al. 2015; Collinson et al. 2013). Navigating system 
complexity can overwhelm finite self-management resource and capacity. Provision of 
care coordination can be considered an enabler of self-management.  
Overarching structural factors are another type of environmental impact that may enable or 
block self-management. Structural factors include access to care (Cormack et al. 2005; 
Rumball-Smith 2009) and variability in care (Cunningham, Triggs, and Te Hoe Nuku Roa 
Research Team, 2014). Cancer care is most often delivered across specialised areas (i.e. 
surgical, oncology, radiation oncology). This differs from care for other conditions which 
are often less siloed and less complex to navigate. The structure of cancer care is a barrier 
to timely, accessible care and challenges exist in coordination across specialist areas 
(Levit et al. 2013; Minister of Health 2003b; Ministry of Health 2010b). 
Another environmental factor at the structural level relates to equity. The evidence of 
effectiveness of supported self-management programs for populations experiencing 
Supported self-management program facilitator competencies identified: 
• Describe and promote self-management by emphasising the patient’s central 
role in managing his/her health 
• Include family members at the patient’s discretion 
• Build a relationship with each patient and family member 
• Explore patient’s values, preferences, and cultural and personal beliefs 
• The patient and providers share information and communicate in a way that 
meets the patient’s and family’s needs and preferences 
• Collaboratively set goal(s) and develop action plans.  Document the patient’s 
confidence in achieving goals, and use skill building and problem-solving 
strategies that help people identify and overcome barriers to reaching goals 
• Provide follow-up on action plans and connect the patient with the community. 
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inequities in healthcare is minimal (Lawn et al. 2007; Greenhalgh et al. 2011). According to 
Greenhalgh et al. (2011) “no model of self-management education or peer support has yet 
achieved widespread reach and acceptability with minority ethnic groups” (Greenhalgh et 
al. 2011, 28). There is limited evidence for the effectiveness of self-management 
interventions in indigenous populations (FHBHRU 2012) which indicates a knowledge and  
practice gap, but, more importantly, raises concerns about whether these types of 
programs may contribute to a widening gap in inequities (Ratima 2009) at the structural 
level in NZ healthcare organisations. 
 
Criteria identified to inform program choice 
 
This section aims to identify criteria for best choice of a supported self-management 
intervention program to pilot with cancer survivors in NZ. There were three programs 
considered. The criteria were developed considering evidence, equity and feasibility 
variables within the cancer context. Specifically, the selection criteria were related to 
program: 1) standardisation and structure to ensure fidelity, 2) adaptability for tailoring 
across conditions and populations, 3) facilitator requirements for professionalism and 
accreditation to build referral confidence, 4) delivery, with emphasis on one-on-one 
delivery that could involve whānau, and 5) environmental context and structural barriers 
considered.  
The three main programs described in this chapter were compared against the criteria. 
Table 6 displays the comparative results. The Flinders Program was identified to be the 
best fit because it met the most points identified in the criteria. It was standardised yet 
could be tailored, required delivery by accredited practitioners, and had the most flexible 
delivery options in that it could be delivered one-on-one during standard hospital 


























The Stanford Program 
(Lorig et al. 2001) 
No Yes No No 
The Expert Patients 
Programme (Wilson 
2008) 
No Yes No No 
The Flinders Program 
(Battersby et al. 2010) 
Yes Yes Yes Yes 
 
The Flinders Program is a high-intensity supported self-management intervention. In other 
words, it is delivered face-to-face and requires a comparatively higher level of time 
investment than the other programs it was compared against. Nevertheless, this high 
intensity program was indicated, based on the criteria, as the most equitable and effective 
approach to explore. 
 
Supported self-management: the NZ context 
 
In this section, the limited research on supported self-management programs in NZ is 
reviewed.  
 
Supported self-management in NZ’s healthcare system 
 
Supported self-management programs emerged in NZ primary care settings in the 1980s. 
Disease-specific supported self-management programs have been administered and 
evaluated in the areas of diabetes, asthma, heart failure and other long-term conditions 
(Beasley et al. 1989; Counties Manukau DHB 2016.; D’Souza et al. 1994; Ritzema et al. 
2010; Steinsbekk et al. 2012; Watson et al. 1997). NZ literature describing self-
management programs have suggested that they can reduce healthcare practitioner 
dependency (Counties Manukau DHB 2016; D’Souza et al. 1994; Town et al. 1995) as 
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well as increase self-determination and wellbeing for those affected by chronic conditions 
(Pere, 2005). According to Pere (2005), supported self-management is needed to 
establish control over long-term conditions such as diabetes. She described the support 
for patient self-management by health and supportive care workers as a “pre-requisite for 
self-determination, and self-determination as a precursor for wellness”, particularly for 
Māori and other indigenous peoples residing in NZ (111).  
It has been shown that a shift from disease-specific patient education-based self-
management programs to non-disease specific problem-solving based supported self-
management has been occurring in NZ since the year 2000 (Ratima 2009). The delivery of 
supported self-management programs has varied widely across the country. Variations 
have occurred in relation to program delivery context (i.e. primary care or secondary care 
environments), disease-focus, and populations targeted. 
The 2008 ABCC study was a major cross-condition national study that promoted 
supported self-management. The series of studies conducted under the auspices of ABCC 
aimed to describe chronic condition management practice in primary care settings across 
NZ. The study series was comprised of literature reviews and a stocktake of chronic 
condition management healthcare practice. Overall, the study findings pointed to national 
variability in chronic condition management practices (Connolly et al. 2009; Connolly et al. 
2011), persistent inequities in healthcare delivery (Sheridan et al. 2011) and 
underdevelopment of best practice, particularly with regard to delivery of supported self-
management intervention (Connolly et al. 2009). Healthcare practitioners stated that self-
management approaches were hard to deliver because they required gaining deeper 
insights into health behaviours, and this approach was not supported by funding models 
and the national data focus on clinical management (Connolly et al. 2008).  
The 2008 ABCC study cited minimal development and integration of supported self-
management initiatives into health delivery across NZ primary care practice (Connolly et 
al. 2009). The study authors concluded that there was a lack of conceptual understanding 
of best-practice chronic condition management in NZ (Connolly et al. 2008). The study 
recommended building and monitoring a systematic structure nationally (i.e. guidelines), 
funding initiatives to train the trainers (especially lay people), community/whānau 




In 2009, Ratima conducted a narrative review of supported self-management in NZ with a 
focus on applicability for Māori health delivery. This review provided further support for 
these types of interventions but identified the complexity of delivering them effectively. 
Ratima (2009) provided an insightful analysis of the self-management literature base and 
the barriers and enablers for Māori. A key issue identified was methodological limitations 
of published research. This issue was named as a barrier to drawing out specific success 
factors and assessing outcomes. Barriers identified with regard to delivery of supported 
self-management for Māori included lack of community/whānau engagement, unclear 
training requirements for facilitators and perceived lack of intervention tailoring to address 
personal priorities, values and goals (Ratima 2009). 
There were two NZ evaluations of The Flinders Program published in 2010 (Horsburgh 
and Bycroft 2010; Horsburgh et al. 2010).  In one study, results of a survey sent to the 500 
NZ-based health professionals who had completed Flinders training since 2005 were 
reported. Of the 152 Flinders trained respondents, most reported that they did not use the 
program routinely in clinical practice (Horsburgh and Bycroft 2010). Organisational barriers 
and lack of buy-in were identified as the biggest barriers to wider program implementation 
in primary care settings (Horsburgh and Bycroft 2010).   
The second NZ-based evaluation of the Flinders Program described NZ-specific system 
and organisational barriers as detrimental to the delivery of the program in primary care 
settings. Funding models were highlighted as the biggest barrier to intervention delivery. 
However, in addition, time-bound appointments were also identified as a barrier because 
they did not allow for effective delivery of conversation-based supported self-management 
initiatives (Horsburgh et al. 2010). The findings from these two studies aligned and 
indicated low levels of Flinders Program delivery in NZ (Horsburgh et al. 2010).  
Although program delivery was problematic, the researchers suggest the program is 
useful, needed and appropriate because it helps support patients to address the biggest 
issues of importance to them first (Bycroft and Boyd 2011). These issues, whether related 
to financial, housing, social and emotional areas, are often so overwhelming that health 
concerns became a lower priority than what health providers expect (Bycroft and Boyd 
2011). Two Primary Health Organisations, Te Hononga and Manaia, reported that they 
successfully use the Flinders Program for assessment and care planning for their patients 
with long-term conditions (Bycroft and Boyd 2011). 
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Efforts continue to support delivery of self-management approaches. In 2011, Health 
Navigator NZ published a supported self-management toolkit (Bycroft and Boyd 2011). 
Health Navigator NZ is an Auckland-based non-profit that continues to support health and 
supportive care workers and interested public through a dedicated website gateway for 
health management resources (Bycroft and Boyd 2011). The toolkit contained assessment 
tools, action plans and goal-setting worksheets as well as care plan suggestions. It has not 
been formally evaluated. 
To date, there have been no published studies of supported self-management intervention 
programs conducted in cancer care settings in NZ. 
 
Supported self-management and Māori 
 
The fit and impact of supported self-management programs with indigenous populations 
internationally is questionable (Greenhalgh et al. 2011). The majority of published 
supported self-management program studies have been carried out with predominantly 
white, middle-class, and female participants (Wilson 2008; Newbould, Taylor, and Bury 
2006; Thoolen et al. 2010; Mills et al. 2014). This indicates a predisposition to participate 
in research by people from these demographic groups likely resulting in increased self-
management skill among this group. There is a risk that inequities can increase if 
supported self-management programs have differential uptake between demographic 
groups. 
Mills et al. (2014) published a review of self-management programs for disadvantaged 
populations living with chronic conditions. The evidence shows that disadvantaged 
populations have higher rates of chronic conditions and worse outcomes but "have less 
access, lower rates of participation and much higher rates of attrition in self-management 
programs than other less vulnerable and affluent groups” (Mills et al. 2014, 1). This raises 
an important consideration for intervention implementation. It also signals the need for 
more research into the underlying causal mechanisms associated with this type of 
intervention. Since 2014, Mills and other collaborators have published a concept map and 
frameworks to inform supported self-management program development and delivery that 




There have been no published data on the actual delivery of supported self-management 
programs specifically with Māori. Yet, as previously described, a key consideration for NZ 
health policy is engagement and partnership with the indigenous Māori population to 
reduce inequities. Ratima’s 2009 narrative review focused on whether supported self-
management approaches could be integrated into Māori whānau-centred care as a way to 
address differential access to care (Ratima 2009). Ratima’s review report emphasised 
cultural relevance for intervention delivery. However, the review failed to consider the 
widely differing categories of programs described in the literature under supported self-
management terminology. Although the review was not intended to be systematic, it would 
have been more useful if it had described the different approaches that comprise the use 
of this terminology and how the various components of supported self-management fit with 
the Māori philosophies of health. Ratima recommended further research with Māori in light 
of  the potential for supported self-management to support self-determination in health 
(Ratima 2009). 
One of the aims of this study was to specifically investigate the acceptability and feasibility 
of this program in cancer care with Māori. In considering Ratima’s (2009) and others 
recommendations (Connolly et al. 2009; Horsburgh and Bycroft 2010; Horsburgh et al. 
2010; Mills et al. 2014), The Flinders Program seemed be the best fit for Māori in terms of 
potential for cultural fit and whānau inclusion because it emphasised relationship building 
through face-to-face delivery, could be tailored to incorporate all aspects of Te Whare 
Tapa Wha and was able to be responsive to context.   
 
Supported self-management for cancer survivors: the 
international literature 
 
Supported self-management programs have been delivered to people managing various 
long-term conditions over the last 20 years. Although contemporary supported self-
management programs more often take a generic, non-disease specific or cross condition 
approach, it seemed useful in this thesis to focus on the cancer-specific literature to help 
identify if this approach had been applied in the cancer setting. Many studies were 
identified. As per the previous approach, the review process focused on meta-analyses 
first and then prioritised relevance to supported self-management programs delivered in 
similar health care settings to NZ.  
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McCorkle et al. (2012) published a meta-analysis of supported self-management across 
the cancer control continuum. The study defined cancer self-management as “those tasks 
that individuals undertake to deal with the medical, role, and emotional management of 
their health condition(s)” (McCorkle et al. 2011, 51) and identified 32 published cancer-
specific supported self-management intervention studies from 1992 onward. They limited 
their review to the 16 studies that were randomised, described the intervention and 
reported phase of treatment. Each study showed modest improvement in at least one 
outcome of interest. However, the reported outcomes varied between studies with 
individual outcome improvements shown most notably in pain coping self-efficacy, quality 
of life and reducing healthcare costs. The authors concluded that cancer trajectory stages 
were critical components of supported self-management outcome with interventions in the 
cancer context occurring differentially during active treatment, across different modalities 
and during the post-treatment transitional survivorship time period. The review concluded 
that this approach was on the rise and that improved outcomes were selectively indicated 
in various domains during treatment (McCorkle et al. 2011). 
Although no NZ studies were found, one evidential review of self-management had been 
published in Australia (Ugalde et al. 2015). This review was based on 15 studies. One 
study reviewed piloted delivery of an adapted Stanford Program for cancer survivors in 
South Australia (Beckmann et al. 2007). An intervention group participated in the adapted 
program while a control group undertook the original program. The 29 cancer survivor 
participants preferred the cancer-specific adapted program while caregivers preferred the 
original program. In another study, the Taking CHARGE program was delivered to twenty-
five women (Cimprich et al. 2005). The program involved four contacts with a nurse or 
health educator over a seven-week period constituting two group meetings and two 
telephone sessions. Women reported that the program was useful and they felt that the 
self-management strategies gained would be useful for coping with concerns in the future 
(Cimprich et al. 2005). 
In 2013, Paula Howell conducted an unpublished study in Melbourne, Australia targeting 
transitional survivorship in cancer survivors (P. Howell, personal communication, 
November 24, 2013). This study implemented a shared care model for survivorship care 
between a cancer centre and cancer non-government organisation. At the end of a 
treatment phase, patients were referred to the project by their healthcare practitioner. The 
Cancer Council Victoria Helpline cancer information nurses were the project 
interventionists. Each project nurse was trained in motivational interviewing and goal 
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setting. The nurses called the participants up to 12 times and collaboratively worked to 
develop a health and wellbeing plan with personalised goals established. Common themes 
for wellbeing goals set by the participants included holiday planning, exercise, dietary 
changes, managing challenging emotions including fear of recurrence or depressive 
symptoms, managing a difficult relationship, and return to work. Follow-up assessment 
calls were scheduled for one, four and eight months post-treatment. Clinically significant 
changes were noted over time in the domains of positive engagement in life (p=0.01), 
emotional wellbeing (p=0.02) and health literacy (p=0.006). An overview of results, 
enablers and barriers from this and five other two-year cancer survivorship demonstration 
projects was published in 2015 by Jefford and colleagues (Jefford et al. 2015). Strong 
clinical leadership was identified as a critical success factor across all six demonstration 
projects (Jefford et al. 2015). 
An additional literature search was conducted to narrow the findings. The terms ‘colorectal 
cancer’ and ‘bowel cancer’ or ‘neoplasms’ in addition to the search term ‘self-management’ 
were utilised. Most resulting abstracts, after being scanned, only mentioned the term 
‘colorectal cancer’ but were not targeted for this cohort. After further review, 18 colorectal 
cancer and self-management studies were identified for in-depth critical analysis. 
Quantitative, qualitative and mixed methods approaches were reported and reviewed in 
these studies with a colorectal cancer cohort. Appendix A provides a summary of each of 
these studies.  
Across the 18 colorectal cancer self-management studies identified, the majority of the 
studies used qualitative methodologies: interviews and focus groups. Most interviews took 
place with participants during a post-surgical treatment phase of colorectal cancer 
treatment. Studies were of mainly low quality with small numbers of participants and 
minimal analyses undertaken.  
Colorectal cancer impacts on quality of life were described in these studies; especially for 
those who were younger, women, those who have had right hemicolectomy surgery and 
those who experienced higher diarrhoeal distress. In general, the main outcome measure 
utilised was QOL with results indicating low mental health satisfaction across the board 
(Pan and Tsai 2012). 
Necessary adjustment was a key theme that emerged from the qualitative studies. 
Adjustment was needed to accept the reality of the cancer diagnosis, survive cancer and 
move forward post-treatment, and cope with lingering side-effects. This theme was 
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eloquently summed up by a Swedish qualitative study as ‘Life is back to normal and yet 
not’ (Ohlsson-Nevo et al. 2012). Despite barriers to self-management reported by some 
colorectal cancer survivors, such as ostomy limitations and fatigue, survivors described 
being motivated to engage in health-promoting behaviours (Ganz, Casillas, and Hahn 
2008; Hewitt, Greenfield, and Stoval 2006).   
Gaps in survivorship care were specifically noted in two of the studies. A UK-based 
qualitative study with 27 colorectal cancer survivor participants reported that participants 
felt they were left to cope alone at home once immediate and acute symptom 
management was no longer needed. This reflected a gap in post-treatment survivorship 
care (Beaver et al. 2010). In an Australian study, colorectal cancer patients reported that 
they wanted lifestyle and psychosocial care advice from health practitioners, however, 
Australian health and supportive care workers who participated reported that they were 
most comfortable stating facts and were not in agreement about the need for providing 
patients with lifestyle and psychosocial care advice or information about side-effects and 
self-management (Baravelli et al. 2009). These studies both indicated the need for 
survivorship support for colorectal cancer survivors.  
In a qualitative study from Canada, participants stated that the unexpected long-term 
duration of side-effects led to colorectal cancer survivorship uncertainty and stress 
(Galloway and Graydon 1996). This represented a mismatch in expectations and created a 
communication gap between survivors, and health and supportive care workers. 
These studies indicate that research evaluating supported self-management programs in 
the cancer context was needed to address perceived gaps in survivorship care (Beaver et 
al. 2010; Baravelli et al. 2009) and mismatched expectations between patients, and health 
and supportive care workers (Institute of Medicine and Committee on Quality of Health 
Care in America 2001; Jefford et al. 2008; Weeks et al. 2012). A further study 
recommended that supported self-management intervention needed to “focus on helping 
patients accept their disease, and then learn how to live with cancer and its various 
ramifications” (Chao et al.  2010, 2279) as well as enhance perceived self-control over 
managing side-effects (Kidd et al. 2008). Although the colorectal cancer care management 
role was often reported as shared between the individual diagnosed with cancer and their 
partner or whānau, supported by health and supportive care workers, coping styles and 
self-management were described in different ways by these various supporters (Ohlsson-
Nevo et al. 2012).  
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Of the reviewed colorectal cancer-specific intervention studies, only one published RCT 
was of good quality and fit. It applied the same definition of supported self-management 
utilised in this thesis. The 2008 two-armed prospective study by Hawkes et al. in Australia 
involved 410 people being treated with chemotherapy for colorectal cancer. The 
intervention group received individual self-management promotion consisting of 11 
telephone coaching sessions based in Acceptance and Commitment Therapy delivered 
over a six-month period. The health coaching sessions were delivered by accredited 
health coaches guided by a custom developed web-based computer application used to 
enhance positive lifestyle behaviours. Hawkes et al. proposed that “interventions to 
improve quality of life after colorectal cancer may be most effective if they target symptom 
management, psychosocial and lifestyle variables, or health behaviours, in a 
comprehensive and integrated approach” (Hawkes et al. 2009, 2). The study did not 
enable inclusion of family or whānau in intervention delivery. The researchers found the 
low-intensity telephone-based self-management intervention to be effective for improving 
physical activity, dietary habits, and body mass index in colorectal cancer survivors but not 
quality of life. The authors concluded the supported self-management telephone-based 
intervention was convenient, low-cost, feasible and improved some important health 




This chapter presents the results of a literature review on supported self-management to 
inform selection of an appropriate intervention program to trial in the NZ context. 
Supported self-management program intervention is a promising approach to address 
survivorship impacts faced by cancer survivors.   
The studies identified under the supported self-management search strategy were found to 
be diverse due to heterogeneity of study populations and differing interpretations of 
supported self-management. The narrative review presented here prioritised meta-
analyses and studies that reflected the aims of this research. The aims of this research 
were to generate NZ-specific information on the acceptability and feasibility of a supported 
self-management intervention program in the hospital-based cancer setting. 
Many of the early published trials of supported self-management were carried out with 
people managing specific chronic conditions. Meta-analyses of these supported self-
management intervention studies identified some positive outcomes in quality of life and 
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clinical parameters. Various outcome measures were utilised but there has been no 
consensus on the most appropriate outcomes measures for use.  
Justification for conducting the phase one and two studies presented in this thesis was 
provided by foundational work and recommendations in published papers, particularly 
informative were publications by Jefford et al. and Sarfati et al. These authors have 
suggested that more research is needed into self-management approaches for cancer 
survivors. They further suggest that lack of hard data on intervention mechanisms and 
specific outcomes should not preclude preliminary and exploratory studies into novel 
approaches that may improve health outcomes.  
Contemporary supported self-management programs have multi-pronged theoretical 
foundations and incorporate four key components:  therapeutic alliance, collaboration, 
therapeutic techniques and goal setting. There are three well-known programs 
internationally: The Stanford Program, The UK Expert Patients Program and The Flinders 
Program. Through each of these programs, health and supportive care workers partner 
with people affected by chronic conditions to identify problems or issues, problem-solve, 
and share in decision-making across an array of possible actions in the face of changing 
life and health circumstances. 
The Flinders Program was identified as the program of choice because it most closely 
matched the criteria developed from the literature. It was structured yet enabled tailoring. It 
was intended to be delivered by accredited practitioners to individuals or whānau. It was 
flexible. It incorporated standardised assessment processes and various strategies and 
tools that could fit with the hospital-setting. 
To date, there have been no published studies of The Flinders Program conducted with a 
colorectal cancer-specific population internationally, nor with the general cancer population 
in NZ. This research can address these gaps and explore the acceptability and feasibility 
of The Flinders Program with Māori and non- Māori cancer survivors. Cultural relevance 
and acceptability for Māori is a priority consideration in light of inequities. Timing, setting 
and mode of delivery are also important considerations with no evidence available on 
these parameters of effective intervention delivery with cancer populations in NZ. More 
research is needed. 
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CHAPTER 4: Phase one qualitative study 
 
E mohiotia ana a waho kei roto he aha 
One cannot know from the outside what is contained within 
The overall purpose of the two-phase study reported in this thesis is to document impacts 
of cancer survivorship and inform equitable redesign of care pathways for cancer 
survivors. If the phase one data provides evidence that progression to a phase two study 
is warranted, a quantitative feasibility study is envisioned. 
This chapter describes the phase one methods and results. It reports on survivors’ and 
health professionals’ cancer experiences and views. The subset of research questions 
addressed in this first phase of the study are: 
1. What are cancer impacts and how are they experienced by survivors in NZ? 
2. What other factors contributed to life and health complexity, and coping for NZ 
cancer survivors? 
3. Can a supported self-management intervention help address cancer and complexity 
impacts for survivors? 
The aims were to: 
A. Qualitatively explore, with survivors and health professionals, cancer treatment 
impacts, life and health complexity, as well as management strategies utilised by 
NZ cancer survivors during and post-treatment; and, 
B. Use an intervention vignette to gauge the perceived acceptability of The Flinders 
Program, a supported self-management intervention program, in the NZ hospital-
based cancer clinical setting. 
The research presented in this thesis follows the flow of the MRC complex intervention 
framework. This chapter and the next one are presented as stand-alone chapters in order 
to assist the reader in following the flow of study phases. This chapter contains the 
rationale, methods, results and discussion for the first phase of the research, a qualitative 
modelling study. The next chapter is a stand-alone chapter describing a phase two 





This first section presents the rationale for the phase one qualitative modelling study. In 
this study, the experience of cancer impact was explored with cancer survivors and health 
professionals.  
Qualitative research is carried out using systematic processes to explore human 
experiences, behaviour and perceptions. By exploring the experiences and views of 
cancer survivors and health professionals, this study aimed to describe cancer impacts, 
management strategies and the acceptability of The Flinders Program as a Chronic Care 
Model-affiliated supported self-management intervention to improve cancer care. The data 
represents a snapshot of NZ survivors’ and health professionals’ experiences and views. It 
can be used to indicate if a new approach is generally acceptable or outright rejected. 
Consideration was given to the best qualitative approach to use to address the aims of the 
study. Qualitative approaches considered included Grounded Theory, Interpretive 
Phenomenological Analysis and Framework Analysis. A Thematic Analysis or Content 
Analysis, incorporating Framework Analysis, was considered the best approach (Denzin 
and Lincoln 2005). A Thematic Analysis develops themes based on commonalities and 
differences in qualitative data in order to draw descriptive conclusions clustered around 
themes (Gale et al. 2013). The addition of a Framework Analysis approach incorporated a 
foundational fore structure to help identify commonalities identified from existing evidence 
(Gale et al. 2013). Framework Analysis has been used extensively in healthcare research 
and is characterised by focusing on specific questions, a priori issues and working in 
limited time frames (Srivastava and Thomson 2009).  Framework Analysis builds a frame 
into thematic analyses (Ritchie and Spencer 1994). The key ideas that form the 
foundational frame are derived from existing theories and philosophies. The frames 
chosen were based on a key guiding principle identified for this study; a person-centred 
rather than disease-centred focus as presented in the Te Whare Tapa Wha model (Durie 
1994). The impact data is structured according to the four cornerstones of wellbeing: 
physical, emotional, social and spiritual health (Durie 1994). 
Klimmek & Wenzel’s (2012) adapted cancer survivorship framework was used as the 
frame for the analysis of self-management strategies. There was no specific Māori-centred 
survivorship framework available to draw on related to this concept. Klimmek & Wenzel’s 
(2012) survivorship framework outlined work in three areas: illness-related work, 
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biographical work, and everyday life work. Illness-related work, as applied to cancer 
survivorship, related to managing symptoms, disability or loss of function, diagnostics and 
ongoing surveillance, crisis prevention and handling, as well as care-planning and 
maintaining the continuum of care. Biographical work included contextualizing (i.e. making 
the illness part of ongoing life), coming to terms with illness consequences and one’s own 
mortality, restructuring one’s self-concept, and recasting one’s biography in to the future. 
Everyday life work related to day-to-day tasks of cancer survivors including household and 
relationship maintenance as well as management of stress and emotion. The Adapted 
Illness Trajectory Framework enabled a structure to assign the many types of visible and 
invisible tasks involved in cancer survivorship (Klimmek and Wenzel, 2012, e501).  
Perceptions and views on supported self-management were derived from a vignette 
approach and results presented in a holistic frame which described the individual and 
environmental determinants identified. According to Hoddinott et al. (2013), intervention 
vignettes can be a useful approach to model acceptability of proposed approaches with 




In this section, interview guide development, stakeholder recruitment, as well as focus 
group and interview processes, are described. Prior to protocol development, consultation 
on the study rationale as well as the focus group and interview approach was conducted 
with Māori leaders and regional representatives from Capital & Coast District Health 
Board. Māori consultation with the C3 study advisory group, Otago University Ngai Tahu 
advisory board and the Capital & Coast Research Advisory Group – Māori was 
informative. Approvals to proceed were provided. These groups were regularly kept up to 
date on the study protocol development. Once the protocol and accompanying information 
sheets, consent forms and discussion guides were developed, an expedited application 
was submitted to the Central Health & Disability Ethics Committee.  This was the first 
application submitted using the now standard electronic system. Approval was granted in 
October 2012. 
Interviews and focus groups were proposed as a way identify any gaps in survivorship 
care and inform the acceptability of The Flinders Program. Focus groups were comprised 
of cancer survivors residing in the lower North Island of NZ, specifically the greater 
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Wellington and Palmerston North regions. Interviews were held with key informant health 
and supportive care workers working in the same parts of NZ.  
Ethical considerations were prioritised. These included ensuring informed and voluntary 
consent, confidentiality and minimisations of risk.  
Informed and voluntary consent was both described and affirmed in writing. All research 
participants were provided with an information sheet describing the purpose and conduct 
of the study. Each participant was asked to sign a consent form which also included 
demographic questions on gender, age, and ethnicity (see Appendices C and E). It was 
confirmed that participation was voluntary and that potential participants could withdraw 
participation and data at any time. 
Confidentiality processes and practices were applied. All data were stored securely in 
locked filing cabinets or password-protected computer files. All identifying information was 
removed from the transcripts and codes used instead. 
Options for minimisations of risk were addressed prior to the start of the sessions. 
Participants were informed that the topics or conversations might cause distress because 
of the sensitive or difficult nature of their personal experience with the subject. Options 
were provided for follow-up to reduce any distress participants might experience as a 
result of the focus groups or key informant interview sessions. 
A focus group discussion guide (see Appendix D) and an interview guide (see Appendix F) 
were developed to facilitate conversations around cancer impact and perceived gaps in 
cancer care, self-management strategies and supported self-management intervention 
with research participants. The development of the guides was informed by the literature 
that showed that cancer impacts on survivors’ abilities to self-manage (see literature 
review chapter 3). Simple, yet targeted, questions were included to assist the facilitator to 
structure the sessions or interviews. Questions posed through focus groups and key 
informant interviews reflected the objectives of the study. Questions around cancer impact 
and self-management strategies were asked first in order to set the scene for the 
introduction of the supported self-management vignette. The vignette, as a qualitative tool, 
was utilised to introduce the concept of supported self-management as an intervention. 
This enabled the facilitator to talk people through the potential intervention and gain 
different perspectives on the concept and its acceptability.  
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A mix of indigenous and non-indigenous New Zealanders was purposefully sought to 
participate in focus groups held in the greater Wellington region and Palmerston North. 
Both men and women were invited to participate. Survivor perspectives on the impacts of 
their cancer experience and the perceived acceptability of the intervention were explored.  
The opportunity to participate in key informant interviews was offered to people who work 
professionally with people affected by cancer. A discussion guide provided the template for 
the exploration of supported self-management and care planning in the NZ hospital-based 
cancer care context (see Appendix F).  Key stakeholders were asked about perceived 





The primary eligibility criteria for participants was a previous colorectal cancer diagnosis 
and receipt of treatment for cancer (see Figure 12). 
 
Figure 12: Phase one focus group eligibility criteria 
 
Focus group participants were purposively recruited and self-selected through project 
advisors, recruitment flyers and an advertisement in CanTalk, the Cancer Society 
newsletter. Potential participants were encouraged to contact the study lead via telephone, 
email or through Cancer Society staff.  The study lead followed up to explain the study and 
to identify best days/times for the focus groups. Monetary incentives ($30) were offered as 
a contribution toward time and travel expenses. 
Best practice focus group methods were reviewed and applied (Liamputtong 2011; Denzin 
and Lincoln 2005; Patton 2002). The participants were linked by eligibility criteria that 
Eligibility criteria for study 
• Acknowledged primary cancer diagnosis, particularly colorectal cancer, with 
receipt of surgery or adjuvant chemotherapy treatment; 
• No apparent or reported physical or mental distress that would deem the trial 
to be overly burdensome; 
• No apparent or reported impaired ability to comprehend the intervention; 
• No history of taking part in Flinders or lay-led self-management programs 




encouraged shared experiences of cancer diagnosis and treatment. The co-facilitators 
prioritised interchange among participants, and sessions lasted for an established length 
of time (Denzin and Lincoln 2005). Each focus group was limited to about 1.5 hours and 
was co-facilitated by an experienced qualitative research team, including the author of this 
thesis. Participants were asked to draw on their social context and lived experiences of 
cancer in response to questions asked. The forum was designed to promote cultural and 
emotional safety during the sessions. 
Principles of Kaupapa Māori research methodology were explored to help inform the 
phase one research. Kaupapa Māori research methodology is underpinned by principles of 
tika (authenticity) and pono (truth) and the values of manaaki (show respect) and tautoko 
(support) which are important to tikanga Māori (Mead 2003). As a non-Maori, I was not 
able to apply Kaupapa Maori research methodology, however, examining the approach 
helped in my attempts to provide a culturally safe research experience for Māori 
participants. Smith (2012) recommends seven intervention elements to guide good 
Kaupapa Māori research practice (see Figure 13). 
 
Figure 13: Seven components of Kaupapa Māori research  
Source: Smith 2012 
A Māori-specific focus group was envisioned. Guidance was sought from Māori study 
advisor, Pauline Wharerau, and researchers at the Te Rōpū Rangahau Hauora a Eru 
Pōmare based at Otago University Wellington. It was suggested that a Māori researcher 
work with me to conduct the Māori-specific focus group so to best deliver empowering, 
culturally safe research practice in line with Kaupapa Māori research principles. 
 
Seven practices to guide Kaupapa Māori research 
Aroha ki te tangata – to show respect towards people. This can be done through 
emphasis on whakawhānaungatanga to establish links through conversations 
Kanohi ki te kanohi – face-to-face conversations shows respect and authenticity 
Titiro, whakarongo, korero – look/watch, listen, then speak 
Manaaki ki te tangata – to care for 
Kia tupato – to be careful 
Accountability to Maori participants 
Kaua e takahia te mana o te tangata – do not stamp/trample on 




Key informant interviews 
 
Potential participants were approached if they were identified as providers of cancer care 
or associated services. Health professionals were recruited based on project advisor 
advice, personal knowledge, and snowball recommendations from interviewees.  The 
health professionals approached included cancer specialists, generalists, clinical nurse 
specialists, community nurses, information nurses, and social workers.  
Potential participants were initially contacted through an email containing a project brief 
and request for 30-minutes of their time to discuss their views on the intervention. The 
author followed up with each contact to explain about the study, identify best days/times 
for the interviews, and record contact details so an information sheet could be sent out 
(see Appendix E). Interviews were conducted face-to-face or by telephone with consenting 
health practitioners. Topics raised included views on supporting patients with life impacts 
of cancer and the possible role of supported self-management intervention in the hospital 
setting. Key informants who participated in interviews were not provided monetary 
incentives. 
The interviews were carried out to gain insights into the particular constraints and 
opportunities afforded by those working in or alongside NZ cancer care settings. Health 
and supportive care workers were asked their views on perceived gaps in cancer care. 
They were also asked about self-management strategies patients used and their views on 
the acceptability of a supported self-management and care planning intervention (e.g. The 




There are multiple steps to data handling within a Framework Analysis (Patton 2002). In 
this study, the steps included data familiarisation, indexing, identifying a thematic frame, 
charting and interpretation. In undertaking this framework analysis, audio-recorded data 
were transcribed from focus groups and key informant interviews. These data were subject 
to iterative review to achieve data familiarisation. The detailed facilitator and interviewer 
notes from the sessions were concurrently reviewed. Data were then openly coded. Each 
code consisted of words or phrases. The codes were then indexed, grouped and 
categorised. These codes were reviewed and cross checked by a study supervisor (LS).  
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The index developed from data was embedded into the foundational frame. The data were 
interpreted deductively to identify key themes. This analysis was cross-checked by the 
study supervisor (LS), discussed with the author, and amended as appropriate once 
consensus was reached. 
Data from the Māori-specific focus group were considered first to inform the foundational 
interpretations of the full data set. This approach aimed to prioritise Māori views as a guide 
to frame experiences and assessment of intervention acceptability. 
In each thematic section, the focus group and key informant interview data were illustrated 
by indicative quotes. The quotes were used to illustrate the groups’ view or an individual 
view. At times, an interpretation on how the quote related to the theme was included. For 
reasons of anonymity, safety and best-practice, comments made by participants in the 
focus groups were not individually identified (Liamputtong 2011). In contrast, the key 
informant interview quotes were kept confidential but identified by a non-representative 
alpha-numerical combination corresponding to each specific key informant. The full results 
informed whether progression into the next phase of the intervention framework, namely a 




Thirty-six people participated in phase one: 24 in focus groups and 12 in interviews 
conducted between October 2011 and March 2012.  
One focus group (n=6) was comprised solely of people who identify as Māori. This was 
purposefully organised in an attempt to provide a cultural safe setting for the research 
participants.  
The other focus group (n=18) can be described as multicultural. This was a larger than 
expected group but it was deemed important not to turn anyone away that showed up. 
There is no gold-standard focus group number but most are reported to have between 7-
15 participants (Liamputtong 2011). Participants in the multicultural focus group ranged in 
age from 36-73 years (average age = 55) with two-thirds of each group being female 
participants (n=17). Life roles varied amongst participants. For example, there was a mix 
of people employed, part- and full-time, and retired. 
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Key informants (n=12) included a social worker, two clinical nurse specialists, three cancer 
information nurses, a general practitioner, a community nurse, a stoma nurse, a radiation 
therapist and a key support worker. These people were purposively selected because they 
were recognised as leaders in delivery of holistic support for people affected by cancer. 
They ranged in age from 30-65 years (average age = 53) with two males participating. 
There was one Māori key informant and one European participant. The majority (n=10) 
identified themselves as NZ European. 
 
Focus group results 
 
The results from the focus groups are synthesised and presented in this section. Focus 
group participants were asked to share impacts of cancer treatment on their life and how 
they managed during that time with the group. Cancer survivors pointed out gaps where 
their expectations for care did not meet their experiences of care. Impacts and gaps 
discussed by survivors were categorised as social, physical, emotional, and spiritual 
following the Te Whare Tapa Wha model cornerstones (Durie 1994). Impact management 
strategies were outlined using the adapted illness trajectory framework (Klimmek and 
Wenzel 2012) as the analytical frame. By using these two frames, what was already 
known about cancer impacts and the work of cancer survivorship served as the fore 
structure for analysing this new NZ data. 
The focus group processes differed between the two groups. The Maori-specific focus 
group began with karakia and whakawhānaungatanga prior to any handing out of 
information sheets and consent forms. Use of these culturally indicated processes 
provided the opportunity for participants to make connections, researchers to show respect 
and to create a safe space for open conversations. All focus group participants were 





The Te Whare Tapa Wha framework identifies tinana as one of the four cornerstones of 
Durie’s 1994 Māori health model. Tinana is defined in the te reo glossary as referring to 
the body (Moorfield 2005). Tinana reflects physical manifestations of health and wellbeing 
on the body.  
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Cancer-related physical impacts were described by all participants. Many described their 
struggle to manage specific physical issues. The issues mentioned included fatigue, 
weight change, bowel incontinence and comorbidity. The extent of physical impact and 
self-management ability varied among participants. 
Focus group participants expressed varying levels of difficulty dealing with toxicities and 
side-effects during and after treatment. Although changes in bowel habits were usually 
readily addressed by the cancer care team, many other common side effects were 
described as predominantly self-managed. 
Fatigue was a common physical impact mentioned by participants. One participant 
described how it felt prior to his emergency admission to hospital. 
I found that I just didn’t have any energy to do anything. I totally lost interest in 
everything. All I was really looking forward to was coming into hospital each day for 
radiation and having a little meal in the cafeteria and then it was time to go home and 
just be a total vegetable.  I was actually in a very, very bad way, but I did not realise it 
until later…the thing was I didn’t know I needed [support]. 
This participant’s experience of fatigue led to a perceived loss of confidence in self-
management ability and control. When he described this experience, his emotional 
reaction was so strong that he cried. 
Some participants discussed the stress of learning to self-manage specific physical 
impacts encountered. A member of the multicultural focus group described uncontrollable 
weight gain contributing to a loss of self.  
I didn’t expect to get fat. It really freaked me out because I didn’t know if I’d be able to 
lose it again. And the other thing was that [it impacted on my willingness] to do 
anything by myself…I hadn’t been myself [in look or feel] for quite some time… It was 
quite freaky.  
This participant described how she had to find ways to address an impact of cancer 
treatment that challenged her sense of physical identity. 
Dealing with changes in sensation, including neuropathy and skin breakdown, was 
described by two focus group participants. As one person said: 
The blisters on my hands were horrific. Each fingertip. The feet. I drove home and 
suddenly this pain was terrific. I went straight through the lights on the motorway 
because of the pain. 
In a similar vein, another participant said: 
 
 105 
I had no skin. It was raw and I was thinking what do I do here? They said it would 
happen. It is one of the side effects. It took me ages to find a cream that would soothe 
it.  
These participants clearly describe the need for self-management of specific side-effects. 
Comorbidity was raised in the Māori focus group session.  One participant, speaking about 
her mother, identified that her mother’s other health issues complicated communication 
and care.  
She had all these other issues [lupus, arthritis], and trying to get them [doctors] to all 
talk to each other was impossible, and so then it was left to the whānau [to talk to the 
doctors].  





The Te Whare Tapa Wha framework identifies hinengaro as another cornerstone of 
Durie’s 1994 Māori health model. Hinengaro is defined in the te reo glossary as referring to 
the mind (Moorfield 2005). Hinengaro reflects emotional manifestations of health and 
wellbeing.  
Emotional impacts of cancer emerged incrementally in the focus group discussions as 
people shared their stories and felt more comfortable in the group.  Some focus group 
participants became outwardly emotional as the group discussions progressed. However, 
the magnitude of the emotional impacts described and displayed varied between 
participants. More negative than positive emotions were described. These included 
shame, worry, uncertainty, loss, anger, fear, anxiety, sadness, and loneliness.  
While the responses in this section are discussed mainly as single emotions to aid 
understanding; in reality, participants described a mixture of complex emotions in their 
narratives. For example, emotive words were used by Māori focus group participants to 
describe reactions to diagnosis and treatment.  Words used included “a blow”, “really hard 
going”, “hit with two barrels”, “stunned”, “horrific” and “frustrating”.   
Worry was one emotion that linked many participant narratives. Cancer-related worries 
around ‘will treatment work?’ and ‘what else will go wrong?’ were articulated by some 
focus group participants. These worries triggered memories of fears for other participants. 
 
 106 
One participant used the analogy of the Christchurch earthquake to describe the fear that 
she felt about not being able to manage emergency physical tasks due to fatigue. Her 
analogy reflected fear, uncertainty, worry and anxiety regarding the environment as being 
generally ‘out of control’, a feeling that seemed to resonate for most participants.  
Focus group participants shared the universal experience of having a potentially fatal 
illness and the loss of what was considered ‘normal’ life into survivorship. Hair loss was 
described as a visual representation associated with cancer treatment loss.   
With our women, there is always this thing about our hair, the fact that we are going to 
lose it. You can still keep your dignity. You do not get that from hospitals. You get that 
[elsewhere].   
This participant described cancer-related loss, visibly portrayed as hair loss, being 
associated with the invisible loss of dignity for Samoan women like her.  
For another participant, a painful loss was felt when she was told her cancer had recurred.  
…that is the hardest thing, being told that you have got cancer AGAIN and having to 
tell my family AGAIN. That loss hurts.  
Various permutations of loss were indicated by the data. Further, a sense of loss was 
palpable during the focus group sessions.  
Fear was another emotion shared by some focus group members. One participant 
reported feeling fearful when her cancer treatment expectations for supportive care went 
unmet.  
 [I did not get] the support from the doctors and the nurses…my very first time. I was 
scared, you know, I was really scared…and I was a bitch…and I say that out here 
because I was, because of the way they treated me.  
In this quote, anger was described as arising from fear. That anger related to loss of 
security and shattered confidence in oneself. At times, that anger was directed at health 
and supportive care workers. Feelings of anger arose from not getting the support 
expected during treatment and those feelings were described as persisting post-treatment. 
Two other participants described being frustrated by care expectations which were not 
being met by their respective cancer teams. Two cancer survivor participants described 




There was no debrief at the end of it. It was just you have finished; get out in to the big 
world. Hope it has worked. It would have been good to have had a bit of a debrief… 
I believe I should have had tests, because bowel cancer can go to the bones. To this 
day I will not know and I have to let it go…[did they do everything they could because 
my cancer has returned in the bone].  
The mismatch between expectation and experience for some participants was described 
as disruptive to putting the cancer experience into perspective and moving forward. 
Another cause for frustration for some was lack of communication about process. 
Participants expressed confusion and frustration around knowing when their respective 
roles as patient or healthcare practitioner were finished.  
Overall the cancer journey impacted on the feeling of being in control. Participants 
described how aspects of life and health were felt to be out of control.  
Cancer takes away from you, it takes a lot of your choices away from you... there was 
that desire to maintain some sort of control over what was happening since health was 
out of control and body was out of control, and so, you just feel like 
controlling…something.  
Control, or feeling in control, was identified as an antidote for the difficult feelings that 
arose intermittently for survivors. 
In summary, a variety of emotions were described by participants across focus groups. 
These included loss and grief, fear, anger and frustration. Some of the negative emotion 
was directed toward health and supportive care workers due to perceived unmet care 
expectations. Most participants described how they still struggled to manage their strong, 




The Te Whare Tapa Wha framework identifies wairua as another cornerstone of Durie’s 
1994 Māori health model. Wairua is defined in the te reo glossary as spirit or soul 
(Moorfield 2005). Wairua reflects spiritual manifestations of health and wellbeing.  
Spiritual and existential impacts of cancer were described by only a few participants. The 
spirit emerged as a contribution to strength in adversity for a few participants and it was 
expressed by one participant in the following way.  
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[What] strengthens us? [Most elements went under] Taha wairua, then it went out 
somewhere else, but it ended in that taha wairua box, and we need to understand and 
get clinicians to understand, for Māori whānau and for anyone else [most things are 
about spirit], because if you get it right for us, you will get it right for everyone else.  
One participant described the importance of their faith. 
Today I had my monthly calcium drip in the cancer day ward. Afterwards I went to the 
chapel, which is something I always do whenever I am in the hospital… 
Another participant described continual efforts to try to find meaning in the experience. 
He used to say to me that you’re fine, there is nothing wrong with you, just go along, 
you are fine and it’s still hard for him to understand that it is with you for life. You can’t 
just shake it off. I’m still trying to understand what it means… 
Whilst issues related to the spiritual were not often spoken about, a minority of participants 
from the multicultural focus group described the experience of ‘spiritual crisis’. In contrast, 




The Te Whare Tapa Wha framework identifies whānau as an important cornerstone of 
Durie’s 1994 Māori health model. Whānau is defined as referring to extended family 
(Moorfield 2005). This is an important concept. This Māori term refers to both descent-
based whānau and whānau who come together for a common purpose. Metge (1995) 
defines the two kinds of whānau as whakapapa-based whānau and kaupapa-based 
whānau. This acknowledges that for people, their whānau can be both their family of 
descent as well as those people they define as important in their support network (Central 
Cancer Network 2016). 
The social impacts of cancer survivorship coalesced around managing relationships. 
When asked about treatment, most focus group participants discussed relationships with 
their cancer team. Relationships with health and supportive care workers were described 
as a key contributor to the experience of care.  
Communication, as the basis for relationships, was described by the survivor participants 
in various ways, from effective to difficult. Some participants focused on connections they 
felt they had with their health professionals. One participant was proud of the collaborative 
relationship and communication he fostered with his oncologist. 
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They are not there just to fix me. I’m there to fix me as well. As soon as you convey 
that to them, they start getting more interested in you anyway, because, hey, this 
person is not just going to sit back and take what is coming. I have got a lot of strength 
out of that kind of interaction, even to the point of exchanging scientific papers with the 
oncologist.  
While another participant described how the poor communication he experienced was fine, 
as long as he received what he regarded as a technically proficient service. 
I just wanted to say the specialists that looked after me, they weren’t wonderful. I sort 
of do not know that I would necessarily expect them to be. I wanted my surgeons to be 
really physically capable.  
Conversely, a few participants described how they wished for more empathetic healthcare 
practitioner encounters. They wanted health and supportive care workers approach to 
convey ‘love’/aroha or ‘warmth’/empathy alongside clinical expertise, and were 
disappointed when this was not provided to them. A few participants mentioned that they 
did not feel heard. 
I do not know how many times I had to jump up and down and say listen to me… 
Similarly, one participant described feeling unsupported beyond the clinical focus of care. 
The surgeons were not in any way connected to cancer really. They just took the 
cancer out. None of the nurses, none of the staff, knew anything about the support 
systems that I actually eventually kind of needed.  
Different relationships and types of connections with health professionals were described. 
Participants held varying expectations for these interactions which impacted on their 
experience of care. 
Two participants used the analogy of a bridge to show their desire for better connection. 
These participants reflected on the perceived gap between the clinicians’ world and their 
own lived reality. 
I became so aware of the gaps between patient and doctor and [nurses] and the need 
for there to be some bridge, call it bridge…(P1) 
Massive bridge (P2).  
These two participants described the need for a bridge that could link their personal reality 
with a clinical world that valued understanding of things like medical terminology and 
navigation of complex clinical pathways between departments. This was described as “…a 
 
 110 
complex process in a foreign environment”. The medical culture challenged people and 
this impact was described passionately by those in the Māori focus group.  
As a patient, relationships with various clinicians were often established quickly without the 
usual application of cultural practices such as whakawhānaungatanga, which was 
perceived to contribute to communication problems.  
if you cannot share it with your own family and if you cannot share it with your doctor, 
who can you share it with? You know, you are stuck there by yourself… some of the 
things they [clinicians] can offer [to make the journey easier], is whānaunatanga, 
whakapapa, whatever… to help walk you through.  
Without the basis for connection and communication established with clinicians, some 
Māori participants felt they were not being treated with dignity and respect. Examples 
included one participant who described their first chemotherapy treatment as “let’s stick 
you up, let’s get you going, then we are out” while another described waiting 45 minutes to 
be unhooked at the end or her chemotherapy infusion. These participants wanted to find 
comfort, respect and a safe place to be in the foreign cancer environment in which they 
found themselves.  
Treatment impacted on and challenged family relationships and roles. Most participants 
reported that they relied heavily on a main family member as a carer during treatment.  
One participant stated that she had wanted whānau to help her navigate. 
It was about wanting somebody to ‘love you’ through it….wanting someone to walk 
[beside] you through it.  
There were instances where a survivor referred to others being worse off, such as 
illustrated by one participant in the quote below: 
As a [survivor] carer…I do not know how many times Mum used to say to me I am so 
lucky you are here. What about all those people who have no-one.  
A main family carer was seen as integral to management of cancer in day-to-day life for 
some participants. 
Conversely, some participants described withdrawing from whānau. One participant 
expressed relief that he moved away from his wife during treatment because he felt he 
needed to focus on himself rather than attend to her. 
So, because my wife, who is still back home in Waitotara, she loves to be a doctor, so I 
have rushed through on the side. I said because this one is so serious for me, I want to 
do this myself. I will tell you what is going on. When I need you, I will call for you.  
 
 111 
Some participants described perceiving a negative impact on whānau. Talking about this 
issue, one participant said: 
My kids and my husband and my family…they have to go through these ups and 
downs that I have and the bad days and the good days that I go through. I feel sorry for 
them…[they didn’t ask for this]… it has happened to our family…and it takes a toll on 
families.  
This participant felt it added a burden to the whānau. 
I had numerous short trips to hospital and I had a young family. I felt guilty the kids kept 
getting hauled out of bed in the middle of the night to go to their grandparents. They 
were quite uncertain. That was a huge thing. I also got quite weak and couldn’t do 
much around the house.  
These quotes relate to participants’ attending to loved ones’ feelings, actions and thoughts 
during cancer treatment but feeling powerless to self-manage the negative impact on the 
family.   
One participant from the multicultural focus group described financial difficulties affecting 
social roles. She described both work and financial concerns. 
I had financial concerns. I was the main breadwinner for our family and the worry was 
that if this does not work. I mean we were all right then, but if it did not work and [I 
couldn’t work] … we would then be falling into quite serious debt.   
The overarching themes that arose from the focus group discussions around impact and 
impact management were that cancer impacted on life in various ways that required 
adjustment and self-management. The impacts that were described as most difficult to 
manage differed amongst survivors. Various physical, emotional, spiritual and social 
impacts were described. All participants reported experiencing physical impacts. Most 
described emotional and social impacts. Few described spiritual impacts. Participants 
developed strategies that worked, at times, for managing impacts. At other times, 
participants reported struggling to manage impacts effectively. 
 
Cancer survivorship work 
 
In this section, focus group participants describe how they managed life and health 
complexity using coping mechanisms and strategies. This addresses the second research 




Focus group participants were asked to describe ways they coped with the physical and 
non-physical impacts associated with cancer treatment. The mechanisms and strategies 
described are presented using the Klimmek & Wenzel (2011) cancer survivorship 
framework. This framework categorises mechanisms and strategies as illness-related, 
biographical and everyday life work. The focus group data in this sub-section is presented 
for illness-related and everyday life work. A separate sub-section for biographical work is 
missing herein because there was not enough data to warrant inclusion. Reference to 





Mechanisms and strategies for coping with physical impacts of cancer and its treatment 
were described. The strategies described by focus group participants in relation to illness-
related work included avoidant coping (e.g. denial, laughter), seeking support from family 
members, trying a variety of over-the-counter and complementary products for side-effect 
relief, and talking with others (e.g. such as staff of the Cancer Society or Māori navigator).  
Denial was mentioned as a coping strategy. One participant stated “just the thought of 
having cancer, it’s like a process of denial”.  Another person described asking for support 
as ‘whakama’ (meaning embarrassing or related to loss of mana), resulting in denial. This 
helped avoid the uncomfortable difficulty and embarrassment of taking actions to manage 
cancer-related impacts. 
One focus group participant said “It is kind of a switch to actually ask for help when you 
have been doing just fine living your life, and suddenly things change…” The main strategy 
described was ‘just getting on with it’ amidst challenges presented by cancer, cancer 
treatment and life in general.  
I found out that you have to believe in yourself even though things might be bad, just 
believe. I mean, that’s what has got me through and today I work… and I am not 
supposed to be doing that…I just got on with life…You have got to have something to 
believe in.  
Intermittent bowel incontinence was an illness-related concern raised that crossed over 
with everyday life work. Colorectal cancer survivors described how they readily received 
assistance with bowel continence from the cancer team during treatment. However, 
participants described sustained changes in bowel habits and ongoing management 
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challenges post-treatment. It led one person to pursue a practical strategy of “…a kit in the 
car [with] all the emergency things you [may] need for diarrhoea or nausea, like a water 
bottle, plastic bags…” Participants described a lack of awareness of post-treatment 
support options to address these types of issues which affected their ability to work, travel 
or participate in social activities. 
A few participants found accessing information to be helpful. People described accessing 
information and support through health professionals, Cancer Society, friends, whānau or 
internet options. Helpful support options mentioned included joining a support group, 
finding cancer buddies through online forums, or by participating in a yoga class or other 
exercise program. Information helped some people find ways to meet their support needs 
and feel more in control. 
Some focus group participants touched on ways they managed the less readily seen social 
and emotional challenges associated with treatment. The importance of social strategies 
was raised by a few participants. Some people mentioned whānau or a ‘buddy system’ as 
an important source of support. As one person said: 
One thing that comes up quite a bit is the support of whānau through the process and 
also having to communicate with whānau about what is going in your lives as well. 
Sometimes I find that friends are better than whānau…. because whānau can get a bit 
too emotional, whereas friends you know...there is more of a chance to talk with them.  
This quote relates to the importance of being able to talk with people who were not as 
emotionally involved as close family. It indicates the value of different sources of social 
support to enable access to those that at different times feels safe and fit for purpose.  
At times, the conversations touched on loss of future security and loss of possibilities and 
opportunities. Personal management strategies were offered by some participants as a 
reaction to the loss narratives shared by group members. Two people described how they 
reverted to their traditions or things they learned from older relatives. A Pacific participant 
described that people she knew often chose to use both traditional medicine alongside 
Western cancer treatments. This was mentioned by a Māori participant as well. 
Some strategies were described as helpful for people but were perceived to get a negative 
reaction in the healthcare environment. A Māori focus group participant described the use 




…what we [Māori] do when we are in pain, we laugh…and so our way [was] trying to 
laugh through a session, because it was really hard… Mum used to say some funny 
things and she would joke away about cancer and it was a way of dealing with the 
pain...  
This participant explained that this coping strategy was judged as negative in the 
healthcare environment due to it being interpreted as incongruous to the seriousness of 
the situation. In a sense, laughter might be considered a form of denial, but it is a useful 
mechanism for some. 
Coping mechanisms and strategies are personal. Focus group discussions reinforced the 
individuality of coping mechanisms and strategies found useful during treatment. 
 
Everyday life work 
 
When you have cancer, you don’t just worry about what will happen to your body, you 
worry about what will happen to your life (Macmillan Cancer Support 2014, 68). 
Mechanisms and strategies for coping with everyday life during cancer treatment were 
described. These overlapped with the data presented in the previous section on illness-
related work. 
At treatment end, everyday life work was seen to be the dominant area of focus. Most 
participants described lingering illness-related impacts disrupting everyday life work and a 
return to normal life. Some participants discussed setting new life goals at this time. 
Examples shared included things such as avoiding recurrence, eating well, exercising or 
coping through the week. These hopes and desires were described more as personal 
aspirations, and did not seem to translate into specific action plans. 
During treatment, people reportedly felt that they were managing mostly well, but after 
treatment ended there was a change. People described holding ‘end of treatment’ as the 
goal, but after treatment it felt like nothing was happening and it was scary “…because I 
am not going to the hospital anymore” (K8).  
The one thing I wanted when I finished was someone to help me set up what sort of 
exercise I was going to do.  
The transition from the hospital ‘safety net’ where patients were urged to call their 
treatment team if they had any concerns, to a perceived post-treatment void in support, 
was described as a ‘let-down’ by some participants. The transition shock contributed to 
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feelings of anxiety that were described using words like “uncertainty” or “powerlessness” 
by participants. One participant was unhappy about this gap in care and described it as 
follows:  
If there is a problem you are told to go back to your primary care provider, your GP, but 
in a world where you lost your job and finances are an issue, you have to pay for that 
privilege.  
The cost of traveling to appointments, time off work, unsubsidised primary care visits and 
the cost of medications were specific examples mentioned as having an impact on 
everyday life. There were no specific strategies mentioned for dealing with these impacts 
except ‘just getting on with it’. 
Focus group data highlighted opportunities for supported self-management intervention. 
Various management strategies were described but gaps were evident. Everyday life work 
was particularly challenged because of cancer-related impacts on finances and 
employment. 
 
Supported self-management intervention impressions 
 
The Flinders Program, illustrated through a vignette, was described to participants as a 
standardised yet personalised intervention that could be delivered in the hospital or 
community setting. As a strengths-based intervention adapted to peoples’ values and 
priorities, it enabled coping strategy development and use. A vignette was read aloud to 
participants. 
John is feeling more unwell and is finding his usual jobs difficult to maintain.  He is the 
main breadwinner for his family. The key support worker is part of the cancer team and 
talks to John privately in 3 sessions, for just a short time, while he is waiting in the day 
ward for his appointments, about how he is going in fitting ‘cancer’ into everyday life at 
home.  Supported self-management encourages individuals to discuss what is most 
important to them at the time with a view to dealing with every day or practical 
concerns. The key support worker reflects John’s concerns and discusses with him 
strategies and ideas. Self-management interventions intend to help people acquire and 
practise skills to carry out different medical regimens and lifestyle changes as well as 
support physical and psychosocial transitions. John and the key support worker 
collaboratively explore John’s values, strengths, strategies and goals in order to 
develop a plan that will work for him and his whānau. Practice in carrying out strategies 
is also encouraged. A written care plan is provided to John. It includes discussed 
strategies, goals and any referrals. It may be of use at the time and/or when treatment 
ends. In this way, John is supported to develop the confidence and skills to self-
manage more through his remaining treatment and post-treatment. It helps him 
develop strategies to deal with long-term impacts, return to work and with managing 
relationships differently. It allows him to move forward with greater confidence.  
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Participants were asked to describe their impressions on the approach presented. There 
was a mix of positive responses and concerns raised regarding the acceptability of 
supported self-management intervention. While, many participants seemed to identify 
promise in the approach, others were dismissive. 
The impressions of supported self-management described varied among participants. 
Survivors’ initial reactions to the vignette ranged from immediate rejection “I do not want a 
life coach” and “I do not like the name” to cautious consideration, such as “It is very easy 
to wallow in self-pity. Someone has to tell you to get up and go” which was also reflected 
in the quote below. 
I think whoever this person is going to be and how that relationship initiates as long as 
you are the driver, and if that person is purely a rebound board…but that journey you 
do not always know at the beginning. I think over your radiation chemo pathway it 
happens in steps.  
Assessment for support needs was one positive benefit foreseen from the approach. This 
was confirmed in this quote from a focus group participant. 
One of the cancer nurses came and said that there are these things available for 
financial help. I tell people about it. My previous cancer nurse assumed that I did not 
need that financial help. I think one of the things that specialists could do is not assume 
they know everything about the person’s situation, but actually ask are you needing 
any help with doctors’ bills? Because that is what I needed help with and would have 
qualified for, but did not get, because they assumed I was well enough off not to need 
it, but I do not think you can assume.  
Along with identifying some positive potential for supported self-management, there were a 
variety of concerns or barriers described by focus group participants. The concerns raised 
about supported self-management intervention were largely around terminology and ‘fit’ 
with existing supports.  
One participant in the Māori group interpreted supported self-management to mean 
support from others. Although most people in that focus group stated their preference for 
their Māori cancer navigator to be their support person, one person stated that support 
could be provided usefully to others by someone who was experienced, knowledgeable 
and caring. 
Experience and the wairua [matters]…it does not matter where you are from.  
In general, the concept of supported self-management was not seen to be easily grasped 
by focus group participants, and only a minority stated that it might be a useful addition to 
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their care. There was concern raised from members of the Māori focus group that this 
approach would replace existing staff, such as the Māori navigator whose job it was “…to 
support the whānau…to make their own decisions and to empower them. [It] is about 
whānau ora.” These concerns are addressed in the discussion. 
The vignette-based focus group enquiry explored how The Flinders Program was 
interpreted from the perspectives of people affected by cancer. The responses to the 
vignette fell into three main categories: individual capacity, support from others, and self-
management environment. These views expand the knowledge base on NZ survivors’ 
views on supported self-management program interventions and their enablers and 
barriers. 
Individual capacity to participate in self-management was described as being affected by 
physical functioning, communication skills, self-confidence and desire for self-
determination. Capacity varied depending on level of wellness experienced. 
Support from others was reported to both hinder and enhance motivation for self-
management at different times. It was generally acknowledged that the health system 
addressed most clinical issues but that this led to feelings of disempowerment after 
treatment. Self-confidence needed to be rebuilt if the same levels of support were not 
taken up by whānau. A health environment, including whānau, which is supportive of self-
management, was described as contributing to improved overall wellbeing. If people 
affected by cancer are supported to be an integral part of the treatment process this can 
counteract some of the impacts of unintended medicalisation described by key informants 
in the next section. 
 
Key informant interview results 
 
The results from the key informant interviews are synthesised and presented in this 
section. Key informants were asked to share their views on cancer impacts and coping for 
those people affected by cancer with whom they worked. They were then asked their 
views on the acceptability of supported self-management approaches. The feasibility of 
carrying out a supported self-management intervention program in the hospital-setting, 





Views on cancer survivor impacts and coping 
 
The concept of surrender and survivors becoming a bit “lost to oneself” which impacted on 
individual capacity to self-manage was touched on by at least two key informants (K5, 
K12).  
We try to see people’s individual needs, and as people come through the day unit or 
the ward, they do present themselves with their personality, their hold on “this is who I 
am”, and we really try to support that, but actually the health system is not really 
structured for you to be too individual (K5). 
Another key informant described this loss of self as being compounded by the hospital 
culture of fixing; where patients are encouraged to be passive in the hospital “…where 
things are done to you” (K6). Cancer survivors described their ability to self-manage in the 
focus group data but this may be discouraged in the hospital-setting. 
The recognition of impacts on identity for patients was not brought up by survivor 
participants in the focus group sessions. However, it was also not specifically raised as a 
topic. Because biographical work is more personal, ephemeral and not readily discussed, 
it may be less likely to be disclosed by survivors. 
During the interviews, one key informant said “my experience of people in a time of 
stress….is that people are not good at reaching out...” (K12). This may refer to a 
reluctance to initiate conversations about less concrete topics. Another key informant 
suggested that people sometimes “…sort of need permission to need [or seek] help” (K1). 
Patients were described by health and supportive care workers as not wanting support, at 
times. According to some key informants, people affected by cancer do not want to be 
seen, labelled or judged as “not coping” or that “something is wrong with them” and may 
feel it is “not OK to need help”.  
Conversely, some patients readily ask for support. One key informant mentioned assisting 
with co-morbidities or other non-cancer related issues as an additional, but necessary, part 
of her role at times. She described working outside her scope of practise to meet patient 
need. 
I have been working with this couple, they have an incredibly complicated [cancer] 
journey, now he has some cardiac issues. The wife rang me yesterday and said, look I 
do not know if you are the right person, but can you help. I said of course…and I was 
able to sort this situation out for them (K1). 
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Another key informant described confusion around discharge procedures which led to 
feeling stretched beyond capacity. 
I discovered we had no idea when to discharge an oncology patient. We were hanging 
on to people long after we should have been and doing follow-up phone calls. Then 
we’d get overworked [and overwhelmed] and couldn’t do our work we had in the day 
(K10).   
Health and supportive care workers described feeling frustrated about not being able to do 
as much as they want to support patients. Key informants described the need for them to 
focus on patients’ physical impacts, which sometimes precluded a holistic approach. One 
key informant wanted to avoid opening “a big, big can of worms that you can potentially 
open” (K6) with little opportunity to do justice to the issues. This key informant wanted to 
avoid holistic care and discussions of self-management in order to protect practice 
boundaries and focus on management of physical impacts. 
All key informants acknowledged that cancer treatment had impacts on life during 
treatment. A few acknowledged post-treatment issues. One key informant used the 
example of bowel management to illustrate the often immense and lingering impact that 
colorectal cancer had on peoples’ lives. She described issues with bowel management 
affecting relationships, as a constant personal reminder of the cancer experience, and as a 
trigger to thoughts of cancer recurrence and the uncertainty that goes along with that 
“monkey on your back”. Whilst some key informants wanted to improve their culturally safe 
practice in an effort to establish effective relationships between health and supportive care 
workers, and patients to deliver holistic care, others indicated that they did not see this to 
be a part of their role.  
 
Views on supported self-management acceptability 
 
Key informants were presented with a synopsis of self-management support and were 
then asked to share their views on the approach. Specifically, they were asked about their 
experience with supportive care as well as their views on the barriers and enablers to a 
supported self-management study in the cancer clinical setting.  
A gap in evidence for survivorship interventions was identified as a positive aspect of 
progressing a study of supported self-management. Establishing credibility and ‘buy-in’ for 
or against intervention was viewed as an important aspect of this type of study taking 
place in NZ. 
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[Do] people need this kind of support? Not everyone does, and people need it to 
certain different levels, but I think just having the [intervention] evidence would be really 
powerful…And for us, I guess it is helpful in knowing what works for people, and just 
planning programmes (K8). 
Pilot interventions were indicated by key informants as an acceptable way to generate 
evidence, however, not without challenge to staff. 
I think we are all doing our best, all trying to get it right…you might literally run into us 
[as a barrier], even more than the patients on some level because we are not 
accustomed to considering that there might be a process that we can actually work 
with…that [new process] might be challenging to us…because we have been working 
around the corners, doing everything else to try and get things done (K5).  
The positive aspects identified for supported self-management intervention were the need 
for a standardised approach to holistic assessment, the need to address the gap in 
survivorship support and the need for more survivorship research. Potential benefits were 
more readily described by key informants than focus group participants.  
Many key informants saw supported self-management as a way to promote routine 
assessment for support needs. One key informant commented “there is certainly a lot of 
support for [standardised assessment] at the moment” (K2) but not a lot of it happens 
consistently.  
Some people get seen [by social workers] for whatever reason, they have more easily 
identified needs or they are more vocal about their needs, so they get referred into our 
service…and others have just as much need and do not get seen and do not even 
know social workers are there, so it is very inconsistent and random assistance (K8). 
There was recognition from both focus group participants and key informants that it was 
difficult to know when people could benefit from support but it was important to assess 
needs and provide patients with the opportunity to discuss pre- and post-treatment 
strategies. 
I would want to make sure that every single person has had the opportunity to sit down 
quietly and discuss what is happening, and ask questions, and also be delivered 
information orally, written, and [digitally]…I would like to think that every person would 
have a contact that they know they could get hold of and talk things through….and for 
them to know where they can connect back and have that information repeated or 
reinforced (K3). 
Some key informants suggested that standardised assessment would enable them to do 




…here are some things you can do for yourself, or maybe with a bit of scaffolding we 
can [help] get you there… (K9).  
…if people can de-escalate, then they can start problem-solving, they can start to think 
about stuff… (K11). 
There was general agreement that assessment and intervention, if routinely applied, 
resulted in better support. 
The potential for supported self-management intervention to ease treatment transitions 
was another point raised in favour of supported self-management intervention. Key 
informants generally expressed a desire for patients to be well supported at post-treatment 
transition time because they often become, effectively, institutionalised or semi-dependent 
on the healthcare team through 6-months or more of frequent procedures, hospitalisation 
or ‘medicalisation’.  
... there are kind of inevitable dependencies that we create with people, because we 
need to, we need to make sure they are safe, we need to make sure they feel safe, and 
we need to actually make sure that they are able to comply with certain things that 
make their treatment as safe as possible.. but, over the years, I have really grappled 
with myself over [creating] this dependency. I really do think I have come to the 
conclusion that it is necessary…but then what? Then what? This [program] seems to 
have a real value in terms of just being almost able to help people re-gather 
themselves up in a way… (K6) 
The ‘medicalisation’ that inevitably occurred during treatment was seen to contribute to 
personal transition difficulties once treatment ended.  
One key informant identified the chronic nature of cancer for survivors in saying “you have 
this intense acute phase, then every now and then, you might have an acute episode in 
the chronic post-treatment phase” (K4). The inevitable need for follow-up care highlighted 
by this key informant related to the importance of strong linkages to post-treatment 
‘aftercare’ or follow-up care. 
…patients disappear for a reasonable period of time so re-linking them up [to primary 
care] to make sure that everything else is kind of integrated into their care would be 
very useful (K7).  
Most clinicians agreed that intervention that supported transition could be useful. This 
support, which needed to be initiated during treatment and prior to handover to primary 
care, could consist of sign-posting likely post-treatment side effects, provide alternative 
pathways to survivorship care and address normal post-treatment anxiety.  
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In summary, whilst a few focus group participants identified potential benefits of the 
intervention, key informants uniformly supported an evidence-based standardised 
assessment and intervention approach, linked with clinical flow, and incorporating 
discharge planning as well as survivorship care pathways. There was recognition of 
potential benefits of hospital-based supported self-management intervention. 
 
Views on supported self-management intervention feasibility 
 
The key feasibility concerns raised by key informants were related to intervention timing, 
setting, and delivery. Participants’ views varied but the need for flexibility and adaptability 
in timing, role and delivery was emphasised. Important intervention elements pointed out 
as needed included ensuring confidentiality, provision of a range of options for information 
delivery, signposting to further information, and allowing for referral and follow-up in 
conjunction with other clinical strategies and plans. 
Intervention timing 
 
Important points were raised related to intervention timing. The first was variability in 
readiness to engage with self-management. One person strongly felt that the earlier the 
better for any cancer patient support intervention. 
I think the sooner the better. You try and kick in further down, you are already 
defensive; you are already withdrawn, you are already a little bit mistrusting…so build 
up that relationship [early] (K4). 
Two people agreed that any support intervention must be put into place “…as soon as 
possible, early intervention” (K4, K5).  However, the opposite was also suggested in 
putting the focus on discharge time “when distress levels are usually lower” (K10). 
Additional brief comments were made on the importance of repeatability of assessment 
and contact so it is not a one-off, and the need for a process for referrals or sign-posting 
which can be followed up on.  In summary, timing and follow-up were indicated as 
important components of intervention, but no clear consensus emerged on appropriate 







No clear consensus on intervention location emerged either. The acceptability of the 
location of the intervention was discussed. With regard to hospital-based support, one 
Māori focus group participant voiced her preference for a community approach. 
..because it is all about that whakawhānaungatanga, it is all about bringing [to the 
home] and she was then able to bring in the whānau and I think if you do things within 
the hospital setting, it can become a little bit sterile… 
Another participant thought it was possible to offer support in the hospital if cultural safety 
could be enhanced. 
I would go to the clinic if I know I was going to be in a safe area. That is what it is about 
for me…being in a safe environment [where] I can feel safe in there… 
On the other hand, a key informant identified that hospital-based intervention was 
preferable for some people “…because it does legitimise more powerfully” and that “the 
hospital is the place where [people] do their illness, and so support would sit within 
that…because when I leave the hospital, that is where I leave it” (K12).  
Overburdened clinic staff and lack of resources were seen as a setting barrier.  
I can see that we [oncology nurses] only really have time for the totally medical focus 
unless a crisis sort of jumps at you (K3). 
Already overburdened hospital-based roles contributed to the disconnect between what 
people who work in the health system can provide and what cancer survivors expect or 
want by way of support. Another key informant described being in “clinic zone” where there 
is not a lot of time to explore feelings or “drill down on where [the patients] head is in all of 
this” (K6). The potential value of non-governmental organisations (NGOs), such as the 
Cancer Society, in the community setting was raised by one key informant. However, for 
some people NGOs were described as not approachable or ‘not the right fit’. 
We were pointed towards Cancer Society, but…for me, it was about older, white 
women with pearls and twinsets, and you know, doing charities and stuff. Sorry. From a 
cultural perspective it is really hard to step into the Cancer Society and go, can I have 
some help please? I tried to approach the Cancer Society but it was too hard...  
Concerns were raised about whether this intervention was the best way to improve the 






Initial reactions from both focus group participants and key informants upon presentation 
of the vignette related to ‘who’…who would deliver the intervention acceptably.  
The role and approach of the interventionist was seen as a key to intervention success. 
One focus group participant indicated that there needs to be a balance between being too 
sterile, and getting “all whānau”.  Another person stated “it needs to be a social worker to 
do it right” while the opposite view was also mentioned. 
They would have to have a passion to do what they do. If someone has a social 
worker’s certificate to do the job, that means jack. Experience and the wairua that is 
what matters… 
This is someone who knows the journey, who has been through it. The qualities of 
someone who has been on the journey to do this role has to be considered. For our 
teenagers, Grandma was the best coach.  
Key informants identified individual barriers to intervention delivery. Individual barriers 
included health professional perceptions of the support patients want or do not want.  
There was no clear consensus on interventionist requirements. Among clinicians, the most 
commonly held view was that the interventionist needed to be someone with a 
qualification. It was proposed that this might foster their confidence in referring patients to 
the interventionist.  This contrasted with the view of the focus group participants that the 
person-centred approach of the interventionist was key, no matter whether the person had 
a qualification or not. 
Intervention outcome measures 
 
The key informant interviewee participants were asked about outcome measures.  
Psychosocial outcomes were mainly suggested. Key informants identified that evaluation 
of the intervention must include patient-reported outcomes including “how people feel they 
are coping”, “whether people feel informed”, “desire for involvement in decision-making”, 
monitoring if people feel “treatment goals made a difference to outcome” (K6), as well as 
the impact of fear of recurrence and lingering anxiety or depression.  
Clinical and process outcomes were also suggested. Clinical outcomes suggested 
included ‘did not attend’ rates, referral rates, complication rates, unintended hospital stays 
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and other health outcome measures. Process outcomes suggested included rates of GP 
visits during and post-treatment. 
The choice of outcome measures for the phase two study were based on key informant 
suggestions, published protocol guidance, and information from the literature review. The 
key outcomes of interest were indicated to be measures of coping self-efficacy, self-
management competence, resilience, distress, quality of life and patient experience. Some 
types of clinical and process indicators were also suggested for inclusion, but were less 




In phase one, people affected by cancer treatment were asked to draw on their lived 
experience of cancer to identify impacts of treatment and management strategies. The 
analysis of qualitative data collected followed Thematic Analysis and Framework Analysis 
with use of a comparative method of developing themes (Baszanger 2012). The analysis 
explored survivors’ experiences of cancer as a chronic condition included identification of 
codes and the grouping of codes into themes. The results from phase one were utilised 
mainly to determine whether to progress to a phase two study. 
Focus group participants described physical, emotional, spiritual and social impacts of 
cancer that they managed in various ways. The differences in participants described 
experiences reflect individualised treatment impacts and management which lend 
themselves to personalised intervention. 
Key informants shared their views on impacts and coping by patients. There was 
agreement that substantial impacts were felt but there was no clear consensus on where 
the responsibility for impact management and coping strategy development best fit.   
The second purpose of the phase one study was to ascertain survivor and health and 
supportive care worker views on a vignette that described The Flinders Program. Key 
informants seemed to better understand the intervention at the outset, compared to focus 
group participants. Phase one participants across the focus groups and key informant 
groups engaged with the vignette and lots of questions were raised. Questions were asked 
around appropriate timing of the intervention, who could deliver the intervention, and 
outcomes to be assessed.  
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There was considerable reluctance voiced around the appropriateness of a ‘one size fits 
all’ approach, as implied by the example vignette. This likely related more to the difficulty 
the author experienced in succinctly explaining the intervention, rather than a critique of 
the intervention itself.  
Participants’ views of what a supported self-management intervention entailed (i.e. who, 
where and when) differed; however, the data clearly indicated a desire by participants for 
better support for the real-world impacts of cancer, particularly during post-treatment 
transition.  
No focus group participant or key informant voiced any major objections to conducting a 
pilot study. However, it must be noted that participants might not have wanted to share any 
negative thoughts about the intervention to avoid perceived disrespect to the author. Given 
the data, it is hard to identify how prevalent this sentiment might be. Therefore, the phase 
two pilot study was initiated to generate more evidence about the acceptability and 
feasibility of administering a supported self-management intervention program. 
Intervention adaptations suggested were incorporated. The Flinders Program was 
developed in Australia and key adaptations were deemed to be required for NZ settings. 
The adaptations suggested were inclusion of whakawhānaungatanga, procedures to invite 
participation by whānau, and koha as a recognition of the gift of time toward the research. 
These adaptations were mainly aimed at addressing 1) cultural and social factors and 




NZ patient and survivor experiences and views on the acceptability of supported self-
management intervention were explored with a purposively selected group of cancer 
survivors and healthcare practitioner key informants. The resulting data indicated that 
there are extensive life impacts of cancer, some unmet expectations for care, and many 
self-management strategies being employed. In this section, specific concepts from the 
data will be discussed and compared with the literature (noted in Chapter three). The 







Cancer impacts on life and challenges self-management. Cancer is described as an 
interruption to normal life. Its impacts can be substantial and varied. The impacts 
described in the phase one study aligned with the Te Whare Tapa Wha Māori health 
framework: body (tinana), mind (hinengaro), spirit (wairua), and friends/family (whānau) 
(Durie 1994). 
Participants’ descriptions of the life impacts of cancer were consistent with both the NZ 
literature (Doolan-Noble et al. 2006; Egan et al. 2014; Hutt Valley DHB et al. 2006; Koea 
2008; O’Brien et al. 2010; Rumball-Smith 2009; Slater et al. 2013; Walker et al. 2008) and 
overseas literature (Baravelli et al. 2009; Ohlsson-Nevo et al. 2012; Richardson et al. 
2011; Watson et al. 2007). The literature suggests that the life impacts of cancer are 
multidimensional and lingering. Although individual cancers may take a varied clinical 
course, people affected by cancer live with the universal experience of having a potentially 
fatal illness, and often surviving with, through or beyond cancer for many years. Living 
with, through or beyond cancer involves managing intermittent yet lingering cancer-related 
impacts on emotional, physical, social and spiritual health. 
Significant impacts across domains were named. Impacts of cancer on individuals and 
whānau have been well documented in the literature. The study data indicated that most 
focus group participants expected health professionals to consider the holistic impacts of 
cancer with the goal of achieving wellbeing. 
Physical impacts described during treatment were similar to those identified by other NZ 
cancer survivors in the literature (Egan et al. 2014). Additional impacts specific to 
colorectal survivors participating in this research were neuropathy-related sensation 
changes, weight fluctuations, bowel or ostomy issues, and comorbidity challenges. 
Emotional impacts described during treatment included distress, worry and anxiety. One 
study found that up to 58% of cancer patients experience some form of anxiety and 
depression (Massie 2004). This corresponds to the wider literature (Hewitt, Greenfield, and 
Stoval 2006; National Comprehensive Cancer Network 1999; National Cancer Suvivorship 
Initiative 2013) that describes the emotional rollercoaster through the cancer journey. 
Emotional impacts named in this phase one study were grief and loss, fear, anger and 
frustration. Two international studies with colorectal cancer survivors found that uncertainty 
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and stress is associated with low mental health satisfaction (Pan and Tsai 2012; Galloway 
and Graydon 1996).  
Spiritual impacts described in this study correspond to the limited NZ and overseas 
literature (Egan 2009; Puchalski 2012). However, this was an area touched on mainly by 
the Māori focus group participants who readily referred to wairua and disruptions to wairua 
in conversations. 
Social impacts, particularly the importance of the healthcare practitioner relationships, are 
described in this study. Research from Australia points to the importance of these 
relationships to Australian survivors and the significant loss associated with disruptions to 
these relationships, particularly at treatment completion (Jefford et al. 2008). 
There were individual and group differences in how much emphasis was placed in each 
cornerstone of the Te Whare Tapa Wha framework (Durie 1994) in narratives.  In general, 
Māori participants described greater challenges around the social, emotional and spiritual 
impacts of cancer while non-Māori participants spoke more about physical impacts and 
challenges to everyday life. This is consistent with literature on Māori experiences of 
cancer (Slater et al. 2013; Walker et al. 2008). In literature around Māori experiences of 
living with and beyond cancer there is a weaving together of talk about physical diagnoses 
with reference to disruptions in the spirit, emotions, or mind (Britt et al. 2014; Slater et al. 
2013; Walker et al. 2008). 
The phase one study data highlights both similarities and differences in emphasis between 
cancer survivors and health and supportive care worker key informant narratives. For 
example, one difference noted is that key informants did not emphasise relationship and 
communication issues as much as cancer survivors. This may be related to differing 
perspectives. During the phase one sessions, cancer survivors seemed to speak from the 
individual and whānau perspectives while key informants vacillated between the individual 
and system perspectives.  
Differences in emphasis can relate to profession or lens. Key informants tended to initially 
discuss physical impacts that impacted in other quarters of Durie’s (1994) framework. 
Studies published in medical journals emphasise substantial lingering physical impacts of 
colorectal cancer treatment (Pan and Tsai 2012; Dunn et al. 2013). In contrast, studies 
published in social science journals and books emphasise the significant impacts of cancer 
survivorship on cancer survivor identity, emotions, sense of wholeness and purpose, and 
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relationships (Muzzin et al, 1994; Kelly & Millward, 2004; Winch, 2013). However, there 
were more similarities than differences overall between focus group participants and key 
informant views on the holistic impacts of cancer and its various treatments.  
Participants in the phase one study described cancer-related impacts on people affected 
by cancer. These impacts were described by focus group participants as intermittent and 
lingering. Key informant participants acknowledged impacts but were focused on 
addressing physical issues. 
 
Cancer survivorship ‘work’ 
 
The work associated with cancer survivorship was a universally shared experience across 
focus group participants. Klimmek & Wenzel (2012) refer to the use of health management 
strategies as the ‘invisible work’ of cancer survivorship. Personal coping and self-
management strategies for managing this work were described by participants, with the 
post treatment transition seen as a particularly complex and difficult period where 
expectations for care and self-management were challenged. Personal and system 
barriers to being able to address support needs were identified. 
Overall, regarding illness-related work, survivor participants described taking personal 
responsibility for doing what they needed to do to meet their needs. When asked about 
what could have been helpful, participant responses focused on social support delivered 
one-on-one by whānau or health and supportive care workers. Research into NZ cancer 
survivor experiences has indicated that people affected by cancer would like more timely 
information, better support, and help fitting the cancer journey into the context of everyday 
life (O’Brien et al. 2010). 
Support to help survivors set specific, motivating goals is something that could be provided 
by health and supportive care workers or peers via supported self-management programs 
or other approaches (Doran 1981). Research indicates that cancer survivors are motivated 
by healthcare practitioner recommendations regarding wellbeing support and behaviour 
change relating to exercise and diet (Michie et al. 2008; National Institute for Health and 
Clinical Excellence 2007; Ryan, Patrick, and Deci 2008). 
Most key informants indicated that they would like to do more to support cancer survivors 
in an evidence-based and timely way. The two key informant nurses who did not see value 
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in supported self-management felt that their role needed to focus on clinical care delivery. 
There was a will to provide holistic support shared by most healthcare practitioner key 
informants, but system barriers were described as prominent. This included lack of time 
and the need to focus on prioritisation of clinical needs. Whilst system barriers do pose 
issues for delivery of supported self-management intervention programs in the hospital-
setting, there is potential for beneficial offset. A supported self-management intervention 
program can offer an approach to substitute necessary dependencies with strategies for 
self-management.  
Communication is a key area of everyday-life repeatedly raised. There was a tension that 
emerged between the views of participants that preferred to talk things through with 
someone versus those that preferred to keep things to oneself. Both have evidence from 
the literature. Support is often expressed by offering survivors the opportunity to talk it 
through. This is thought to increase a sense of alliance, insight, and opportunity to express 
thoughts and emotions (Wampold 2001). It is not for everyone. Some people prefer to 
keep silent. A code of silence has been identified as a component of coping by survivors 
(Zhang and Siminoff 2003). This tension in views on the importance of communication 
reflects different coping styles and signals the need to allow for multiple tailored 
approaches to providing survivorship support. 
Despite different communication preferences, the addition of a specific rapport building 
component into intervention delivery was indicated by the data. This is consistent with the 
literature which identifies the importance of the relationship and alliance in the therapeutic 
process (Wampold 2001). This may be done through processes to support 
whakawhānaungatanga and to allow for whānau inclusion, including whakapapa, as 
culturally safe practice (Pitama, Robertson, and Cram 2007; Slater et al. 2013).  
Biographical work was not prevalent in the data. Because biographical work is more 
personal and ephemeral it may be less likely to be directly disclosed by cancer survivors. 
However, reference to ‘loss of self’ in focus group participant narratives alludes to Bury’s 
(1994) chronic-condition related concept of biographical disruption. 
Most focus group participants agreed that better support interventions for people living with 
cancer in NZ would be useful. The challenge is that cancer survivors experience a wide 
variety of life impacts, hold differing expectations for care, cope in various ways, and want 
access to support from different people at variable times and locations. Can one 
intervention address all these challenges and improve the experience of care? The 
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purpose of the phase one study was to inform a recommendation on whether to proceed 
with a phase two feasibility study of a supported self-management intervention program to 
see if this was possible. 
 
Supported self-management intervention views 
 
The phase one study ultimately centred around views on whether The Flinders Program 
can improve the experience of care. While reactions to the intervention vignette or 
synopsis were equivocal, several concerns were raised. It is helpful to note that supported 
self-management intervention was a new concept introduced for the first time to many key 
stakeholders. It is not clear how much participants’ understandings of the approach 
through the vignette matched the reality of The Flinders Program. This alludes to the 
complexity of terminology and definitions in this field. A more understandable lexicon is 
required considering the misunderstandings of terms that likely occurred among 
participants. This terminology confusion introduces potential bias and is a known limitation 
for research in this field (PoCoG 2012; Jefford et al. 2015) and with The Flinders Program 
(Lawn and Battersby 2009). 
The impact and coping data indicated that cancer survivors found ways to self-manage, 
but more support was desired to fill gaps in care. A recent NZ study found that personal 
attitude and appropriate social support, alongside clinical support, were considered key 
contributors to getting through treatment (Egan et al. 2014).  
The focus group data indicated that ongoing adjustment is required to adapt to being a 
cancer survivor, manage treatment, achieve wellbeing through cancer and cope with 
lingering impacts. These were key themes that aligned with overseas studies of colorectal 
cancer survivorship reported in the literature review. Accordingly, supported self-
management interventions were identified as an approach to help people “…accept their 
disease, and then learn how to live with cancer and its various ramifications…” (Chao et al 
2010, 2279) as well as to enhance perceived self-control over managing lingering side-
effects (Kidd et al 2008). 
There was concern raised by Māori focus group participants about whether the 
intervention would take the place of existing supports, specifically the Māori navigator. It 
was explained that the interventionist would ideally be working alongside the Māori 
navigator, during treatment, to provide links or bridges to culturally and spiritually safe and 
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acceptable options for treatment support if, and when, needed. This is important because 
research shows that support carried out poorly or with insufficient cultural awareness can 
be detrimental to the cancer survivor and negatively influence willingness to access future 
support options (Dew et al 2015).  
The capability of the interventionist was seen as critical to intervention success. A 
necessary balance was inferred by participants. This balance was based in collaboration. 
It was manifested as the program facilitator encouraging self-management, yet still 
encouraging survivors to access support provided by whānau, health and supportive care 
workers, and other non-health specific support workers. Multiple support options were 
preferable to less.  
Regarding intervention timing, setting and delivery, no clear consensus emerged on these 
components. The data did indicate that the intervention needed to address the important 
emotional, physical, social and spiritual aspects of the cancer journey for the individual and 
whānau. An intervention that addressed these domains might be able to be delivered 
during treatment to address survivorship. Therefore, flexibility and personalisation of 
intervention delivery was important. The interventionist would need to tailor the 
intervention to reach concordance between the various priorities, needs and goals of 
individuals and whānau affected by cancer. Finally, supported self-management 
intervention in hospital clinic settings may help address cancer care gaps identified in NZ, 
but adaptations to the approach and the need for more research was clearly indicated. 
 
Strengths and limitations 
 
Qualitative research is subjective by nature. Narratives are affected by memory, 
perception, social bias and context (Denzin and Lincoln 2005). The phase one study 
generated insights into impacts of cancer, coping strategies and the potential of The 
Flinders Program as an acceptable survivorship support option in the hospital-based 
cancer care setting. Focus groups and key informant interviews were chosen as the 
methods of qualitative enquiry in this study (Patton 2002; Strauss and Corbin 2008). The 
aim was to inform whether to proceed to a phase two feasibility study. 
Focus groups are an inexpensive method that can aid respondents’ recall of the cancer 
experiences shared by members of the group (Denzin and Lincoln 2005). During the focus 
group sessions, there was a lot of material to cover in a short period of time. In following 
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best practice, the focus groups were limited to 1.5 hours (Silverman 2005). However, there 
was a larger number of participants than usual in the multicultural focus group. This time 
constraint impacted on the depth of data gathered and questions asked in both groups. It 
hindered understanding and discussion of The Flinders Program. There were differences, 
and possible misconceptions, noted in how people interpreted the vignette and the nature 
of the intervention. However, the vignette did not seem to aid group participants’ 
understanding of the intervention and it impacted on perceptions reported by participants 
and the subsequent data analysis. In hindsight, it may have been more useful to conduct 
interviews with both survivors and health professionals to clarify the intervention 
presented. Other options for presenting the intervention include demonstrating the process 
live with a participant while others observed, or showing a video of a care planning 
process.  
Key informant interviews were also subject to limitations. Key informants, as experts in 
their field, were being asked to share their views on something they may not have had 
much knowledge about (i.e. The Flinders Program). Therefore, their view relied on 
assumptions. Health professionals’ perceptions of what constitutes the practice of person-
centred care and those of people utilising the healthcare system can be quite different 
(The Health Foundation 2014).  
Limitations are inherent in any study design. One key limitation in this study across both 
methods utilised was self-selection. Participants chose to participate. It is not known how 
these participants’ views differ from the views of non-participant survivors. Other limitations 
include not knowing the extent social desirability and acquiescence played in respondent 
responses to make the researchers feel good or establish fit within the group (Patton 2002; 
Strauss and Corbin 2008; Liamputtong 2011). However, the nature of the conversations 
was felt to be honest and emotional. Participants’ comments were frank and there were 
indications of considerable agreement in the data around key points. Many of these points 
aligned with literature. 
This study had significant strengths. Focus group participants stated that they ‘found 
benefit’ in sharing their experiences (Winch 2013; Liamputtong 2011). Participants shared 
their experiences with others who have had a similar experience which may have shifted 
how they thought about their experiences. Interviews were conducted with health 
professionals and affirmed their expertise in the field. Reflexivity was practiced providing 
research integrity. A journal was used to document any observed personal reactions and 
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potential influences on choices made about the research. This journal and other 
observations were discussed with the research supervisors or study advisors. 
Another strength of this work was that a Māori only focus group was held, in addition to a 
separate multi-cultural focus group. This aimed to provide a culturally safe context guided 
by Māori perspectives. 
Analysis in qualitative work needs rigour and transparency. This can always be improved. 
For example, qualitative studies of this nature may use an independent coding process to 
improve rigour. Consideration was given to the need for the use of an independent coding 
process and further in-depth analysis of the phase one data. Based on the study 
objectives, it was determined that breadth be prioritised over in-depth qualitative analyses. 
So, comparisons based on ethnicity and gender-specific narratives were not pursued, for 
example. The data were not analysed at this level because the objectives of this phase 
one study were to determine the perceived ‘fit’ and acceptability of the intervention in NZ 
and inform a recommendation to pursue a phase two exploratory study.  
The focus groups and key informant interviews as methods were considered the best way 
at the time to gather information that provided a valuable perspective on peoples’ 
experience of impacts, perceived gaps in care and views on the acceptability of 
intervention that may address those gaps. Further limitations and strengths relevant to 




There is a growing body of NZ-based research that describes cancer survivors 
experiences and gaps in expectations of care (Egan et al. 2014; O’Brien et al. 2010). 
However, there is a lack of published ‘intervention-science’ based research in NZ. This 
study aimed to contribute to the limited international survivorship and intervention literature 
with a NZ perspective. It was guided by indigenous perspectives on survivorship and 
potential interventions to improve the experience of care for Māori and non-Māori 
survivors. 
This research provided an opportunity for people affected by cancer and clinicians to 
contribute to quality improvement. Focus group participants clearly identified support gaps 
and unmet expectations for care. Key informants identified the need for more survivorship 
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research in the NZ context and, for most, the desire to provide better support to address 
inevitable dependencies created during cancer treatment in the hospital care setting. Most 
key informants described wanting to provide better support. There were no obvious 
solutions suggested by focus group participants or key informants on how this could be 
done. 
In this thesis, the premise proposed was that the experience of cancer survivorship may 
be improved by delivery of a supported self-management intervention program alongside 
clinical care in the hospital setting. The literature review indicated potential utility of the 
approach with emphasis on the barriers to and potential benefits of the approach. 
Supported self-management interventions were identified as potentially beneficial for some 
people at some points in time. Focus groups and key informant interview data indicated 
mixed reactions to The Flinders Program vignette. However, there was agreement that 
enhancing and supporting individual and whānau capacity to self-manage during treatment 
may be helpful. 
The recommendation to pursue a phase two study was based on a review of the literature 
combined with analysis of data gathered from focus groups and key informant interviews. 
The summarised data indicated a gap in survivorship support existed and The Flinders 
Program offered a potential pathway that may be acceptable in light of equity 
considerations and hospital-based delivery. There was no compelling reason provided by 
phase one participants to not proceed with a phase two pilot study. 
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CHAPTER 5: Phase two feasibility study 
 
This chapter describes the methods and results for a phase two supported self-
management intervention program feasibility study. The specific objectives were to: 
• Test study design aspects of recruitment, randomisation, intervention delivery and 
assessment by linking in with clinical flow in ambulatory care clinics; 
• Provide insights into intervention content as well as identify enablers and barriers of 
key aspects of intervention delivery; 
• Explore and compare outcome measures of self-efficacy; and, measures of global 
quality of life, distress, resilience and patient experience. 
The overarching aim of this study was to explore the acceptability and feasibility of 
supported self-management intervention delivered in the hospital-based cancer care 
clinical setting. After theoretical knowledge gained from the literature review and qualitative 
phase one work established the study foundation in the earlier chapters of this thesis, pilot 
work reported in this chapter informs the acceptability and feasibility of conducting this 
type of survivorship intervention in NZ hospitals.  
NZ-specific supported self-management interventions designed to support cancer 
survivorship do not currently exist. The literature review indicated that supported self-
management programs are a fruitful area for further study to address this gap (Sarfati, 
Koczwara, and Jackson 2016; Minister of Health 2016b).  
After development and review of program criteria, the decision was made to pilot The 
Flinders Program out of Australia, instead of developing and testing a new intervention 
without established evidence. The Flinders Program has been widely utilised and 
evaluated favourably in Australia (Battersby et al. 2007; Battersby et al. 2010) and this 
published literature provided a rich source of data for reviewing the program in light of the 
criteria. Of the three programs reviewed, The Flinders Program most closely met the 
criteria described in Chapter three. The first criterion was that the program needed to be 
well-structured to ensure fidelity and The Flinders Program was able to be structured into 
sessions, yet tailored, to meet this requirement. The second criterion was that the program 
enable tailoring for use across health conditions and populations. A strength of The 
Flinders Program was the emphasis on program tailoring to address a wide range of 
impacts and priorities identified in collaboration between the interventionist and the 
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survivor. The Flinders Program was not developed specifically for people affected by 
cancer, which was considered useful given the high and rising prevalence of comorbidity in 
this population. Further, it was not designed for a particular population and could be 
amended to suit different world views, which is important given the unequal impact of 
cancer on Māori. The third criterion related to the need for trained and accredited 
facilitators who could demonstrate key competencies and this was met by the program. 
The fourth criterion related to the ability of the program to be delivered one-on-one with 
whānau involvement and this was met. The final criterion was that it was foreseen to be 
able to be embedded in hospital-based care settings and this was also met by The 
Flinders Program. Before embedding the Flinders Program through a large multi-site 
intervention study, a mixed method pilot study was indicated in order to evaluate key 
components of acceptability and feasibility in NZ that could improve the feasibility of a 
larger study. 
This phase two study pilots an intervention in a real-world setting to guide 
recommendations on whether to proceed to a subsequent phase three multi-site RCT 
(Beebe 2007; Prescott and Soeken 1989). The pilot took place at Wellington Hospital in 
two cancer clinic settings. The Flinders Program was administered on-site during standard 
clinical appointments. 
This chapter describes the pilot study research design that was developed. It is presented 
in two parts. The first part of this chapter describes the pilot study aims and study design 
including methods for recruitment, randomisation, intervention, and assessment. The 
second part describes the results. The results relate to acceptability and feasibility of the 
study; as well as indicate the potential effectiveness of the intervention. The RE-AIM 




This methods section describes the design of The Flinders Program pilot study, a phase 
two feasibility study. This study took place in hospital settings to address cancer care gaps 
reported by NZ cancer survivors.  
The methods outlined in this section include descriptions of various adaptations that were 
incorporated into the study protocol as the study progressed to improve intervention 
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acceptability and feasibility in hospital clinic settings. The reasons for the specific 
adaptations will be explored in the results section.  
 
Design, sample and setting 
 
The Flinders Program was delivered in two ambulatory cancer treatment clinics at 
Wellington Hospital as part of a RCT feasibility study. An RCT pilot study design was 
utilised because it was deemed to be the most scientifically rigorous and efficient way to 
explore initial utility of the intervention and identify both potential benefits and adverse 
effects. It also provided a model for a larger phase three RCT, if indicated (Lancaster, 
Dodd, and Williamson 2004; Abbott 2014).  
The overall study attempted to prioritise intervention acceptability and feasibility for Māori 
cancer survivors. The HEAT tool was used to assess The Flinders Program for its impact 
on health inequities (Signal et al. 2008). Adaptations were made to refine the intervention 
so it might be more responsive to Māori. For example, the intervention was delivered in NZ 
cancer clinic settings during standard clinic appointments. Therefore, it was available to 
everyone receiving treatment and did not require people affected by cancer to seek it out 
and opt-in. Adaptations also included addition of whakawhānaungatanga and inclusion of 
whānau. 
Although The Flinders Program could be potentially valuable for any population affected by 
any cancer or long-term condition, the sample for this pilot study was limited to patients 
diagnosed with colorectal cancer. This cohort was chosen in order to limit heterogeneity in 
the sample and reduce case mix bias (Paddison et al. 2012). Additional reasons for  
selecting a colorectal cancer cohort included: 1) colorectal cancer is a very common 
cancer in NZ (Ministry of Health 2015a; World Health Organization 2008), 2) colorectal 
cancer intervention research is relatively underfunded considering relative disease burden 
(Carter and Nguyen 2012), 3) 70% of people diagnosed with colorectal cancer manage 
additional health complexity at diagnosis (Sarfati et al. 2009) and may benefit considerably 
from supported self-management intervention, and 4) there is an unequal burden on 
mortality by ethnicity for people diagnosed with colorectal cancer in NZ (Robson, Purdie, 
and Cormack 2010) so intervention with this cohort may contribute to reduction in inequity. 
The setting for the study was Wellington Hospital. Wellington Hospital houses the regional 
Blood & Cancer Centre for people residing in the lower North Island and upper South 
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Island of NZ. In 2010, this facility treated approximately 2500 newly-diagnosed people 




Potential participants were recruited from two ambulatory care clinics at Wellington 
Hospital, namely the oncology day ward and the surgical outpatient clinics. Consultations 
were held with health and supportive care workers from the recruiting clinics to obtain their 
views on the most feasible recruitment period for the study, considering clinic load and 
flow. Based on oncologists’, surgeons’ and nurses’ estimates, an 8-12-month period of 
recruitment was planned to take place between May 2013 and May 2014.  
The protocol specified a recruitment target of 30-50 patients, with half to receive the 
intervention and the other half to be designated the control group. The literature supported 
the sample size for pilot trials being typically determined pragmatically and no rules were 
identified for minimum numbers of pilot study participants needed to ensure a robust pilot 
study (Thabane et al. 2010). A pragmatic target of 30-50 total participants was agreed.  
The implementation of the study was dependent on the goodwill and active participation of 
clinic staff at Wellington Hospital. Their enthusiasm was encouraging and critical to the 
success of the pilot. The recruiting oncologists, surgeons and nurses were briefed by the 
author. The study was to be introduced by recruiting clinicians who were provided with a 
brief script. It was to be introduced to colorectal cancer patients selected by them. 
Incentives provided to staff as recruiting clinicians included regular communication, via 
email and face-to-face, as well as update meetings where refreshments were provided. 
The recruiting clinicians agreed to discuss the study with potentially eligible patients and 
emphasise that the study was about improving survivorship care.  
A recruitment referral form, entitled the Authorisation to Release Information for Research 
Study Purposes, was to be completed by the recruiting clinician for each patient that they 
informed about the study. The recruiters first provided each potential participant with a 
study overview, clinical trials pamphlet and a copy of the information sheet and consent 
form (see Appendices H & I). They explained that the study author wanted to meet with 
them to discuss the study if they were interested in participating. Potential participants 
were also told that the author provided a contribution toward their travel and time costs in 
the form of petrol vouchers. If the patient wanted to find out more, the Authorisation to 
 
 140 
Release Information for Research Study Purposes form was to be signed by the patient 
(see Appendix J). That signature indicated that the patient consented to sharing their 
contact details with the author. A screening log was kept tracking study eligibility.  
The author collected the signed recruitment referral forms from a secure drawer in the 
clinics. The referred patients were followed-up by telephone or at their next scheduled 
hospital appointment, depending on their indicated preference on the form. The author met 
with the potential participant, and whānau if present, and described the study in further 
detail. Most of these face-to-face meetings took place in a private room, such as the 
‘family room’, within outpatient clinics. If the patient expressed an interest in participating in 
the study, he/she was provided with an information sheet (see Appendix H).  
The patient was screened for study eligibility by the author. The eligibility criteria were 
determined by published protocol guidance (Battersby et al. 2010) and personal 
communication with Dr Anne O’Donnell, Wellington Blood & Cancer Centre clinic lead. 
These are shown in Figure 14. 
 
Figure 14: Eligibility criteria for the phase two pilot study 
 
Eligible participants were asked to review and sign an informed consent form to participate 
in the study (see Appendix I). The participants were provided with a copy of the consent 
form for their records. 
Once informed consent was obtained, a baseline assessment was scheduled with the 
participant. It was intended to take place at the next scheduled hospital appointment. The 
approximately 30-minute assessment consisted of self-report completion of a series of 
survey instruments (see Appendix K). At the time of assessment, vouchers were provided 
to study participants as a contribution toward their time and travel costs. At baseline 
assessment, a $20 petrol voucher was given to the participant and at the follow-up 
assessment a $30 voucher was provided.  
The phase two study eligibility criteria were:  
• Acknowledged primary colorectal cancer diagnosis being treated with surgery 
and/or adjuvant chemotherapy 
• No apparent, or reported, physical or mental distress that would deem the trial to 
be overly burdensome 
• No apparent, or reported, impaired ability to comprehend the intervention 
• No history of taking part in Flinders or lay-led self-management programs 
• Normally resident in Aotearoa NZ. 
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Originally, the pilot was limited to patients of the outpatient day ward receiving 
chemotherapy treatment for colorectal cancer. However, recruitment proceeded slower 
than expected in the first three months at that clinic site with only five patients enrolled in 
that timeframe; 40% of the anticipated recruitment rate. In July 2013, recruitment and 
eligibility criteria were expanded to include patients receiving surgical colorectal cancer 
treatment through the main outpatient clinic. 
Figure 15 shows the phase two study procedures and flow. 
Oncologist or surgeon gives colorectal patient study 




   
At the next appointment, the researcher follows-up & 
completes written informed consent if interested; 30-minute 
baseline assessment scheduled 
 
 
   




   
Supported self-management Intervention group  Control group 
   
First self-management intervention session takes place at 
regular treatment appointment 
 
 
   
Two follow-up check-in intervention sessions take place –to 
meet during regularly scheduled appointments 
 
 
   
Follow-up assessment – to occur ~4-months after baseline assessment (and 6 weeks 
post-intervention for intervention group) at post-treatment follow-up appointment 
 





Consenting study participants were randomly allocated to The Flinders Program three 
session intervention group or a standard supportive care control group. If the participant 
was randomly assigned to the intervention group, the intervention sessions took place at 
three regularly scheduled hospital appointment times. If the participant was randomly 
assigned to the control group, the researcher followed up with the participant at the 
treatment follow-up appointment. In the control group, standard supportive care by hospital 
staff was provided with no extra visits or intervention support. The people randomised to 
the control group received the standard medical and supportive care provided routinely to 
people receiving cancer treatment. Control group participants were informed that they 
would meet the researcher again at the treatment follow-up appointment. 
Randomisation took place immediately following baseline assessment using a computer 
generated random number sequence. People were added to a list sequentially while the 
allocation sequence was concealed. The participants that were allocated odd numbers 
were placed in the control group and those allocated even numbers were assigned to the 
intervention group. All participants were told their group assignment directly after the 




The Flinders Program was delivered to those in the intervention group as a structured, 
professionally facilitated, tailored supported self-management program and care planning 
intervention. Intervention delivery took place at three standard clinic appointments 
attended by consenting study participants. These appointments occurred in the middle to 
late phase of a treatment regime (i.e. chemotherapy or surgical treatment).  
Intervention sessions were planned to take place during appointment waiting times and 
sessions were timed to last no more than 30 minutes. All intervention sessions were 
convened by the author who was accredited to deliver The Flinders Program. Each 
session was based in collaboration between the interventionist and the study participant. 




The Flinders Program provided the framework to enable health and supportive care 
workers, and cancer survivors, to work together collaboratively and flexibly to address 
changing priorities and health needs. Sessions drew on a set of generic tools and 
processes tailored to inspire and enable increases in self-management competence for the 
participant. The intervention was adjusted for the NZ context. For example, a specific 
rapport building process to support meaningful participation and collaboration of 
participants was added. It specifically addressed whānaungatanga, identified as an 
important element of relationship building with Māori whānau. This component was added 
in response to recommendations from the phase one focus group work. 
The toolbox of resources utilised for this pilot included goal setting worksheets, action 
plans, NZ patient experience DVDs, recommended internet sites, storytelling kits, and 
inspirational quotes. The session content was tailored based on intentional discussions 
around the personal life impact of cancer for the participant, life priorities in the midst of 
cancer, and collaborative problem-solving discussions to address values, barriers and 
goals. The author attempted to provide targeted support through culturally responsive 
interactions, using techniques such as active listening, reflection, and motivational 
coaching. If indicated, information resources were provided but the program sessions were 
intended as coaching sessions rather than information-delivery sessions.  
At the first of three Flinders Program sessions, the author asked the participant to 
complete the Partners in Health scale. This one-page tool was completed independently. It 
asks the person to self-rate statements about their self-management capability such as “I 
take action when my symptoms get worse”, “I manage the effect of my health condition(s) 
on my social life” and, “I am able to deal with health professionals to get the services I 
need that fit with my culture, values and beliefs”. This is followed up by the Cue & 
Response Interview which clarifies through a collaborative assessment process the 
participant Likert scale ratings on the Partners in Health scale. It also checks assumptions 
held by healthcare practitioners about what the person knows and does to address 
wellbeing. Examples of interview topics discussed included relationships with whānau 
members, work and income concerns, and the impact of stress or fatigue. These 
discussions are underpinned by CBT and motivational processes. The tools foster further 
discussions around goals, action plans and enablers at the second session. Any agreed 
areas for addressing barriers and setting goals were recorded during and after this session 
on the Flinders Program care planning tools.   
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At the second session, a Problems & Goals Assessment tool was completed. This tool is a 
structured form that builds on the tools from the first session to guide discussion of factors 
that block or enable self-management. Enablers are then collaboratively identified and 
SMART goals set (Doran 1981). The documentation of SMART goals is aimed to enhance 
goal-setting in Specific, Measurable, Attainable, Relevant and Time-related ways. The 
three tools sequentially form the basis for intentional conversations leading to collaborative 
goal setting and survivorship/recovery care planning. A Flinders Care Plan was completed 
by the facilitator after the second session. The care plan included data collected from the 
assessment sessions, any amendments and some clinical data from the person’s medical 
record. The care plan is where felt impacts, life priorities, goals, barriers and any strategies 
discussed were documented. 
During the third intervention session, the session facilitator and the participant reviewed 
the completed Flinders Care Plan. The Flinders Care Plan consisted of both structured 
and tailored components that reflect strategies to meet collaboratively discussed priorities, 
needs and goals. Progress on strategies discussed in previous sessions were reviewed. 
Any additional strategies, information, goals and adaptations were able to be added to the 
care plan with coaching provided to support developing self-management competence in 
key areas. The supported self-management program sessions provided to intervention 
group participants as part of this pilot study culminated in development and review of 




The outcome measures chosen reflect intervention acceptability, feasibility and utility. 
Acceptability was measured from process evaluation and surveys undertaken with 
intervention participants and recruiting clinicians. Feasibility was measured using process 
measures of intervention adoption and protocol implementation. Initial utility was measured 
with instruments that reflected intervention outcome or effectiveness related to intervention 
targets and effects. 
Multiple measures exist to assess intervention-related constructs and outcomes of interest. 
There are many factors which can be used to choose outcome measures for a study. The 




Usability is one factor for consideration in choosing outcome measures. Assessment of 
measure usability includes consideration of respondent burden and ease of self-
completion (Ugalde et al. 2015; Spinks et al. 2014). Respondent burden can be estimated 
based on the length of the instrument and the reported average time required for 
completion.  
The psychometrics, specifically reliability and validity, are considered important 
considerations with regard to the choice of measures to be administered. Reliability and 
validity are terms used to describe the amount of error associated with a measures’ ability 
to reflect the construct being measured. Outcome measure validity is a measure of how 
accurately an instrument measures what it is intended to measure while reliability is a 
measure of how consistent it is at measuring a variable (Balnaves and Caputi 2001). 
Validity and reliability of measures differ across populations (Scott et al. 2000; Frieling, 
Davis, and Chiang 2013).   
Validity of studies can be internal or external. Internal validity refers to the extent to which 
the findings of the study are affected by random and non-random error, such as bias and 
confounding. External validity refers to the extent to which the findings of a study can be 
applied to populations other than that studied. Validity is also an important component of 
outcome measure psychometrics. 
Reliability also relates to both studies and outcome measures. Study reliability refers to the 
repeatability of results. Instrument reliability refers to the ability of a measure to detect the 
true score in a given population, rather than any measurement error.  
The RE-AIM analytical framework guided the presentation of outcome measure data. Each 
component of RE-AIM is described under individual sub-headings. Their application within 




Intervention reach, in the RE-AIM context, reflects study participation. Study participation 







Measures of effectiveness aim to determine the impact of the intervention and, in the 
construct of a feasibility study, inform recommendations on which measures to use for a 
larger-scale study. It is worth noting that the pilot data gathered for this study were not 
intended to achieve adequate power to prove intervention efficacy or utility due to the 
small anticipated sample size. The primary measures of effectiveness assessed self-
efficacy while secondary measures were used to assess distress levels, quality of life, 
resilience and patient-reported experience of care. 
Primary outcome measure: Self-management competence 
The primary outcome measures of self-management competence were aligned with the 
construct of self-efficacy. Three measures related to self-efficacy were compared in this 
study. These were: 1) The Flinders Partners in Health scale, 2) The Stanford Program 
Chronic Disease Self-efficacy scale, and 3) The Patient Activation Measure. Each of these 
measures assess the concept of self-efficacy in that they relate to the confidence or 
motivation a person in managing aspects of their life, health and goals of care in the 
context of health conditions. 
The Flinders Partners in Health scale was described as easy to use (Battersby et al. 
2003). The measure validity and reliability were initially assessed by the developers and 
reported to be acceptable with construct validity shown and an internal consistency of 0.82 
reported, exceeding the 0.75 Cronbach’s alpha score considered minimum for an 
adequate measure of this aspect of reliability (Battersby et al. 2003). The PIH was 
originally developed as an 11-item self-report measure of chronic condition self-
management (Commonwealth Department of Health and Aged Care 1999). In 2010, the 
scale was modified to a 13-item NZ version and administered to people with chronic 
conditions accessing primary care (Horsburgh et al. 2010). Each of the 13-items in the NZ 
version elicited a response on the sliding scale of 0 to 8 representing level of agreement 
with specific statements. The reported psychometrics show high usability, demonstrated 
construct validity and adequate internal reliability (Petkov, Harvey, and Battersby 2010; 
Smith et al. 2016). It takes approximately 5-10 minutes to complete. 
The Chronic Disease Self-Efficacy scale was developed and tested for the Kaiser 
Permanente Chronic Disease Self-Management Program, now known as The Stanford 
Program. Developed in 1998, this easy to use 6-item scale (Lorig et al., 1996) was 
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administered as a point in time measure of self-management competence. The validity and 
reliability have been assessed with construct and criterion validity demonstrated and a 
high internal consistency score of 0.89 reported as reflecting adequate measure reliability 
(Lorig et al. 2001; Salvatore et al. 2015) . The usability, reliability and validity of the scale 
has been shown to be high in numerous studies (Bodenheimer et al. 2002; Clark et al. 
1991; Wilson 2008; Salvatore et al. 2015). It takes approximately 3-5 minutes to complete. 
First published in 2004, the Patient Activation Measure was originally developed as a 22-
item self-report measure to reflect motivation for self-management. This was later revised 
to a 13-item measure which is more commonly utilised (Hibbard et al. 2005). A conversion 
table translates the survey raw scores into a relative measure of activation level. Hibbard 
et al. reported that an increased self-rated activation score was predictive of increased 
self-efficacy and self-management competence (Hibbard et al. 2007). High levels of 
reliability and validity for the instrument have been demonstrated across populations 
(Lubetkin, Lu, and Gold 2010). Anecdotally, Flinders staff have found that Patient 
Activation Measure scores closely align with, and are reflective of, Partners in Health scale 
scores (Malcolm Battersby, personal communication, 2014). PAM has been used to 
indicate self-management support needs (Dixon, Hibbard, and Tusler 2009) as well as 
being used as an evaluative measure in research studies to assess the impact of 
supported self-management intervention on behaviour change (Fowles et al. 2009; Harvey 
et al. 2012). It takes approximately 5-10 minutes to complete. 
Secondary outcome measure: Distress scale - Distress Thermometer (DT) 
The Distress Thermometer is a single item visual analogue scale shaped like a 
thermometer with a numerical scale between 0 (no distress) and 10 (extreme distress) 
(National Comprehensive Cancer Network, Holland, and Bultz 2007). Respondents are 
asked to circle the number on the thermometer that best describes their level of distress 
over the last week. Several studies indicated a cut-off score of 4-5 as having optimal 
sensitivity to detect clinically significant levels of psychopathology (Dolbeault et al. 2008; 
Gessler et al. 2008; Graves et al. 2007; Ransom, Jacobsen, and Booth-Jones 2006; 
Tuinman, Gazendam-Donofrio, and Hoekstra-Weebers 2008). Smaller numbers of studies 
recommended higher or lower cut-off scores. The Distress Thermometer contains a 
complementary problem list that asks respondents to tick boxes to indicate areas where 
problems exist in practical, familial, emotional, physical, or spiritual domains. This 
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instrument has been used in a growing number of studies overseas (Patel et al. 2011; 
Zabora et al. 2001; Roth et al. 1998). It takes approximately 8-15 minutes to complete. 
Secondary outcome measure: Quality of Life (global) SF-12v2 
Quality of life is a complex construct with no agreed definition in the literature. Quality of 
life in cancer is generally accepted as a sense of wellbeing across the physical, 
psychological, social and spiritual aspects of life (Ferrell 1996). For this study, a generic 
quality of life measure was chosen for administration because it was recommended in the 
Battersby protocol for administration of The Flinders Program (Battersby et al. 2010). The 
SF-12v2 was the specific measure identified and recommended for use in the protocol 
guidance published by the Flinders Program founder (Battersby et al. 2010). The SF 
quality of life measures are internationally validated, have proven psychometrics and are 
widely respected and used (Ware and Sherbourne 1992). The SF-12, a shortened version 
of the original SF-36, was revised in 2002. The SF-12v2 quality of life measure was 
chosen for this study because it is short and usable while retaining adequate reliability and 
validity as a global quality of life measure across different population cohorts (Ware et al. 
2002). It takes approximately 10 minutes to complete. 
Secondary outcome measure: Resilience scale - Connor-Davidson Resilience Scale (CD-
RISC) 
Resilience is a concept that describes adaptability and response to stress or trauma 
(Seville 2008). For this study, the shortened version of the full 25-item CD-RISC measure 
(Connor and Davidson 2003) was administered. The 2-item CD-RISC (Vaishnavi, Connor, 
and Davidson 2007) asks the person to self-rate how true these statements are for them, “I 
am able to adapt when changes occur” and  “I tend to bounce back after illness, injury or 
other hardships”. These statements reflect perceived adaptability to stress. Summary 
scores range from zero (indicating low resilience) to eight (indicating high resilience). The 
literature describes the instrument as having convergent and discriminant validity with a 
Cronbach’s alpha score of 0.89 (Yu and Zhang 2007). In a general population survey, the 
mean CD-RISC 2 score was reported as just under a score of seven (Vaishnavi, Connor, 
and Davidson 2007). It takes approximately 1 minute to complete. 
Secondary outcome measure: Patient experience – 2009 NZ Cancer Care Survey 
The 2009 NZ Cancer Care Survey was used as a measure of patient experience. The 
original survey was adapted from the internationally utilised National Research 
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Corporation and Picker Institute (NRC+Picker) ambulatory oncology instrument (NRC 
2005) which had already been slightly modified by researchers who used the survey in 
New South Wales (NSW), Australia (Heading et al. 2009). The survey consists of 96 
questions on many aspects of the cancer journey including diagnosis, treatment (surgery, 
chemotherapy and radiotherapy), symptom management, healthcare team, care 
environment and overall impressions of care. The baseline data from the first 
administration of the survey in NZ did not include assessment of measure validity and 
reliability with a NZ survivor cohort. No follow-up patient experience studies have been 
conducted in NZ. Administration of this survey in this study will enable comparison to the 
original baseline data. Although this measure has low usability due to its length, and no 
psychometric assessment to report, it is conceived to be a useful addition to the 
assessment package because of its NZ-specific baseline data. It is interesting to explore 
whether inclusion of a supported self-management intervention compared to standard 
supported care, impacts on the patient experience in any particular domains. The literature 
indicates that there is an association between patient experiences of care and person-
centred care outcomes (Delnoij 2009; Paddison et al. 2012; Watson et al. 2005.; 
Zimlichman, Rozenblum, and Millenson 2013). Supported self-management programs 
emphasise collaboration between patients and clinicians to achieve optimal outcomes. It 
would be useful to see if supported self-management intervention impacts on patient 
experience. 
Most survivorship studies incorporate multiple measures to evaluate intervention outcome 
as standard practice. Table 7 provides an overview of outcome measures used in the 
feasibility study. The choice of outcome measures was experimental and based on 
published Flinders Program protocol guidance (Battersby et al. 2010). Additional measures 
of self-efficacy were included for comparative purposes. The distress measure was 
included because versions of this measure are in routine use in some NZ cancer clinics. 
The patient experience survey was included because it provides a source of NZ baseline 
data in a relevant area. 
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criteria (item # 
and time to 
complete) 
Response options 
Demographics Patient Information 
on study consent 
6 items 
3-5 minutes 
Fill in the blanks 



















Likert-type scale of self-
management capability 
rated from 0 (poor) to 8 
(very good) 
Likert-type scale rated 
from 0 (not confident) to 
10 (very confident) 
4-response Likert-type 
scale rated from 









& Problem List 
8-15 minutes 
Circle response & tick 
boxes on problem list 
Quality of Life SF12v2 
(Greenfield, 
Kaplan, and Ware 
1985; Frieling, 
Davis, and Chiang 
2013; Cheak-
Zamora, Wyrwich, 












scale rated from 




2009 Cancer Care 











Adoption was defined as the feasibility for carrying out The Flinders Program in the NZ 
hospital setting. It was indicated in this study by process data from field notes on actual 




Implementation describes the extent to which a program or study is delivered acceptably 
and as intended. This was shown by data from a satisfaction survey as well as process 
data. 
Satisfaction was measured in both study participants and recruiting clinicians. The 
instruments used to measure study satisfaction in this study were adapted from a survey 
developed in NZ. This survey had been used to measure the acceptability of a guided self-
help brief intervention in general practice to address sub-threshold mental health 
syndromes (Collings et al. 2012). Study participants in the intervention group rated their 
satisfaction with the intervention around nine statements (Collings et al. 2012).The survey 
asks the person to self-rate statements about their intervention satisfaction such as “I am 
satisfied with the self-management support sessions I received”, “I found the sessions 
helpful” and, “I would recommend these sessions to a friend.” Statements are included to 
assess satisfaction with the length and number of sessions provided. Figure 16 shows all 
nine statements included in the follow-up assessment for intervention participants. 
Clinician satisfaction with the intervention was assessed based on responses to a subset 
of four statements chosen from the patient satisfaction measure as seen in Figure 17 
(Collings et al. 2012).  
Further contributing to implementation evaluation was process data. Process data was 
obtained from a screening log, randomisation log, and The Flinders Program care planning 






1. I am satisfied with the self-
management support sessions. 
Disagree 
Strongly 
Disagree Agree Agree 
Strongly 
N/A 
2. I found the sessions helpful. Disagree 
Strongly 
Disagree Agree Agree 
Strongly 
N/A 
3. The sessions were long enough. Disagree 
Strongly 
Disagree Agree Agree 
Strongly 
N/A 
4. There were enough sessions. Disagree 
Strongly 
Disagree Agree Agree 
Strongly 
N/A 
5. I felt the person working with me 
was interested in me as a person. 
Disagree 
Strongly 
Disagree Agree Agree 
Strongly 
N/A 
6. I was able to make useful changes 
with the help of the sessions. 
Disagree 
Strongly 
Disagree Agree Agree 
Strongly 
N/A 
7. The changes have improved the way 
I am feeling.  
Disagree 
Strongly 
Disagree Agree Agree 
Strongly 
N/A 
8. I am confident that these changes 
will be lasting. 
Disagree 
Strongly 
Disagree Agree Agree 
Strongly 
N/A 
9. I would recommend these sessions 
to a friend.  
Disagree 
Strongly 
Disagree Agree Agree 
Strongly 
N/A 
Figure 16: Survey questions used to assess study participant satisfaction with the 
intervention 
 
1. I thought the supported self-
management intervention was 










2. The supported self-
management intervention 



















4. I would like to see supported 
self-management intervention 














Maintenance was not assessed in this pilot study. It refers to the extent to which a program 
has become embedded and changes sustained in the longer term. This was out of scope 
for the feasibility study undertaken and reported on in this thesis. 
Table 8 shows a summary highlighting the four of five RE-AIM elements addressed in the 
context of the phase two Flinders Program feasibility study. More information on RE-AIM 
can be found in Chapter three. 
Table 8: Summary of the RE-AIM framework as it relates to phase two The Flinders Program 
feasibility study  
RE-AIM framework outcomes Methods Data collection tool 
Reach: The absolute number of 
participants who participate in a 
given program 











impact of an intervention on 
important outcomes 
Self-efficacy 




Partners in Health scale, 
Patient Activation Measure, 





2009 NZ Cancer Care Survey 
Adoption: The setting, timing 
and context for delivery. This 
outcome is for the intervention 





Implementation: The extent to 
which a program or study is 
delivered as intended. 
Intervention satisfaction  
 
 
Care plan review 
Protocol deviations 




- Clinician  







Assessment of outcomes 
 
The outcome measures were administered to study participants by the author or one of 
two research assistants. The author was the study interventionist. In light of potential 
social desirability and acquiescence bias, follow-up assessments for all intervention 
participants were undertaken by research assistants. 
Prior to an assessment session, the assessor ensured that screening and informed 
consent processes had been completed. The baseline assessment was stated to take 
approximately 30 minutes and consisted of: 1) standard demographic questions utilised by 
the Ministry of Health for the NZ Health Survey (Statistics NZ 2011); 2) instruments to 
measure self-efficacy, distress, quality of life, and resilience (see Table 7); and 3) three 
open ended questions about life impacts of cancer and coping strategies.  
The follow-up assessment was conducted in person at the 6-week post-treatment follow-
up appointment. The assessment was estimated to take about 75 minutes. The follow-up 
assessment included the same surveys as participants had completed during the baseline 
assessment, with additions of a measure of patient experience and intervention 
satisfaction. Five qualitative open-ended questions were added to obtain further 
information on intervention acceptability and utility. The participant was sent home with the 
patient experience survey to complete and mail back in a pre-paid self-addressed stamped 
envelope if it could not be completed at the appointment due to time constraints. 
 
Analysis of data 
 
The phase two pilot study empirical data included process documentation, field notes, 
outcomes data from survey instruments and a care plan audit. Process documentation 
relied on study forms and field notes. Outcomes data, including demographic data for 
consenting participants, were recorded on the consent form and survey instruments. The 
care plan audit was based on completed care plan forms.  All forms were stored in a 
secure location in folders labelled with participants’ study numbers. 
Data were treated in different ways. Process data were recorded, summarised and 
reported. Assessment data were entered into an MS Access database by one research 
assistant (Appendix M contains full outcomes data sets for key patient-reported outcome 
measures). Entries were quality checked by the author. Data were exported to MS Excel. 
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Data files were imported into STATA and R for analysis. Scoring instructions 
accompanying the registered use of the data collection tools were referenced to guide 
scoring, calculation of average scores, and subscale reporting. Simple descriptive and 
univariate between group analyses were performed on baseline demographic and 
outcome measure data. Further analyses on the small data set was not attempted 
because of the low numbers, corresponding to low power, and large confidence intervals 
which would preclude any conclusions being drawn. 
It was originally planned that data would be analysed on two levels: intention-to-treat and 
“as-treated”. However, the small sample size and withdrawal of only one participant part-
way through the study, meant that the practical decision was made to analyse only the 




This feasibility study evaluated the acceptability, feasibility and initial utility of The Flinders 




The reach of the intervention reflected the study sample. Recruiting clinicians controlled 
study access. Between May 2013 and October 2014, thirty-three people in total were 
referred to the study and twenty-eight consented to participate. Those who did not consent 
refused mainly due to poor health or feeling already overwhelmed by cancer and its 
treatment. The majority of total referrals were from the Wellington Blood & Cancer Centre 




Figure 18: Flow of participants during the course of the pilot study 
 
Originally, the field component of the study was estimated to last a total of 12-months. This 
comprised an 8-month recruitment period and approximately 4-months of follow-up for 
each study participant. The recruitment target was two subjects enrolled per week 
resulting in 50 subjects recruited over 25 weeks. A margin of error was built into this rate 
calculation to allow for holidays, staff leave and other disruptions, hence the proposed 8-
month recruitment period. 
However, due to slower than expected recruitment rates, the recruitment procedures 
required adaptation during the pilot study. In order to address recruitment challenges, the 
study lead began to meet regularly with the clinical leads to review recruitment progress 
and discuss recruitment options. The first option suggested by a clinic lead was that the 
patient list be reviewed each week to identify and flag potentially eligible patients. This pre-
screening method did not substantially impact on the study referral rate. The next strategy 
to boost participation and reduce inclusion criteria confusion was to expand recruitment 
eligibility. The recruitment referral form (in Appendix J) was simplified in July 2013 to 
indicate that all patients “with a confirmed diagnosis of colorectal cancer” were eligible for 
referral to the study. The eligibility criteria were also adapted and the words ‘outpatient 





















met the eligibility criteria, not just those receiving chemotherapy. In August 2013, 
recruitment was expanded to include the main outpatient surgical department. The surgical 
nurse was an enthusiastic study champion and recruited patients to the study. This 
resulted in increased study referrals. Recruitment ended in July 2014. Although 
recruitment did not reach the anticipated number of 50 patients, the data gathered from the 
27 participants who completed the study provided key insights into study acceptability and 
feasibility.  
Downstream recruitment barriers did not seem to be related to identification of potential 
participants but more to do with recruiting clinician priorities which included time pressure 
and judgements about patient suitability for the study that determined who heard about the 
study. With regard to time pressure, recruiting clinicians inferred that important clinical 
issues needed to be addressed first meaning little time was left to introduce the study. This 
was identified as a source of bias in the study. 
 
Randomisation procedures 
The randomisation procedures worked well and resulted in a relatively even distribution of 
patients in the intervention and control groups in terms of demographic and clinical 
characteristics as seen in Table 9. The demographic characteristics of the 27 subjects who 
completed the study in the intervention and control groups are reflected though 
frequencies and percentages for the categorical variables of gender, ethnicity and age. 
These can be compared to the demographic characteristics of all NZ cancer registrants 
with a first-time diagnosis of colon cancer from the year 2008, the most recent year for 
which data is currently available (Ministry of Health 2015a). 
The representativeness of the study participants was broadly similar to the demographics 
of colon cancer registrants in NZ in 2008 (Ministry of Health 2015a) in gender, ethnicity 
and age. The majority of participants were 60 years of age or older (85%) which closely 
aligns with the demographics for those diagnosed with colorectal cancer. More males 
(59%) than females participated in the study and colorectal cancer is more common in 
males in NZ. Further, study participants were more likely to be Māori (in keeping with the 
study priorities) than would be expected from the comparative national data. However, the 
study cohort was closely representative of those identifying as Māori in NZ, which is 
approximately 15% of the population. Māori are under-represented in registrations for 
colorectal cancer compared to non-Māori. Although not shown in the table, 70% of 
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participants in this study had diagnosed comorbidities recorded in their electronic health 
record. 




(n = 14) 
 
Frequency    % 
Control group 
(n = 13) 
 
Frequency    % 
All colon cancer registrants 
in NZ 2008 (n = 2801)* 





9                64.3 
5                35.7 
 
7                53.9 
6                46.2 
 
1441             51.4 





2                14.3 
12              85.7 
 
2                15.4 
11              84.6 
 
  121              4.3 










1                  7.1 
1                  7.1 
2                14.3 
7                50.0 
1                  7.1 
1                  7.1 
1                  7.1 
 
1                  7.7 
1                  7.7 
2                15.4 
5                38.5 
2                15.4 
2                15.4 
0                  0 
 
Two studies have reported the 
mean age of diagnosis in NZ to 
be 70 (Cunningham et al. 2009; 
Murray et al. 2011) 




The primary goal of this sub-section is to report on the usability of several instruments as 
outcome measures for intervention studies. There was insufficient power, due to low-
participant numbers, to warrant in-depth interpretation of this data. Individual-level 
analyses reported are indicative of potential areas of interest for future inferential analyses 
in larger studies. 
In this sub-section, the pre- and post-assessment survey results are presented for the 
intervention and control groups. Baseline assessment took place mid-way through a phase 
of cancer treatment. Post-assessment took place at the 6-week follow-up appointment. 
This represented assessment of short-term outcome only. Observations related to 
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instrument usability are also presented. Scores for all primary and secondary measures for 
each participant, except for the patient experience survey, are available for review in 
Appendix M. 
The tables shown in this sub-section show the mean and standard deviation of the data. 
The higher the standard deviation, relative to the scale, the larger the variability in scores 
between individuals. The accompanying box plot figures are also shown to allow for a 
better visual sense of the comparative distributions between intervention and control group 
data. Boxes represent the data within the interquartile range from the 25th to 75th 
percentile. The lines or whiskers extend to encompass the full range of the data. 
 
Self-efficacy: primary outcome measure 
Three self-efficacy measures were compared: the Partners in Health Scale, The Patient 
Activation Measure and the Chronic Disease Self-efficacy Scale. 
Each of the 13 –item Partners in Health scale statements were rated by participants on a 
scale of 0 to 8 where 0 indicates low self-management competence and 8 indicates the 
highest competence. Each item related to a different aspect of self-management 
competence. When these statements are analysed at single item level, 58% (8/14) of 
intervention participants scored one or more of the 13-items as 4 or below at baseline 
assessment. 31% (4/13) of control group participants scored one or more items as 4 or 
below at baseline assessment. Scores of 4 or below indicates low perceived self-
management competence in that area. Table 10 shows the counts of items with scores of 








Number of items scored 
at 4 or below at baseline 
Number of items scored at 
4 or below at follow-up 
01-112-51 0 2 
01-114-51 1 3 
01-115-51 0 4 
01-117-51 9 9 
01-119-51 0 3 
01-118-51 10 1 
01-120-51 3 1 
01-123-51 0 0 
01-124-51 0 0 
01-132-51 2 0 
01-134-51 8 0 
01-136-51 1 1 
01-139-51 0 0 
01-140-51 13 0 
 
Given the small number of participants, it is not possible to discern any clear pattern in the 
results. A small increase in overall reported self-management competence was identified 
in the intervention group follow-up scores where 58% (8/14) of intervention participants 
scored one or more items at 4 or below. However, the individual participants scoring items 
at 4 or below differed between baseline and follow-up. In other words, some people who 
reported high levels of self-management competence in certain areas at baseline reported 
lower self-management competence in certain areas after the intervention.  
A small increase in overall reported self-management competence was also identified in 
control group participant follow-up scores where only 15% (2/13) of control participants 
scored one or more items at 4 or below. Once again, the individual participants scoring 
items at 4 or below were seen to differ by individuals between baseline and follow-up. 
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Table 11 shows the counts of items with scores of 4 or below at baseline compared to 
follow-up for control group participants.  




Number of items scored 
at 4 or below at baseline 
Number of items scored at 
4 or below at follow-up 
01-113-21 0 0 
01-125-21 1 0 
01-126-21 0 0 
01-127-21 1 0 
01-128-21 0 0 
01-129-21 0 0 
01-130-21  0 1 
01-131-21 0 0 
01-133-21 2 0 
01-135-21 1 0 
01-138-21 0 0 
01-141-21 0 6 
01-142-21 0 0 
 
Partners in Health scale means and standard deviations are shown in Table 12. The 
average scores showed little change between baseline and follow-up assessment. More 
variability in overall change scores is seen in Figure 21 with intervention group scores 
ranging above and below the median.  
Patient Activation Measure mean scores for intervention and control group participants 
were similar at baseline. However, the mean scores diverged at follow-up by group. 
Scores indicated increases in self-efficacy and activation across both groups. However, 
the control group showed greater increase in patient activation mean scores between 
baseline and follow-up. Variability in change scores, as demonstrated in the box plots 
shown in Figure 19, were broadly similar in interquartile range spread between the control 
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and intervention groups with large variability seen. Again, small numbers mean that these 
results are not likely to be representative. 
The Chronic Disease Self-efficacy Scale means and standard deviations were more 
similar at baseline then at follow-up assessment. The mean confidence scores for the 
intervention group decreased while scores increased in the control group. The box plots 
show large variability in change scores for both the groups. 
Two representations of the resulting scores from the three self-efficacy measures 
administered and compared in this study are shown in Table 12 and Figure 19. Table 12 
identifies the mean and standard deviation for combined intervention and control group 
scores. It also shows the mean and standard deviation of the change over time.  
Table 12 highlights a consistent variation between control and intervention group change 
scores. The baseline self-efficacy assessment measures’ mean scores for people in the 
control group were higher than those reported at baseline in the intervention group. Figure 
19 does not show any consistent variation in scores. 
 
Table 12: Self-efficacy measure scores (means and standard deviations) 









































Figure 19: Change in self-efficacy score distributions between baseline and follow-up 
assessment (medians and ranges)  
 
Quality of life SF12v2: secondary outcome measure 
The SF-12v2 results were calculated for the mental and physical health components of 
global quality of life health and wellbeing. The scores were computed into the norm-based 
physical health component score (PCS) and the mental health component score (MCS). 
The summary scores show decreases in global quality of life between baseline and follow-
up for the intervention group across both physical and mental health scores. Small 
increases in mean scores over time can be seen for the control group. SF12v2 mean 




Table 13: SF12v2 scores (means) 
































Distress and Resilience 
Distress Thermometer combined means were higher for the intervention group at baseline 
assessment and this pattern continued at follow-up assessment.  Average scores and 
standard deviations are shown in Table 14. The means for both groups showed a similar 
slight downward trend from baseline assessment to follow-up assessment resulting in the 
same mean and median change score. There was more variability identified in the 
intervention group change scores over time. For two people in the intervention group, 
distress scores greater than six were reported at baseline and those scores dropped to 
three at follow-up assessment. Conversely, one person in the intervention group reported 
a score of two at baseline which rose to eight at follow-up. Although, individual variability in 
scores was noted there were no major changes in scores noted for the control group 
participants. 
Resilience scale combined means for the groups were between six and seven out of eight. 
The means diverged between baseline and follow-up for the intervention and control 
groups. The intervention group showed a decrease in mean resilience score (-1.0 change 
score) over time while the control group showed an increase in mean resilience score (0.4 
change score). The variability in change over time scores for both groups was fairly similar 
overall although it extended mainly above the median for the control group and below the 
median for the intervention group. 
The calculated means and standard deviations as well as change scores for the distress 
and resilience scales are shown in Table 14 and Figure 20. 
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Table 14: Distress and resilience scores (means and standard deviations) 





























Figure 20: Change in distress and resilience score distributions between baseline and 
follow-up assessment measures (medians and ranges) 
 
Patient experience measure 
The Cancer Care Survey results from pilot study participants were compared to baseline 
data collected in the national survey administered in 2009 (Cancer Control Council of NZ, 
2009). In the analysis only the ‘ideal’ response, such as “always” or “definitely”, was 
equated with a positive experience. Confidence intervals were included with the baseline 
data from the original survey but these were not calculated for the small data set from this 
study as these intervals would likely be very large and uninformative in this context. 
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A subset of participants chose to complete this survey at home with eight respondents 
from the intervention group (57%) and ten respondents from the control group (77%) 
returning it completed. All 18 respondents (100%) indicated that the overall quality of all 
cancer care received over the last 12-months was excellent, very good or good.  This is 
similar to the score of 97% of patients who rated cancer care at this level in the 2009 
Cancer Care Survey administration.  
Areas of strong performance and opportunities for improvement reported in the original 
Voice of Experience report (Cancer Control Council of New Zealand 2009) were compared 
with results for intervention and control groups in this study. Table 15 shows that results 
varied significantly from baseline data across both study arms. 
Table 15: Original key strengths of cancer care, highlighted by the percentage of high score 
responses > 85% to the 2009 Cancer Care Survey. 












Coordination of care 63 75 91 (90-93) 
Ease of understanding 
directions/signs 
63 80 90 (89-92) 
Level of privacy provided 38 80 87 (85-89) 
Dignity and respect provided 88 100 86 (85-88) 
 
 
Table 16 shows scores for intervention, control and baseline on aspects of care that 
baseline respondents from the 2009 Cancer Care Survey were least positive about. These 





Table 16: Original key cancer care opportunities for improvement, highlighted by the 
percentage of scores < 50% in response to the 2009 Cancer Care Survey. 












Providing enough information on: 
Relationship changes 














Providing explanations for 
treatment waiting times 
25 50 34 (30-37) 
Putting patients in touch with care 
providers to help with anxiety and 
fear, if this was required 
40 0 36 (33-39) 
Taking living situation into account 13 50 49 (46-51) 
 
 
The results for aspects of cancer care that represented key strengths and opportunities for 
improvement were outlined in the original Cancer Care Survey report. When these are 
compared to the data from this phase two study, the data indicates that the control group 
had higher percent positive scores in the aspects of care identified as strengths of cancer 
care from the baseline survey. Results were, for the most part, lower in the aspects of care 
originally identified as opportunities for improvement. However, scores were variable 
across intervention and control groups with regard to opportunities for improvement with 
no discernable pattern.  
Intervention experiences were also addressed in this study using open-ended questions 
(see Appendix L). The purpose of the qualitative component of the pilot study was to 
explore patients’ experiences of cancer life impacts, support and the intervention. These 
three main topics were assessed with qualitative open-ended questions as part of the 
follow-up assessment. This contributed to data on burden and benefit from study 




Participants were asked about the same topics addressed in the phase one study, namely 
their experience of life impacts of cancer, effective coping strategies and their views on 
supported self-management intervention. With regard to life impacts of cancer, responses 
reflected similar multidimensional and holistic social, physical, emotional and spiritual 
themes reported in the phase one study. A noted difference was that most of the 
participants receiving treatment, stated that they were looking forward to treatment end so 
they could move forward, one person described it as “forget the year”, and get on with life 
or work. Other unique perspectives included one person who reported feeling shunned at 
work during treatment while another stated that it was “extraordinarily difficult to try to deal 
with the concept of a shortened life span”. Participants identified support or coping 
strategies that they found helpful which included rest, working to routine, whānau support 
and meditation. Programs accessed by two individuals included home help, counselling, 
and Cancer Society courses. The intervention was identified as useful by all participants 
who completed the three-session Flinders Program. One person reported that it was 
“helpful to be reflective” while another found benefit in action plans. 
There were a few recommendations shared for how the experience could be better. One 
person from the intervention group stressed the importance of communication and 
coordination across departments. Another intervention group participant wondered if the 
supported self-management sessions could take place via Skype. In summary, 
participants in the study reported that cancer did impact on their lives in many ways and 




Data for this sub-section was sourced from process documentation related to the adoption 
of the intervention and adaptations for the setting. 
The adoption of the intervention was impacted by appointment timing. The intervention 
sessions were to be undertaken during regular hospital clinic appointments. The variable 
waiting times meant that the logistics of meeting sometimes entailed multiple visits by the 
study lead to meet the participant for a session.  
The timing of the intervention was established based on recommendations by the clinical 
advisory team. Clinical advisors were instrumental in designing this study. 
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Although the focus group participants were asked about timing of the intervention, no clear 
consensus was reached on the most appropriate time, so the recommendation of the 
clinical advisory team was to administer the intervention mid-way through a phase of 
treatment. It was envisioned that the timing of the three intervention sessions would be 
similar for every participant. However, in practice, there were some differences in when 
people received their first intervention session. For example, for some people it was at the 
third appointment and for others the sixth. The sessions took place at variable clinic 
appointments. Many occurred prior to a standard clinical appointment and some during 
chemotherapy delivery. Sometimes sessions took place during unplanned hospital 
admissions for complications or post-surgery. It was difficult to achieve a standard 
procedure because of the variability in appointment keeping. However, a key reason for 
choosing this intervention was flexibility in intervention delivery. 
The intervention sessions ranged in duration from 15 to 90 minutes with a median duration 
of 29 minutes. The duration of the intervention sessions was impacted by appointment 
priority, whereby the intervention was stopped when the clinical appointment began. The 
duration of the intervention sessions seemed appropriate and 85% of the sessions lasted 
under one hour. Therefore, the total time needed for the full intervention, delivered over 
three sessions, was approximately one and a half hours. 
Barriers to planned intervention session delivery included unplanned hospitalisations, 
changed appointments and various health status factors. Although all participants did 
receive three sessions during their treatment phase, sometimes these were conducted 
outside the established routine when people were at hospital for various other reasons. 
All intervention participants collaborated in development of a survivorship care plan (see 
example in Appendix N). An audit of completed care plans identified various priority issues 
and goals discussed collaboratively between the consenting participant and the author. 
The care plan issues or goals which were most prevalent for the 14 participants related to 
relationships, combating fatigue, participation in active recovery, and employment. These 




Table 17: Top Flinders Care Plan issues or goals reported by study participants 
Identified care plan issues or goals Prevalence 
Improve whānau relationships 10/14 = 71% 
Build strength and stamina 9/14 = 64% 
Pursue active post-treatment recovery/survivorship 9/14 = 64% 
Find or return to work 7/14 = 50% 
Support others going through colorectal cancer 2/14 = 14% 
Advance care plan for future health events 2/14 = 14% 
Move house/fix up house 2/14 = 14% 
Travel or revive hobbies 2/14 = 14% 
Cope better with low mood 1/14 = 7% 
 
Actions identified from these collaboratively identified issues and goals ranged from 
establishing regular family get-togethers to a stepped return to work plan. The most 
common action listed in the care plan incorporated SMART goals for undertaking regular 
exercise. Example actions discussed specifically to address the most prevalent goal (i.e. to 
improve whānau relationships) included: holding regular family meetings, accessing 
counselling sessions, hosting a celebratory meal, planning a holiday, or developing a 
whānau inclusive advanced care plan.  
Bias may have been introduced by the examples provided by the author in relation to 
actions. The author did comment that other people have suggested actions of specific 
types to give the participant a sense of action planning. Further, actions proposed by 
participants are likely to have associations with demographic characteristics but this was 




The implementability of the intervention addressed study processes as well as stakeholder 
experience and satisfaction. Process data were reviewed to inform study enablers and 
barriers as well as protocol deviations required to administer assessment and intervention 
sessions. A satisfaction survey was administered to intervention group participants and 
clinicians to assess study experience. 
A key barrier to study implementation was recruitment. Recruitment processes were an 
area where enablers and barriers were apparent. Recruiting clinicians included oncologists 
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and surgeons, clinical nurse specialists and clinic nurses. These individuals varied in their 
recruitment success. For example, nurse recruiters achieved better recruitment rates than 
oncologists and surgeons. Recruitment barriers within the hospital setting were identified 
in two main areas. Firstly, recruiting clinicians had limited time with patients and needed to 
prioritise clinical requirements over introducing the study. Secondly, when the study did get 
presented, recruiting clinicians anecdotally reported that many eligible patients did not 
wish to participate in the study. Based on verbal reports of the recruiting clinicians and 
nurses, the main reasons for patients refusing participation were: wanting to focus just on 
treatment at that time, not knowing how supported self-management could help, or no 
interest in taking part in research. These reasons were not documented, although the 
participant referral form did request this information. Consequently, a determination of the 
feasibility of achieving, for example, a 70% recruitment rate for eligible patients, was not 
able to be assessed. Lack of process data on recruitment rate was identified as a barrier in 
this study.  
It was unclear if the clinicians understood and explained to patients the balance between 
potential intervention benefit compared to additional burden during treatment. Reasons 
reported by patients for choosing study participation included: wanting to help others, 
appreciation of extra support, or wanting to take advantage of any opportunity to ensure 
treatment success. 
It is recommended that more effort be put into establishing standardised recruitment 
pathways to help clinicians present the study to potential patients as well as providing 
materials to enable the study to be described in ways that support participation. Recruiting 
clinicians were asked to record information on those who could not be referred or refused 
referral to the study. This was not feasible. Anecdotally, some clinicians mentioned that 
they had talked to one or two patients about the study but had received negative 
responses. Clinical judgement calls were also made by the clinicians on whether that 
patient would be able to take in the study information at that time. One clinician stated “I 
introduce the study to patients who could use some love”.  
The majority of patients who did hear about the study and met with the study lead, enrolled 
in the study. The randomisation to group worked well. Although patients who signed the 
consent form were made aware that there was a 50% chance of being assigned to the 
control group, some were disappointed about their assignment. The study team did 
discuss making the intervention available to control group participants post-treatment, but 
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the logistics of this suggestion prevented this. The intervention could have been delivered 
by phone or appointments made at an alternative location, but this was not undertaken 
due to complexity in delivery and time constraints for the study.  Nevertheless, it was 
recommended that this opportunity be made available for participants in subsequent 
studies. 
The attrition rate for study participants was low with just one person withdrawing from the 
study part-way through due to poor health, complex family pressures and failure to realise 
immediate benefit from study participation. That person’s data were not included in any 
analyses. It would be expected that attrition would be higher if the recruitment rate were 
higher, if the intervention had lasted over a longer period of time, or if longer-term 
outcomes were measured post-treatment. 
Engagement with study advisors and clinical staff was another area of focus. Study 
advisors provided advice critical to addressing issues that arose. Advisors were 
approached during meetings for the C3 studies or individually as needed. Clinical staff 
were approached, at first, through scheduled brief meetings that were scheduled at 
specific intervals (i.e. monthly). Then, engagement occurred individually at opportune 
moments in the ward or clinic. 
Intervention delivery was a third area of focus. Flexibility in meeting changing 
appointments and health needs, as well as the need to address support person 
participation, were adaptations required for intervention delivery. Waiting times for 
appointments or treatments did present opportunities to carry out study procedures. 
However, there was always a time pressure and unknown around how much time was 
available for sessions. Sometimes appointments were adjusted as unanticipated 
hospitalisations and appointment changes occurred affecting participation.  
Adjustments were made to incorporate whānau who attended the appointments with the 
study participant. Whānau participation was not assumed. If a support person 
accompanied the study participant to the clinical appointment where an intervention 
session was scheduled, a discussion about taking part in future sessions was broached. 
The research participants were also asked privately, if feasible, if they wanted their 
whānau to take part in future sessions. If agreed by the participant, whānau were asked to 
participate in the intervention session and be included as a named participant in the 
Flinders Care Plan documentation.  
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Outcome assessments were carried out at baseline and follow-up. Particularly problematic 
was administration of the follow-up assessment. This was envisioned to take place at the 
standard 6-week follow-up appointment but it was rarely able to be completed in the 
timeframe of prior to or after that specific appointment which tended to be of short duration 
and run to schedule. Therefore, for 80% of participants, the follow-up assessment was 
completed in part at the clinic and in part at home. 
The second component of intervention implementability was satisfaction. A satisfaction 
survey was administered to most intervention group participants and referring clinicians. 
87% (13 out of 15) of intervention group participants responded to the survey. Four out of 
nine (44%) recruiting clinicians responded to the satisfaction survey. 
100% of intervention group respondents reported high levels of satisfaction (score >3.5 out 
of 4) with the supported self-management intervention program. All respondents reported 
that they would recommend these sessions to a friend. 92% (12/13) of respondents 
reported that they agreed or strongly agreed that the self-management support sessions 
were helpful. The same percentage agreed that there were enough sessions and that 
these were helpful and long enough. The majority (85%) strongly agreed that the 
intervention felt highly person-centred with the other two respondents agreeing with this 
statement. However, many intervention group respondents disagreed that the intervention 
improved the way they were feeling (46%) or that they would be able to make lasting 
changes from the intervention (46%).  
Four out of nine clinicians (44%) responded to the clinician satisfaction survey. Scores 
indicated that some aspects of the intervention program were more acceptable than 
others. All four of the clinician respondents agreed or strongly agreed that the intervention 
program was acceptable in the outpatient clinic setting. Three out of four agreed or 
strongly agreed that it could address some patient needs (75%) and was easy to access 
(75%). Two agreed that they would like to see the program made available to patients 
again. 
Process measures were also reviewed to assess implementability of the intervention. 
Although participants and health practitioners identified the survey processes to be 
acceptable, issues were identified during the study which may indicate that the intervention 
is not suitable for all cancer patients. For example, cognitive impairment was identified as 
a barrier to intervention suitability. One participant was identified by his oncologist as likely 
experiencing cognitive impairment, a relatively common side-effect experienced in 
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conjunction with some cancer treatments. The assessment data showed no change in any 
outcome measures from pre- to post-assessment.  This finding may indicate that need for 
intervention suitability assessment. A screening tool might be useful to determine future 




Intervention mapping is recommended as best-practice in intervention planning and 
delivery. Intervention mapping involves planning program delivery based on information 
from the target population (Kilbourne et al. 2007), the literature and any pilot research.  
Bartholomew et al identifies five steps: (1) creating a matrix of proximal program objectives 
and outcomes, (2) selecting theory-based intervention methods and practical strategies, 
(3) designing and organizing a program, (4) specifying adoption and implementation plans, 
and (5) generating program evaluation plans (Bartholomew, Parcel, and Kok 1998). 
Intervention mapping is a stepwise approach for theory and evidence-based development 
and implementation of interventions (Bartholomew et al. 2006; Bartholomew, Parcel, and 
Kok 1998; Kok et al. 2004; Michie et al. 2008). An intervention mapping exercise was 
undertaken using the stepped approach including creating a matrix of proximal program 
objectives and outcomes. This matrix or map is shown in Figure 21. It visually displays the 
proposed intervention effects and outcomes considered. Figure 21 shows the proposed 
interaction of the person, cancer and treatment relating to the person, whānau and the 
environment but also taking into consideration cancer-related symptoms and side-effects. 
Proximal, or short-term, intervention targets were identified from the literature review and 
studies presented in this thesis. Intervention targets were included in the phase two study 
were resilience, distress, self-efficacy, quality of life and patient experience. No gold-
standard process or clinical outcome measures were identified from the literature. Further, 
the phase two study indicated less utility for using the specific patient experience survey 
as an outcome measure.  An intervention map reflects best-practice. It can be updated, 
based on study data, to reflect more specific target outcomes and the working map is 










The phase two pilot study evaluated acceptability and feasibility of conducting a supported 
self-management intervention program in hospital-based cancer care settings. The study 
was administered utilising a pre- and a post-assessment design to explore outcomes of 
interest for intervention and control groups. This study met its objectives by generating 
data that addressed acceptability and feasibility of the program.  
The MRC framework recommends a phase two pilot study as an iterative step to progress 
a well-designed intervention study (MRC 2009). The feasibility study design considered 
three components of acceptability and feasibility for conducting a trial: 1) recruitment and 
randomisation of enrolled participants; 2) an intervention and control group; and, 3) a pre-
post assessment design. The specific aims of this exploratory pilot study were to assess 
the acceptability and feasibility of a study design for a supported self-management 
intervention program, tailor intervention delivery to ensure fidelity, explore useful outcome 
measures and recommend next steps to inform a decision on whether to pursue a well-
powered, multi-site phase three cancer survivorship clinical trial. The quantitative pilot 
study provided descriptive insights into study feasibility.  
Supported self-management was able to be piloted and results reported effectively using 
the RE-AIM framework. In applying the framework, reach was the term used to outline the 
sample recruitment and retention data. Effectiveness was shown by data from outcome 
measures which, albeit underpowered, did not suggest obvious intervention effectiveness. 
Adoption was addressed by review of study processes as well as enablers and barriers to 
delivery of the intervention in hospital settings. Implementability was reflected in study 
process review as well as satisfaction survey results from intervention group participants 
and recruiting clinicians. Table 18 summarises the key findings across the five RE-AIM 




Table 18: Key result findings reported using the RE-AIM framework 
RE-AIM framework Pilot findings 
Reach: The absolute number 
of people who participate in a 
given programme 
Acceptability measures: 
Number of final participants = 27; a lower than ideal 
recruitment number  
Participants were representative of cancer-affected 
population in ethnicity and age. More females chose to 
participate in the study. 
Drop-outs = 1; points to intervention acceptability 
Effectiveness: The impact of 
an intervention on important 
outcomes 
Utility indicators generated data to enable exploration of: 
Self-efficacy – all measures usable 
Quality of life – high usability; results reflect population 
norms 
Distress – high usability; little change in score noted over 
time 
Resilience - high usability; little change in score noted over 
time 
Patient experience – low usability; similar results to 2009 
survey for those who did complete the survey 
Adoption: The absolute 
number and 
representativeness of setting 
and interventionist. 
Feasibility measures: 
Intervention location in hospital clinics was acceptable but 
less feasible 
Intervention delivery varied and required flexibility 
14 care plans developed with prevalent issues identified in 
areas of relationships, fatigue, active recovery and work. 
Implementation: The extent to 
which a programme is 
delivered as intended. 
Protocol deviations recommended and required 
Single site, two clinic, single interventionist delivery  
Staff involved had variable contributions and hugely impacted 
on recruitment and delivery 
Study participants and clinicians agreed that they were 
satisfied with the intervention in the short-term 
Maintenance: Sustainability  Not assessed in this pilot 
 
To the extent it was able to be evaluated, the intervention appeared to be acceptable for 
Māori. The phase two study enrolled two Māori participants in each arm of the study. For 




A randomised sample was indicated for the phase two study because there is little 
evidence to show supported self-management program intervention utility in NZ, 
specifically with a cancer survivor cohort. Intervention and control groups worked well. 
Once patients were enrolled in the pilot study, procedures for random assignment to 
intervention or control group were adequate. In both groups, some participants had higher 
scores at follow-up, while others had lower scores and some showed no change over time. 
The decrease in feelings of wellbeing reflected by the low follow-up scores may reflect an 
unintended consequence of the intervention. Small sample size could account for these 
differences; however these results need further exploration. 
This study results suggest there is a complex mix of enablers and barriers for delivery of 
supported self-management program intervention in NZ. It showed that conducting pilot 
intervention research within the NZ clinical setting is important because modifications to 
proposed protocols are necessary. The unforeseen challenges encountered in this 
feasibility study can inform protocol modifications to improve future study fidelity.  
The focus of this study was on supported self-management program intervention 
acceptability and feasibility. The intervention was evaluated as acceptable by most 
participants and recruiting health and supportive care workers involved in the provision of 
care impacted by intervention. With regard to implementation feasibility, the following 
issues were documented as needing to be addressed further :1) the need for functioning 
and appropriate referral pathways, 2) pre-screening and regular follow-up screening of 
patient and survivor readiness to engage with self-management, and 3) availability of 
outcome measures of areas impacted by supported self-management intervention 
programs validated in survivor populations. 
From the key factors of acceptability and feasibility, acceptability of the intervention was 
indicated on a survey completed by recruiting staff and study intervention participants. 
Feasibility for progression to a phase three trial was questionable based on barriers 
identified and concerns for fidelity. An RCT would be indicated if feasibility issues could be 
addressed. It may be logical to conduct a second feasibility study testing updated 
procedures, in the cyclical fashion suggested by the MRC guidance, prior to conducting a 




CHAPTER 6: Discussion 
 
‘If we knew what we were doing, it wouldn’t be research” (Unknown) 
Cancer is common, unevenly distributed and rising in prevalence for New Zealanders. The 
mortality rate has decreased and cancer survival is on the rise (Ministry of Health 2015a). 
In order to improve care for cancer survivors, redesigned care pathways are needed to 
enable provision of better quality survivorship care across NZ (Sarfati, Koczwara, and 
Jackson 2016; Jackson 2016). This study contributes research to inform survivorship care 
pathway development and redesign. 
The studies described in this thesis specifically explore survivors’ experiences and the 
acceptability and feasibility of supported self-management program intervention to address 
unmet needs and cancer care gaps reported in NZ. The results point to significant 
physical, emotional, social and spiritual impacts due to living with, through or beyond 
cancer in NZ. Supported self-management was shown to be an acceptable, but a 
questionably feasible, intervention program to address these impacts in the hospital-based 
cancer outpatient clinic during treatment. 
A summary of the full findings is first presented. Then, the phase one and phase two 
combined results are integrated with published data to address the research questions. 
The second section considers the strengths and limitations of the study design and data. 
Finally, implications and recommendations for practice and future research are suggested. 
The objectives of the qualitative phase one study were to: 
• Qualitatively explore, with survivors and health professionals, cancer treatment 
impacts, life and health complexity, as well as management strategies utilised by 
NZ cancer survivors during and post-treatment; and, 
• Use an intervention vignette to gauge the perceived acceptability of The Flinders 





The objectives of the quantitative phase two study were to: 
• Test study design aspects of recruitment, randomisation, intervention delivery and 
assessment by linking in with clinical flow in ambulatory cancer care clinics; 
• Provide insights into intervention content as well as identify enablers and barriers of 
key aspects of intervention delivery; 
• Explore and compare outcome measures of self-efficacy; and, measures of global 
quality of life, distress, resilience and patient experience.  
 
Summary of findings 
 
Survivorship is an area of growing concern and research in NZ and overseas as more 
people affected by cancer live with, through and beyond cancer-related impacts. This 
study explored supported self-management intervention as an approach to address the 
unmet needs of cancer survivors. In brief, supported self-management intervention 
programs aim to inspire and empower people to acquire and practice skills to carry out 
different medical regimens and lifestyle changes as well as to navigate social, physical, 
emotional and spiritual impacts associated with chronic condition treatment and recovery.  
The key theoretical models guiding the studies exploring survivors’ experiences and 
supported self-management program intervention presented in this dissertation were 
Durie’s 1994 Te Whare Tapa Wha Māori health model, Wagner’s 1996 Chronic Care 
model and the 2012 descriptive cancer survivorship framework by Klimmek and Wenzel. 
Each phase of the research structure and methods presented were informed by the 
revised MRC guidance on complex interventions (MRC 2009). Phase one qualitative data 
were presented thematically using a Framework Analysis (Srivastava and Thomson 2009) 
and phase two quantitative data were presented categorically using the RE-AIM 
framework (Glasgow et al. 2001). 
The key findings from the phase one study were: 
• Cancer survivor impacts were experienced across physical, emotional, spiritual and 
social domains. Impacts were intermittent and persisted over the long-term.  
• Impacts needed to be self-managed, in part, alongside day-to-day life challenges 
and health complexity related to other conditions. 
 
 181 
• Survivors’ life and health complexity management strategies aligned to Klimmek 
and Wenzel’s (2012) characterisation of cancer survivorship work. Different types of 
work were prioritised for different individuals and population groups. 
• Survivors identified supported self-management program intervention as a 
promising area for further research but did not want it to replace any existing 
supports. 
The key findings from the phase two study were: 
• A supported self-management program was piloted and results reported using the 
RE-AIM framework. 
• The intervention was acceptable to most participants and health and supportive 
care workers involved in the provision of care impacted by intervention. Whānau 
were interested and able to be involved with the intervention. 
• The intervention had questionable feasibility for delivery in the treatment setting. To 
embed supported self-management intervention effectively into the existing care 
pathways during treatment, the following issues need to be reconsidered: 
o Functioning and appropriate referral pathways with clinical champions that 
assist colleagues to comply with study protocols including adverse event 
reporting and documentation of those who decline to participate; 
o Addition of pre-screening, risk stratification and regular follow-up screening 
of patient and survivor readiness to engage with self-management;  
o Use of outcome measures validated in survivor populations that can be 
assessed both in the short-term and longer-term. Further consideration of 
robust and validated clinical process and outcome measures. 
 
Insights into the research questions 
 
In this section, data will be integrated between the studies presented in this thesis and the 
literature to address the research questions. 
Durie’s (1994) Te Whare Tapa Wha Māori health model was a good fit to describe the 
impacts reported by cancer survivors in this study. Social, physical, and emotional impacts 
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were clearly described by NZ cancer survivors in the literature. There was a more limited 
literature base on spiritual impacts. Differences were noted in reported experiences shared 
in this study with some people describing impacts in one area while others described 
impacts across areas. 
Wagner et al.’s Chronic Care Model (1996) was used as a guide to inform research into 
redesigned cancer care pathways that incorporate survivorship. Supported self-
management is an integral component of this Model. The evidence from the literature 
indicates that supported self-management programs deliver modest improvements in 
variable outcomes of interest. Evidence in the cancer literature was found to be minimal. 
Nevertheless, supported self-management was considered to be an intervention identified 
and recommended for further research. It was envisioned as able to address cancer-
related and comorbidity impacts through boosting individual self-efficacy alongside 
collaborative development of tailored strategies to strengthen relationships with whānau, 
health and supportive care workers, and communities.  
The purposes behind the first two research questions were to: 1) ascertain how cancer 
impacts were experienced by NZ cancer survivors, and 2) explore how survivorship 
impacted on QOL, if at all, in NZ.  The ways NZ survivors self-managed any impacts was 
also documented. 
 
What and how are cancer impacts experienced by survivors in NZ? 
 
There is a limited body of existing literature describing the experiences of NZ cancer 
survivors (Doolan-Noble et al. 2006; Egan et al. 2014; Hutt Valley DHB et al. 2006; O’Brien 
et al. 2010; Walker et al. 2008). However, there exists a substantial body of international 
literature describing cancer survivor experiences (Coulter 2006; Heading et al. 2009; 
Henry et al., 2008; Jefford et al. 2008; Kennedy et al. 2007; Little et al. 1998; Ohlsson-
Nevo et al. 2012). The phase one study contributed data to fill the gap in the literature 
around survivorship impact for Māori and non-Māori New Zealanders. 
In the phase one study, people described the impact of cancer in different ways. Diagnosis 
was experienced as a shock and treatment was associated with impacts that lingered. This 
is congruent with the international literature that showed treatment and survivorship are 
associated with adverse physical and psychological impacts to varying degrees (Earle and 
Neville 2004; Hewitt, Greenfield, and Stoval 2006; Jefford et al. 2008; Koczwara 2015; 
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Richardson et al 2011). Life after cancer treatment was described as both hopeful and 
frustrating which is congruent with other overseas research (Lakdawalla et al. 2012). The 
finding of persistent and intermittent cancer impacts for New Zealanders post-treatment 
aligns with previously published reports from both qualitative and quantitative cancer 
survivor experience studies (Egan et al. 2014; O’Brien et al. 2010).  
The recognised emotional, social and spiritual impacts of cancer and other chronic 
conditions on Māori wellbeing have been previously documented in NZ (Dew et al. 2015; 
Slater et al. 2013; Walker et al. 2008). Kidd et al. (2013) described these undiscussed 
emotional, social and spiritual impacts that impacted on wellbeing as part of the reason 
why addressing health needs was perceived as whakāma for Māori. Embarrassment 
prevented Māori from openly discussing health and wellbeing with healthcare practitioners 
because safe topics were seen to be related to physical health issues, while other areas of 
health-related impact were not raised (Kidd et al. 2013). The data collected in this study 
added to the international literature by showing that cancer treatment impacts described in 
focus groups seemed to differ somewhat by ethnicity. In general, Māori participants’ 
narratives included greater integration of the emotional, social and spiritual impacts of 
cancer while the non-Māori participant narratives were characterised by a focus on the 
physical impacts of cancer treatment. These varying emphases placed on the emotional, 
social and spiritual aspects of cancer by Māori focus group participants were consistent 
with the predominant holistic wellbeing-based Māori health philosophies described by 
Durie (1994, 2012) and Pere (Pere 2005) as well as Pasifika health philosophies (Fotu and 
Tafa 2009). 
Cancer treatment impacts were described by focus group participants as intermittent and 
unpredictable over time. This also describes survivors’ experience of the landscape 
associated with modern-day cancer treatment (Moorcraft, Smyth, and Cunningham 2013; 
Aklilu and Eng 2011; El-Amm and Aragon-Ching 2013). In the phase one study, 
participants reported experiencing difficulties with treatment side-effects that lingered into 
post-treatment. This result is like that described by Hewitt et al. (2006) in their review of 
the literature on the transition from cancer patient to cancer survivor. The authors 
described managing treatment and managing post-treatment as equally challenging for 
survivors (Hewitt, Greenfield, and Stoval 2006). The challenges associated with treatment 
have been shown to last many years for some. Research from the UK has indicated that 
64% of colorectal cancer survivors report ongoing health problems five to seven years 
after diagnosis (Macmillan Cancer Support 2011; Wells 2011). Phase one data pointed to 
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the need for further clarity on referral options or sources of support for these intermittent 
impacts that affect survivor wellbeing. 
Cancer was referred to in the 2016 NZ Health Strategy, for the first time, as a long term 
condition (Minister of Health 2016a) lending authority to the chronic nature of cancer 
experienced and described by survivors. However, there is ongoing debate about this 
classification and whether it does justice to the very different experience of cancer 
survivors to those who manage other long-term conditions (Tritter and Calnan 2002). 
 
What else contributes to life and health complexity for NZ cancer 
survivors? 
 
The integration of cancer treatment with everyday life contributed to reported life and 
health complexity of study participants. Participants in the phase one study described the 
multiple impacts cancer and cancer treatment had on wellbeing. Wellbeing was impacted 
during treatment by varying levels of fatigue, unpredictable emotions and various other 
problems. These impacts were most often managed outside the treatment setting (Hewitt, 
Greenfield, and Stoval 2006). The need to manage treatment impact outside of the clinical 
setting aligned with reports from the literature (Klimmek and Wenzel 2012). Focus group 
participants discussed dealing with cancer-related impacts in many aspects of their lives. 
They described how they tried to self-manage impacts or seek helpful advice from whānau 
or other community members. These findings align with the results reported in Egan et 
al.’s 2014 Cancer Stories Project. The Cancer Stories Project identified important factors 
that helped people cope with cancer. Specifically, the authors identified that coping 
strategies utilised were often “wrapped around the concept of empowerment” (Egan et al., 
2014, p. 94). In this study, the phase one focus group participants described seeking 
health practitioner support as a last resort; most participants first tried to manage physical, 
emotional, social and spiritual impacts on their own or with strategies supported by 
whānau. The practice of self-management is already common for New Zealanders, but 
data indicated that it could be better supported by health and supportive care workers. 
Comorbidity was identified as contributing to health complexity for survivors in both the 
phase one and phase two studies. Cancer and comorbidity often coexist (Sarfati, 
Koczwara, and Jackson 2016). Data from the 2006/7 NZ Health Survey indicated that two 
out of three New Zealanders live with a long-term health condition (Frieling, Davis, and 
 
 185 
Chiang 2013). Approximately 70% of the pilot study participants in the phase two study 
had comorbidities recorded in their electronic health record. This finding directly aligns with 
data from other NZ studies that identified comorbidity as common in people affected by 
cancer (Sarfati, Koczwara, and Jackson 2016), with research specifically identifying high-
levels of comorbidity prevalent in colorectal cancer survivors in NZ (Sarfati et al. 2009). 
Life and health complexity is compounded by living with, through or beyond cancer 
according to the study data. 
 
Can supported self-management approaches help address cancer and 
comorbidity impacts for survivors? 
 
The research presented in this thesis suggests that a supported self-management 
intervention program may help address cancer and comorbidity impacts for some 
survivors. It is not a one-size fits all solution. 
Multiple recommendations have been made for further research into supported self-
management as a promising approach for survivorship intervention (NHS Improvement 
2013; Sarfati, Koczwara, and Jackson 2016; Minister of Health 2016a). However, there 
has been no research on this approach in NZ cancer-affected populations published to-
date nor sufficient conceptualisation of why or how this particular approach should actually 
bring about a sustained change in survivor wellbeing in a given setting (Boger, Demain, 
and Latter 2013).  
A main weakness associated with supported self-management as a complex intervention 
is that the theoretical underpinnings and mechanisms of action related to this type of 
program are diffuse (see Chapter three for more on this topic). This research did not 
answer the question of ‘how’ supported self-management intervention impacts on 
outcomes. One proposed hypothetical mechanism of action for supported self-
management programs is that this complex intervention approach acts as an 
environmental mediator that may counteract or mediate negative impacts on wellbeing 
associated with cancer treatment (Parkhurst 2013). Supported self-management 
intervention, as an environmental mediator, may provide a ‘safety net’ of resilience that 
helps prevent treatment opt-out or breakdowns. This hypothesis was not born out in the 
underpowered phase two resilience measure scores. Research continues into 
conceptualisation of these concepts and mechanisms of action (Battersby et al. 2010). 
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Further research with longer term outcome assessments built in is warranted to clearly 
identify what and how supported self-management can target unmet survivor needs. 
 
Is supported self-management acceptable in outpatient cancer care 
settings? 
 
The intervention was acceptable in hospital-based cancer clinical settings. Results from 
the survey measures completed by study participants and healthcare practitioners involved 
with recruitment for the phase two study indicated overall supported self-management 
program acceptability.  
It is possible to infer from the data that some cancer survivors may prefer to do their own 
self-care; without support for self-management from healthcare practitioners (Pan et al. 
2011; Omisakin and Ncama 2011; Kidd et al. 2008; Lawn and Battersby 2009). A key 
recommendation to address personal choice with regard to wellbeing practices is use of a 
screening tool. Cancer survivors can be screened for supported self-management program 
suitability (Waller et al. 2013). Cancer survivors screened as unsuitable for supported self-
management intervention may be provided with alternative options. For example, watchful 
waiting can be offered to those who prefer self-care or who are currently self-managing 
effectively and not wanting additional support. Another potential option for those assessed 
with severe deficiencies in self-management ability may be referral to psychologist-
delivered support services. Six psychology positions were funded in the 2014 Budget; with 
each of the six regional cancer centres in NZ allocated a psychologist (Ministry of Health 
2014).  
With regard to the intervention itself, the use of whakawhanauntaganga and other 
relationship building processes to establish therapeutic alliance was noted to be important 
for acceptability in the NZ setting (Dew et al. 2015; Walker et al. 2008; Slater et al. 2013). 
This was highlighted in the phase one data when one participant stated that qualification or 
ethnicity was less important to her than a caring approach. NZ research shows that the 
use of appropriate cultural processes is important for delivery of acceptable person-
centred and culturally-centred care for Māori (Dew et al. 2015; Walker et al. 2008; Slater et 
al. 2013).  
Effective communication between survivors and, health and supportive care workers was 
highly valued by study participants. The literature suggests that collaboration and shared 
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decision-making can contribute to decreasing the complexity of clinical care and increasing 
effective management of complexity associated with cancer (Battersby et al. 2010; 
Stiggelbout et al. 2012). Collaboration may also support treatment completion, regular 
follow-up attendance, and better management of psychosocial impacts. There is a role for 
supported self-management which has collaboration at the core of its foundation. 
Strategies utilised in supported self-management programs, such as goal setting and 
action planning, can help support collaboration and goal concordance. 
The cancer survivorship framework of Klimmek & Wenzel (2012) categorised the often 
‘invisible’ work of cancer survivorship. The acceptability-specific findings from the 
qualitative studies supported the concept of work. Cancer-related impacts were described. 
Some of these increased the workload and reduced the self-management capacity of 
those affected by cancer. It could be that the additional workload of self-management was 
beyond the capacity of some survivors to achieve. Tritter & Calnan, 2002a pointed out in 
their critique of the categorisation of cancer as a chronic condition, that supported self-
management may not be realistic for survivors. However, the supported self-management 
tailored approach was considered acceptable by some focus group participants who stated 
they wanted to ensure that ongoing wellbeing support was available for others. 
Participants in the study were able to engage with the tools and care plan. What was 
lacking was sustained follow-up that would help support the survivor through the 
transitional survivor period and into extended survivorship. There was a need to assess 
capacity and consider whether goal-setting presented an unnecessary burden to survivors, 
as suggested by Tritter & Calnan (2002a). By increasing awareness of these areas of 
work, further nuanced discussions on interventions to support life and health complexity 
management for survivors can begin. 
Intervention effectiveness is impacted by environmental context and these studies 
generate evidence that can be used to improve organisational policy and practice to make 
the setting more conducive for delivery of acceptable intervention. In the phase two study, 
study participants’ responses to the acceptability survey provided data that support 
program acceptability. However, system-based study barriers presented a barrier to 





Can a supported self-management intervention program be feasibly 
integrated into the outpatient treatment setting? 
 
Pilot projects embedding supported self-management approaches in cancer care have 
been carried out in Australia (Jefford et al. 2015) and the UK (Wilson 2008). There were no 
examples in the literature where supported self-management interventions had yet been 
fully integrated into the cancer care setting in NZ. 
The basic pilot study design for this survivorship intervention study proved acceptable for 
delivery in cancer outpatient clinics. Modifications to the study protocol (Carroll et al. 2007; 
Horner, Rew, and Torres 2006) were necessary as the study progressed. The study 
processes provided insights into the burden and benefit of study participation within 
resource constraints (Beebe 2007) and helped the researcher gain experience delivering 
the intervention program with participants in the clinical setting (Beebe 2007). 
Three specific areas of concern were identified as threats to feasibility in the study: referral 
pathways, survivor preparedness and outcome measures. Referral pathways hindered 
recruitment. It was noted that survivors’ preparedness to engage in self-management 
intervention varied. The predominantly patient-reported outcome measures did not seem 
to assess program impact. This could mean that the program was ineffective or that the 
measures were inadequate. The known limitation of sample size was a key factor. These 
areas of concern will each be described in the following sub-sections. 
 
The need for functioning and appropriate referral pathways 
 
Study recruitment was problematic. Ethics committee requirements mandated clinician-
guided referral of patients into the phase two feasibility study. Clinician-guided referral is 
considered an important way to protect patient vulnerability. In this study, the intervention 
delivery was proposed to take place in the clinic so that all colorectal cancer patients could 
equitably be offered the opportunity to participate. This was thought to reduce inequitable 
access which is the norm for survivorship programs (i.e. many programs are accessed via 
opt-in).  
Focus group participants’ consideration of supported self-management was reported to 
range from supportive to cautious acceptance. This indicated that brief presentation of 
study information to cancer patients during treatment in phase two was unlikely to achieve 
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enthusiastic participation by current patients. Nevertheless, there was no reasons 
indicated not to proceed and the phase two study progressed with assurances from clinical 
champions that recruitment would be viable. The biggest concern was recruitment of Māori 
participants and maximising Māori participation was a key aim of the study to meet 
identified needs and prioritise equity considerations in supported self-management 
intervention delivery (Signal et al. 2008).  
In the end, recruitment processes were not delivered in the systematic way envisioned and 
recruitment was not as successful as hoped. Some individual clinicians described how 
they vetted potential study participants. The criteria used by recruiting clinicians was 
unclear. Anecdotally, one clinician described referring someone ‘who could use some 
love’. In reality, there were few incentives for clinicians to present the study in the time-
poor, disease-focused and complex environment of the cancer centre. Further, supported 
self-management was not a simple intervention to describe and often the time was not 
available for clinicians to explain it adequately. More time to offer better explanations 
regarding potential benefit to patients and clinicians might have increased enrolment rates 
(Berger, Neumark, and Chamberlain 2007). Further, participants who were approached 
could opt out and the likelihood that they did so was undoubtedly related, at least in part, 
to the way the study was presented to them. Therefore, the plan for equitable and 
systematic recruitment did not seemingly work out to be very equitable at all. A regular 
debrief with recruitment clinicians would be a valuable addition for future studies. 
Multiple referral pathways worked better than a single pathway moderated. The 
importance of clinical champions working across referral pathways with multiple clinician 
referrers cannot be underestimated. Reliance on a single recruitment pathway presented a 
barrier to recruitment success in the phase two study. Clinician-based referral is impacted 
by factors including: clinical priorities taking precedent over study introduction, time 
pressures interfering with study presentation, and clinician leave putting a halt to 
recruitment. Goodwill was not enough to ensure study uptake and this aligns with results 
reported in another NZ-based study of The Flinders Program (Horsburgh et al. 2010).  
The results from the pilot study indicated that colorectal cancer survivors can be recruited 
to participate in a supported self-management intervention study during treatment. 
Achievable procedures for recruitment were considered important to the study’s internal 
validity (Prescott and Soeken 1989). There were enablers and barriers to recruitment 
identified. Main study enablers were clinical champions and participant incentives or koha. 
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A group of clinical champions enabled greater opportunity for patient entry into the referral 
pathway. The provision of monetary incentives for participants represented a recognition 
and contribution to the financial constraints associated with cancer treatment (Levit et al. 
2013; Mehnert 2011; Hewitt, Greenfield, and Stoval 2006).  
Key study barriers included timing issues and referral pathways that were not embedded 
well into clinical flow. Clinician-based referral pathways and recruitment procedures did not 
work well. Dilemmas related to timing and recruitment were not adequately resolved. This 
poses challenges for future studies. The implications of not addressing new approaches to 
intervention recruitment and timing mean high potential for study failure. 
While evidence for supported self-management intervention is being developed, the need 
for accessible referral pathways is critical. Clinician-guided referral presented a barrier to 
patients equitably hearing about the study, although in theory, the concept of protecting 
patient vulnerability is sound. Alternative suggestions for future trial recruitment might 
involve enlisting clinical nurse-led recruitment, instead of oncologist or surgeon-dependent 
recruitment. It is hoped that, eventually, evidence-based interventions can be routinely 
embedded within redesigned cancer care pathways enabling efficient and equitable 
delivery of survivorship care. However, in the interim, committed and active clinical 
champions have been identified as crucial to intervention study success (Jefford et al. 
2015).  
 
Self-management terminology and preparedness 
 
Survivors’ values and priorities, as described in the phase one data, were identified to vary 
and change over time. The literature aligns with this description of a changing landscape 
and fluctuating levels of physical and psychosocialspiritual impacts throughout the cancer 
trajectory (Dunn et al. 2013; Klimmek and Wenzel 2012; Jones et al. 2016; Egan et al. 
2014). The literature and study results suggest tailored, flexible intervention content and 
delivery styles are needed that take into consideration variations in experience and 
priorities over time.  
Phase one study participants found the terminology of self-management to be confusing 
and, by extension, off-putting to potential participants. The use of the term ‘self’ suggests 
that this intervention is not whānau-friendly. The importance Māori place on whānau for 
support, challenges the self-management terminology which identifies ‘self’ as singular. 
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Consideration of the Māori worldview and health philosophies, early on in this research, 
readily pointed to whānau inclusion. Supported self-management is best undertaken with 
whānau inclusion and this fits within this approach, despite the terminology. Secondly, 
management is not necessarily seen as an empowering term and may also be taken to 
mean ‘going it alone’. This is not the intent of the intervention. In line with the 
recommendations by Jefford et al. (2015), survivorship terms that match those used by 
individuals and cultural groups are needed. A possible alternative terminology for 
survivorship intervention, such as ‘moving forward’, could be considered and is reflective 
of terminology that has been used in Australia (Jefford et al. 2015). 
In terms of participant preparedness, some study participants seemed to be able to make 
the transition to survivorship discussions toward the end of treatment, while others were 
disengaged. This is congruent with findings from Jefford et al. (2015) that indicated 
variability in patients’ readiness to engage with survivorship interventions.  
Some of the issues identified in this study have been due to the need to adjust the 
supported self-management intervention approach developed within a chronic care 
population to a cancer population with unique perspectives and needs (Tritter and Calnan 
2002). The Chronic Care Model was not originally developed to be applied in the cancer 
setting. The categorisation of cancer as a chronic condition is a relatively recent 
phenomenon due to epidemiologic shifts impacting on cancer survival. Application of 
chronic care approaches do not always have a seamless fit into the cancer setting and 
three ways that cancer disrupts this fit is described by Tritter and Calnan in their 2002 
article. A disconnect between cancer and other chronic conditions prompts these authors 
to question whether supported self-management intervention is realistic for survivors. In 
response to this debate, the phase one results suggest that there is a gap in survivorship 
care that may be able to be addressed by this type of intervention. The phase two results 
indicate that this approach is potentially beneficial, but only for some people. Therefore, it 
seems that participation in a supported self-management intervention program is realistic 
but the extent of program utility needs further exploration. 
Although Bandura (1977) identified self-efficacy as a key contributor to self-management 
competence, the phase one data in this study suggested that self-efficacy is not the only 
intermediary of effective cancer self-management. Other elements that were proposed as 
important by focus group participants were: 1) having someone caring, safe and 
knowledgeable to stand by you, and 2) clear clinical pathways for support. The focus 
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group findings indicated that the role of whānau, healthcare practitioners, society, and the 
health system also impacted on self-management competence. This reflects the concept 
that human behaviour is deeply embedded in, and shaped by, underlying social, 
economic, and legal-political structures (Golden and Earp 2012). Addressing unmet needs 
of cancer survivors is likely to require combinations of strategies, including supported self-
management programs, aligned to environmental context and priorities. 
Various factors can inform important priorities when considering embedding future 
intervention for survivors. More than individual motivation determines the success of 
intervention. The acknowledgement of the contribution of environmental influences, 
including the health system processes, is a critical aspect of the embedded model utilised. 
Participants in the focus groups described unmet needs. Comparable to the Australian 
focus group findings study by Jefford et al. (2008) survivors attributed feeling abandoned 
by health services to system-related barriers. 
 
The need for effective outcome measures validated in the target population 
 
There is a lack of consensus in the literature on which measures to use to effectively show 
the impact of supported self-management programs (Boger et al. 2013; Nolte and Osborne 
2013). Many different measures have been utilised. The primary outcome measures used 
to evaluate supported self-management in this study were measures related to self-
efficacy. These three measures were The Flinders Partners in Health scale (Petkov, 
Harvey, and Battersby 2010; Battersby et al. 2003), The Patient Activation Measure 
(Hibbard et al. 2004), and the Chronic Disease Self-Management Program self-efficacy 
scale (Lorig et al. 2001). Self-efficacy has been assessed with variety of validated self-
report measurement tools. However, the underlying construct of self-efficacy is likely to be 
limited by lack of clarity around the conceptual relationship of the construct to the concept 
of self-management competence. One potential reason for this perceived lack of clarity 
may be related to the multi-pronged theoretical underpinnings of supported self-
management which indicate potentially wide ranging outcomes. The intervention may not 
have included sufficient components that impacted on the patients’ self-efficacy (e.g. 
verbal persuasion or role modelling). If that is the case, the role of therapeutic alliance, 
collaboration, therapeutic techniques and goal setting as components of the approach 
need further evaluation. On the other hand, these results could indicate that the outcome 
 
 193 
measures for this construct were not adequate. However, it is worth pointing out again that 
the study was substantially underpowered to detect any improvement. 
There was a lack of consistency shown in scores obtained from the three measures of 
self-management competence administered in the phase two study. For example, one 
person scored high on one measure of self-management competence and scored low on 
another. Concurrent validity was not achieved. The lack of obvious and consistent 
improvement across self-management competence measures might indicate differences 
between the measures underlying assessment constructs or that self-efficacy was variably 
impacted by the intervention. The validity and reliability of the measures recommended for 
use by Battersby et al. (2010) in their published Flinders Program protocol were found to 
have questionable use in the colorectal cancer-affected target population in these studies. 
This points to the need for further validation of recommended outcome measures within 
this population. 
No significant or consistent intervention effect on proxy measures of self-management 
competence, distress, resilience, or QOL was found. However, since The Flinders 
Program pilot protocol was developed, the literature and research base has grown.  
In 2008 Don Baken and colleagues at Massey University conducted a NZ-based study to 
validate the distress/wellbeing thermometer which was published in 2011. They found the 
distress thermometer to be acceptable for detecting broadly defined distress/wellbeing in 
NZ cancer survivors (Baken and Woolley 2011). They incorporated an impact thermometer 
into the measure to improve its psychometrics. In their study, distress/wellbeing 
thermometer and impact thermometer scores were added together. A cut-off score of 6-7 
was indicated to have optimal sensitivity (0.86) and specificity (0.76) and the measure had 
adequate construct validity adequate test-retest reliability (r=0.80) when tested with a NZ 
cancer survivor cohort (Baken and Woolley 2011). Addition of the impact thermometer 
does not substantially increase the time to complete the measure. It would be 
recommended that any future NZ studies addressing self-management in cancer 
populations use this NZ-specific adapted version of the distress/wellbeing thermometer. 
One of the aims of the pilot study was to explore and compare measures of self-
management competence to recommend effective outcome indicators for future studies. 
Both short and longer-term outcome measures have been recommended for inclusion in 
pilot studies to allow for evaluation of sustained actions or behaviour changes (Carroll et 
al. 2007). The criteria for comparing outcome measures of self-management competence 
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in this pilot study focused on consideration of usability and acceptability at a pilot stage. 
This feasibility study did not focus on ascertaining intervention efficacy. Future studies are 
recommended to explore measure validity, reliability, sensitivity to change and symmetry 
with the intervention in further detail.  
There is debate about the ability of any existing outcome measure to adequately reflect 
outcomes of interest in supportive care and survivorship studies (Gilbert et al. 2008; Naus 
et al. 2009; Tritter and Calnan 2002; Nolte and Osborne 2013). This is reflected in the 
predominance of qualitative methodologies reported in this context. As this literature 
broadens, more targeted quantitative work is needed to refine or develop traditional 
psychological measures or validate new quantitative measures as they relate to 
survivorship self-management. Recommendations on outcome measures to use for future 
survivorship self-management studies are made with extreme caution pending more 
research into this construct in the population.  
It is important to assess the psychometric properties of outcome measures. It has been 
shown that the usability of instruments varies according to the target population (Boger et 
al. 2013). The reliability and validity of self-efficacy and other self-management support 
outcome measures in cancer populations has not been reported. More research is 
indicated to enable guidance on choice of the numerous potential proxy outcome 
measures to use to assess supported self-management competence in cancer-affected 
populations.  
No clear conclusions could be drawn about the psychometric properties of the outcome 
measures utilised in this study. There are multiple measures of self-efficacy and all are 
likely to measure the complex underlying construct to some extent. The individual results 
varied between different measures suggesting that each is in fact measuring a different 
underlying construct. The data from the study cannot provide any indication which is the 
most valid in the context of a cancer population. It can only be concluded that The 
Partners in Health scale, the distress thermometer and the satisfaction/acceptability survey 
were the most easily administered outcome measures. The patient experience survey had 
low usability with it being a relatively long form (97 questions) and many took it home to 
complete and did not send it back. Alternate self-management-specific measures and 
measures to reflect intervention effectiveness need further investigation. It would be useful 




Can supported self-management intervention in the hospital-setting 
address cancer care gaps reported by NZ cancer survivors? 
 
Effective cancer survivorship interventions are needed in NZ. There have been growing 
calls for self-management research (Richardson et al. 2011; Sarfati, Koczwara, and 
Jackson 2016; Macmillan Research Unit 2009) but few studies to date have delivered 
evidence on supported self-management intervention in cancer-survivor populations. 
These studies raised a number of issues. 
There continues to be a question about the ideal supported self-management intervention 
setting. The focus group participants and key informants expressed a variety of positions 
on this topic. Hospital-based intervention may reinforce dependency (Aziz 2007) and 
community-based opt-in intervention may get less buy-in (Beckmann et al. 2007) As this 
study took place in the hospital setting, adaptation of the program in that setting was 
seemingly indicated by the data. 
The qualifications of the interventionist also elicited varied opinions. There were some 
people who felt interventionists should have healthcare practitioner qualifications while 
others felt experience and wairua were critical components of interventionist requirements.   
The specific content of the intervention for cancer survivors was also unclear. The 
traditional focus of supported self-management is on supporting health promotion 
behaviours such as healthy eating and increasing appropriate exercise (van Weert et al. 
2008; Gao and Yuan 2011; Anderson, Steele, and Coyle 2013). Within a cancer context, 
there are additional barriers to wellbeing that arise for survivors. These include fatigue 
management and dealing with fear of recurrence. These cancer survivor-specific issues 
may need to be specifically discussed during sessions to better target this intervention to 
the population. Although the intervention is based on patient preferences, needs and 
values, there is still a component of collaboration which relies on the expertise of a 
healthcare practitioner to raise issues in conversations about potential impacts. 
In both the intervention and control groups, the pilot study outcomes data were 
inconsistent. Some participants improved, while others appeared to do worse, and others 
showed no discernible impact based on outcome measure scores. Again, these results are 
likely due to chance due to low participant numbers. However, there is the theoretical 
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possibility that the poor follow-up results for some participants reflects unintended 
consequences of the intervention. 
The patient experience measure results are particularly puzzling. The intervention group 
rated the aspects of care considered strengths by the 2009 administration respondents 
lower than both the baseline group and the phase two study control group. This could 
reflect the impact of raising awareness of the potential for cancer care to improve. This 
observation aligns with the overall better scores given by the intervention group 
respondents around the aspects of care that reflect non-clinical provider dependent 
opportunities for improvement. These may have been addressed by the intervention 
increasing the ratings of patient experience in these perceived gap areas.  
However, it must be remembered that the literature alludes to differential effects for those 
participating in supported self-management programs (Salvatore et al. 2015; Newbould, 
Taylor, and Bury 2006; S. Lawn et al. 2007; Wilson 2008). This was an underpowered 
feasibility study so the results from outcome measures are only indicative. Nevertheless, 
there are suggestions of potential impact on important outcomes associated with wellbeing 
from the data and these are promising in light of equity considerations (Greenhalgh et al. 
2011) and potential for improved follow-up care (Jackson 2016). Supported self-
management is one approach to addressing cancer care gaps reported by NZ cancer 
survivors. It is not a one size fits all. Further research into the utility and effectiveness of 
this type of intervention is indicated. A natural progression of this work would be to 
determine whether some groups benefit more from this intervention, than others, to further 
address equity considerations in light of the literature that indicates this approach is less 
effective for ethnic minority groups (Greenhalgh et al. 2011).  
Even though the ‘standard supportive care’ control arm of the study proved to be feasible, 
ethical questions were raised by study advisors and the ethics committee about 
withholding the potential benefits of the intervention. In NZ, usual care generally does not 
entail standardised support for self-management during and after treatment. In future 
studies, if the efficacy of the intervention is established, it is recommended that different 
intervention session structures or modes of delivery of the intervention be tested using a 





Evaluating the research frameworks 
 
The evidence derived from any study is a product of the study framework. The MRC 
guidance on complex interventions provided the basis for a phased approach to the design 
of these studies (Craig et al. 2008). This frame and stepped approach guided iterative 
development and evaluation of intervention evidence to inform effective delivery in 
healthcare environments. Often full-scale intervention studies are embedded into the 
environment without adequate consideration of multi-level impacts on intervention 
success. This increases the potential for research study failure at potentially great cost to 
the public and the fields of study under research. The use of a framework aims to stack the 
odds against intervention failure by incorporating preliminary work to identify enablers and 
barriers prior to full-scale intervention delivery. 
The author’s interpretation of the MRC guidance on complex intervention, called for 
methodical build-up of evidence through qualitative modelling and a randomised pilot 
study. These specific approaches were not pre-determined by the guidance. The guidance 
allows for flexibility in approach toward evidence development. This is in line with 
recommendations from the Cochrane Collaboration (The Cochrane Collaboration 2008). 
The Cochrane Collaboration advises that there is no ‘gold-standard’ intervention study 
design in fields outside of biomedicine (The Cochrane Collaboration 2008). Therefore, the 
types of studies or approaches to development of evidence are able to be guided and 
matched to the intervention goals and environment. 
 
Reflections on overall study design 
 
There were key priorities considered that impacted on the study design. The first priority 
was to respect and apply best-practice principles for research involving Māori (Health 
Research Council of New Zealand 2010; National Ethics Advisory Committee 2012). The 
phase one study sought to include an indigenous perspective. The phase two study was 
transformative in that the research itself addressed some unmet needs, contributed to 
increased awareness of survivorship, and informed potential for change in care pathways. 
The studies that developed evidence for the intervention approach were delivered using 
sequential mixed methods. The qualitative and quantitative methods utilised were 
considered complementary and sequential; neither was considered dominant (Mertens et 
al. 2010) and triangulation was not the goal (Strauss and Corbin 2008).  
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The qualitative enquiries provided interesting and useful insights into survivors’ cancer 
experiences and self-management. The data indicated unmet needs and provided insights 
into the perceived utility of a supported self-management intervention program in cancer 
care settings. Qualitative data was collected from two focus groups: a Māori only group 
and a mixed ethnicity group. These rich data sources were supplemented by interview 
data collected from healthcare practitioners.  
The quantitative exploratory pilot study design provided an opportunity to better 
understand the links between intervention, outcome measures, data collection processes 
and analyses. It was hoped that the study design would meet the objectives and also yield 
insights into the numbers of potential participants required to obtain adequate power levels 
for future studies. However, due to low recruitment, this did not occur. It may be useful to 
conduct a further feasibility study with a revised protocol to better indicate potential 
recruitment numbers. 
The phase two study was a feasibility study. Modifications to the protocol indicated during 
the study were extensive. Issues with the phase two study design were identified in three 
main areas: referral pathways for recruitment, patient’s intervention readiness, and 
outcome measures. The proposed recruitment pathways were hindered by lack of referrals 
to the study. Once a patient was recruited, patient suitability and interest was found to be 
variable indicating a need to explore pre-screening for vulnerability and intervention 
readiness.  The assessments were readily and easily administered with consenting 
participants but the ability of the chosen measures to reflect intervention outcomes was 
deemed questionable. The pre-post assessment design was inadequate to assess 
outcomes. Timing for delivery of the single short-term follow-up assessment was 
problematic. Follow-up assessment timing coinciding with the six-week follow-up 
appointment at the hospital was inadequate. Research shows that transitional survivorship 
is a time of particular difficulty for survivors and is associated with the need to manage 
multi-level anxieties, decrease attachment to specialist care providers and re-establish life 
routines (Hewitt, Greenfield, and Stoval 2006; Zapka et al. 2012). This could have 
impacted on outcomes measured. Longer-term follow-up is recommended. 
The literature addresses the question of research design for these types of studies. Some 
authors question the validity of the need to generate high-quality RCT evidence for quality 
of life interventions (Petticrew, Chalabi, and Jones 2011). Some NZ psychology 
researchers have advocated for alternative approaches to intervention research studies, 
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taking into consideration alignment of research goals with survivors’ therapeutic goals in 
real world settings or, alternatively, with the organisations’ health policy and cost-neutral 
goals (Heron 2009; Croy 2010). If evidence-based survivorship research is to progress, an 
understanding and case for alternative research designs may be helpful. Alternative 
designs might include quasi-experimental studies that do not use random assignment. 
This would enable the intervention to be delivered to those assessed to be at risk of poorer 
outcome. Risk stratification is likely to be a component of any future support intervention 
considering that resources are limited (Central Cancer Network 2016). 
 
Reflections on the analytical frameworks 
 
Framework Analysis was used for the evaluation of the phase one qualitative data. 
Pragmatically, framework analyses helped focus the extrapolation of data in order to meet 
the objectives of the study. Data were first condensed into themes. The themes were 
framed by the Te Whare Tapa Wha (Durie 1994) four cornerstones of health and well-
being: physical, emotional, spiritual and social. Data were analysed deductively according 
to what fit into the frame. An emphasis on deductive analysis was undertaken in this study 
to streamline the presentation of results and reduce complexity in data interpretation. 
Anomalies in the data were found that did not fit cleanly within the chosen frame but these 
were not thoroughly reviewed. The interpretation of the results would benefit from a 
complementary inductive analysis to more comprehensively review this data. This 
approach may reveal other issues around self-management in a NZ context for survivor 
populations.  
The RE-AIM framework was used for the evaluation of the phase two quantitative data. 
The use of the RE-AIM framework required interpretation but it was ultimately found to be 
usable and suitable for reflecting the feasibility study outcomes. 
 
Study strengths and limitations 
 
Key study strengths 
 
These two studies had important strengths. This research aimed to be relevant for Māori. 
The incorporation of a Maori-specific focus group in the phase one study was intended to 
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promote cultural understanding and cultural safety in intervention research. This may 
inform future studies that can improve equity in cancer care for Māori. 
This is the first survivorship study which was situated in the acute cancer setting within 
hospital clinics. Survivors who participated were motivated to share their experiences in 
hopes that these could contribute to improvements in care for future cancer survivors. This 
project brought a greater degree of survivorship awareness into the clinical environment. 
Clinical champions have been critical to study success. Multiple clinical barriers were 
identified and addressed in order to embed the intervention into clinical flow. This clinician 
support shows awareness of the issues and an interest in putting in place better processes 
to address survivorship issues. 
The MRC complex intervention framework guided the design and enabled the NZ 
participants’ experiences and described impacts to guide pilot study design. While pilot 
studies enable useful consideration of the acceptability and feasibility of intervention 
processes and delivery, they also can contribute to improving the scientific integrity of 
future RCTs (Thabane et al. 2010). A key strength of these studies is the use of the MRC 
framework which has provided a strong template, foundation and learnings to inform future 
programs of interventional research. 
The engagement with study advisors was also considered a key strength across both 
studies. These relationships enabled wide consultation on the potential meaning and 
emphasis placed on specific study results. Multiple advisors were engaged and they 
included international intervention experts and local cultural, clinical and research experts. 
The author was involved in all focus groups and key informant interviews. Therefore, when 
it was time to analyse the transcripts, the words and their associated context and 
meanings, were able to be reviewed as the author experienced them. The emerging 
themes were also able to be better described to study supervisors and advisors that 
checked them. This informed the interpretive approach that was consistently applied 
across all group discussions and key informant conversations. Although the phase one 
data on survivors’ experiences may not be generalisable to the wider NZ survivorship and 
health practitioner communities, it does show that cancer impacts are often felt long after 
treatment ends for many. This finding aligns to the first recommendation of From Cancer 
Patient to Cancer Survivor: Lost in Transition (Hewitt, Greenfield, and Stoval 2006) that 
calls for raising awareness of these issues.  
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The phase two study used a robust RCT design. However, the protocol needed 
modification during the study. It would have been problematic to continue with a design 
that was not working to ensure fidelity. The basic study design enabled a useful ‘dummy 
run’ of processes and procedures for future studies. This type of pilot work provided an 
important, but often neglected, step toward development of an acceptable and feasible 
protocol for larger intervention studies.  
Another strength was that the study achieved a range of participants by gender, ethnicity 
and age. All participants completed multiple validated outcome measures that might be 
useful for inclusion or exclusion in future studies.  
 
Key study limitations 
 
The two studies had several limitations. The limitations have been named in relation to the 
qualitative phase one and quantitative phase two studies separately. For both studies, the 
size of the participant groups was a key limiting factor. The majority of participants across 
both studies were colorectal cancer survivors. This limited the opportunity for other 
interested cancer survivors to share their experiences and views. It also limited the 
generalisability of the results to other cancer survivors. It is important to point out that it is 
not clear who chose not to participate in the studies. It is not known if the studies 
participants comprised the proposed subset of survivors that would suit a supported self-
management program intervention. Selection bias impacted on both studies. Adequate 
procedures for obtaining information on people who chose not to participate are important 
to refine for future studies. 
In phase one, there were important limitations to consider. This information builds on the 
limitations described in Chapter four. First, the foundations for delivery of the study could 
have been enhanced through stronger identified linkages between Klimmek and Wenzel’s 
(2012) survivorship framework and the discussion guides. Second, data collection could 
have been improved given more time. The time constraint for focus groups and interviews 
limited data gathered. This especially impacted on the large multicultural focus group and 
may have prevented some people from being heard. In hindsight, it may have been better 
to split the large focus group into two smaller groups but, at the time, it was thought better 
to go ahead with a group of 18. Part of the reasoning was that some focus group members 
brought whānau and it seemed better to keep the group together. In NZ, flexibility around 
focus group management is required due to the unknowns of who will actually show up. 
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For example, sometimes a focus group turns into a hui or fono, meaning a large gathering. 
Different techniques for engaging with larger groups are needed. In this case, the large 
focus group was managed as a focus group but with both individual and group work time 
for participants to address questions. Responses seemed frank and everyone contributed. 
In the phase two study, limited recruitment prevented the study from achieving a minimum 
of 30 participants per arm in the pilot, as suggested by guidance from one study 
(Lancaster, Dodd, and Williamson 2004). Further, non-standard selection processes were 
used to recruit the 27 participants. The small sample size increases the risk of sampling 
error (Balnaves and Caputi 2001). It is difficult to know what, if any, impact this would have 
on study results. It is possible that the study may have achieved greater insights from a 
larger pool of participants and equitable access to study participation. The key external 
validity issue arising from these studies is likely related to representativeness of the data. 
In phase two, as previously stated, by far the biggest threat to internal validity was small 
sample size. In addition, research assistants carried out the follow-up assessments for the 
intervention group participants, but they were not blinded to the randomisation assignment 
as would have been best practice. Participants were also not blinded to whether they were 
in the intervention or control arm of the study. OF course, this is not possible in this type of 
intervention pilot. This information bias may have impacted on the results. For example, 
those who underwent the intervention may have felt a stronger desire to report positive 
findings to support the researcher which would exaggerate any positive effects of the 
intervention. On the other hand, the potential for research bias was minimised by use of 
standard assessment instruments that could have counteracted, in part, some information 
bias. The extent that information and researcher biases contributed to the data were not 
able to be assessed but were important to recognise.  
There was a limitation introduced due to the tension between tailoring and fidelity which 
occurred in the phase two study. Fidelity is related to reproducibility of the intervention. 
Due to the personalised or tailored nature of supported self-management approaches, 
there is no single measurable dose. There are sessions. Behavioural interventions cannot 
easily be measured as a standardised dose. The same intervention is not able to be 
carried out in the same way with everyone. The issue here is that there is a tension 
between delivering an individualised programs which differs between people on one hand, 
and treating the intervention as if it is a single ‘standard’ intervention. Tailored 
interventions are person-centred and individualised. They are considered more efficacious 
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than single component symptom-centred interventions. Wellings et al. (2006) in a review of 
health behaviour studies in 59 countries, concluded “Evidence from behavioural 
interventions shows that no general approach…will work everywhere and no single 
component intervention is likely to work anywhere” (1724). There is, therefore, a definite 
need indicated for tailored interventions. In NZ and overseas, behavioural interventions 
have been shown to improve psychosocial health for individuals in the short term 
(Jacobsen, Holland, and Steensma 2012; National Comprehensive Cancer Network, 
Holland, and Bultz 2007; Levit et al. 2013; Croy 2010). However, when compared to 
biomedical studies, it is easy to be critical of the results based on fidelity concerns. 
Also, there was some potential for contamination noted between participants in the 
intervention group and the control group. Participants may have discussed the intervention 
while waiting for or receiving their treatments.  
Intervention setting, delivery and content impacted on intervention outcomes. The setting 
was the hospital but that may have not been the best setting for supporting self-
management in context of everyday life. It is also important to recognise that there was 
only one interventionist, the author. Therefore, intervention effectiveness depended on just 
one individual. There was no Māori interventionist. The interventionist would have had an 
impact on intervention delivery, cultural relevance and results. The intervention content 
also needs evidence for what is required in cancer survivor populations. 
Feasibility issues characterised both the phase one and phase two studies. Results from 
these small studies should not be considered out of context. This pilot generated 
preliminary data that allowed for ascertaining survivor experiences, testing and adaptation 
of an intervention protocol, usability of forms and content, and testing of instruments for 
measuring outcomes. The mixed methods feasibility study yielded valuable information to 
inform future studies. The internal and external validity issues identified will inform future 
study designs. 
In the phase two, a large degree of deviation was required from the protocol due more to 
recruitment-related barriers than intervention delivery barriers. Protocol redesign was 
required throughout the study implementation time frame. As a feasibility study, 
modifications were allowed in the hopes of informing a more robust future study protocol. 
Although fidelity was compromised and outcomes impacted, lessons learned and 





Implications for practice 
 
Documenting the experiences and views of cancer survivors enables awareness to be 
raised of the impact of cancer survivorship. The experiences of survivors reported in this 
study indicate that there is a gap in survivorship care and support for a redesign of cancer 
care pathways to incorporate a focus on addressing survivorship impacts. There are 
significant physical and social, emotional and spiritual needs going unrecognised and 
unaddressed. Cancer-related impacts contribute to life complexity and vulnerability over 
the long-term for survivors. 
Survivorship impacts for Māori are multi-faceted. The work of cancer survivorship needs to 
be further explored for Māori and the framework of Klimmek & Wenzel (2012) expanded 
upon to show how it applies for this and other indigenous groups. 
A person-centred intervention can be guided by existing frameworks. Te Whare Tapa Wha 
(Durie 1994) and The Chronic Care Model (Wagner et al. 1996) provided useful 
foundational and logical frameworks for progressing research into supported self-
management program intervention in cancer care settings. Further research applying the 
cancer survivorship framework of Klimmek & Wenzel (2012) would help build knowledge 
around cancer survivorship for Māori and non-Māori in NZ. 
 
Implications for research 
 
There is considerable concern amongst practitioners in the fields of psycho-oncology, 
supportive care and survivorship that research has failed to show efficacy of therapeutic 
and interventional approaches (Dow 2003; Grunfeld et al. 2011; Viswanathan et al. 2014; 
Richardson et al. 2011). There is practice-based conviction among practitioners that the 
interventions and approaches utilised within these disciplines make a difference but this 
has not been consistently validated through evidence-based research. The assumptions 
from these studies that show little or no impact is that the interventions studied were 
ineffective. This may be so but, there are two alternative explanations or contributing 
factors. One is that the outcome measures utilised to assess complex human behaviour 
may not be as robust as they could be. The second contributing factor being that the 
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outcomes identified are not those that are expected or being measured, so may go 
unrecognised. 
The patient-reported outcome measures, albeit underpowered and only reflective of short-
term outcomes in the phase two study, did not indicate clear utility for this program. There 
is a need for a systematic review of international research on outcome measures used in 
survivorship studies, including cancer self-management studies. Research is needed to 
explore how the measures identified align with the hypothetical mechanisms of action 
associated with supported self-management. According to Battersby et al., self-
management is a difficult concept to operationalize (Battersby et al. 2010). Therefore, it is 
understandable that there is a lack of consensus on valid cancer self-management 
competence measures. However, the use of outcome measures with questionable validity 
in cancer populations, limits the ability to build the evidence base for survivorship and self-











This research contributes to increasing the awareness of the impacts of cancer 
survivorship and provides pilot intervention data to help inform ways to address survivors’ 
unmet needs. The first recommendation from the IOM report on cancer survivorship is to 
raise awareness of the broad and holistic needs of cancer survivors (Hewitt, Greenfield, 
and Stoval 2006). Although numerous papers have been published overseas on the needs 
of cancer survivors (Earle and Neville 2004; Cooley 2010; van Mossel et al. 2012; Faller et 
al. 2016; Eiser 2007), the importance of local context is critical for convincing policymakers 
of the need for interventions to address overall wellbeing for Māori and non-Māori cancer 
survivors in NZ. The evidence-based research platform enhanced by these studies 
presented in this thesis can be the springboard to raise awareness of unmet cancer 
survivor needs in NZ. 
I have argued that ensuring appropriate systems, services and support for cancer 
survivors is a priority area for public health research and in NZ healthcare practice. 
Assessment of distress/wellbeing and unmet survivor needs is not enough. Interventions 
to address unmet needs, suited to the unique NZ environment, are needed. This study 
contributes to the evidence base but no definitive practice recommendations can be made 
now regarding this kind of intervention. 
Although there are many potential survivorship interventions that could be studied in the 
NZ context, a supported self-management program was chosen for further study because 
it was indicated by classifying cancer as a chronic condition. The data did not answer 
whether this classification was suitable or helpful. Supported self-management is not 
considered to be a replacement for other interventions but is a tool to enable more 
standardised and appropriate access into these services that support moving forward after 
cancer treatment.  
Supported self-management was not proposed as a stand-alone intervention to meet the 
needs of all cancer survivors. It was not seen as a replacement for specialised psycho-
oncology or other high intensity and specific interventions targeted to complex needs. 
However, it was an approach that could be carried out in the hospital setting to address 
survivorship care. It aimed to support survivors and caregivers to move forward during 
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treatment. It utilised a screening tool and enabled development of a care plan that was 
based on survivors identified preferences, needs and values. It could be used as a stand-
alone intervention for those with high-levels of self-management affinity and could assess 
suitability for referral to other services for those who wanted to increase their self-
management competence in ways agreed to be acceptable.  
Possible survivorship pathways are shown in Figure 22. Because it is unlikely that there 
will be a single survivorship pathway acceptable for all survivors, future work must use risk 
stratification and individual preferences, among other indicators, to inform collaboration 
between health and supportive care workers, and survivors on moving forward. Moving 
forward is made easier if options are made available and if discussions are initiated before 
the end of treatment and reviewed at follow-ups.  
Late acute survivorship stage (during treatment) 
 
Survivorship Support Assessment 
Partners in Health scale 
Risk stratification related to cancer type, comorbidity 
     
Nurse-led clinics  Kia ora – E te iwi  The Flinders Program 




Specialist consult for impact 
management (i.e. continence 
or ostomy support) 
 
Cancer Connect – 
phone-based peer 
support    
Watchful waiting 
   
Figure 22: A selection of survivorship care pathways 
 
Key practice recommendations to improve survivorship intervention delivery and outcome 
assessment include: more research into intervention timing to coincide with survivor 
readiness, delivering interventions within brief timeframes, and working within variable 
appointment timeframes that were adaptable based on changing appointments. It was not 
possible or desirable to deliver this intervention to all cancer survivors, so assessing 
readiness and conducting risk stratification based on needs could help target supported 







These studies sequentially delivered phases one and two of the MRC framework on 
complex interventions. The data from these studies contributes to the literature. On 
balance, more research is warranted and progression to a phase three trial is 
recommended with reservation. Prior to progressing another study, the data from these 
studies suggest there is a need to re-assess intervention terminology, appropriate settings, 
interventionist requirements and intervention content targeted for cancer survivors. 
Further, a screening tool to assess preparedness for self-management is needed.  
Survivorship terminology is problematic in the NZ setting. Further debate is encouraged to 
identify terms acceptable to key stakeholders. Terminology confusion should not stall 
progress toward developing evidence for survivorship interventions. 
With regard to settings for the intervention, future survivorship studies would work best if 
they could bridge between treatment times and the post-treatment transition period. For 
example, if at least two post-treatment rehabilitation assessment sessions took place 
during treatment appointments, further sessions could take place after the final treatment 
appointment. Transition from clinic-based survivorship to community-based survivorship 
could then take place more seamlessly. Community-based survivorship interventions 
might include counselling support for biographical work, support groups or further 
supported self-management delivered in primary care.  
Adequate recruitment and assessment processes are critical to intervention success. 
Recruitment could be enabled by appropriate intervention staff identifying eligible 
participants through clinical record review of patients with upcoming appointments. A 
research assistant could speak with the healthcare practitioners, get approval, and 
approach potential participants during their clinic appointment. With regard to assessment, 
it is recommended that readiness to engage with survivorship care be assessed during 
treatment, at the final treatment appointment, and at post-treatment follow-up. 
The Partners in Health scale was the screening tool that was developed for The Flinders 
Program. It is an integral component of the program. The Partners in Health scale is only 
one measure of self-management competence available. Further research to validate 
alternative self-management competence measures in cancer affected populations is 
needed. Further research could address the mechanisms of action for the approach and 
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help determine what a reasonable size change in score would be associated with clinical 
significance.  
Research shows that most survivors who were working when they received their 
diagnosis, return to work (Mehnert 2011). Vocational support is indicated. Therefore, 
equitable survivorship intervention may need to be delivered both during treatment for 
some, and outside treatment settings and work hours for others.  
Clinical champions can support the work and have been identified as critical for future 
research (Jefford et al. 2015). Clinical champions can support colleagues to comply with 
study protocols. 
Further research and future survivorship care pathways would also benefit from: 
o Inclusion of whānau included through an integrated Whānau Ora approach with 
content that incorporates cultural processes as desired; 
o Motivated, skilled and accredited interventionists who are caring and motivated to 
deliver person-centred and tailored interventions; 
o Incorporation of longer-term outcome measures, at 6 or 12-months post-treatment, 
and inclusion of ‘harder’ process or clinical outcome measures to more effectively 
show efficacy and utility of the intervention in the clinical and policy environments; 
o Redesigned systems (e.g. redesigned care pathways) and adequate funding 
models in place at both the organisational and national level to support survivorship 
initiatives and resulting change in practice or processes; 
o More studies, including those that incorporate cost/benefit analysis, to increase the 
evidence base for survivorship.  
Future research should focus on trialling and evaluating a range of new initiatives in 
different areas to further fill the gap in cancer survivorship care and delivery. If a multi-site 
supported self-management RCT is progressed based on these recommendations, a 
scaling up strategy would need to be included to help address sustainability concerns 
related to the intensity of resources and labour required for intervention maintenance in 
various hospital settings. If barriers related to study processes and outcome measures can 






The findings from this research make several contributions to the current literature. These 
studies raise awareness of the growing issues and impacts associated with cancer 
survivorship in NZ. This is the first NZ-based study of supported self-management 
intervention carried out with a cancer-affected cohort. The data show that cancer has 
impacts on NZ survivors. Health and supportive care workers want to provide better 
support.  
The identified themes from the phase one study have been placed in the context of the 
wider literature. The study has identified many points of synergy, but some differences 
noted in how cancer survivorship impacts are experienced and described differentially 
between Māori and non-Māori. These findings suggest that tailored intervention 
approaches, that can accommodate individual and whānau differences in emphasis and 
priority values, are indicated for further research. 
This is the first study to link cancer survivorship to The Chronic Care Model (Wagner et al. 
1996) as the foundation for supported self-management intervention delivery within a 
cancer care environment. The findings add to the international literature by highlighting 
enablers and barriers to embedding survivorship intervention in cancer care settings.  This 
research also adds to the research supporting improvements in quality colorectal cancer 
care in NZ.  
Interventions to address cancer care gaps for survivors need to be tailored, easily 
accessible and flexible for patients. Equally, they should be supported by robust systems 
for equitable delivery and evaluation. In these studies, supported self-management was 
explored as a way to support survivors in active treatment and as they transition to post-
treatment survivorship. Supported self-management intervention programs emphasise 
partnership and collaboration with experts to build individual knowledge, attitude and 
strategies. The Flinders Program was delivered as a tailored intervention that incorporated 
other interventions to address survivors’ priorities, values and goals. 
The Flinders Program is a good option because it has flexibility to be culturally relevant. 
While there were challenges with the pilot study, and the evidence could be interpreted as 
equivocal, it seemed to be an acceptable and somewhat feasible option. The next logical 




In light of The Chronic Care Model (Wagner et al. 1996), there are still questions 
concerning the fit of this model to cancer survivorship and its accompanying complexity. 
Delivery of The Flinders Program in the cancer care setting did not adequately address the 
broader inherent structural factors and risks that impact on the intervention. However, by 
pointing this out, it is hoped that this research will prove useful for broadening the 
perception of intervention as only one facet of a complex system of influence aimed at 
improving health status and outcomes.  
The acceptability of The Flinders Program was indicated for NZ populations. Although the 
approach is acceptable, integrating survivorship intervention to improve the quality of 
cancer care in the clinical environment faces many challenges to feasibility. Results of the 
studies reported herein, based on small numbers of participants, did not clearly show utility 
of the intervention. Future studies should concentrate on how to best pre-screen survivors 
for preparedness to undertake supported self-management. This can help reduce potential 
unintended consequences and threats to fragile coping mechanisms. The following 
environmental factors that impact on intervention delivery require further work: functioning 
referral pathways for study recruitment, pre-screening processes for intervention 
readiness, and stratified intervention delivery mechanisms. Another fruitful area for further 
work would be to investigate development or identification of robust outcome measures 
relevant to chronic care and validate them with cancer survivors. 
The objectives for the phase one and phase two studies were achieved. Both studies 
presented in this thesis provide evidence on the acceptability, feasibility and early utility of 
supported self-management in cancer care. This data contributes to the small pool of 
cancer survivorship studies. It is one of only a handful of studies to prioritise intervention 
equity. Supported self-management intervention or other tailored approaches to address 
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Appendix A: A summary of 18 colorectal cancer experience studies described as self-
management studies 
Study 
Phase of illness 
trajectory 






Treatment 20 men & 20 women 
with colon resection 




None Individuals post-surgery for colorectal cancer have low 
levels of symptom distress, moderate uncertainty, and 
have a greater need for discharge health information as 
perceived uncertainty increased. 
The authors’ findings support Lazarus & Folkman’s 
Transactional Model that people seek information to 
cope with uncertainty that may lead to stress if the 
stressor overwhelms perceived coping ability (Lazarus 
and Folkman 1984). 
“Uncertainty may be increased if symptoms are 
unexpected or do not form a distinguishable pattern” (p. 
112). 
The unexpected long-term duration of side-effects in 
people post-treatment leads to colorectal cancer 
survivorship uncertainty and stress. 






None People affected by colorectal cancer are rarely asked 
about their info needs in published research, but, on the 
other hand, they cannot be expected to know/anticipate 
what info they will need or find useful, nor when. 
Practical advice related to diet/nutrition or bowel 
management not often reported/researched. 
Pan et al., 2011 Treatment 35 cancer patients in 
one Taiwanese 
hospital interviewed 
at 1 week and 1,2 
and 3 months after 
surgery 
None Frequency of using self-care strategies did not change 
over time, but the self-care strategies used changed. 
Dietary modification and exercise highly rated self-care 
strategies. 
Factors affecting self-care strategies were age, cancer 








Phase of illness 
trajectory 




Pan & Tsai, 2012 Treatment 35 cancer patients in 
one Taiwanese 
hospital interviewed 
at 1 week and 1,2 
and 3 months after 
surgery 
None Quality of life (QOL) changes and generally improves for 
physical health satisfaction and environmental 
relationship satisfaction from 1 week to 3-months post-
surgery. 
Mental health satisfaction of patients with L 
hemicoloectomy is higher than patients with R 
hemicoloectomy.  
Satisfaction with mental health is lowest overall and 
does not improve with time. 
Low QOL associated with people who are younger, 
women, have had R hemicolectomy and experience 
higher diarrhoea distress. 




13 patients & 13 
partners interviewed 
separately one year 
after colorectal 
cancer surgery 
None Qualitative descriptive interview study 
Main theme ‘Life is back to normal and yet not’ 
‘Life has a shadow of death’ 
‘The treated body sets the rules’ 
‘To share or not share the illness’ 
Views differed within and between couples which makes 
it difficult to meet the needs of both patients and partners 
during treatment and recovery. 
Main influences on lives were uncertainty and condition 
of the patient. Support, coping styles and info needs 
differ within whānau. 
Chao et al. 2010 Treatment 110 colorectal 
cancer patients from 
one Taiwanese 
hospital 
None Study examined factors associated with the perception 
of acceptance of disability. 
Poorer acceptance of disability associated with shorter 









Phase of illness 
trajectory 




Other studies (breast cancer specific) have indicated 
that a useful intervention is one that “…focuses on 
helping patients accept their disease, and then learn 
how to live with cancer and its various ramifications…” 
(2279). 
Beaver et al. 2010 Post-treatment 
survivorship 
27 patients from one 
hospital trust in 
England 
None Qualitative descriptive interview study 
Main theme ‘knowing what to expect’ 
‘living with altered bowel function’ 
‘trial and error’ 
‘information and support from specialist nurses’ 
Perception of being left to cope alone at home 
Kidd et al. 2009 Treatment 11 patients from one 
Scottish cancer 




None Qualitative descriptive longitudinal interview study 
Study explored self-care experiences and views on 
perceived control in managing treatment related side-
effects. 
Interventions should focus on enhancing patients’ 
perceived control over managing side-effects. 
People may be ‘high’ or ‘low’ perceived controllers.   
High perceived controllers more likely to self-care and 
less likely to rely on others to manage.  Low perceived 
controllers less likely to self-care and more likely to rely 
on others to manage side-effects. 
Baravelli et al. 2009 Survivorship 20 survivors and 
100+ healthcare 
professionals 
participated in this 
Melbourne, Australia 
based study 
None Two studies – one of survivors and their primary care 
practitioners; the other a survey of nurses and medical 
practitioners 
All participating survivors and primary care practitioners 
interviewed as Part of Study 1 reported the Survivorship 








Phase of illness 
trajectory 




The survivors commented most positively on the 
incorporation of the ‘novel’ practical components 
included regarding lifestyle and psychosocial care. 
“It seems that the healthcare practitioners are most 
comfortable reporting ‘just the facts’ and are not sure 
about providing lifestyle and psychosocial care advice or 
info about recovery from potential toxicities and self-
management.” 
Paddison et al. 2009 Treatment (surgery) 51 patients from one 
hospital in Auckland, 
New Zealand 
assessed for fatigue 
at 6 time points 
None Study of expectations and realities of post-surgical 
fatigue assessed at baseline and 2, 5, 14, 30 and 60 
days post colorectal cancer surgery. 
Findings suggest that most aspects of fatigue resolve 
within 1-2 months of colorectal cancer surgery. 
However, study shows feelings of fatigue and impacts of 
fatigue resolve across significantly different time frames. 
Preoperative expectations are associated with the 
resolution of post-surgical fatigue with minimised 
expectations was associated with an increased 
likelihood of experiencing post-surgical fatigue that was 
significantly more sustained that than reported by 
patients with more realistic expectations. 





intervention – up to 
11 sessions delivered 
over a 6-month period 
Protocol for a two-armed prospective RCT 
Evidence-based intervention approach with strategies 
drawn from the core components of Acceptance and 
Commitment Therapy (ACT). 
ACT strategies used to enhance positive lifestyle 
behaviours not as a psychotherapeutic intervention. 
“Previous research has suggested that interventions to 
improve quality of life after colorectal cancer may be 








Phase of illness 
trajectory 




psychosocial and lifestyle variables, or health 
behaviours, in a comprehensive and integrated 
approach”. Steginga et al, 2009 
“The health coaching sessions will be delivered by study 
trained health coaches who will be guided by a custom 
developed web-based computer application and will key 
enter all session information” 
Molassiotis et al. 
2009 
Treatment 164 patients from 
one hospital in 
England with 
colorectal or breast 
cancer receiving oral 
capecitabine 
Home care program 
vs standard 
supportive care 
Physical symptom focused study outcomes included 
toxicity levels, anxiety, depression, QOL, service 
utilisation. 
A symptom-focused program works best during the initial 
two cycles of chemotherapy to improve treatment and 
symptom experiences. 
Kidd et al. 2008 Treatment 11 patients from one 
Scottish cancer 




None Qualitative descriptive longitudinal interview study 
Study explored self-care experiences and views on 
perceived control in managing treatment related side-
effects. 
‘Self-care was not simply a process of physical 
management, but was also about an emotional process 
of transition in which they employed strategies to create 
order, reconstruct their sense of self and maintain a 
sense of normality” (475) 
“Self-care for patients undergoing treatment for cancer is 
largely carried out in a quest to preserve self-identity and 
maintain normality and to manage the physical and 
emotional impact associated with treatment.” 
Preservation of identity is a key role of self-care 
Nikoletti et al. 2008 Survivorship 101 patients from 
one hospital who 








Phase of illness 
trajectory 





surgery in the last 6-
24 months 
70% had a change in bowel habits after surgery 
Information needs reported were diet, managing change 
in bowel habits and pain, and ongoing concerns about 
managing symptoms. 
Siassi et al. 2008 Treatment 35 patients from one 
hospital in Germany 
with a stoma after 
colorectal cancer 






None Qualitative interviews and surveys administered 
Median time between primary operation and stoma 
reversal was 4-months. 
“Although from a surgeon’s point of view the reversal of 
a stoma is a minor procedure, it has a significant 
negative impact on the patient’s daily lives” (1211). 
No change in QOL reported over the time frame of the 
study. 
Improvements reported in body image and leisure 
activities. 
Patients’ expectations were not met due to 
gastrointestinal symptoms persisting. 
Increased number of complaints about the hospital and 
the medical staff. 
Knobf et al. 2007 Across the 
continuum 
Narrative review None Strong evidence to support positive effects of exercise 


























Appendix D: Focus group discussion guide 
 
Outline process (topics to be discussed) and inform P [Participant] of rights (confidentiality, right to 
refuse to answer questions etc). Give P opportunity to ask any questions. Thank P for agreeing to 
take part. 
 
Ice breaker - 20 mins (including intro above)  
 
This PhD research evaluates a supportive care program that may be practically useful for people 
coping with cancer treatment side-effects and other long-term conditions now and into the future.  I’d 
like to start out with questions about your cancer experiences. 
- How would you describe how “cancer” has impacted on life for you during treatment? 
- What did you worry about and how did you manage? 
- Would you describe the cancer experience for you and/or your whanau or support people 
as long-term or ongoing?  
- What are you doing to cope with ongoing cancer-related side effects, if any? 
 
Self-Management Support Acceptability – 20 mins 
 
Support can help people cope with cancer treatment side-effects and co-occurring conditions.  This 
pilot study explores whether a type of support, self-management support, may be usefully provided 
in the outpatient clinic setting.   
Read vignette. 
Here’s a specific example of self-management… John is feeling more unwell and is finding his 
usual jobs difficult to maintain.  He is the main breadwinner for his family.  The self-management 
person is part of the cancer team and talks to John privately, for just a short time, while he is in the 
day ward, about how he is going in fitting ‘cancer’ into everyday life at home.   Self-management 
support encourages individuals to discuss what is most important to them at the time with a view to 
dealing with practical concerns.  The coach reflects John’s concerns and discusses with him things 
other people have tried.  John and the self-management person collaboratively develop a plan that 
will work for him and his family or whānau.  A written care plan is provided to John.  It includes his 
goals.  It may be of use at the time and/or when treatment ends.  This may help John develop the 
confidence and skills to weave together what has happened in treatment with impacts at home and 
is an example of self-management. 
Do you think this type of program might be useful? Why? Why not? 
- What are your first impression views on self-management support provided during 
outpatient cancer treatment given that self-management support attempts to aid and inspire 
patients and caregivers to become better problem-solvers?  
 
Self-Management Support Feasibility – 10 mins 
 
Few studies identify the best time and place to provide support during a cancer journey.   
- In your opinion, when is the ideal time to provide support considering the ups and downs of 
cancer diagnosis and treatment?  Why? 
- Where would be the best place to intervene with the patient/whānau to provide support?   
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- How do you see these sessions taking place?  Who would provide the program? Who would 
be invited to participate, etc.?  
 
Closing – 10 mins 
 
Give a short summary (2 or 3 minutes) of the key questions and the big ideas that emerged from 
the discussion.  Tie the summary to the purpose of the focus group. Then ask: 
1. Is this an adequate summary? 
2. How well does that capture what was said here? 
3. Do you have any further comments? 
 
Kia ora and thank you for sharing your views with me.  Your input will help in the support of individuals 
and families/whānau affected by cancer in the future. 
 
If this discussion has brought up anything distressing for you please don’t be shy about contacting 
the Cancer Society Information Nurses on 0800 CANCER or your care coordinator or your doctor.  
We will be around to chat as well.  Help yourselves to refreshments and I will hand out some 
vouchers. 














Self-management Support in Cancer Care Pilot Study 
Stage One – Key Informant Interviews 
HEALTH PROFESSIONAL INFORMATION SHEET 
Thank you for showing an interest in this research.  Please read this information sheet carefully 
before deciding whether or not to participate.  If you decide to participate we thank you.  If you decide 
not to take part there will be no disadvantage to you of any kind and we thank you for considering 
our request.   
Who is doing this study?  
This study is being led by researchers at the University of Otago in Wellington. 
What are the aims of the study? 
Due to improvements in cancer screening and treatment, the cancer journey often lasts many years 
for survivors who routinely manage cancer-related side-effects and sometimes complex medication 
regimes.  Research is needed to identify and evaluate new supportive care approaches that can 
better enable individuals and families/whānau to work in partnership with health professionals during 
cancer treatment and survivorship. The proposed study evaluates an integrated model of care, 
borrowed from chronic care, and transplanted to the cancer treatment context, to support people 
experiencing health complexity to become better self-managers.  A three-phase approach will 
explore self-management and care planning support delivered during outpatient cancer treatment 
for New Zealanders affected by cancer.  During this first stage of the study, the researchers are 
interested in your views and experiences of cancer care, support and ways patients cope at home.  
The next stage of the study takes place in the outpatient clinic in Wellington piloting an intervention 
with people who are receiving cancer treatment. 
What does this Stage One study involve? 
You will be asked to participate in a 30-minute interview with a researcher which may be recorded 
and transcribed.  You do not have to answer all the questions, and you may stop the interview at 
any time.  We would also like to collect information on you including: your age, gender and ethnicity.  
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The name/s of all interviewees will be anonymysed for the report and your name will not be linked to 
any comments in reports of the research.  
Participation in this study is voluntary (your choice) and we appreciate your contribution pro bono 
(we cannot provide you with renumeration).  You may withdraw from participation in this project at 
any time.  If you withdraw, the information on you will not be used in the research.  
If you do participate the results of the project may be published but you will not be named and every 
effort will be made to ensure that you are not identified in any reported data. Information about your 
age, gender and ethnicity will be used to describe the people who participated in the research.  It will 
be used collectively and will in no way identify you as an individual.  Transcripts and audio recordings 
will be kept on password protected computers and in locked filing cabinets for ten years, at which 
time they will be destroyed by Dr Sarfati. You are most welcome to request a copy of the results of 
the project should you wish.   
 
Ethics Approval 
This study has received ethical approval from the Central Health and Disability Ethics Committee, 
which reviews regional studies, and has ethics reference number 12/CEN/12. 
 
If you have any questions about the research please contact:  
Inga O’Brien, Ph (04) 918 6549; University of Otago Wellington; email: 
obrin889@student.otago.ac.nz 
 
or Research Fellow Diana Sarfati, Ph (04) 918-6042 or (04) 918 6040; University of Otago, 
Wellington; email: Diana.sarfati@otago.ac.nz 
 
or Associate Professor Louise Signal, Ph (04) 918-6477 or Mobile 021 0324 720; University of 







Self-management Support in Cancer Care Pilot Study 
Stage One – Key Informant Interviews 
 
HEALTH PROFESSIONAL CONSENT FORM 
• I have read and understood the information sheet explaining this research.  
• I have had the opportunity to talk about the research and ask questions. I am satisfied with the 
answers I have been given.  
• I understand that my participation is voluntary and that I can withdraw from this research at any 
time.  
• I understand that I will not be named and that every effort will be made to ensure that I am not 
identified in any reported data. 
• I know whom to contact if I have any questions about this research. 
• I agree to take part in this research. Please circle the option that applies to you. 
   □ YES   □ NO 
• I agree to allow the interview with me to be recorded. Please circle the option that applies to 
you. 
   □ YES   □ NO 
If you have any queries or concerns regarding your rights as a participant in this study, you may 
wish to contact an independent health and disability advocate: 
Free phone: 0800 555 050 
Free fax: 0800 2 SUPPORT (0800 2787 7678) 
Email: advocacy@hdc.org.nz 
I ________________________________________hereby consent to take part in this study 
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  (First Name/Surname) 
Signature:____________________________________ Date: _______________________ 
Project explained by: _____________ Initials: ______ Date: _______________________ 
Note:  Copies of consent forms will be given to you.  
 
PARTICIPANT DEMOGRAPHIC INFORMATION  
We would like to collect a few details for statistical purposes.  This information will assist us 
describe the group of people who took part.  No individual names will be used in any reports.   
1. Are you:   □ Male   □ Female  
 
2. When were you born? 
Day _________ Month ____________________ Year you were born __________ 
 
3. Which ethnic group do you belong to? (tick the box or boxes that apply to you) 
⁭□ New Zealand European 
⁭□Māori 
⁭□ Samoan 
⁭□ Cook Island Māori 
⁭□ Tongan 
⁭□ Niuean 
⁭□ Chinese  
⁭□ Indian 
⁭□ Other (such as Dutch, Japanese, Tokelauan)  
 





• I would like to receive a summary of the findings of the Stage One research.  Please circle the 
option that applies to you. 
   □ YES   □ NO 
• I would like a copy of the final findings of the research to be sent to me after the research is 
completed in 2014.  Please circle the option that applies to you. 
   □ YES   □ NO 




  _______________________________________________________ 
Email: ____________________________________ 
Signature: ____________________________________Date: ______________ 
 
Thank you 
This research is being led by researchers from the University of Otago-Wellington. 
If you have any questions about the research please contact:  
Inga O’Brien, Ph (04) 918 6549; University of Otago Wellington; email: 
obrin889@student.otago.ac.nz 
or Research Fellow Diana Sarfati, Ph (04) 918-6042; University of Otago, Wellington; email: 
Diana.sarfati@otago.ac.nz 
or Associate Professor Louise Signal, Ph (04) 918-6477, Mobile 021 0324 720 University of Otago, 




Appendix F: Discussion guide for key informant interviews 
 
Introduce self.  Give overview of the project. Outline process (topics to be discussed) and inform P 
[Participant] of rights (confidentiality, right to refuse to answer questions etc). Give P opportunity to 
ask any questions. Thank P for agreeing to take part. 
 
Ice breaker - 10 mins (including intro above)  
 
This PhD research evaluates a support program that may be practically useful for people coping with 
cancer treatment side-effects and other long-term conditions now and into the future.   
- What is your experience of cancer as a long-term condition?   
- Do you find many people have other health issues to deal with in addition to cancer? 
- How do you work with people to manage these complex health stresses? 
- What kinds of things have your found helped people to cope with these health stresses? 
Self-Management Support Acceptability – 10 mins 
 
Supportive care helps people cope with cancer treatment side-effects and co-occurring conditions.  
This pilot study explores whether a type of supportive care, self-management support, may be 
usefully provided in the outpatient clinic setting.  Self-management describes how people manage 
and make sense of their lives, in the context of physical, environmental, spiritual and social 
influences.  However, self-management support encourages individuals to discuss what is most 
important to them at this time, promotes collaborative  problem-solving and decision-making, 
considers an array of possible actions in the face of the reality of changing life circumstances, and 
attempts to motivate individuals and whānau to take action to reach their own self-determined 
goals.  
- What is your experience of supportive care? 
- What are your first impression views on self-management support provided during 
outpatient cancer treatment given that self-management support attempts to aid and inspire 
patients and caregivers to become better problem-solvers?  
- What would you want to know in order to measure the acceptability of a self-management 
support programme? 
Self-Management Support Feasibility – 10 mins 
 
Few studies identify the best time and place to provide support during a cancer journey.   
- In your opinion, when is the ideal time to provide supportive care considering the ups and 
downs of cancer diagnosis and treatment?  Why? 
- Where would be the best place to intervene with the patient/whānau to provide supportive 
care?   




Self-Management Support Utility – 10 mins 
It is important to evaluate tools and approaches for working in partnership from the perpective of 
both the patient and clinician. 
- Given your role, what and how would you like to see the outcomes of a supportive care 
intervention measured? 
Closing – 5 mins 
I just want to ask one more question 
 
If you were in charge, what would you do to incorporate more support into cancer care? Thank 






Appendix G: Thematic development 
 
  
Conceptual Framework (Index) for study 
of self-management support during 
cancer care 
    
    Frame      
1 Personal details   4 Supportive care 
1.1 Demographic   4.1 Bridges  
1.2 Cancer journey   4.2 Cultural relevance 




  4.4 Organisations  
1.5 Employment   4.5 Roles  
1.6 Health    4.6 Timing  
1.7 Other    4.7 Location  
1.8 Recurrence   4.8 What works  




2 Cancer as a life-changing experience      
2.1 Crisis  Emotion  5 
Expectations of healthcare 
practitioners 
2.2 Treatment Physical  5.1 Cancer care  
2.3 Side-effects Physical  5.2 Information  
2.4 Chronic impacts Physical  5.3 Empathy  
2.5 "getting through" Physical  5.4 Building relationships 
2.6 Coping  Emotion  5.5 Holistic care  
2.7 
Hard to ask for 
help 
Social  5.6 Values consideration 
2.8 Scared  Emotion   5.7 Distrust of HCP and system 
2.9 Identity  Spiritual  5.8 Discharge planning 
          
3 Concerns/worries outside of treatment  6 Recovery  
3.1 Family/Whanau Social  6.1 Normality 
Survivorship 
work 






Physical  6.3 Ongoing care 
Survivorship 
work 





3.5 Financial  Social  7 Self-management support 
3.6 Work roles Social  7.1 Knowledge about 
3.7 Life roles Social  7.2 Views about  
3.8 Mana  Spiritual  7.3 Acceptability  
3.9 Home  Physical  7.4 5 core skills 
resource 
utilisation 
      7.4.1  
healthcare 
partnerships 
      7.4.2  
taking action in 
order to manage 
health 
complexity 
      7.4.3  
collaborative 
decision-making 
      7.4.4  problem-solving 
      7.4.5   
          
     8 
Other key issues (not covered 
above) 
     8.1 co-morbidity  
     8.2 people on their own 
     8.3 Travel for treatment 





























Appendix J: Authorisation to release information for research 
study purposes 
 
There is a study being run to support individuals and families/whānau affected by cancer 
to better cope at home during treatment and recovery.  The study leader can discuss the 
study with you at hospital, by phone or at your next appointment if you wish to know more.  
If you do wish for me to ask her to call you in a few days or meet with you, written consent 
is required.  
Consent to Release Information for Research Study Recruitment 
I ________________________________________ 
(Patient’s Full Name)  
Authorise _____________________________________ 
(Referring Clinician’s Name) 
To give my name, contact details and study eligibility information to Inga O’Brien (PhD 
Candidate/Researcher) for the purposes of giving me more information about the 
University of Otago, Wellington- based research study called: Self-management support in 
cancer care pilot study. 
I give my consent to release my name, contact details and study eligibility information 
knowing that: 
• I do not have to sign this consent.  If I do not sign it, it will not affect my treatment and 
my information will not be released for research. 
• I can cancel this authorisation any time in writing. However, if I cancel it, the researcher 
may already have been given the information but they will not use it in the future. 
• This research conforms to the New Zealand Privacy Act. 
 
_____________________________________________ 




Note:  The researcher will need to meet with patient at the time of the surgical follow-up 
appointment and two other times. 
Name of person completing this form:  
Eligible for study: □  Confirmed diagnosis of COLORECTAL 
CANCER       
Has the patient agreed to be 
contacted by the researcher? 
□  Yes, please complete Section B.       
□  No, please complete Section C.  
B. Participant Details:  
First Name:  Surname:  
Preferred name:                                                  Ethnicity: 
Sex: M / F  Comorbidities:   
□  Heart disease        
□  Diabetes 
□  Other (specify) 
_______________ 
Preferred contact: 
□  At hospital 
□  By phone 
Contact phone number:__________________       
□  In person at next appointment 
Next appointment scheduled for____________ 
 
C. Decliner Details: To help us know if we’re missing a particular group of people, it would 
be helpful to have age, sex & ethnicity recorded, if the person is happy with this. 
Age:  Sex: M / F           Ethnicity:   
     
Reason for declining (if given): 
 
 







Appendix K: Baseline and follow-up assessment forms 
SF12v2 
These questions ask for your views on how you are feeling now and how well you are able 
to do your usual activities.  Answer every question by ticking or filling in one of the 
answers. If you are unsure about how to answer a question, please give the best answer 
you can.  
 
  
1. In general, would you say your health is: 
 
 Excellent Very good Good Fair Poor 
      
 
 
2. The following questions are about activities you might do during a typical day. Does 














a Moderate activities, such as moving a table, pushing a 




b Climbing several flights of stairs 
   
 
 
3. During the past 4 weeks, how much of the time have you had any of the following 






















a Accomplished less than you would like 




b Were limited in the kind of work or other 






4. During the past 4 weeks, how much of the time have you had any of the following 
problems with your work or other regular daily activities as a result of any emotional 




















a Accomplished less than you would like 




b Did work or activities less carefully than 




5. During the past 4 weeks, how much did pain interfere with your normal work 
(including both work outside the home and housework)? 
 Not at all A little bit Moderately Quite a bit Extremely 
      
 
 
6. These questions are about how you feel and how things have been with you during 
the past 4 weeks. For each question, please give the one answer that comes closest to 
the way you have been feeling. 
 





















a Have you felt calm and peaceful? 
     
 
 
b Did you have a lot of energy? 
     
 
 
c Have you felt downhearted and 
depressed?      
 
 
7. During the past 4 weeks, how much of the time has your physical health or emotional 
problems interfered with your social activities (like visiting friends, relatives, etc.)? 
 
All 
of the time 
Most 
of the time 
Some 
of the time 
A little 
of the time 
None 
of the time 





Resilience & Activation Scales 
 
Here are some statements that people sometimes make when they talk about their health.  Please 
indicate how true they are for you for the first two and how much you agree or disagree with each 
statement for the remaining ones after the first two.  Your answers should be what is true for you and 
not just what you think anyone around here wants you to say. 






















If any of the next statements do not apply to you, circle N/A.   
1. When all is said and done, I am the person 




Disagree Agree Agree 
Strongly 
N/A 
2. Taking an active role in my own health care is 




Disagree Agree Agree 
Strongly 
N/A 
3. I am confident I can help prevent or reduce 
problems associated with my health 
Disagree 
Strongly 
Disagree Agree Agree 
Strongly 
N/A 




Disagree Agree Agree 
Strongly 
N/A 
5. I am confident that I can tell whether I need to 
go to the doctor or whether I can take care of 
a health problem myself. 
Disagree 
Strongly 
Disagree Agree Agree 
Strongly 
N/A 
6. I am confident that I can tell a doctor 




Disagree Agree Agree 
Strongly 
N/A 
7. I am confident that I can follow through on 




Disagree Agree Agree 
Strongly 
N/A 




Disagree Agree Agree 
Strongly 
N/A 
9. I know what treatments are available for my 
health problems  
Disagree 
Strongly 
Disagree Agree Agree 
Strongly 
N/A 
10. I have been able to maintain (keep up with) 




Disagree Agree Agree 
Strongly 
N/A 




Disagree Agree Agree 
Strongly 
N/A 
12. I am confident I can figure out solutions when 
new problems arise with my health. 
Disagree 
Strongly 
Disagree Agree Agree 
Strongly 
N/A 
13. I am confident that I can maintain lifestyle 
changes, like eating right and exercising, 
even during times of stress. 
Disagree 
Strongly 





Self-Efficacy for Managing Chronic Disease 6-Item Scale 
These next 6 questions are also about how confident you are in doing certain activities.  
I would like to know how confident you feel in doing these specific activities as indicated by 
your choice of a number 1 - 10 that corresponds to your confidence that you can do the 
tasks regularly at the present time. 
1. How confident are you that you can keep the fatigue caused by your disease from 
interfering with the things you want to do?    
1 2 3 4 5 6 7 8 9 10 
Not at all confident     Totally confident 
2. How confident are you that you can keep the physical discomfort or pain of your disease from 
interfering with the things you want to do?  
1 2 3 4 5 6 7 8 9 10 
Not at all confident     Totally confident 
3. How confident are you that you can keep the emotional distress caused by your disease from 
interfering with the things you want to do?  
1 2 3 4 5 6 7 8 9 10 
Not at all confident     Totally confident 
4. How confident are you that you can keep any other symptoms or health problems you have from 
interfering with the things you want to do?  
  1 2 3 4 5 6 7 8 9 10 
Not at all confident     Totally confident 
5. How confident are you that you can do the different tasks and activities needed to manage your 
health condition so as to reduce your need to see a doctor?  
1 2 3 4 5 6 7 8 9 10 
Not at all confident     Totally confident 
6. How confident are you that you can do things other than just taking medication to reduce how 
much you illness affects your everyday life?  
1 2 3 4 5 6 7 8 9 10 
Not at all confident     Totally confident 
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Open-ended questions – please record answers using 
an audio recorder or legible written responses 
 
1.  What are the main things you do now to support your 





2. If you could change one thing about managing life during 





3. What support programmes, if any, have been or would be 






4. Any extra information you can provide about how to make 
cancer care better is very useful, is there anything else 
you want to share about your experience or that of others 











Appendix L: Additional follow-up assessment components 
For Intervention Group ONLY – Acceptability of intervention  
Please circle a response to indicate how much you agree or disagree with the following 
statements. 
1. I am satisfied with the self-
management program sessions. 
Disagree 
Strongly 
Disagree Agree Agree 
Strongly 
N/A 
2. I found the sessions helpful. Disagree 
Strongly 
Disagree Agree Agree 
Strongly 
N/A 
3. The sessions were long enough. Disagree 
Strongly 
Disagree Agree Agree 
Strongly 
N/A 
4. There were enough sessions. Disagree 
Strongly 
Disagree Agree Agree 
Strongly 
N/A 
5. I felt the study was delivered by 
someone who was interested in me 
as a person. 
Disagree 
Strongly 
Disagree Agree Agree 
Strongly 
N/A 
6. I was able to make useful changes 
with the help of the sessions. 
Disagree 
Strongly 
Disagree Agree Agree 
Strongly 
N/A 
7. The changes have improved the way 
I am feeling.  
Disagree 
Strongly 
Disagree Agree Agree 
Strongly 
N/A 
8. I am confident that these changes 
will be lasting. 
Disagree 
Strongly 
Disagree Agree Agree 
Strongly 
N/A 
9. I would recommend these sessions 
to a friend.  
Disagree 
Strongly 












































Appendix M: Calculated scores on outcome measures by participant 
 
Partners in Health 
Scale (PIH) 










Baseline Follow-up Baseline Follow-up Baseline Follow-up Baseline Follow-up Baseline Follow-up 
Intervention 6.9 6.4 5 5 43.4 68.5 5.3 5.2 1 5 
Intervention 7.5 6.7 8 8 86.3 75.3 8.7 7.3 3 1 
Intervention 7.2 5.2 5 3 80 40.1 6.8 3.5 2 5 
Intervention 3.2 5.2 6 6 56.4 56.4 7 7 1 1 
Intervention 7.2 6.2 6 5 40.1 47.4 5.5 4.2 8 3 
Intervention 4.2 6.3 8 7 47.4 68.5 8.3 6.5 5 2 
Intervention 6.2 6.7 8 7 70.8 91.6 3.3 8.3 2 8 
Intervention 6.8 6.5 5 6 60 56.4 6.8 6.8 5 4 
Intervention 7.5 7.7 8 8 56.4 77.5 10 9 0 0 
Intervention 7 7 8 0 45.2 45.2 8.5 8.5 2 0 
Intervention 4.5 6.8 3 4 40.1 60 4.8 3.5 9 3 
Intervention 6.7 6.7 8 6 70.8 63.2 7.3 6 3 6 
Intervention 7.8 7.8 8 8 80 80 5.5 8 0 0 
Intervention 4 6.2 4 4 60 68.5 6.5 6.5 0 0 
Control 7.2 7.2 8 8 68.5 68.5 8.8 9 2 3 
Control 6.5 7.8 8 8 68.5 68.5 8.2 10 0 0 
Control 7.5 7.1 7 8 68.5 66 7 8 0 0 
Control 7.7 7.9 8 8 82.8 100 7.5 9.3 0 0 
Control 6.58 7.9 8 8 70.8 100 6 9.7 8 2 
Control 6.7 6.9 5 7 56.4 75.3 7.2 7.2 4 2 








Partners in Health 
Scale (PIH) 










Baseline Follow-up Baseline Follow-up Baseline Follow-up Baseline Follow-up Baseline Follow-up 
Control 6.9 6.9 6 8 56.4 70.8 8.2 8.8 0 1 
Control 6.6 7.5 6 6 52.9 68.5 6 9.3 2 0 
Control 7 6.8 6 7 56.4 45.2 8.5 7.3 5 8 
Control 7.6 7.4 8 7 56.4 75.3 8 9 1 1 
Control 4.9 4.5 4 4 63.2 63.2 7 7 1 1 
Control 6.8 6.8 8 8 52.9 56.4 8 8 0 0 
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Appendix N: Example Flinders Care Plan 
Date: 29/8/2013                Flinders Care Plan & Health Summary                Review Due 1/11/2013 
Personal Details  
Title: Surname: First Names: Date of Birth:    Age: 68 
Address :  Gender: M 
Phone: Mobile:  Occupation:  NHI: 
Doctor:  
Dr X - Oncology 
Phone: Preferred language:  
The key people (family/whānau/carers) I want included in my care plan are:  
Family and work colleagues 
 
I have problems with: 
  My hearing  
 Understanding English 
  Reading/writing 
 
  My vision 
  Mobility 
  Understanding 
numbers 
What motivates me and how I learn best: Reading 
Advanced Care Plan/ Power of Attorney / appointed? [please specify]  
Yes    No   N/A  If yes, provide details: 
Diagnoses & Active Problem List  
1. Colorectal cancer T3 N2 M0 3.  5.  
2. Hypertension 4.  6.  
Allergies (or Nil Known) 
1.  3.  5.  
2.  4.  6.   
Hospital Admissions / After Hour Clinics & ED Visits / Procedures 
Date Hospital or Clinic Reason Notes 
July 2011 Wellington Hospital Hernia repair  
July 2013 Wellington Hospital Colorectal surgery  

















M L D N 
Simvastin 10mg Cholesterol   X  GP    
Cardizem 180mg Heart/BP   X  GP    
Accupril 20mg Blood 
pressure 
  X  GP    
Loperamide  Diarrhoea     Hospital    
Furosemide 40mg Fluid 
retention 
  X  GP    
Gastrosoothe 10mg Abdominal 
spasms 
  X  Hospital    
Healthcare Team & Planned Visits/ Services for next 12 months       From  ____/____/____       To  ____/____/____ 





Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 
GP 
          X X X   
Practice Nurse               
Specialist - 
Oncology 







Client /Patient Problem Statement:  
Side-effects, associated with cancer treatment, means I’m less productive than I used to be which makes me frustrated and angry. 
         How much of a problem is this for me?                         
          0       1       2        3       4       5       6        7        8      
             Not              Very little       Somewhat           A fair                  A lot      
            at all                                                                      bit 
Client/Patient Goal Statement: 
In 2014, I will work to build my stamina in order to be able to address my productivity and work/life balance so I can indulge my 
interests and relax at times with things in order. 
          My progress towards achieving this goal 
    0       1        2       3       4       5       6        7       8      
              No success               25%                    50%                  75%                   
Complete  







(What I want to achieve)  
Interventions 
(Steps to Get There) 
Who is 
Responsible? 
Date to be 
reviewed 
Progress 




Main priorities – Work 
 





Watch Dr Mike’s youtube link on cancer-related fatigue 
(worksheet provided) 
Exercise – mowing lawn, walks with pets 
 
 




Second priority – Family & 
Friends 
 




Plan an after cancer ‘new-normal’ celebration meal 
 








Third priority – Be the 
best you, you can be! 
Get back into life Try something new.  Rediscover an old interest. Volunteer 
your skills for a good cause. 
 
Carry on exploring authenticity and vulnerability. 




Referral to Cancer 
Society 
 
Fourth priority -  Getting 
house fixed up 
 
Have a list of jobs Do something, even if you do not feel like it.  Go slow, try to 
plan to do a small amount per day or week and build up to 
usual routine  




Plan, prioritise and pace  
day-to-day activities during active 
treatment 
 
Do things you love to gain 
confidence 
Pay attention to my symptoms and early warning signs (if 
treatment-related – contact cancer clinic) 
 
 
Be curious. Catch sight of the beauty around you. 
Be grateful. This helps to remind what matters most 










‘stack the odds in your favour’ 
Schedule visit with GP in 2014 to update him in person on 







Identify my new normal 
(CancerConnect - 0800 CANCER) 
The Cancer Society can put you in phone contact with 
another guy who has a similar experience of cancer, if you 
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O’Brien IM, Sarfati D & Signal L. Supported self-management as a survivorship 
intervention: A phase I/II study with patients receiving colorectal cancer treatment in New 
Zealand. In MASCC Annual Scientific Meeting. Adelaide, Australia: June 2016 
O’Brien IM. Cancer survivorship: Survivorship care pathways are needed in Aotearoa New 
Zealand. Cancernet, April 2016, pp. 5-6. Available from: http://www.nzno.org.nz/ 
Portals/0/Files/Documents/Groups/Cancer%20Nurses/Cancernet%20April%202016-3.pdf 
O’Brien IM. Hospital-based supported self-management intervention for colorectal cancer 
survivors: Acceptability and feasibility in New Zealand. In 2015 FCIC Survivorship 
conference. Adelaide, Australia: February 2015 
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O’Brien IM, Sarfati D, Signal L, Bycroft J, Lawn S and Koczwara B. Self-management of 
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